<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PATDOC SYSTEM "ST32-US-Grant-025xml.dtd" [
<!ENTITY US06467521-20021022-M00001.NB SYSTEM "US06467521-20021022-M00001.NB" NDATA NB>
<!ENTITY US06467521-20021022-M00001.TIF SYSTEM "US06467521-20021022-M00001.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-M00002.NB SYSTEM "US06467521-20021022-M00002.NB" NDATA NB>
<!ENTITY US06467521-20021022-M00002.TIF SYSTEM "US06467521-20021022-M00002.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-M00003.NB SYSTEM "US06467521-20021022-M00003.NB" NDATA NB>
<!ENTITY US06467521-20021022-M00003.TIF SYSTEM "US06467521-20021022-M00003.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-M00004.NB SYSTEM "US06467521-20021022-M00004.NB" NDATA NB>
<!ENTITY US06467521-20021022-M00004.TIF SYSTEM "US06467521-20021022-M00004.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-M00005.NB SYSTEM "US06467521-20021022-M00005.NB" NDATA NB>
<!ENTITY US06467521-20021022-M00005.TIF SYSTEM "US06467521-20021022-M00005.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-M00006.NB SYSTEM "US06467521-20021022-M00006.NB" NDATA NB>
<!ENTITY US06467521-20021022-M00006.TIF SYSTEM "US06467521-20021022-M00006.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-M00007.NB SYSTEM "US06467521-20021022-M00007.NB" NDATA NB>
<!ENTITY US06467521-20021022-M00007.TIF SYSTEM "US06467521-20021022-M00007.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-M00008.NB SYSTEM "US06467521-20021022-M00008.NB" NDATA NB>
<!ENTITY US06467521-20021022-M00008.TIF SYSTEM "US06467521-20021022-M00008.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-D00000.TIF SYSTEM "US06467521-20021022-D00000.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-D00001.TIF SYSTEM "US06467521-20021022-D00001.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-D00002.TIF SYSTEM "US06467521-20021022-D00002.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-D00003.TIF SYSTEM "US06467521-20021022-D00003.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-D00004.TIF SYSTEM "US06467521-20021022-D00004.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-D00005.TIF SYSTEM "US06467521-20021022-D00005.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-D00006.TIF SYSTEM "US06467521-20021022-D00006.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-D00007.TIF SYSTEM "US06467521-20021022-D00007.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-D00008.TIF SYSTEM "US06467521-20021022-D00008.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-D00009.TIF SYSTEM "US06467521-20021022-D00009.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-D00010.TIF SYSTEM "US06467521-20021022-D00010.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-D00011.TIF SYSTEM "US06467521-20021022-D00011.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-D00012.TIF SYSTEM "US06467521-20021022-D00012.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-D00013.TIF SYSTEM "US06467521-20021022-D00013.TIF" NDATA TIF>
<!ENTITY US06467521-20021022-D00014.TIF SYSTEM "US06467521-20021022-D00014.TIF" NDATA TIF>
]>
<PATDOC DTD="2.5" STATUS="Build 20020918">
<SDOBI>
<B100>
<B110><DNUM><PDAT>06467521</PDAT></DNUM></B110>
<B130><PDAT>B1</PDAT></B130>
<B140><DATE><PDAT>20021022</PDAT></DATE></B140>
<B190><PDAT>US</PDAT></B190>
</B100>
<B200>
<B210><DNUM><PDAT>09520590</PDAT></DNUM></B210>
<B211US><PDAT>09</PDAT></B211US>
<B220><DATE><PDAT>20000308</PDAT></DATE></B220>
</B200>
<B500>
<B510>
<B511><PDAT>B32B  502</PDAT></B511>
<B512><PDAT>B32B 3106</PDAT></B512>
<B512><PDAT>B32B 3108</PDAT></B512>
<B516><PDAT>7</PDAT></B516>
</B510>
<B520>
<B521><PDAT>156351</PDAT></B521>
<B522><PDAT>156361</PDAT></B522>
<B522><PDAT>156440</PDAT></B522>
</B520>
<B540><STEXT><PDAT>Apparatus for making damped composite structures with fiber wave patterns</PDAT></STEXT></B540>
<B560>
<B561>
<PCIT>
<DOC><DNUM><PDAT>1800179</PDAT></DNUM>
<DATE><PDAT>19310400</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Darrow</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>3361616</PDAT></DNUM>
<DATE><PDAT>19680100</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Scharf</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>3937559</PDAT></DNUM>
<DATE><PDAT>19760200</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Ferrentino et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4028081</PDAT></DNUM>
<DATE><PDAT>19770600</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Marcatili</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT> 65  2</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4084029</PDAT></DNUM>
<DATE><PDAT>19780400</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Johnson et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4111733</PDAT></DNUM>
<DATE><PDAT>19780900</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Periers</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>156204</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4140827</PDAT></DNUM>
<DATE><PDAT>19790200</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Willwerth et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>428151</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4734146</PDAT></DNUM>
<DATE><PDAT>19880300</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Halcomb et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4942080</PDAT></DNUM>
<DATE><PDAT>19900700</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Heuel et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4971846</PDAT></DNUM>
<DATE><PDAT>19901100</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Lundy</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5009732</PDAT></DNUM>
<DATE><PDAT>19910400</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Ikeda et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5108802</PDAT></DNUM>
<DATE><PDAT>19920400</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Sattinger</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5203435</PDAT></DNUM>
<DATE><PDAT>19930400</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Dolgin</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5335463</PDAT></DNUM>
<DATE><PDAT>19940800</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Reinhall</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5788804</PDAT></DNUM>
<DATE><PDAT>19980800</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Horsting</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5863368</PDAT></DNUM>
<DATE><PDAT>19990100</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Perrin</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>0 133 340</PDAT></DNUM>
<DATE><PDAT>19850200</PDAT></DATE>
<CTRY><PDAT>EP</PDAT></CTRY>
</DOC>
</PCIT>
<CITED-BY-OTHER/>
</B561>
<B562><NCIT><STEXT><PDAT>Trego et al., &ldquo;Reduced Boring Bar Vibrations Using Damped Composite Structures&rdquo; </PDAT><HIL><ITALIC><PDAT>Design Engineering Technical Conferences </PDAT></ITALIC></HIL><PDAT>vol. 3 Part A pp. 305-311 (1995). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Trego et al., &ldquo;Optimization of Passively Damped Composite Structures&rdquo; </PDAT><HIL><ITALIC><PDAT>International Journal of Modeling and Simulation </PDAT></ITALIC></HIL><PDAT>17:No.4:284-287 (1997). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Trego et al., &ldquo;Improved Axial Damping of Mechanical Elements Through the Use of Multiple Layered, Stress Coupled, Co-Cured Damped Fiber Reinforced Composited&rdquo; </PDAT><HIL><ITALIC><PDAT>Journal of Advanced Materials </PDAT></ITALIC></HIL><PDAT>pp. 28-34 (1977). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Composite Struts Would Damp Vibrations </PDAT><HIL><ITALIC><PDAT>NASA </PDAT></ITALIC></HIL><PDAT>XP 000264118 15:718 (1991).</PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
</B560>
<B570>
<B577><PDAT>5</PDAT></B577>
<B578US><PDAT>1</PDAT></B578US>
</B570>
<B580>
<B582><PDAT>156439</PDAT></B582>
<B582><PDAT>156440</PDAT></B582>
<B582><PDAT>156177</PDAT></B582>
<B582><PDAT>156350</PDAT></B582>
<B582><PDAT>156351</PDAT></B582>
<B582><PDAT>156361</PDAT></B582>
</B580>
<B590><B595><PDAT>14</PDAT></B595><B596><PDAT>15</PDAT></B596><B597US/>
</B590>
</B500>
<B600>
<B620><PARENT-US><CDOC><DOC><DNUM><PDAT>09/520590</PDAT></DNUM></DOC></CDOC><PDOC><DOC><DNUM><PDAT>08/970141</PDAT></DNUM><DATE><PDAT>19971114</PDAT></DATE><CTRY><PDAT>US</PDAT></CTRY><KIND><PDAT>00</PDAT></KIND></DOC></PDOC><PSTA><PDAT>01</PDAT></PSTA><PPUB><DOC><DNUM><PDAT>6048426</PDAT></DNUM><CTRY><PDAT>US</PDAT></CTRY><KIND><PDAT>A </PDAT></KIND></DOC></PPUB></PARENT-US></B620>
<B680US><DOC><DNUM><PDAT>60/030989</PDAT></DNUM><DATE><PDAT>19961115</PDAT></DATE><KIND><PDAT>00</PDAT></KIND></DOC></B680US>
</B600>
<B700>
<B720>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>William Fossum</PDAT></FNM><SNM><STEXT><PDAT>Pratt</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Pleasant Grove</PDAT></CITY>
<STATE><PDAT>UT</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
</B720>
<B730>
<B731>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Brigham Young University</PDAT></STEXT></ONM></NAM>
<ADR><CITY><PDAT>Provo</PDAT></CITY><STATE><PDAT>UT</PDAT></STATE></ADR>
</PARTY-US>
</B731>
<B732US>
<PDAT>02</PDAT>
</B732US>
</B730>
<B740>
<B741>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Foley &amp; Lardner</PDAT></STEXT></ONM></NAM>
</PARTY-US>
</B741>
</B740>
<B745>
<B746>
<PARTY-US>
<NAM><FNM><PDAT>Sam Chuan</PDAT></FNM><SNM><STEXT><PDAT>Yao</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B746>
<B748US><PDAT>1733</PDAT></B748US>
</B745>
</B700>
</SDOBI>
<SDOAB>
<BTEXT>
<PARA ID="P-00001" LVL="0"><PTEXT><PDAT>A method and apparatus of manufacturing a composite material which is light weight and highly damped against vibration. The composite material comprises fibers embedded in a resin matrix wherein the fibers are oriented in a waveform that is substantially continuously variable as to period, amplitude and/or shape. A viscoelastic material is combined with the resin matrix to provide vibration dampening characteristics. The variation in the period/amplitude takes place in a region of the composite structure which is selected to provide optimum strength and dampening characteristics as desired for the particular application. Even without the viscoelastic material, the light weight structure is useful as a pre-preg material from which other composite structures may be formed. Methods of manufacturing the composite material include using multiple, identical cells in which each cell is used to fabricate a fiber, resin matrix and viscoelastic adhesive composite. Rollers, sprays or perforated roller techniques may be employed to lay down the various layers. During the fabrication process, plural pairs of pinch rollers, moving axially with respect to each other are used to lay down the fibers within the resin/viscoelastic composite in a waveform pattern having a variable and controllable period, amplitude and/or shape.</PDAT></PTEXT></PARA>
</BTEXT>
</SDOAB>
<SDODE>
<RELAPP>
<BTEXT>
<H LVL="1"><STEXT><PDAT>CROSS-REFERENCES TO RELATED APPLICATIONS</PDAT></STEXT></H>
<PARA ID="P-00002" LVL="0"><PTEXT><PDAT>This application is a divisional of U.S. patent application Ser. No. 08/970,141, filed Nov. 14, 1997 now U.S. Pat. No. 6,048,426.</PDAT></PTEXT></PARA>
<PARA ID="P-00003" LVL="0"><PTEXT><PDAT>This application claims the benefit of U.S. Provisional Application No. 60/030,989, filed Nov. 15, 1996. The whole of related PCT Publication WO 93/08023, published Apr. 29, 1993, is incorporated herein by reference.</PDAT></PTEXT></PARA>
</BTEXT>
</RELAPP>
<GOVINT>
<BTEXT>
<H LVL="1"><STEXT><PDAT>STATEMENT OF U.S. GOVERNMENT INTEREST</PDAT></STEXT></H>
<PARA ID="P-00004" LVL="0"><PTEXT><PDAT>This invention was made with Government support under grant No. DMI-9413808 awarded by the National Science Foundation. The Government has certain rights in this invention.</PDAT></PTEXT></PARA>
</BTEXT>
</GOVINT>
<BRFSUM>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BACKGROUND OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00005" LVL="0"><PTEXT><PDAT>1. Field of the Invention</PDAT></PTEXT></PARA>
<PARA ID="P-00006" LVL="0"><PTEXT><PDAT>The control of vibrations in composite structures is an important area of research in aerospace, automotive and other industries. For example, spacecraft vibrations initiated by attitude adjusting thrusters, motors and thermally induced stresses inhibit accurate aiming of antennas and other equipment carried by the craft. Such vibrations can cause severe damage to the craft and its associated equipment. Fatigue failure of structural components can occur at stresses well below static load limits.</PDAT></PTEXT></PARA>
<PARA ID="P-00007" LVL="0"><PTEXT><PDAT>Composite materials have been used to construct a wide variety of structural elements, including tubes, enclosures, beams, plates and irregular shapes. Objects as diverse as rocket motor housings and sporting goods, notably skis, archery arrows, vaulting poles and tennis rackets have been structured from composite materials. While composite constructions have offered many significant advantages, such as excellent strength and stiffness properties, together with light weight, the poor vibration damping properties of such constructions have been of concern.</PDAT></PTEXT></PARA>
<PARA ID="P-00008" LVL="0"><PTEXT><PDAT>The invention relates to composite material structures having increased damping with little or no sacrifice of structural stiffness or strength.</PDAT></PTEXT></PARA>
<PARA ID="P-00009" LVL="0"><PTEXT><PDAT>The invention also relates to the methods and apparatus for manufacturing the aforementioned composite material structures.</PDAT></PTEXT></PARA>
<PARA ID="P-00010" LVL="0"><PTEXT><PDAT>Another aspect of the invention is directed toward the fabrication of a wavy fiber pregreg (fibers preimpregnated with epoxy resin). Such prepregs not only have an aesthetic appeal but also may be fabricated with selected variable volume fractions to accommodate a variety of applications.</PDAT></PTEXT></PARA>
<PARA ID="P-00011" LVL="0"><PTEXT><PDAT>2. Description of Related Art</PDAT></PTEXT></PARA>
<PARA ID="P-00012" LVL="0"><PTEXT><PDAT>The following terms used herein will be understood to have their ordinary dictionary meaning as follows:</PDAT></PTEXT></PARA>
<PARA ID="P-00013" LVL="1"><PTEXT><PDAT>Fiber: a thread or a structure or object resembling a thread. a slender and greatly elongated natural or synthetic filament. (This definition includes metal fibers).</PDAT></PTEXT></PARA>
<PARA ID="P-00014" LVL="1"><PTEXT><PDAT>Matrix: material in which something is enclosed or embedded.</PDAT></PTEXT></PARA>
<PARA ID="P-00015" LVL="1"><PTEXT><PDAT>Viscoelastic: having appreciable and conjoint viscous and elastic properties.</PDAT></PTEXT></PARA>
<PARA ID="P-00016" LVL="1"><PTEXT><PDAT>Lamina(e) a thin plate . . . : LAYER</PDAT></PTEXT></PARA>
<PARA ID="P-00017" LVL="1"><PTEXT><PDAT>Composite: made up of distinct parts.</PDAT></PTEXT></PARA>
<PARA ID="P-00018" LVL="0"><PTEXT><PDAT>It may be further helpful to note the definitions of G</PDAT><HIL><SP><PDAT>0 </PDAT></SP></HIL><PDAT>and G</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>geometric continuity. &ldquo;If two curve segments join together, the curve has G</PDAT><HIL><SP><PDAT>0 </PDAT></SP></HIL><PDAT>geometric continuity. If the directions (but not necessarily the magnitudes) of the two segments&apos; tangent vectors are equal at a join point, the curve has G</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>geometric continuity. G</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>continuity means that the geometric slopes of the segments are equal at the join point.&rdquo; Foley et al. </PDAT><HIL><ITALIC><PDAT>Computer Graphics Principles and Practice</PDAT></ITALIC></HIL><PDAT>, Addison-Wesley, 1996, p. 480.</PDAT></PTEXT></PARA>
<PARA ID="P-00019" LVL="0"><PTEXT><PDAT>The article &ldquo;Understanding Vibration Measurements,&rdquo; George F. Lang, Sound and Vibration, March, 1976, p. 26, presents a generally accepted mathematical treatment of the vibration of mechanical structures under environmental loading. This treatment applies generally to composite structures, and is incorporated by reference for purposes of this disclosure for its explanation of the amplification factor Q and its relationship to the viscous damping factor &zgr;. The &ldquo;loss ratio&rdquo; referred to in this disclosure is twice the viscous damping factor as defined by Lang.</PDAT></PTEXT></PARA>
<PARA ID="P-00020" LVL="0"><PTEXT><PDAT>Conventional methods used to control the often destructive levels of vibration take many forms, from simple passive treatments to extensive redesign of structures. One of the simplest and often most effective passive damping treatments involves the use of thermo-visco-elastic (TVE) materials. TVE materials such as 3M&apos;s Scotchdamp series (ISD-112 is one example), exhibit dissipative qualities which make them useful in a number of passive damping treatments. Some of the first uses of TVE materials to increase structural damping involved the use of surface patches of aluminum foil and viscoelastic adhesives. These conventional approaches to surface damping treatments are called constrained or embedded-layer damping, and produce modest gains in damping over undamped structures.</PDAT></PTEXT></PARA>
<PARA ID="P-00021" LVL="0"><PTEXT><PDAT>One of the more common passive damping methods, &ldquo;constrained layer damping&rdquo; or CLD is discussed in the article &ldquo;Damping of Flexural Waves by a Constrained Viscoelastic Layer,&rdquo; Kerwin, Journal of the Acoustical Society of America, 1959, Vol. 31, Issue 7, pp. 952-962. According to Kerwin, CLD is achieved by bonding a thin layer of metal sheet, usually aluminum, to an existing structure with a viscoelastic adhesive. According to this technique, damping material, typically a viscoelastic material, is applied to the surface of a composite structure, such as an airplane wing. The damping material is sandwiched between the composite surface and a rigid layer, such as a thin aluminum sheet. This approach has generally been remedial in character and is accomplished at the sacrifice of other considerations, such as weight, aesthetics and ideal surface configuration. Shear strains are developed in the viscoelastic material when the original structure bends or extends. Damping occurs when the deformation of the viscoelastic adhesive creates internal heat in the viscoelastic material and dissipates energy.</PDAT></PTEXT></PARA>
<PARA ID="P-00022" LVL="0"><PTEXT><PDAT>Compared to an undamped structure, this approach is modestly successful but its effectiveness decreases markedly as the ratio of the thickness of the base structure to the thickness of the viscoelastic material increases. Thus, surface treatments alone cannot provide significant levels of damping to structural members where greater strength and stiffness are important. In the article &ldquo;Use of Strain Energy Based Finite Element Techniques in the Analysis of Various Aspects of Damping of Composite Materials and Structures,&rdquo; Hwang, et al., Journal of Composite Materials, 1992, Vol. 26, Issue 17, pp. 2585-2605, this problem was reported, and it showed that the advantage of aluminum foil viscoelastic constrained layer damping was eclipsed by the inherent damping in conventional composites when the required thickness of the structure exceeded about three tenths of an inch. The authors determined that a &plusmn;45&deg; graphite/epoxy composite provided approximately uniform damping of about 1.5% in thick sections.</PDAT></PTEXT></PARA>
<PARA ID="P-00023" LVL="0"><PTEXT><PDAT>It is known that laminated beams composed of alternating layers of elastic and viscoelastic materials can dissipate vibratory energy while maintaining a degree of structural integrity. The article &ldquo;Composite Damping of Vibrating Sandwich Beams,&rdquo; DiTaranto, et al, Jour. of Engineering for Industry, November, 1967, p. 633, presents a theoretical description of such structures.</PDAT></PTEXT></PARA>
<PARA ID="P-00024" LVL="0"><PTEXT><PDAT>The feasibility of co-curing embedded layers of damping materials in a composite structure has been demonstrated. See, for example, Rotz, Olcott, Barrett, &ldquo;Co-cured Damping Layers in Composite Structures,&rdquo; </PDAT><HIL><ITALIC><PDAT>Proceedings </PDAT></ITALIC></HIL><PDAT>23rd </PDAT><HIL><ITALIC><PDAT>International SAMPE Technical Conference</PDAT></ITALIC></HIL><PDAT>, Vol. 23, pp. 373-387, 1991. Vibration control can thus be designed into a structure prior to its actual construction. Composite tubes have been constructed from a pair of concentric composite stiffness layers, the annular space between them being occupied by a damping layer. It is known that when fiber-reinforced materials are loaded along any axis not parallel or perpendicular to the fibers, shear deformations are induced. A tube with plies oriented &ldquo;off-axis&rdquo; (with respect to the central axis of the tube) will twist when loaded axially. With the plies of the two stiffness layers oriented at opposite but similar angles with respect to the tube axis, intense shear deformation is induced in the. damping layer when the tube is loaded axially. The stiffness of the tube remains high because the load passes only through the stiffness layers, and the damping layer adds little weight to the structure. Unfortunately, the most significant shear displacements occur at the free ends of the tube. Constraining the rotational deformations of the stiffness plies at either end of the tube eliminates any shear deformations in the damping layer at that end, thereby reducing the damping effect of the system. Complicated end fixtures are thus required to allow the requisite free end displacements while still transmitting axial loads.</PDAT></PTEXT></PARA>
<PARA ID="P-00025" LVL="0"><PTEXT><PDAT>Stress-coupled co-cured composite viscoelastic structures are formed when layers of uncured fiber composites and TVE materials are alternately stacked together and co-cured in an oven. These structures provide impressive levels of damping and can be categorized by the fiber orientation methods used to induce damping in the TVE material.</PDAT></PTEXT></PARA>
<PARA ID="P-00026" LVL="0"><PTEXT><PDAT>The article &ldquo;A Design for Improving the Structural Damping Properties of Axial Members,&rdquo; Barrett, Proceedings of Damping, 1989, Vol. HBC-1-18, proposed designs using conventional angled-ply (&plusmn;&thgr;) composite lay-ups of straight fiber pre-preg materials (e.g., fabric layers preimpregnated with resin material). Barrett used the inherent shear coupling properties of composite materials to design damped composite tubular components which would induce significant damping in the structure. Fiber-reinforced composites will shear as the fibers attempt to align themselves with the applied loads when these loads are not parallel or perpendicular to the fiber. Because of this behavior, a plate constructed with a positive &thgr; fiber layer, a viscoelastic material layer, and a negative &thgr; fiber layer will generate large shear strains (&ggr;) in the TVE material when an axial load is applied to the tube. Barrett&apos;s research showed that maximum shearing was experienced at the ends of the tubes. However, connections at the tube ends eliminated much of the damping effect, rendering the design impractical for many applications.</PDAT></PTEXT></PARA>
<PARA ID="P-00027" LVL="0"><PTEXT><PDAT>U.S. patent application Ser. No. 07/780,923 to Olcott et al., filed Oct. 22, 1991, proposes &ldquo;stress coupled damping&rdquo; (SCD) which also uses conventional angled ply (&plusmn;&thgr;) composite lay-ups of straight fibers, but abruptly changes the fiber orientation several times throughout the structure. According to Olcott et al., each composite layer is comprised of multiple segments of pre-preg composite material. The patent teaches the use of adjacent segments, having fibers therein which cumulatively form a chevron pattern. The composite layer may include several pre-preg plies in which the segments are staggered or overlapped to strengthen the joint. This creates a region in the composite layer that exhibits quasi-isotropic properties.</PDAT></PTEXT></PARA>
<PARA ID="P-00028" LVL="0"><PTEXT><PDAT>By selecting the fiber angle, thickness, and segment lengths, significant shearing in the viscoelastic layers was observed over the entire structure, not just at the ends as in Barrett&apos;s design. As a result, the structure retained high stiffness and exhibited improved damping even when the ends were clamped. The following publications, incorporated herein by reverence, are cited for further details on this subject.</PDAT></PTEXT></PARA>
<PARA ID="P-00029" LVL="1"><PTEXT><PDAT>1. Olcott, D. D., &ldquo;Improved Damping in Composite Structures Through Stress Coupling, Co-Cured Damping Layers, and Segmented Stiffness Layers,&rdquo; Brigham Young University, Ph.D. Thesis, August 1992.</PDAT></PTEXT></PARA>
<PARA ID="P-00030" LVL="1"><PTEXT><PDAT>2. Trego, A., Eastman, P. F., Pratt, W. F., and Jensen, C. G., &ldquo;Reduced Boring Bar Vibrations Using Damped Composite Structures,&rdquo; Proceedings of the 1995 </PDAT><HIL><ITALIC><PDAT>Design Engineering Technical Conferences</PDAT></ITALIC></HIL><PDAT>, Vol. 3, Part A, pp. 305-311.</PDAT></PTEXT></PARA>
<PARA ID="P-00031" LVL="1"><PTEXT><PDAT>3. Trego, A. and Eastman, P. F., &ldquo;Optimization of Passively Damped Composite Structures,&rdquo; </PDAT><HIL><ITALIC><PDAT>International Journal of Modelling and Simulation</PDAT></ITALIC></HIL><PDAT>, Vol. 17, No, 4, 1997;</PDAT></PTEXT></PARA>
<PARA ID="P-00032" LVL="1"><PTEXT><PDAT>4. Trego, A., Olcott, D. D., and Eastman, P. F., &ldquo;Improved Axial Damping of Mechanical Elements Through the Use of Multiple Layered, Stress Coupled, Co-Cured Damped Fiber Reinforced Composites&rdquo;, </PDAT><HIL><ITALIC><PDAT>Journal of Advanced Materials</PDAT></ITALIC></HIL><PDAT>, January, 1977, p.28.</PDAT></PTEXT></PARA>
<PARA ID="P-00033" LVL="0"><PTEXT><PDAT>The text </PDAT><HIL><ITALIC><PDAT>Vibration Damping of Structural Elements</PDAT></ITALIC></HIL><PDAT>, by C. T. Sun and Y. P. Lu, Prentice Hall PTR, 1995, presents a discussion of fiber reinforced damping in composite materials using viscoelastic materials for damping, and is incorporated herein by reference.</PDAT></PTEXT></PARA>
<PARA ID="P-00034" LVL="0"><PTEXT><PDAT>Although damping was improved, such structures manufactured by conventional lay-ups of straight fiber segments were time consuming to make, error prone, and could not be readily automated. The use of composite struts to dampen vibrations has been proposed in U.S. Pat. No. 5,203,435 to Dolgin. According to Dolgin, plies with opposing chevron patterns of fibers would convert longitudinal vibrational stresses into shear stresses in an intermediate viscoelastic layer which would then dissipate the vibrational energy. One specific structure proposed is a tube with an inner ply oriented at 0&deg;, a second layer oriented at &plus;45&deg;, a central viscoelastic layer, a subsequent layer oriented at &minus;45&deg;, and an outer layer oriented at 90&deg;. Dolgin also illustrates a sinewave pattern. The disclosure of the Dolgin patent is incorporated herein by reference.</PDAT></PTEXT></PARA>
<PARA ID="P-00035" LVL="0"><PTEXT><PDAT>The materials, methods and applications of composites manufacturing are set forth in detail in the literature. An exemplary source for information of this kind is the textbook &ldquo;FUNDAMENTALS OF COMPOSITES MANUFACTURING&rdquo; by A. Brent Strong, published by The Society of Manufacturing Engineers, Dearborn, Mich. is 1989. The disclosure of this textbook is incorporated herein by reference for its explanation of the art of composites manufacturing as it is currently practiced. Similarly, the textbook &ldquo;VISCOELASTIC PROPERTIES OF POLYMERS,&rdquo; John D. Ferry, Wiley, New York, (3rd Ed., 1980) presents a thorough summary of the nature, behavior and identity of typical materials which may be selected by composites technicians for use as damping materials. A good discussion of viscoelasticity as it applies to materials of interest to this disclosure is presented in the publication &ldquo;Linear Viscoelasticity,&rdquo; Driscoll, et al., available from the Structural Products Department of 3M Company, St. Paul, Minn.</PDAT></PTEXT></PARA>
<PARA ID="P-00036" LVL="0"><PTEXT><PDAT>There remains a need for a composite structure capable of diverse configuration with improved damping characteristics and which avoids the limitations of the structural approaches heretofore suggested for use with composites materials.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>SUMMARY OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00037" LVL="0"><PTEXT><PDAT>The present invention is directed to &ldquo;continuous wave composite viscoelastic&rdquo; (CWCV) structures, as well as the methods and apparatus of manufacturing them.</PDAT></PTEXT></PARA>
<PARA ID="P-00038" LVL="0"><PTEXT><PDAT>The invention is also directed to a CWC (continuous wave composite) which forms a continuously wavy prepreg for use with or without a separate viscoelastic layer.</PDAT></PTEXT></PARA>
<PARA ID="P-00039" LVL="0"><PTEXT><PDAT>In both the CWCV and CWC structures, the wavy characteristic of the fiber is optimally varied in at least one of a period, amplitude or shape characteristic.</PDAT></PTEXT></PARA>
<PARA ID="P-00040" LVL="0"><PTEXT><PDAT>In accordance with another aspect of the invention, there is provided a fiber reinforced viscoelastic tape which may be used in many diverse applications.</PDAT></PTEXT></PARA>
<PARA ID="P-00041" LVL="0"><PTEXT><PDAT>The lay of fiber in a CWCV composite layer is varied continuously in a periodic wavelike form. A simple sinusoid wave form may be used, however, other wave forms which may or may not be periodic may also be used. It is also envisioned to employ an optimal wave form for damping particular vibration frequencies at particular locations of a structure.</PDAT></PTEXT></PARA>
<PARA ID="P-00042" LVL="0"><PTEXT><PDAT>The terminology CWC (continuous wave composite) will be used to defined any fiber-matrix combination having at least one fiber without a break (or interruption) and having a pattern which can be defined by a mathematical algorithm. Typically, such curves have G</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>geometric continuity. A fourier series expansion is a mathematical algorithm which can, in general, be used to define nearly any desired shape such as pseudo random, square wave, straight line, triangular wave or any of the shapes shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 1-6</PDAT></FGREF><PDAT> below.</PDAT></PTEXT></PARA>
<PARA ID="P-00043" LVL="0"><PTEXT><PDAT>The terminology CWCV (continuous wave composite viscoelastic) will be used to defined a composite structure which uses at least one layer of CWC material having viscoelastic properties (or &lsquo;anisotropic viscoelastic&rsquo;); or at least one layer of CWC material combined with at least one layer of viscoelastic material either in a sandwich construction or adjacent construction.</PDAT></PTEXT></PARA>
<PARA ID="P-00044" LVL="0"><PTEXT><PDAT>A CWCV is defined by specifying the angle of the fiber lay along the composite layers (e.g. the orientation angles of the fiber with respect to the loading direction), the thickness of the composite layers, and the number of composite and viscoelastic layers in the structure.</PDAT></PTEXT></PARA>
<PARA ID="P-00045" LVL="0"><PTEXT><PDAT>The ends of a CWCV structure according to the present invention may be restrained without significantly reducing the overall damping properties of the structure. There results a structural element possessing high axial stiffness and low weight. The structural elements of this invention offer markedly superior damping capabilities but are nevertheless useable with simple attachment fixtures and methods.</PDAT></PTEXT></PARA>
<PARA ID="P-00046" LVL="0"><PTEXT><PDAT>The composite structures of this invention may take a variety of forms, including tubes, plates, beams or other regular or irregular shapes. In any event, a typical structure will at a minimum include a first stiffness layer or matrix, a damping material, and a second stiffness layer or matrix. Each stiffness layer or matrix will include at least one reinforcing fiber and will be at least several thousandths of an inch thick. Layers with multiple plies and of much greater thickness; e.g. several inches, are envisioned. The fibers of a multi-ply layer may be of similar or dissimilar orientation. The damping material may be of any appropriate thickness, depending upon the application involved, as well as the properties of the damping material. selected. The damping material may comprise another layer interposed between the stiffness layers, or may be incorporated into the stiffness layer. Typically, the damping material will be as thin as is practical, to avoid adding excess weight to the structure. It is not unusual, however for a layer of damping material to exceed in thickness the total thickness of the stiffness layers. The stiffness layers may be constructed of any of the reinforcing fibers and matrix materials which would otherwise be appropriate for a particular application. The damping material will ordinarily be selected to provide optimum damping loss at the temperatures and vibrational frequencies expected to be encountered by the composite structure.</PDAT></PTEXT></PARA>
<PARA ID="P-00047" LVL="0"><PTEXT><PDAT>With two stiffness layers, shear strain occurs between the two stiffness layers, e.g. in an intermediate damping layer. Other embodiments contemplate the use of multiple damping layers. For example, the use of three stiffness layers permits the exercise of two intermediate damping layers, with greater damping effect. The stiffness layer may be combined with the damping layer by utilizing a viscbelastic material as all or a portion of the impregnating resin. Co-curing of the stiffness and damping layers simplifies the construction of both complex structures and structural components.</PDAT></PTEXT></PARA>
<PARA ID="P-00048" LVL="0"><PTEXT><PDAT>One embodiment of the invention may be characterized as a structure for use as a pre-preg comprising a fiber tow, and a resin matrix containing the fiber tow, wherein the fiber tow is held in the resin in a waveform varying in at least one of a period, amplitude or shape characteristic. The prepreg may be utilized as at least part of a support structure and in such a case, the fiber tow may have a first waveform characteristic selected to dampen a first vibration mode of the support structure and a second waveform characteristic, superimposed on the first waveform, wherein the second waveform characteristic is selected to dampen a second vibration mode of the support structure. The first waveform characteristic may be one of a period and amplitude characteristic and the second waveform characteristic may also be one of a period and amplitude characteristic.</PDAT></PTEXT></PARA>
<PARA ID="P-00049" LVL="0"><PTEXT><PDAT>Another embodiment of the invention may be characterized as a structure comprising a fiber tow, a resin matrix containing the fiber tow, and a viscoelastic material adjacent to or contacting the fiber tow, wherein the fiber tow is held in the resin in a waveform varying in at least one of a period, amplitude or shape characteristic.</PDAT></PTEXT></PARA>
<PARA ID="P-00050" LVL="0"><PTEXT><PDAT>Another embodiment of the invention may be characterized as a material for damping vibration, the material having a loading direction and comprising a first matrix containing a first set of fibers, the first set of fibers having a first waveform varying in at least one of a period, amplitude or shape characteristic along the loading direction; a second matrix containing a second set of fibers, the second set of fibers having a second waveform; and an viscoelastic material positioned between the first matrix and the second matrix. The first and second waveforms may be different from one another, and they may differ only in their phase angle relative to one another. Further, the second waveform may vary in at least one of a period, amplitude or shape characteristic along the loading direction, and at least one of the first and second sets of fibers may be at least partially contained within the viscoelastic material. The fibers of the first and second sets may be relatively oppositely oriented along the loading direction.</PDAT></PTEXT></PARA>
<PARA ID="P-00051" LVL="0"><PTEXT><PDAT>The CWC material is also characterized in that the volume fraction changes in such a way that the first set of fibers comprises a plurality of first fibers relatively laterally spaced with respect to the loading direction, wherein the relative lateral spacing is inversely proportional to the angular orientation with respect to the loading direction.</PDAT></PTEXT></PARA>
<PARA ID="P-00052" LVL="0"><PTEXT><PDAT>Another embodiment of the invention may be characterized as a method of fabricating an impregnated material comprising the steps of (a) passing a plurality of fibers to at least one first roller, the first roller contacting the plurality of fibers for moving same along a first direction, (b) passing the plurality of fibers to at least one second roller, the second roller contacting the plurality of fibers for moving same along the first direction, (c) transversely relatively moving at least one of the first and second rollers in a second direction while each of the first and second rollers contacts the plurality of fibers thereby moving the plurality of fibers generally perpendicular to the first direction, and (e) applying a carrier to the fibers as the fibers pass proximate the second roller.</PDAT></PTEXT></PARA>
<PARA ID="P-00053" LVL="0"><PTEXT><PDAT>The applying step may comprise applying an uncured polymer matrix to the fibers as the fibers pass proximate the second roller.</PDAT></PTEXT></PARA>
<PARA ID="P-00054" LVL="0"><PTEXT><PDAT>The applying step may comprises applying a viscoelastic material to the fibers as the fibers pass proximate the second roller.</PDAT></PTEXT></PARA>
<PARA ID="P-00055" LVL="0"><PTEXT><PDAT>The step of transversely relatively moving set for above may comprises utilizing a controller to generate control signals according to a desired waveform for the fibers, feeding the control signals to a device for relatively moving the at least one of the rollers with respect to the other of the rollers in the second direction to thereby cause the shape of the fibers to conform to the desired waveform. The controller may comprise an electronic controller and the control signals may comprise electronic control signals which generate a waveform varying in at least one of a period, amplitude or shape characteristic. The step of applying the resin material may include spraying a resinous material onto the fibers or passing a support member carrying resinous material on at least one side of the fibers prior to the fibers making contact with the second roller to thereby impregnate the fibers with the resinous material, and subsequently separating the support member from the fibers.</PDAT></PTEXT></PARA>
<PARA ID="P-00056" LVL="0"><PTEXT><PDAT>Another embodiment of the invention may be characterized as a method of fabricating a material comprising the steps of a. passing a plurality of fibers to at least one first roller, the first roller contacting the plurality of fibers for moving same along a first direction, b. passing the plurality of fibers to at least one second roller, the second roller contacting the plurality of fibers for moving same along the first direction, c. transversely relatively moving at least one of the first and second roller in a second direction while each of the first and second rollers contacts the plurality of fibers thereby moving the plurality of fibers generally perpendicular to the first direction, d. applying a resin matrix to the fibers as the fibers pass proximate the second roller, and e. positioning a viscoelastic material at least adjacent the fibers. The positioning of the viscoelastic material may include commingling the viscoelastic material with the fibers and may be performed after the resin matrix applying step. The positioning step may include applying the viscoelastic material to the fibers at the same time as applying the resin matrix.</PDAT></PTEXT></PARA>
<PARA ID="P-00057" LVL="0"><PTEXT><PDAT>Transversely relatively moving the rollers may be achieved by utilizing an electronic controller to generate control signals according to a desired waveform for the fibers, and feeding the control signals to a device for relatively moving the at least one of the rollers with respect to the other of the rollers in the second direction to thereby cause the shape of the fibers to conform to the desired waveform.</PDAT></PTEXT></PARA>
<PARA ID="P-00058" LVL="0"><PTEXT><PDAT>Yet another embodiment of the invention is characterized as tape comprising a fiber tow, and a viscoelastic material containing the fiber tow. The viscoelastic material may be uncured or cured. Typically, the tow is orientated in substantially a straight line parallel to the direction of longitudinal axis of the tape. However, the tow may also form a sinusoidal waveform or a waveform that varies in one of a period, amplitude or shape characteristic along the longitudinal axis of the tape.</PDAT></PTEXT></PARA>
<PARA ID="P-00059" LVL="0"><PTEXT><PDAT>Yet another embodiment of the invention may be characterized as a composite structure comprising a first fiber tow, a resin matrix containing the fiber tow, a second fiber tow, a viscoelastic material containing the second fiber tow, the resin and viscoelastic material positioned adjacent one another. Typically at least one of the fiber tow of the matrix and the fiber tow of viscoelastic material has a waveform characteristic selected to dampen the at least one vibrational mode of a support structure. The fiber tow of the matrix may have a first waveform characteristic and the fiber tow of the viscoelastic material may have a second waveform characteristic, different from the first waveform characteristic. The first and second waveform characteristics may have opposite phases from one another. Further, at least one waveform may have a waveform characteristic variable in at least one of a period, amplitude or shape characteristic along the longitudinal direction of the composite structure.</PDAT></PTEXT></PARA>
<PARA ID="P-00060" LVL="0"><PTEXT><PDAT>In use, the composite structure comprising the resin and viscoelastic material are positioned adjacent an isotropic structure, the isotropic structure forming at least a part of a support structure. The composite structure dampens at least one vibrational mode of the support structure.</PDAT></PTEXT></PARA>
<PARA ID="P-00061" LVL="0"><PTEXT><PDAT>Yet another embodiment of the invention may be characterized as a method of applying a strengthening layer to a workpiece comprising the steps of wrapping a fiber tow about at least a portion of the workpiece, the fiber tow serving a strengthening layer, and subsequently applying a fiber re-enforced viscoelastic tape about at least the portion to secure the fiber tow to the workpiece.</PDAT></PTEXT></PARA>
<PARA ID="P-00062" LVL="0"><PTEXT><PDAT>Another embodiment of the invention may be characterized as a method of applying a strengthening layer to a workpiece comprising the steps of wrapping a fiber tow about at least a portion of the workpiece, the fiber tow serving a strengthening layer, and subsequently securing the fiber tow to at least the portion of the workpiece, wherein the step of wrapping the fiber tow includes the step of applying the fiber tow to the workpiece so as to take the shape of a desired non-spiral waveform. The step of securing the fiber tow may include applying a viscoelastic tape to the portion of the workpiece or applying a resinous material to the portion of the workpiece. Further, the applying step may include applying the fiber tow to the workpiece so as to take the shape of a sinusoidal waveform.</PDAT></PTEXT></PARA>
<PARA ID="P-00063" LVL="0"><PTEXT><PDAT>Yet another embodiment of the invention may be characterized as a method of applying a strengthening layer to a workpiece comprising the steps of wrapping a fiber tow about at least a portion of the workpiece, the fiber tow serving a strengthening layer, and subsequently securing the fiber tow to at least the portion of the workpiece, wherein the step of wrapping the fiber tow includes the step of applying the fiber tow to the workpiece so as to have a waveform characteristic varying in at least one of a period, amplitude or shape characteristic.</PDAT></PTEXT></PARA>
<PARA ID="P-00064" LVL="0"><PTEXT><PDAT>Yet another embodiment of the invention may be characterized as an apparatus for controlling the fiber angle of a fiber tow embedded in a carrier comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00065" LVL="2"><PTEXT><PDAT>a first pair of rollers including a first and second roller,</PDAT></PTEXT></PARA>
<PARA ID="P-00066" LVL="2"><PTEXT><PDAT>at least a third roller,</PDAT></PTEXT></PARA>
<PARA ID="P-00067" LVL="2"><PTEXT><PDAT>the fiber tow pressed between the first and second rollers and contacting the third roller for movement along a first direction due to rotation of the first, second and third rollers, a first drive mechanism for rotating the first, second and third rollers,</PDAT></PTEXT></PARA>
<PARA ID="P-00068" LVL="2"><PTEXT><PDAT>a second drive mechanism connected to at least one of the first pair of rollers and the third roller, the second drive mechanism responsive to control signals for displacing the at least one of the first pair of rollers and the third roller axially along the rotation axis of the at least one of the first pair of rollers and the third roller, and</PDAT></PTEXT></PARA>
<PARA ID="P-00069" LVL="2"><PTEXT><PDAT>an electronic controller connected to the second drive mechanism for generating the control signals to control the amount of axial displacement of the at least one of the first pair of rollers and the third roller.</PDAT></PTEXT></PARA>
<PARA ID="P-00070" LVL="0"><PTEXT><PDAT>The electronic controller may comprise a digital computer programmed to generate the control signals as a function of at least one of distance along the first direction and time. Further, the carrier may comprises a matrix material in the form of a rolled sheet and the apparatus further comprises. at least one support roller for securing the matrix material, the at least one support roller positioned for feeding the matrix material for contact with the third roller together with the fiber tow for at least partially securing the fiber tow in place within the matrix material.</PDAT></PTEXT></PARA>
<PARA ID="P-00071" LVL="0"><PTEXT><PDAT>The apparatus may further comprise:</PDAT></PTEXT></PARA>
<PARA ID="P-00072" LVL="2"><PTEXT><PDAT>a fourth roller positioned adjacent the third roller to form a second pair of rollers,</PDAT></PTEXT></PARA>
<PARA ID="P-00073" LVL="2"><PTEXT><PDAT>the fiber tow passing between the third and fourth rollers,</PDAT></PTEXT></PARA>
<PARA ID="P-00074" LVL="2"><PTEXT><PDAT>at least a first and second support roller and a first and second sheet of matrix material,</PDAT></PTEXT></PARA>
<PARA ID="P-00075" LVL="2"><PTEXT><PDAT>the first support roller supporting the first sheet of matrix material and the second support roller supporting the second sheet of matrix material, and</PDAT></PTEXT></PARA>
<PARA ID="P-00076" LVL="2"><PTEXT><PDAT>the first support roller positioned for feeding the matrix material of the first sheet between one of the third and fourth rollers and the fiber tow, and the second support roller positioned for passing the matrix material of the second sheet between the other of the third and fourth rollers and the fiber tow.</PDAT></PTEXT></PARA>
<PARA ID="P-00077" LVL="0"><PTEXT><PDAT>The matrix material may comprises an uncured polymer, a metal matrix or a ceramic matrix.</PDAT></PTEXT></PARA>
<PARA ID="P-00078" LVL="0"><PTEXT><PDAT>The apparatus may further comprise heating elements downstream of the second pair of rollers, in reference to the first direction, for causing wicking of the fibers with an uncured polymer matrix.</PDAT></PTEXT></PARA>
<PARA ID="P-00079" LVL="0"><PTEXT><PDAT>The carrier may comprise a viscoelastic material in the form of a rolled sheet and the apparatus may further comprise at least one support roller for securing the viscoelastic material, the at least one support roller positioned for feeding the viscoelastic material for contact with the third roller together with the fiber tow.</PDAT></PTEXT></PARA>
<PARA ID="P-00080" LVL="0"><PTEXT><PDAT>Additional objects and advantages of the invention will be set forth in the description which follows, and in part will be obvious from the description, or may be learned by practice of the invention. The objects and advantages of the invention may be realized and obtained by means of the instrumentalities and combinations particularly pointed out in the appended claims.</PDAT></PTEXT></PARA>
</BTEXT>
</BRFSUM>
<DRWDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BRIEF DESCRIPTION OF THE DRAWINGS</PDAT></STEXT></H>
<PARA ID="P-00081" LVL="0"><PTEXT><PDAT>The accompanying drawings, which are incorporated in and constitute a part of the specification, illustrate a presently preferred embodiments of the invention, and, together with the general description given above and the detailed description of the preferred embodiments given below, serve to explain the principles of the invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00082" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> is an exploded perspective view of a composite material according to a generalized embodiment of the present invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00083" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT> is an exploded perspective view of a composite material according to an alternate embodiment of the present invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00084" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 3</PDAT></FGREF><PDAT> is an exploded perspective view of a composite material according to another alternate embodiment of the present invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00085" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 4</PDAT></FGREF><PDAT> is a perspective view illustrating two examples of matrices according to yet another embodiment of the present invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00086" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 5</PDAT></FGREF><PDAT> is an exploded perspective view of a composite material according to yet another alternate embodiment of the present invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00087" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIGS. 6A</PDAT></FGREF><PDAT>, </PDAT><HIL><BOLD><PDAT>6</PDAT></BOLD></HIL><PDAT>B and </PDAT><HIL><BOLD><PDAT>6</PDAT></BOLD></HIL><PDAT>C are exploded perspective view of a composite material and damping layer coupled to an isotropic layer in accordance with another embodiment of the invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00088" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT> is a schematic illustration of an apparatus according to the present invention for manufacturing a composite material.</PDAT></PTEXT></PARA>
<PARA ID="P-00089" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIGS. 8A and 8B</PDAT></FGREF><PDAT> are illustrations of bent fibers showing how the volume fraction is enhanced with the use of bending.</PDAT></PTEXT></PARA>
<PARA ID="P-00090" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 9</PDAT></FGREF><PDAT> is a schematic illustration of an alternate apparatus according to the present invention for manufacturing a composite material.</PDAT></PTEXT></PARA>
<PARA ID="P-00091" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 10</PDAT></FGREF><PDAT> is a schematic illustration of another alternate apparatus according to the present invention for manufacturing a composite material.</PDAT></PTEXT></PARA>
<PARA ID="P-00092" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 11</PDAT></FGREF><PDAT> is a schematic illustration of yet another alternate apparatus according to the present invention for manufacturing a composite material.</PDAT></PTEXT></PARA>
<PARA ID="P-00093" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 12</PDAT></FGREF><PDAT> is a schematic illustration of still another alternate apparatus according to the present invention for manufacturing a composite material.</PDAT></PTEXT></PARA>
</BTEXT>
</DRWDESC>
<DETDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>DESCRIPTION OF THE PREFERRED EMBODIMENTS</PDAT></STEXT></H>
<PARA ID="P-00094" LVL="0"><PTEXT><PDAT>According to one aspect of the invention, a particular wave fiber pattern reinforces a matrix in such a way that wave patterns from two collateral CWC laminae act in a shearing manner on a sandwiched viscoelastic adhesive. When axial or in-plane shear forces are imposed upon this combination, enhanced shearing is induced in the viscoelastic adhesive producing an unexpected increase in structure damping.</PDAT></PTEXT></PARA>
<PARA ID="P-00095" LVL="0"><PTEXT><PDAT>As shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT>, a first matrix </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT> contains a pattern of reinforcing fibers </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>, and a second matrix </PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT> contains a pattern of reinforcing fibers </PDAT><HIL><BOLD><PDAT>16</PDAT></BOLD></HIL><PDAT>. A viscoelastic material such as an adhesive is interposed therebetween and secures the first and second CWC lamina </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT>,</PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT> to one another.</PDAT></PTEXT></PARA>
<PARA ID="P-00096" LVL="0"><PTEXT><PDAT>The number and pattern of the fibers </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>,</PDAT><HIL><BOLD><PDAT>16</PDAT></BOLD></HIL><PDAT> illustrated in the figures is exemplary. More or less fibers in any desired pattern are envisioned.</PDAT></PTEXT></PARA>
<PARA ID="P-00097" LVL="0"><PTEXT><PDAT>In </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT>, a generally sinusoidal shaped fiber pattern is contained by both CWC lamina </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT>,</PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT>; however, the patterns as illustrated are opposite with respect to the direction of loading L. In particular, at any given point along the loading direction L, the angle of orientation of fibers </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> with respect to the loading direction L has the same magnitude and the inverse sign of the angle of orientation of fibers </PDAT><HIL><BOLD><PDAT>16</PDAT></BOLD></HIL><PDAT> with respect to the loading direction L.</PDAT></PTEXT></PARA>
<PARA ID="P-00098" LVL="0"><PTEXT><PDAT>The invention also includes fiber patterns which change their wavelength and/or waveform along the loading direction. The inventors have discovered that for a given frequency and temperature many viscoelastic adhesives will require an optimal wavelength to maximize damping in the structure. While a structure with a constant wavelength can be optimized for a given frequency and/or temperature, placement of a changing wavelength or waveform can optimize a structure for a broader range of frequencies and/or temperatures. This concept is illustrated in FIG. </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00099" LVL="0"><PTEXT><PDAT>Stress coupled composite structures having one fiber angle at any given point along the loading direction are not able to withstand as much stress as one having multiple angles contained within a matrix. This is because failures occur in composite materials starting at areas of maximum in-plane shear stress in the composite layer, and propagate in the matrix material along the fiber direction.</PDAT></PTEXT></PARA>
<PARA ID="P-00100" LVL="0"><PTEXT><PDAT>Although shear stress gradients in continuous wave stress coupled composites are lower than straight fiber chevron patterns, the use of different patterns overlaid on each other increases the ultimate strength of the structure. An alternate embodiment of the present invention shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 3</PDAT></FGREF><PDAT> illustrates matrix </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT>A containing fibers </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>A in a first wave pattern and matrix </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT>B containing fibers </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>B in a second wave pattern. Similarly, matrix </PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT>A contains fibers </PDAT><HIL><BOLD><PDAT>16</PDAT></BOLD></HIL><PDAT>A in an opposite wave pattern to fibers </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>A and matrix </PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT>B contains fibers </PDAT><HIL><BOLD><PDAT>16</PDAT></BOLD></HIL><PDAT>B in an opposite wave pattern to fibers </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>B.</PDAT></PTEXT></PARA>
<PARA ID="P-00101" LVL="0"><PTEXT><PDAT>The present invention further envisions complex fiber patterns, such as those shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 4</PDAT></FGREF><PDAT>, generated by an algorithm for optimizing pattern and/or shape, wave period, wave amplitude, structural stiffness, and structural damping. Using techniques similar to electronic signal processing, wave forms can be generated algorithmically which vary wave patterns by mixing two or more algorithmically defined waves with one or more differences in shape, period, amplitude, etc. For example:</PDAT></PTEXT></PARA>
<PARA ID="P-00102" LVL="2"><PTEXT><PDAT>A period modulated wave shape where two or more waves of differing period with or without the same amplitude, combined into one composite shape. This could be used to optimize damping and/or stiffness in complex structures where modal vibration and/or forcing functions require special design considerations.</PDAT></PTEXT></PARA>
<PARA ID="P-00103" LVL="2"><PTEXT><PDAT>An amplitude modulated wave shape could be used to modify stiffness and damping properties at varying positions in the structure.</PDAT></PTEXT></PARA>
<PARA ID="P-00104" LVL="2"><PTEXT><PDAT>A wave shape composed of two or more similar or dissimilar wave forms of different periods such that the combined wave form shows a mixed characteristic of all such combined waves. This would allow tailoring of structural properties for multiple modes and forcing functions.</PDAT></PTEXT></PARA>
<PARA ID="P-00105" LVL="2"><PTEXT><PDAT>A bessel based wave shape, a fourier series driven shape, sawtooth, trapezoidal, square wave, and modulated (by other similar or dissimilar wave forms) patterns.</PDAT></PTEXT></PARA>
<PARA ID="P-00106" LVL="2"><PTEXT><PDAT>Optimized patterns not necessarily algorithmically driven which are tailored by an optimization program to provide special structural response characteristics.</PDAT></PTEXT></PARA>
<PARA ID="P-00107" LVL="2"><PTEXT><PDAT>Random and/or neo-random patterns, and patterns which are a mixture of random or neo-random and periodic wave shapes.</PDAT></PTEXT></PARA>
<PARA ID="P-00108" LVL="2"><PTEXT><PDAT>A structure which uses conventional straight fiber composites to constrain an anisotropic viscoelastic material.</PDAT></PTEXT></PARA>
<PARA ID="P-00109" LVL="0"><PTEXT><PDAT>In the case of utilizing two or more different wave lengths for constructing the waveform, one may look at a cantileved structure by way of example. It is known that the prediction of the resonant frequency of a cantilevered structural element (such as a diving board, robotic sliding arm, etc.) is given by the formula: </PDAT>
<CWU>
<MATH-US ID="MATH-US-00001">
<MATHEMATICA ID="MATHEMATICA-00001" ALT="mathematica file" FILE="US06467521-20021022-M00001.NB"/>
<MATHML>
<math>
<mrow>
  <msub>
    <mi>f</mi>
    <mi>r</mi>
  </msub>
  <mo>=</mo>
  <mrow>
    <mfrac>
      <msup>
        <mi>&lambda;</mi>
        <mn>2</mn>
      </msup>
      <mrow>
        <mn>2</mn>
        <mo>&CenterDot;</mo>
        <mi>&pi;</mi>
        <mo>&CenterDot;</mo>
        <msup>
          <mi>L</mi>
          <mn>2</mn>
        </msup>
      </mrow>
    </mfrac>
    <mo>&it;</mo>
    <msqrt>
      <mfrac>
        <mrow>
          <msub>
            <mi>E</mi>
            <mn>11</mn>
          </msub>
          <mo>&CenterDot;</mo>
          <mi>I</mi>
        </mrow>
        <mrow>
          <mi>p</mi>
          <mo>&CenterDot;</mo>
          <mi>A</mi>
        </mrow>
      </mfrac>
    </msqrt>
  </mrow>
</mrow>
</math>
</MATHML>
<EMI ID="EMI-M00001" ALT="embedded image" FILE="US06467521-20021022-M00001.TIF"/>
</MATH-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00110" LVL="7"><PTEXT><PDAT>where &lgr;</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;1.88; &lgr;</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;4.7; etc</PDAT></PTEXT></PARA>
<PARA ID="P-00111" LVL="2"><PTEXT><PDAT>where lamda is the mode shape factor, L is the length, E</PDAT><HIL><SB><PDAT>11 </PDAT></SB></HIL><PDAT>is the equivalent elastic modulus of the long axis, I is the section modulus, rho is the density, and A is the cross sectional area of the cantilevered element. In CWCV structures E</PDAT><HIL><SB><PDAT>11</PDAT></SB></HIL><PDAT>, is a function of both the constraining composite layer and the viscoelastic properties of the damping layer. Since both the elastic and damping properties of the viscoelastic material are frequency and temperature dependent, then by extension, the elastic and damping properties of E</PDAT><HIL><SB><PDAT>11</PDAT></SB></HIL><PDAT>, are also functions of the frequency and temperature.</PDAT></PTEXT></PARA>
<PARA ID="P-00112" LVL="0"><PTEXT><PDAT>It has been shown that higher frequency resonances or forcing functions require shorter wave periods for optimization of damping in CWCV structures. See, for example, the following publications incorporated herein by reference:</PDAT></PTEXT></PARA>
<PARA ID="P-00113" LVL="1"><PTEXT><PDAT>1. Pratt, W. F., Rotz, C. A. and Jensen, C. G. 1996 &ldquo;Improved Damping and Stiffness in Composite Structures Using Geometric Fiber Wave Patterns,&rdquo; </PDAT><HIL><ITALIC><PDAT>Proceeding of the ASME Noise Control and Acoustics Division</PDAT></ITALIC></HIL><PDAT>, Vol. NCA 23-2, pp. 37-43.</PDAT></PTEXT></PARA>
<PARA ID="P-00114" LVL="1"><PTEXT><PDAT>2. Pratt, W. F., Rotz, C. A., and Jensen, C. G., 1996, &ldquo;On the Use of Continuous Wave Composite Structures in Stress Coupled Interlaminar Damping,&rdquo; </PDAT><HIL><ITALIC><PDAT>Advanced Materials: Development, Characterization Processing, and Mechanical Behavior Book of Abstracts</PDAT></ITALIC></HIL><PDAT>, Vol. MD 74, pp. 63-64.</PDAT></PTEXT></PARA>
<PARA ID="P-00115" LVL="1"><PTEXT><PDAT>3. Pratt, W. F., Rotz, C. A., and Jensen, C. G., 1996, &ldquo;On the Use of Continuous Wave-like Geometric Fiber Patterns in Composite Structures to Improve Structural Damping,&rdquo; Proceedings of the </PDAT><HIL><ITALIC><PDAT>ASME Aerospace Division</PDAT></ITALIC></HIL><PDAT>, Vol. AD 52, pp. 415-433.</PDAT></PTEXT></PARA>
<PARA ID="P-00116" LVL="0"><PTEXT><PDAT>Therefore a cantilevered structure that is design to vary its length would require a wave form of variable period to optimize its damping such as shown, for example in FIG. </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00117" LVL="0"><PTEXT><PDAT>As an example, if a diving board was shortened to half its length, the resonant frequency would be quadrupled. This would shorten the optimal wave period. In like manner, a cantilevered robotic arm whose length was variable would require a wave period that would be continuously variable as well. Since most of the strain energy is concentrated at the root of the element, a continuously variable wave period would more readily optimize damping in the structure. </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT> is an example of a continuously variable wave period.</PDAT></PTEXT></PARA>
<PARA ID="P-00118" LVL="0"><PTEXT><PDAT>As a second example, suppose the cantilevered beam was not variable in its length but two separate forcing frequencies were applied to the structure that were close to the natural frequencies of the 1st and 2d modes (lambda for the first two modes is given above). The resonant frequency for the 2d mode would be more than six times that of the primary or first mode. Optimization of damping in the beam for the first mode would require a long wave pattern (using a simple sinusoidal wave as an example). While the longer wave length would have some damping benefit for the 2d vibration mode, a shorter wave length would provide greater damping. In this case two waves, each of fixed but different frequencies but superimposed upon each other, similar to that shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 4</PDAT></FGREF><PDAT>, would optimize damping for both modes.</PDAT></PTEXT></PARA>
<PARA ID="P-00119" LVL="0"><PTEXT><PDAT>Additionally, it is also envisioned that the present invention may include a plurality of viscoelastic materials between CWC laminae. By way of example, </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 5</PDAT></FGREF><PDAT> illustrates three viscoelastic materials </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT>A,</PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT>B,</PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT>C, which may be of the same or different compositions, interposed between CWC laminae </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT>,</PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT>,</PDAT><HIL><BOLD><PDAT>20</PDAT></BOLD></HIL><PDAT>,</PDAT><HIL><BOLD><PDAT>22</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00120" LVL="0"><PTEXT><PDAT>In summary, a continuous wave fiber composite material according to the present invention may include one or more anisotropic composite layers with or without viscoelastic properties, and therefore respectively used without or with a separate viscoelastic layer. Of course, one may also utilize composite layers with viscoelastic properties (i.e., the viscoelastic material may comprise all or a part of the matrix material binding the fibers) and separate viscoelastic layers as well. Features of the pattern of reinforcing fibers may include:</PDAT></PTEXT></PARA>
<PARA ID="P-00121" LVL="2"><PTEXT><PDAT>A constant wavelength and/or waveform (see FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>);</PDAT></PTEXT></PARA>
<PARA ID="P-00122" LVL="2"><PTEXT><PDAT>A wavelength and/or waveform that varies along the length of the structure (see FIG. </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT>);</PDAT></PTEXT></PARA>
<PARA ID="P-00123" LVL="2"><PTEXT><PDAT>A pattern in one CWC laminae having multiple wavelengths and/or waveforms (see FIG. </PDAT><HIL><BOLD><PDAT>4</PDAT></BOLD></HIL><PDAT>); and</PDAT></PTEXT></PARA>
<PARA ID="P-00124" LVL="2"><PTEXT><PDAT>Multiple combinations of CWC laminae and viscoelastic layers using one or more of the above features (see FIGS. </PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>5</PDAT></BOLD></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00125" LVL="0"><PTEXT><PDAT>In a further aspect of the present invention, an apparatus and method for manufacturing composite materials such as those described above are also envisioned.</PDAT></PTEXT></PARA>
<PARA ID="P-00126" LVL="0"><PTEXT><PDAT>Generally, characteristics of the processes and machines include:</PDAT></PTEXT></PARA>
<PARA ID="P-00127" LVL="2"><PTEXT><PDAT>laying the fiber(s) in a controlled pattern which can be periodic or non-periodic;</PDAT></PTEXT></PARA>
<PARA ID="P-00128" LVL="2"><PTEXT><PDAT>controlling the pattern with mechanical linkages such as (but not limited to) cams and levers, or by automated controls; and</PDAT></PTEXT></PARA>
<PARA ID="P-00129" LVL="2"><PTEXT><PDAT>producing a fiber reinforced composite material consisting of matrices containing continuous fibers. The matrices can consist of conventional polymers, viscoelastic materials, or more exotic materials including (but not limited to) metal, ceramic, or combinations of materials. The fibers can consist of unidirectional tow or woven mats.</PDAT></PTEXT></PARA>
<PARA ID="P-00130" LVL="0"><PTEXT><PDAT>In another embodiment of the CWCV structure, the use of CWC material with a separate viscoelastic layer or with CWC material which has an inherent viscoelastic property has a beneficial damping effect when used in conjunction with isotropic materials. One such structure utilizes a single viscoelastic layer </PDAT><HIL><BOLD><PDAT>30</PDAT></BOLD></HIL><PDAT> and a single CWC layer </PDAT><HIL><BOLD><PDAT>32</PDAT></BOLD></HIL><PDAT>, as a constrained layer damping treatment to an isotropic structure </PDAT><HIL><BOLD><PDAT>34</PDAT></BOLD></HIL><PDAT> as shown in FIG. </PDAT><HIL><BOLD><PDAT>6</PDAT></BOLD></HIL><PDAT>A. In </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 6A</PDAT></FGREF><PDAT>, the CWC viscoelastic layer </PDAT><HIL><BOLD><PDAT>30</PDAT></BOLD></HIL><PDAT> has a defined waveform, and is shown in the center of the structure with the CWC layer </PDAT><HIL><BOLD><PDAT>32</PDAT></BOLD></HIL><PDAT> in the form of a conventional cross-ply laminate placed on one side thereof. The two layers </PDAT><HIL><BOLD><PDAT>30</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>32</PDAT></BOLD></HIL><PDAT> are secured to the isotropic layer </PDAT><HIL><BOLD><PDAT>34</PDAT></BOLD></HIL><PDAT> on the other side of viscoelastic layer </PDAT><HIL><BOLD><PDAT>30</PDAT></BOLD></HIL><PDAT>. The viscoelastic layer </PDAT><HIL><BOLD><PDAT>30</PDAT></BOLD></HIL><PDAT> may be a fiber-reinforced viscoelastic layer as shown. Most preferably, the fiber pattern of layer </PDAT><HIL><BOLD><PDAT>30</PDAT></BOLD></HIL><PDAT> may be continuous wave such as a sine wave and may have at least one of its period, amplitude or shape characteristic variable along the longitudinal length of the layer (such as the waveform shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 3</PDAT></FGREF><PDAT> or </PDAT><HIL><BOLD><PDAT>4</PDAT></BOLD></HIL><PDAT>). Isotropic layer </PDAT><HIL><BOLD><PDAT>34</PDAT></BOLD></HIL><PDAT> is generally part of or attached to a support structure. Layers </PDAT><HIL><BOLD><PDAT>30</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>32</PDAT></BOLD></HIL><PDAT> serve a damping function to dampen modes of vibration of the support structure, and in some cases can also serve a support function together with isotopic layer </PDAT><HIL><BOLD><PDAT>34</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00131" LVL="0"><PTEXT><PDAT>Many variations of </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 6A</PDAT></FGREF><PDAT> can be fabricated. For example, </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 6B</PDAT></FGREF><PDAT> illustrates layer </PDAT><HIL><BOLD><PDAT>30</PDAT></BOLD></HIL><PDAT> in the form of a variable wave period fiber pattern in a viscoelastic matrix. Layer </PDAT><HIL><BOLD><PDAT>32</PDAT></BOLD></HIL><PDAT> may then take the form of a variable wave period pattern in a conventional matix where the wave pattern is opposite (opposite phase) that of the viscoelastic matrix. </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 6C</PDAT></FGREF><PDAT> shown layer </PDAT><HIL><BOLD><PDAT>30</PDAT></BOLD></HIL><PDAT> in the form of a constant period wave pattern in a viscoelastic matrix and layer </PDAT><HIL><BOLD><PDAT>32</PDAT></BOLD></HIL><PDAT> in the form of a constant wave fibe pattern in a conventional matrix having opposite phase to that of FIG. </PDAT><HIL><BOLD><PDAT>6</PDAT></BOLD></HIL><PDAT>B.</PDAT></PTEXT></PARA>
<PARA ID="P-00132" LVL="0"><PTEXT><PDAT>While both </PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 6B and 6C</PDAT></FGREF><PDAT> show that the waveforms in layers </PDAT><HIL><BOLD><PDAT>30</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>32</PDAT></BOLD></HIL><PDAT> are opposite one another, the opposite phase relationship, while desirable, may not be necessary in every application. The shape of the waveforms in layers </PDAT><HIL><BOLD><PDAT>30</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>32</PDAT></BOLD></HIL><PDAT> can vary individually in period and/or amplitude to take into effect desired damping characteristics. The waveforms may also be built from multiple wave periods with a first wave period selected to dampen a first vibrational mode of the support structure and the second wave period selected to dampen a second vibrational mode of the support structure. Third and additional wave periods may also be superimposed to dampen other modes or harmonics of vibration of the support structure or structures coupled to the support structure.</PDAT></PTEXT></PARA>
<PARA ID="P-00133" LVL="0"><PTEXT><PDAT>In other embodiments, additional layers of viscoelastic material may be used either between layers </PDAT><HIL><BOLD><PDAT>30</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>32</PDAT></BOLD></HIL><PDAT> or between layers </PDAT><HIL><BOLD><PDAT>30</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>34</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00134" LVL="0"><PTEXT><PDAT>The described combinations of fiber-polymer matrix and fiber-viscoelastic (anisotropic viscoelastic) materials may be used in structures as additional damping treatments or integrated into the structure at the time of construction to provide both damping and structural benefits.</PDAT></PTEXT></PARA>
<PARA ID="P-00135" LVL="0"><PTEXT><PDAT>The viscoelastic layer </PDAT><HIL><BOLD><PDAT>30</PDAT></BOLD></HIL><PDAT> of </PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 6A-6C</PDAT></FGREF><PDAT> may be fabricated using similar techniques as discussed below in connection with FIG. </PDAT><HIL><BOLD><PDAT>7</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00136" LVL="0"><PTEXT><PDAT>Generally, a typical arrangement which is coupled to a structure includes at least one layer or matrix with damping qualities (a layer of &ldquo;anisotropic viscoelastic&rdquo; properties) or at least one CWC layer and at least one viscoelastic layer. Each CWC or &lsquo;anisotropic viscoelastic&rsquo; layer will include at least one reinforcing fiber. Such a structure would be used in conjunction with another CWC, or &lsquo;anisotropic viscoelastic&rsquo;, or isotropic layer.&rdquo;</PDAT></PTEXT></PARA>
<PARA ID="P-00137" LVL="0"><PTEXT><PDAT>An apparatus </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT> for practicing an embodiment of a method of manufacturing continuous wave pre-preg materials is illustrated in FIG. </PDAT><HIL><BOLD><PDAT>7</PDAT></BOLD></HIL><PDAT>. The basic process is described using polymer matrices containing carbon fibers for illustrative purposes and should not be construed as limiting the design or application of the machine. This example machine is capable of producing any number of different wavy patterns, combined patterns, and computer generated patterns optimized for a specific structure.</PDAT></PTEXT></PARA>
<PARA ID="P-00138" LVL="0"><PTEXT><PDAT>Continuous fibers </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT> are fed into the machine </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT> from a series of spools with tension adjusters (not shown). The fibers </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT> are moved over rollers </PDAT><HIL><BOLD><PDAT>104</PDAT></BOLD></HIL><PDAT> to obtain a tow of fibers </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT> uniformly spaced apart and flattened so as to have a uniform thickness. The uniform fiber tow is then pulled through a set of pinch rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> which place sufficient compression on the tow to prevent lateral slippage of the fibers </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT> when relative axially movement occurs between the pinch rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> and a second set of pinch rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>. (In a prototype machine, pinch rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> are held fixed to the machine frame, and pinch rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> move axially along the rotation axis of the rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>; however, the rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> could alternately be fixed with the rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> movable axially. It is even possible to have both rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> movable, as long as there is a net relative movement between the two. Further, in the prototype machine, the rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> are rotated simply by the pull of the fiber therebetween).</PDAT></PTEXT></PARA>
<PARA ID="P-00139" LVL="0"><PTEXT><PDAT>The pinch rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> may be made of metals, hard rubber, or metal with a thin compliant material coating depending on the characteristics of the fiber. For carbon fiber, metal rollers with a thin compliant coating are preferred to prevent chopping or breakage of the fibers </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00140" LVL="0"><PTEXT><PDAT>The fibers </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT> are pulled through the second set of pinch rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> where one or more matrix materials </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> are combined with fibers </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT>. The matrix material may be in the form of rolled sheets carried by support rollers </PDAT><HIL><BOLD><PDAT>111</PDAT></BOLD></HIL><PDAT>. </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT> illustrates two paper sheets </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> (more generally &ldquo;support sheets&rdquo;) being brought together to sandwich the fibers </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT> In this example the paper sheets </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> have a thin coating of uncured polymer matrix which is thick and tacky at room temperature. The tackiness of the polymer matrix is sufficient to &ldquo;lock&rdquo; the fibers </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT> in place at the moment of contact with the paper sheets </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> without the addition of heat or other chemicals. Use of other materials may require the addition of heat and/or chemicals to lock the fiber pattern into place.</PDAT></PTEXT></PARA>
<PARA ID="P-00141" LVL="0"><PTEXT><PDAT>The matrix containing the fibers is then passed through a series of cylinders </PDAT><HIL><BOLD><PDAT>112</PDAT></BOLD></HIL><PDAT> which causes complete commingling of the matrix material </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> and fibers </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT>, and/or curing of the material </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT>. In the example of the polymer matrix containing the carbon fiber tow, the cylinders </PDAT><HIL><BOLD><PDAT>112</PDAT></BOLD></HIL><PDAT> are heated enough to cause complete wicking of the matrix material </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> into the fibers </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT>, but not enough to cure the matrix material </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT>. The pre-preg material so produced may then be rolled up on a drum </PDAT><HIL><BOLD><PDAT>114</PDAT></BOLD></HIL><PDAT> and placed in a freezer until ready to use on a composite structure as is normal for other conventional composite materials. When the pre-preg material is to be used, it is thawed at room temperature, laid up or wrapped on the structure to be damped (with or without a viscoelastic layer) and cured in an oven with heat lamps, or the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00142" LVL="0"><PTEXT><PDAT>Other materials (e.g. fibers and/or matrix) may require the addition of heat, controlled pressure, chemicals, or other processes to finish the production of the material, which could included shaping, curing, and/or cutting to final dimensions. The pre-preg material produced in accordance with </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT> may also be used in the process of </PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 9-11</PDAT></FGREF><PDAT> as described below.</PDAT></PTEXT></PARA>
<PARA ID="P-00143" LVL="0"><PTEXT><PDAT>A key to the manufacturing process is the differential movement of the two (or more) sets of rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>. For the example of carbon fibers in a polymer matrix, the enlarged portion of </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT> shows how relative movement of the rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>,</PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> along their parallel axes of rotation introduces an angle &thgr; of the fibers </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT> with respect to the longitudinal advance of the matrix. The angle &thgr; of the fiber tow may be set by computer control where the axial movement of the combination rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> is tied algorithmically to the rotary movement of the combination pinch rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>. In a prototype machine, the rotary position of the combination pinch rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> was used to compute its axial movement.</PDAT></PTEXT></PARA>
<PARA ID="P-00144" LVL="0"><PTEXT><PDAT>In the prototype machine, combination pinch rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> was fixed against axial movement. The pinch rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> apply sufficient compression force onto the fiber tow </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT> to prevent axial slippage of the fiber tow </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT> (relative to the pinch rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>) so that the fiber tow </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT> is displaced at the continuously controlled angle &thgr; relative to the combination pinch rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> by axial movement of the combination pinch rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00145" LVL="0"><PTEXT><PDAT>There are a host of other ways to control relative movement of the pinch rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>,</PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> along their axes of rotation, including but not limited to cams, linkages, mechanical devices, and including various methods of sensing, position control, and computer control. In the example, computer control was used because it could be combined with optimization, drafting, analysis, design, and other computer programs, to create a concept-to-production capability.</PDAT></PTEXT></PARA>
<PARA ID="P-00146" LVL="0"><PTEXT><PDAT>Also illustrated in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT> is the manner of controlling the relative axial movement of the rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>. In general, any desired waveform for the fibers may be made using axial movement of any one or both of the pairs of pinch rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>,</PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>. Thus, in the general case, drive mechanism </PDAT><HIL><BOLD><PDAT>118</PDAT></BOLD></HIL><PDAT> (such as a motor and appropriate gearing) and mechanical linkage </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT> is provided to control the axial motion of the pair of rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>, it being understood that the upper and lower rollers of the pair of rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> are mechanically linked to move together axially as well as rotationally. Similarly, a.mechanical linkage </PDAT><HIL><BOLD><PDAT>122</PDAT></BOLD></HIL><PDAT> is coupled to drive mechanism </PDAT><HIL><BOLD><PDAT>118</PDAT></BOLD></HIL><PDAT> to control the axial motion of the pairs of rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>, it being likewise understood that the upper and lower rollers of the pair of rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> are mechanically linked to move together axially as well as rotationally. In practice, it is only necessary to axially move one pair of pinch rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>,</PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> while keeping the other pair stationary. Thus, in the prototype apparatus, rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> are fixed against axial movement (linkage </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT> is not needed) while the drive mechanism </PDAT><HIL><BOLD><PDAT>118</PDAT></BOLD></HIL><PDAT> and mechanical linkage </PDAT><HIL><BOLD><PDAT>122</PDAT></BOLD></HIL><PDAT> is used to control the axial movement of rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00147" LVL="0"><PTEXT><PDAT>The rotational movement of rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>,</PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> may also be controlled by the control system described herein. For this purpose, a drive mechanism </PDAT><HIL><BOLD><PDAT>140</PDAT></BOLD></HIL><PDAT> is provided in the form of motors and appropriate mechanical linkages </PDAT><HIL><BOLD><PDAT>142</PDAT></BOLD></HIL><PDAT>. Such systems are conventionally used in fabricating fibers aligned in the direction of travel (&thgr; equals zero) of the fiber tow through the machine. In accordance with one aspect of the invention, however, the rotational velocity of rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>,</PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> is fixed, but, more generally, could be varied in cooperation with the relative axial movement of rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>,</PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> to produce the desired waveform of the tow. The rotary motor of the drive mechanism </PDAT><HIL><BOLD><PDAT>140</PDAT></BOLD></HIL><PDAT>, may thus be responsive to a rotation control signal to vary the speed of rotation of the rollers.</PDAT></PTEXT></PARA>
<PARA ID="P-00148" LVL="0"><PTEXT><PDAT>It is noted that the rotary motion of the rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>,</PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> need not be controlled in the same manner. For example, rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> can be rotated to pull the tow with roller </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> simply being rotated by the pull of the tow help tightly between the rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> without any driving force to the rollers. Further, it is possible to control the rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> to roll at a lower velocity from that of the rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> to account for the angular variations imparted to the tow. It is even possible that the rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> could be rotated in the counter direction of rotation of rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> to maintain the tow taught while laying some high &thgr; waveforms.</PDAT></PTEXT></PARA>
<PARA ID="P-00149" LVL="0"><PTEXT><PDAT>Control of the drive mechanism </PDAT><HIL><BOLD><PDAT>118</PDAT></BOLD></HIL><PDAT> and the mechanical linkage </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT> is governed by a control system </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> which is generally an electronic controller and may comprise a programmed data processor or digital computer (e.g., microprocessor) having an input device </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> such as a keyboard. The control system </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> may be programmed to generate waveform control signals to the drive mechanism </PDAT><HIL><BOLD><PDAT>118</PDAT></BOLD></HIL><PDAT> to thus move the rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> axially in such a manner that, when coupled to the known rotational speed of the rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>,</PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>, produces a waveform having desired period, amplitude or shape characteristics. The waveforms shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 1-6</PDAT></FGREF><PDAT> are examples of such waveforms. It is also possible to couple the axial motion of the rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> to the rotational position of the rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> For this purpose, a position sensor </PDAT><HIL><BOLD><PDAT>134</PDAT></BOLD></HIL><PDAT> is provided which generates pulses at regular angular intervals of the rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>. These position pulses are fed along lines </PDAT><HIL><BOLD><PDAT>136</PDAT></BOLD></HIL><PDAT> as an input to the control system </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> and used in the control algorithm to control the axial movement of the rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>. Alternatively, the control system may assume a fixed rotational speed of the rollers </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> as an input to the control algorithm.</PDAT></PTEXT></PARA>
<PARA ID="P-00150" LVL="0"><PTEXT><PDAT>As an example of implementing the above described control procedures, one may employ stepper motors and simple automated controls to place a waveform in the prepreg. The control of the machine was accomplished with the following algorithm and pseudo code, designed to produce a sine like wave. All comments are referenced to FIG. </PDAT><HIL><BOLD><PDAT>7</PDAT></BOLD></HIL><PDAT>. The stepper motor employed in a prototype machine was a S83-93-MO stepper motor and the software employed was Compumotor&apos;s &ldquo;Motion Architect v3.32&rdquo; for the 6200 series controller. Other types of motor controls may be used including servo systems and the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00151" LVL="0"><PTEXT><PDAT>Variable definitions:</PDAT></PTEXT></PARA>
<PARA ID="P-00152" LVL="2"><PTEXT><PDAT>&thgr;</PDAT><HIL><SB><PDAT>0 </PDAT></SB></HIL><PDAT>is the maximum angle of the wave form;</PDAT></PTEXT></PARA>
<PARA ID="P-00153" LVL="2"><PTEXT><PDAT>&thgr; is the angle at any given position;</PDAT></PTEXT></PARA>
<PARA ID="P-00154" LVL="2"><PTEXT><PDAT>L is the period of the half wave form;</PDAT></PTEXT></PARA>
<PARA ID="P-00155" LVL="2"><PTEXT><PDAT>V</PDAT><HIL><SB><PDAT>x </PDAT></SB></HIL><PDAT>is the constant feed speed of the rollers (</PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>);</PDAT></PTEXT></PARA>
<PARA ID="P-00156" LVL="2"><PTEXT><PDAT>D is the perpendicular distance between pinch rollers (</PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> &amp; </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>);</PDAT></PTEXT></PARA>
<PARA ID="P-00157" LVL="2"><PTEXT><PDAT>&Dgr;h is the step size of one coordinated move; </PDAT>
<CWU>
<MATH-US ID="MATH-US-00002">
<MATHEMATICA ID="MATHEMATICA-00002" ALT="mathematica file" FILE="US06467521-20021022-M00002.NB"/>
<MATHML>
<math>
  <mtable>
    <mtr>
      <mtd>
        <mrow>
          <mrow>
            <mi>&Delta;</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>t</mi>
          </mrow>
          <mo>=</mo>
          <mfrac>
            <mrow>
              <mi>&Delta;</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>h</mi>
            </mrow>
            <msub>
              <mi>V</mi>
              <mi>x</mi>
            </msub>
          </mfrac>
        </mrow>
      </mtd>
      <mtd>
        <mstyle>
          <mtext>Calculated time for a given move</mtext>
        </mstyle>
      </mtd>
    </mtr>
  </mtable>
</math>


<math>
  <mstyle>
    <mtext>Begin the wavy pattern compiled loop for both axis</mtext>
  </mstyle>
</math>


<math>
  <mtable>
    <mtr>
      <mtd>
        <mrow>
          <mrow>
            <msub>
              <mi>X</mi>
              <mrow>
                <mi>i</mi>
                <mo>+</mo>
                <mn>1</mn>
              </mrow>
            </msub>
            <mo>=</mo>
            <mrow>
              <msub>
                <mi>X</mi>
                <mi>i</mi>
              </msub>
              <mo>+</mo>
              <mrow>
                <mi>&Delta;</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>h</mi>
              </mrow>
            </mrow>
          </mrow>
          <mo>&it;</mo>
          <mstyle>
            <mtext>&emsp;</mtext>
          </mstyle>
        </mrow>
      </mtd>
      <mtd>
        <mrow>
          <mi>X</mi>
          <mo>&it;</mo>
          <mrow>
            <mo>(</mo>
            <mrow>
              <mi>i</mi>
              <mo>+</mo>
              <mn>1</mn>
            </mrow>
            <mo>)</mo>
          </mrow>
          <mo>&it;</mo>
          <mstyle>
            <mtext>&emsp;</mtext>
          </mstyle>
          <mo>&it;</mo>
          <mstyle>
            <mtext>position</mtext>
          </mstyle>
        </mrow>
      </mtd>
    </mtr>
  </mtable>
</math>


<math>
  <mrow>
    <mtable>
      <mtr>
        <mtd>
          <mrow>
            <mi>&theta;</mi>
            <mo>=</mo>
            <mrow>
              <mrow>
                <msub>
                  <mi>&theta;</mi>
                  <mn>0</mn>
                </msub>
                <mo>&CenterDot;</mo>
                <mi>Cos</mi>
              </mrow>
              <mo>&it;</mo>
              <mrow>
                <mo>(</mo>
                <mfrac>
                  <mrow>
                    <mi>&pi;</mi>
                    <mo>&CenterDot;</mo>
                    <msub>
                      <mi>x</mi>
                      <mrow>
                        <mi>i</mi>
                        <mo>+</mo>
                        <mn>1</mn>
                      </mrow>
                    </msub>
                  </mrow>
                  <mi>L</mi>
                </mfrac>
                <mo>)</mo>
              </mrow>
            </mrow>
          </mrow>
        </mtd>
        <mtd>
          <mstyle>
            <mtext>The angle calculation as a function of linear&NewLine;x-position of the feed rollers (108) for a&NewLine;simple sine wave of period 2L where the&NewLine;maximum angle is controlled.</mtext>
          </mstyle>
        </mtd>
      </mtr>
      <mtr>
        <mtd>
          <mrow>
            <msub>
              <mi>y</mi>
              <mrow>
                <mi>i</mi>
                <mo>+</mo>
                <mn>1</mn>
              </mrow>
            </msub>
            <mo>=</mo>
            <mrow>
              <mrow>
                <mi>D</mi>
                <mo>&CenterDot;</mo>
                <mi>tan</mi>
              </mrow>
              <mo>&it;</mo>
              <mrow>
                <mo>(</mo>
                <mi>&theta;</mi>
                <mo>)</mo>
              </mrow>
            </mrow>
          </mrow>
        </mtd>
        <mtd>
          <mrow>
            <mstyle>
              <mtext>The calculated</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mrow>
              <mi>y</mi>
              <mo>&af;</mo>
              <mrow>
                <mo>(</mo>
                <mrow>
                  <mi>i</mi>
                  <mo>+</mo>
                  <mn>1</mn>
                </mrow>
                <mo>)</mo>
              </mrow>
            </mrow>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mstyle>
              <mtext>position</mtext>
            </mstyle>
          </mrow>
        </mtd>
      </mtr>
      <mtr>
        <mtd>
          <mrow>
            <mrow>
              <mi>&Delta;</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>y</mi>
            </mrow>
            <mo>=</mo>
            <mrow>
              <msub>
                <mi>y</mi>
                <mrow>
                  <mi>i</mi>
                  <mo>+</mo>
                  <mn>1</mn>
                </mrow>
              </msub>
              <mo>-</mo>
              <msub>
                <mi>y</mi>
                <mi>i</mi>
              </msub>
            </mrow>
          </mrow>
        </mtd>
        <mtd>
          <mstyle>
            <mtext>Delta </mtext>


            <mtext>y</mtext>
          </mstyle>
        </mtd>
      </mtr>
      <mtr>
        <mtd>
          <mrow>
            <msub>
              <mi>V</mi>
              <mi>y</mi>
            </msub>
            <mo>=</mo>
            <mrow>
              <mo>&LeftBracketingBar;</mo>
              <mfrac>
                <mrow>
                  <mi>&Delta;</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>y</mi>
                </mrow>
                <mrow>
                  <mi>&Delta;</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>t</mi>
                </mrow>
              </mfrac>
              <mo>&RightBracketingBar;</mo>
            </mrow>
          </mrow>
        </mtd>
        <mtd>
          <mstyle>
            <mtext>Compute absolute velocity</mtext>
          </mstyle>
        </mtd>
      </mtr>
      <mtr>
        <mtd>
          <msub>
            <mi>V</mi>
            <mi>y</mi>
          </msub>
        </mtd>
        <mtd>
          <mstyle>
            <mtext>the absolute velocity of the y-axis move</mtext>
          </mstyle>
        </mtd>
      </mtr>
      <mtr>
        <mtd>
          <mrow>
            <mi>D</mi>
            <mo>&af;</mo>
            <mrow>
              <mo>(</mo>
              <mrow>
                <msub>
                  <mi>x</mi>
                  <mrow>
                    <mi>i</mi>
                    <mo>+</mo>
                    <mn>1</mn>
                  </mrow>
                </msub>
                <mo>,</mo>
                <msub>
                  <mi>y</mi>
                  <mrow>
                    <mi>i</mi>
                    <mo>+</mo>
                    <mn>1</mn>
                  </mrow>
                </msub>
              </mrow>
              <mo>)</mo>
            </mrow>
          </mrow>
        </mtd>
        <mtd>
          <mstyle>
            <mtext>Distance command</mtext>
          </mstyle>
        </mtd>
      </mtr>
      <mtr>
        <mtd>
          <mrow>
            <mi>V</mi>
            <mo>&af;</mo>
            <mrow>
              <mo>(</mo>
              <mrow>
                <msub>
                  <mi>V</mi>
                  <mi>x</mi>
                </msub>
                <mo>,</mo>
                <msub>
                  <mi>V</mi>
                  <mi>y</mi>
                </msub>
              </mrow>
              <mo>)</mo>
            </mrow>
          </mrow>
        </mtd>
        <mtd>
          <mstyle>
            <mtext>Velocity command</mtext>
          </mstyle>
        </mtd>
      </mtr>
    </mtable>
    <mo>&it;</mo>
    <mstyle>
      <mtext>&emsp;</mtext>
    </mstyle>
  </mrow>
</math>
</MATHML>
<EMI ID="EMI-M00002" ALT="embedded image" FILE="US06467521-20021022-M00002.TIF"/>
</MATH-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00158" LVL="0"><PTEXT><PDAT>It will be appreciated by those of skill in the art that many types of waveforms could be created using a similar method as described above. A fourier series expansion may be used to represent nearly any desired waveform and the computer may be programmed to output the new x,y position data (and V</PDAT><HIL><SB><PDAT>x</PDAT></SB></HIL><PDAT>, V</PDAT><HIL><SB><PDAT>y </PDAT></SB></HIL><PDAT>velocity date) corresponding of the incremental changes in &thgr;.</PDAT></PTEXT></PARA>
<PARA ID="P-00159" LVL="0"><PTEXT><PDAT>As another example, the amplitude &ldquo;y&rdquo; shown in the right hand side of </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 4</PDAT></FGREF><PDAT> may be represented by the formula: </PDAT>
<CWU>
<MATH-US ID="MATH-US-00003">
<MATHEMATICA ID="MATHEMATICA-00003" ALT="mathematica file" FILE="US06467521-20021022-M00003.NB"/>
<MATHML>
<math>
<mrow>
  <mi>y</mi>
  <mo>=</mo>
  <mrow>
    <mrow>
      <mi>Y</mi>
      <mo>&af;</mo>
      <mrow>
        <mo>(</mo>
        <mi>x</mi>
        <mo>)</mo>
      </mrow>
    </mrow>
    <mo>&af;</mo>
    <mrow>
      <mo>[</mo>
      <mrow>
        <mrow>
          <mrow>
            <mi>A</mi>
            <mo>&af;</mo>
            <mrow>
              <mo>(</mo>
              <mi>x</mi>
              <mo>)</mo>
            </mrow>
          </mrow>
          <mo>*</mo>
          <mrow>
            <mi>sin</mi>
            <mo>&af;</mo>
            <mrow>
              <mo>(</mo>
              <mfrac>
                <mrow>
                  <mi>n</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>&pi;</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>x</mi>
                </mrow>
                <mi>L</mi>
              </mfrac>
              <mo>)</mo>
            </mrow>
          </mrow>
        </mrow>
        <mo>+</mo>
        <mrow>
          <mrow>
            <mi>B</mi>
            <mo>&af;</mo>
            <mrow>
              <mo>(</mo>
              <mi>x</mi>
              <mo>)</mo>
            </mrow>
          </mrow>
          <mo>*</mo>
          <mrow>
            <mi>sin</mi>
            <mo>&af;</mo>
            <mrow>
              <mo>(</mo>
              <mfrac>
                <mrow>
                  <mi>&pi;</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>x</mi>
                </mrow>
                <mi>L</mi>
              </mfrac>
              <mo>)</mo>
            </mrow>
          </mrow>
        </mrow>
      </mrow>
      <mo>]</mo>
    </mrow>
  </mrow>
</mrow>
</math>
</MATHML>
<EMI ID="EMI-M00003" ALT="embedded image" FILE="US06467521-20021022-M00003.TIF"/>
</MATH-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00160" LVL="0"><PTEXT><PDAT>The equation shows the general form where Y, A and B are functions of x, but in practice, some or all of these may be constants. Y(x) is used to control the maximum amplitude of the wave. In reference to the claims, variations in amplitude should thus be interpreted to be defined by variations in Y(x) and not Y. A(x) and B(x) are weighing factors to weigh the two different constituent waveforms.</PDAT></PTEXT></PARA>
<PARA ID="P-00161" LVL="0"><PTEXT><PDAT>The above formula may be used in a control system that specifies position. To set the angle of the fibers, the following formula may be used with the example controller (Compumotor series 6200) and substituted in place of the simple sine wave formula given above. </PDAT>
<CWU>
<MATH-US ID="MATH-US-00004">
<MATHEMATICA ID="MATHEMATICA-00004" ALT="mathematica file" FILE="US06467521-20021022-M00004.NB"/>
<MATHML>
<math>
<mrow>
  <mi>&theta;</mi>
  <mo>=</mo>
  <mrow>
    <msub>
      <mi>&theta;</mi>
      <mn>0</mn>
    </msub>
    <mo>&CenterDot;</mo>
    <mrow>
      <mo>[</mo>
      <mrow>
        <mrow>
          <mrow>
            <mi>A</mi>
            <mo>&af;</mo>
            <mrow>
              <mo>(</mo>
              <mi>x</mi>
              <mo>)</mo>
            </mrow>
          </mrow>
          <mo>*</mo>
          <mrow>
            <mi>Cos</mi>
            <mo>&af;</mo>
            <mrow>
              <mo>(</mo>
              <mfrac>
                <mrow>
                  <mi>n</mi>
                  <mo>&CenterDot;</mo>
                  <mi>&pi;</mi>
                  <mo>&CenterDot;</mo>
                  <msub>
                    <mi>x</mi>
                    <mrow>
                      <mi>i</mi>
                      <mo>+</mo>
                      <mn>1</mn>
                    </mrow>
                  </msub>
                </mrow>
                <mi>L</mi>
              </mfrac>
              <mo>)</mo>
            </mrow>
          </mrow>
        </mrow>
        <mo>+</mo>
        <mrow>
          <mrow>
            <mi>B</mi>
            <mo>&af;</mo>
            <mrow>
              <mo>(</mo>
              <mi>x</mi>
              <mo>)</mo>
            </mrow>
          </mrow>
          <mo>*</mo>
          <mrow>
            <mi>Cos</mi>
            <mo>&af;</mo>
            <mrow>
              <mo>(</mo>
              <mfrac>
                <mrow>
                  <mi>&pi;</mi>
                  <mo>&CenterDot;</mo>
                  <msub>
                    <mi>x</mi>
                    <mrow>
                      <mi>i</mi>
                      <mo>+</mo>
                      <mn>1</mn>
                    </mrow>
                  </msub>
                </mrow>
                <mi>L</mi>
              </mfrac>
              <mo>)</mo>
            </mrow>
          </mrow>
        </mrow>
      </mrow>
      <mo>]</mo>
    </mrow>
  </mrow>
</mrow>
</math>
</MATHML>
<EMI ID="EMI-M00004" ALT="embedded image" FILE="US06467521-20021022-M00004.TIF"/>
</MATH-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00162" LVL="7"><PTEXT><PDAT>The above formula represents the angle calculation as a function of linear x-position of the feed rollers (</PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>) for a compound sine wave of period 2L/n superimposed on a wave of period 2L where the maximum angle &thgr;</PDAT><HIL><SB><PDAT>0 </PDAT></SB></HIL><PDAT>is controlled. Again, A(x) and B(x) are weighting factors for the two different waveforms. The angle &thgr;</PDAT><HIL><SB><PDAT>0 </PDAT></SB></HIL><PDAT>may also be a function of x. This equation above may be substituted for the equation shown in the example of the stepper motor algorithm and would produce a mixed waveform similar to the left hand side of FIG. </PDAT><HIL><BOLD><PDAT>4</PDAT></BOLD></HIL><PDAT>. (In </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 4</PDAT></FGREF><PDAT>, A&equals;0.2 and B&equals;0.8).</PDAT></PTEXT></PARA>
<PARA ID="P-00163" LVL="0"><PTEXT><PDAT>Optimization of this wave form would be accomplished by varying the weight of each sine wave component, &ldquo;n&rdquo; the number of smaller waves, L the length of the larger wave period, and &thgr;</PDAT><HIL><SB><PDAT>0 </PDAT></SB></HIL><PDAT>the maximum angle of the fiber lay. This could be done by an optimization routine or by a design-of-experiments (DOE). If done by an optimization program, the outputs (stiffness and damping) would be weighted based upon their relative importance and iterative calculations accomplished to determine the design space and optimal combinations of parameters. If the parameters are optimized by a design-of-experiments, levels would be chosen for each factor and a test matrix would be chosen to determine the optimal combinations. For example, one factor is the wave period of the larger wave (2L). The designer may chose three levels for L of 2, 3, and 4 (inches) so that a non-linear estimate could be obtained for the final optimized design. A good reference for designs-of-experiments may be found in </PDAT><HIL><ITALIC><PDAT>Taguchi Techniques for Quality Engineering</PDAT></ITALIC></HIL><PDAT>, by Phillip J Ross, McGraw-Hill Book Company, 1988, incorporated herein by reference.</PDAT></PTEXT></PARA>
<PARA ID="P-00164" LVL="0"><PTEXT><PDAT>As another example, the outermost waveform at the bottom of </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 3</PDAT></FGREF><PDAT> may be represented by &ldquo;y&rdquo; in a control system that specifies position by using the following formula: </PDAT>
<CWU>
<MATH-US ID="MATH-US-00005">
<MATHEMATICA ID="MATHEMATICA-00005" ALT="mathematica file" FILE="US06467521-20021022-M00005.NB"/>
<MATHML>
<math>
<mrow>
  <mi>y</mi>
  <mo>=</mo>
  <mrow>
    <msub>
      <mi>Y</mi>
      <mn>0</mn>
    </msub>
    <mo>*</mo>
    <mrow>
      <mi>sin</mi>
      <mo>&af;</mo>
      <mrow>
        <mo>(</mo>
        <mfrac>
          <mrow>
            <mi>&pi;</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>x</mi>
          </mrow>
          <mrow>
            <mi>L</mi>
            <mo>-</mo>
            <mfrac>
              <mi>x</mi>
              <mi>A</mi>
            </mfrac>
          </mrow>
        </mfrac>
        <mo>)</mo>
      </mrow>
    </mrow>
  </mrow>
</mrow>
</math>
</MATHML>
<EMI ID="EMI-M00005" ALT="embedded image" FILE="US06467521-20021022-M00005.TIF"/>
</MATH-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00165" LVL="0"><PTEXT><PDAT>The formula shown above represents a constant amplitude as shown in the </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 3</PDAT></FGREF><PDAT>, where L is the wave period at the start and A is the wave period modifier. (In the more general case, both Y</PDAT><HIL><SB><PDAT>0 </PDAT></SB></HIL><PDAT>and A may be functions of x). To determine the angle of a similar variable period wave where the maximum angle is held constant, the following formula would be used with the example controller (Compumotor series 6200) and substituted in place of the simple sine wave formula used in the first example. </PDAT>
<CWU>
<MATH-US ID="MATH-US-00006">
<MATHEMATICA ID="MATHEMATICA-00006" ALT="mathematica file" FILE="US06467521-20021022-M00006.NB"/>
<MATHML>
<math>
<mrow>
  <mi>&theta;</mi>
  <mo>=</mo>
  <mrow>
    <msub>
      <mi>&theta;</mi>
      <mn>0</mn>
    </msub>
    <mo>&CenterDot;</mo>
    <mrow>
      <mi>Cos</mi>
      <mo>&af;</mo>
      <mrow>
        <mo>(</mo>
        <mfrac>
          <mrow>
            <mi>&pi;</mi>
            <mo>&CenterDot;</mo>
            <msub>
              <mi>x</mi>
              <mrow>
                <mi>i</mi>
                <mo>+</mo>
                <mn>1</mn>
              </mrow>
            </msub>
          </mrow>
          <mrow>
            <mi>L</mi>
            <mo>-</mo>
            <mfrac>
              <msub>
                <mi>x</mi>
                <mrow>
                  <mi>i</mi>
                  <mo>+</mo>
                  <mn>1</mn>
                </mrow>
              </msub>
              <mi>A</mi>
            </mfrac>
          </mrow>
        </mfrac>
        <mo>)</mo>
      </mrow>
    </mrow>
  </mrow>
</mrow>
</math>
</MATHML>
<EMI ID="EMI-M00006" ALT="embedded image" FILE="US06467521-20021022-M00006.TIF"/>
</MATH-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00166" LVL="0"><PTEXT><PDAT>The above equation shows the angle calculation as a function of linear x-position of the feed rollers (</PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>) (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT>) for a variable period sine wave of beginning period 2L modified by the factor A, where the maximum angle is controlled. In general, &thgr; and A may be functions of x. Optimization of this wave form would vary the wave period (variable A), L the length of the beginning wave period, and &thgr; the maximum angle of the fiber lay. This could be done by an optimization routine or by a design-of-experiments (DOE). If done by an optimization program, the outputs (stiffness and damping) would be weighted based upon their relative importance and iterative calculations accomplished to determine the design space and optimal combinations of parameters. If the parameters are optimized by a design-of-experiments, levels would be chosen for each factor and a test matrix would be chosen to determine the optimal combinations. For example, one factor is the wave period of the beginning wave (2L). The designer may chose three levels for A and three for L so that a non-linear estimate could be obtained for the final optimized design. Again the Ross text mentioned above is a good reference.</PDAT></PTEXT></PARA>
<PARA ID="P-00167" LVL="0"><PTEXT><PDAT>It is also envisioned that instead of individual fibers </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT>, a woven mat or fiber cloth may be used with the process and apparatus described in connection with FIG. </PDAT><HIL><BOLD><PDAT>7</PDAT></BOLD></HIL><PDAT>. This would eliminate the need for the fiber arranging function performed by the rollers </PDAT><HIL><BOLD><PDAT>104</PDAT></BOLD></HIL><PDAT>. Instead, the woven mat or fiber cloth would be unwound from a spool and directly passed through the pinch rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>. The pinch rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> would keep the woven mat or fiber cloth from slipping and the side to side movement described above would produce a fiber pre-preg woven mat with a desired wave pattern.</PDAT></PTEXT></PARA>
<PARA ID="P-00168" LVL="0"><PTEXT><PDAT>The basic process described above may also be used with a fiber winding machine that is capable of placing a controlled fiber wave pattern on a structure in a continuous process. As described above, this machine also has the flexibility of producing any number of wave patterns tailored to the dynamics of a specific structure.</PDAT></PTEXT></PARA>
<PARA ID="P-00169" LVL="0"><PTEXT><PDAT>One of the beneficial aspects of the way CWC is made according to </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT> is that the fiber volume fraction changes as a function of angle &thgr;. This results in a prepreg that increases its strength where the angle deviates from 0&deg; unlike conventional prepregs. There are many composite structures with curved surfaces or that require abrupt changes in fiber direction that could benefit from stronger composite at the bends and thus utilize the invention as described herein.</PDAT></PTEXT></PARA>
<PARA ID="P-00170" LVL="0"><PTEXT><PDAT>It is known, for example, that the elastic moduli of unidirectional composites can be predicted from the properties and volume fractions of the constituents. See, S. W. Tsai and H. Thomas Hann, </PDAT><HIL><ITALIC><PDAT>Introduction to Composite Materials</PDAT></ITALIC></HIL><PDAT>, pp. 317-405, 1980, incorporated herein by reference. As an example, one such modulus important in prediction of bending and axial response is the equivalent modulus in the axial direction (E</PDAT><HIL><SB><PDAT>11</PDAT></SB></HIL><PDAT>) of a tube which is a function of the angle and the various Young&apos;s modulii of the material. The effect of increasing volume fraction on the stiffness of the prepreg can be illustrated by showing its effect on the longitudinal Young&apos;s modulus E</PDAT><HIL><SB><PDAT>x</PDAT></SB></HIL><PDAT>, (the modulus in the primary fiber direction but which is the main contribution to the equivalent modulus in the axial direction. See Tsai et al. p. 87. E</PDAT><HIL><SB><PDAT>x </PDAT></SB></HIL><PDAT>is given by: </PDAT>
<CWU>
<MATH-US ID="MATH-US-00007">
<MATHEMATICA ID="MATHEMATICA-00007" ALT="mathematica file" FILE="US06467521-20021022-M00007.NB"/>
<MATHML>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>v</mi>
          <mi>f</mi>
        </msub>
        <mo>=</mo>
        <mstyle>
          <mtext>&emsp;</mtext>
        </mstyle>
        <mo>&it;</mo>
        <mfrac>
          <msub>
            <mi>Vol</mi>
            <mi>fiber</mi>
          </msub>
          <msub>
            <mi>Vol</mi>
            <mi>total</mi>
          </msub>
        </mfrac>
      </mrow>
    </mtd>
  </mtr>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>v</mi>
          <mi>m</mi>
        </msub>
        <mo>=</mo>
        <mstyle>
          <mtext>&emsp;</mtext>
        </mstyle>
        <mo>&it;</mo>
        <mfrac>
          <msub>
            <mi>Vol</mi>
            <mi>matrix</mi>
          </msub>
          <msub>
            <mi>Vol</mi>
            <mi>total</mi>
          </msub>
        </mfrac>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
</MATHML>
<EMI ID="EMI-M00007" ALT="embedded image" FILE="US06467521-20021022-M00007.TIF"/>
</MATH-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00171" LVL="7"><PTEXT><PDAT>However, in CWC prepreg materials, the volume fraction changes as a function of the angle: </PDAT>
<CWU>
<MATH-US ID="MATH-US-00008">
<MATHEMATICA ID="MATHEMATICA-00008" ALT="mathematica file" FILE="US06467521-20021022-M00008.NB"/>
<MATHML>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>Vol</mi>
          <mi>fiber</mi>
        </msub>
        <mo>=</mo>
        <mstyle>
          <mtext>&emsp;</mtext>
        </mstyle>
        <mo>&it;</mo>
        <mfrac>
          <msub>
            <mi>Vol</mi>
            <mrow>
              <mi>fiber</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>at</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>&theta;</mi>
            </mrow>
          </msub>
          <mrow>
            <mi>Cos</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>&theta;</mi>
          </mrow>
        </mfrac>
      </mrow>
    </mtd>
  </mtr>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>Vol</mi>
          <mi>total</mi>
        </msub>
        <mo>=</mo>
        <mstyle>
          <mtext>&emsp;</mtext>
        </mstyle>
        <mo>&it;</mo>
        <mrow>
          <mfrac>
            <msub>
              <mi>Vol</mi>
              <mrow>
                <mi>fiber</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>at</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>&theta;</mi>
              </mrow>
            </msub>
            <mrow>
              <mi>Cos</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>&theta;</mi>
            </mrow>
          </mfrac>
          <mo>+</mo>
          <msub>
            <mi>Vol</mi>
            <mi>matrix</mi>
          </msub>
        </mrow>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
</MATHML>
<EMI ID="EMI-M00008" ALT="embedded image" FILE="US06467521-20021022-M00008.TIF"/>
</MATH-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00172" LVL="7"><PTEXT><PDAT>Using typical values of carbon fiber and epoxy matrix, a 30&deg; fiber angle would increase the longitudinal Young&apos;s modulus E</PDAT><HIL><SB><PDAT>x </PDAT></SB></HIL><PDAT>by about 7% and E</PDAT><HIL><SB><PDAT>11 </PDAT></SB></HIL><PDAT>by about 5% for a 50% fiber volume fraction (at 0&deg;) prepreg. As the 0&deg; fiber volume fraction becomes greater, the modulus increases.</PDAT></PTEXT></PARA>
<PARA ID="P-00173" LVL="0"><PTEXT><PDAT>One possible use for CWC prepregs (without the use of viscoelastic layers) would be curved parts similar to elbows, where the lay of the fiber was designed to follow the general curve of the part. Another possibility is to use CWC prepregs in more conventional cross ply laminate lay-ups where differing patterns or offsets are used to give the structure unique qualities.</PDAT></PTEXT></PARA>
<PARA ID="P-00174" LVL="0"><PTEXT><PDAT>Resin pre-impregnated wavy pattern fiber composites fabricated according to the apparatus shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT> have the key characteristic that their fiber volume fraction changes as a function of the angle deviation from 0&deg;. Such volume fraction changes also take place in woven fabrics with wave like forms. The key characteristic of all of these patterns is that they increase fiber volume as a function of the angle. Moreover, the volume fraction change is not limited to the use of carbon fibers or conventional resin matrix materials but extends to include metallic or other fibers and ceramic or sintered metal matrixes. Generally, the wave forms made in accordance with an embodiment of the invention may be characterized as any wave form which can be described by a polynomial series, fourier series, bezier, NUPB (Non-Uniform Rational B-spline), periodic, non-periodic, random or pseudo-random method which has at least one continuous fiber and which has the key characteristic of changing fiber volume fraction.</PDAT></PTEXT></PARA>
<PARA ID="P-00175" LVL="0"><PTEXT><PDAT>The fact that we can &ldquo;bend&rdquo; the fibers in a prepreg has application and benefit outside of damping structures. For example, there are many small molded parts with bends and curvature which can be made much more easily and are stronger by using pieces cut from a continuous wave. One of the significant problems of molded composites is trying to get the fibers to &ldquo;bend&rdquo; around the curvature.</PDAT></PTEXT></PARA>
<PARA ID="P-00176" LVL="0"><PTEXT><PDAT>As an example, a composite wave form of the kind shown </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 8A</PDAT></FGREF><PDAT> may be made utilizing the apparatus of </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT> for lay-up in a mold which requires a curve at the end. The prepreg with the pattern of </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 8A</PDAT></FGREF><PDAT> could be cut as shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 8B</PDAT></FGREF><PDAT>, and the pieces used in molds to produce stronger curved members. A typical example that could benefit from this technology would be the ends of modern helicopter blades where the blade tips are swept back. Added strength at the critical bending region is provided by the increase in density where the fiber lay deviates from 0&deg;.</PDAT></PTEXT></PARA>
<PARA ID="P-00177" LVL="0"><PTEXT><PDAT>As shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 9</PDAT></FGREF><PDAT>, a structure or workpiece W can be held stationary or fed into the machine </PDAT><HIL><BOLD><PDAT>200</PDAT></BOLD></HIL><PDAT>. </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 9</PDAT></FGREF><PDAT> illustrates a side view of the workpiece, and the workpiece itself may be of cylindrical or rectangular shape and is typically not rotated. A tow ring </PDAT><HIL><BOLD><PDAT>202</PDAT></BOLD></HIL><PDAT> is partially rotated back and forth around the workpiece W. For example, the tow ring </PDAT><HIL><BOLD><PDAT>202</PDAT></BOLD></HIL><PDAT> may rotate clockwise 20 degrees and then counter-clockwise 20 degrees as the workpiece moves from right to left in the figure. This procedure produces a sinewave pattern as shown. Alternately, the tow ring </PDAT><HIL><BOLD><PDAT>202</PDAT></BOLD></HIL><PDAT> may translate from left to right in the drawing to achieve the same relative translational movement. In yet another embodiment, the tow ring </PDAT><HIL><BOLD><PDAT>202</PDAT></BOLD></HIL><PDAT> can be stationary and the workpiece can rotate back and forth. In principle it is only necessary to provide a relative translational and rotational movement between the workpiece and the tow ring </PDAT><HIL><BOLD><PDAT>202</PDAT></BOLD></HIL><PDAT>. Production of a wavy pattern directly on the workpiece enhances the strength of the workpiece.</PDAT></PTEXT></PARA>
<PARA ID="P-00178" LVL="0"><PTEXT><PDAT>As the workpiece W is fed into the machine </PDAT><HIL><BOLD><PDAT>200</PDAT></BOLD></HIL><PDAT> and the fiber tow </PDAT><HIL><BOLD><PDAT>204</PDAT></BOLD></HIL><PDAT> is positioned, fiber reinforced viscoelastic tape </PDAT><HIL><BOLD><PDAT>206</PDAT></BOLD></HIL><PDAT> is wound around the workpiece W to hold the fiber tow </PDAT><HIL><BOLD><PDAT>204</PDAT></BOLD></HIL><PDAT> in place with respect to the workpiece W. The fiber reinforcement in the wound viscoelastic tape </PDAT><HIL><BOLD><PDAT>206</PDAT></BOLD></HIL><PDAT> provides additional strength to the viscoelastic material to lock the fiber tow </PDAT><HIL><BOLD><PDAT>204</PDAT></BOLD></HIL><PDAT> in place. Alternately, in some applications, viscoelastic tape without the fiber reinforcement may be used to secure the fiber tow in place. While this example uses a &ldquo;wet&rdquo; or resin impregnated fiber tow </PDAT><HIL><BOLD><PDAT>204</PDAT></BOLD></HIL><PDAT>, the process may also be performed with a dry fiber tow, i.e. a fiber tow without resin. In this case additional equipment, such as a spray nozzle </PDAT><HIL><BOLD><PDAT>220</PDAT></BOLD></HIL><PDAT>, may be used to deposit a thin layer of resin in front of the viscoelastic tape </PDAT><HIL><BOLD><PDAT>206</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00179" LVL="0"><PTEXT><PDAT>Where dampening is desired, it is advantageous to utilize the viscoelastic tape (with or without the fiber reinforcements) as described.</PDAT></PTEXT></PARA>
<PARA ID="P-00180" LVL="0"><PTEXT><PDAT>In yet another embodiment, the viscoelastic tape may be omitted. In this case the wavy pattern needs to be fixed rather quickly after being laid down on the workpiece. To achieve this fixation, the resin may be cooled quickly upon contact with the fibers to thus harden and secure the fibers in place. Cooling may be achieved by cooling the workpiece itself or providing outside cooling to the area of contact between the resin and the fibers.</PDAT></PTEXT></PARA>
<PARA ID="P-00181" LVL="0"><PTEXT><PDAT>It is also possible to use a viscoelastic tape </PDAT><HIL><BOLD><PDAT>206</PDAT></BOLD></HIL><PDAT> that would also serve as the matrix for the fiber tow </PDAT><HIL><BOLD><PDAT>204</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00182" LVL="0"><PTEXT><PDAT>In the example given above, a completed workpiece W would be placed in an oven for curing as is normal for conventional composite materials. Other materials (e.g. fibers and/or matrix) may require the addition of heat, controlled pressure, chemicals, or other processes to finish the production of the material, which could included shaping, curing, and/or cutting to final dimensions.</PDAT></PTEXT></PARA>
<PARA ID="P-00183" LVL="0"><PTEXT><PDAT>In another embodiment, the relative motion between the workpiece and the tow ring </PDAT><HIL><BOLD><PDAT>202</PDAT></BOLD></HIL><PDAT> takes place in full circle (360 degrees). Thus, if the workpiece is stationary, the tow ring </PDAT><HIL><BOLD><PDAT>202</PDAT></BOLD></HIL><PDAT> continuously rotates in one direction around the workpiece. At the same time, the workpiece W is fed longitudinally into the machine </PDAT><HIL><BOLD><PDAT>200</PDAT></BOLD></HIL><PDAT> (from right to left in the FIG. </PDAT><HIL><BOLD><PDAT>9</PDAT></BOLD></HIL><PDAT>). The rotary movement of the tow ring </PDAT><HIL><BOLD><PDAT>202</PDAT></BOLD></HIL><PDAT> is controlled by the advance of the workpiece W. The fibers are thus laid in a spiral pattern around the workpiece. A superimposed oscillatory movement (rotational velocity components in the clockwise and counter-clockwise directions) of the tow ring may then be used to produce a sine wave or other pattern as desired including a pattern varying in at least one of a period, amplitude or shape characteristic. As an example, if the tow ring is rotated at 30 RPM&apos;s clockwise, an additional variation of plus or minus 5 RPM&apos;s (varying sinusoidally in time) can be superimposed on the clockwise rotation to cause a sine wave superimposed on a spiral pattern. The fiber reinforced viscoelastic tape used in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 9</PDAT></FGREF><PDAT> may be fabricated using the apparatus shown in FIG. </PDAT><HIL><BOLD><PDAT>7</PDAT></BOLD></HIL><PDAT>. Now, however, there need not be any relative movement between the rollers </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> Further, the matrix material </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> is now replaced with a viscoelastic tape such as &ldquo;3M&apos;s&rdquo; &ldquo;ISD112&rdquo; wound on the support rollers </PDAT><HIL><BOLD><PDAT>111</PDAT></BOLD></HIL><PDAT> This commercially available viscoelastic tape has a paper backing which is most preferably removed (but not necessarily removed) prior to application when used as the tape </PDAT><HIL><BOLD><PDAT>206</PDAT></BOLD></HIL><PDAT> in FIG. </PDAT><HIL><BOLD><PDAT>9</PDAT></BOLD></HIL><PDAT>. While the &ldquo;ISD112&rdquo; is cured, it would be most preferably to use a tape having an uncured viscoelastic layer thereon so that subsequent heating of the tape viscoelastic material after wrapping as shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 9</PDAT></FGREF><PDAT> would cure the viscoelastic material and more completely secure the fibers therein. Further, while the fiber tow of tape </PDAT><HIL><BOLD><PDAT>206</PDAT></BOLD></HIL><PDAT> which is embedded within the viscoelastic material is shown in a straight line orientation with respect to the longitudinal direction of the tape, it is also advantageous to utilize a varying waveform tow such as a sine wave, and it is further advantageous to utilize a variable waveform varying in one of a period, amplitude or shape characteristic.</PDAT></PTEXT></PARA>
<PARA ID="P-00184" LVL="0"><PTEXT><PDAT>Since the apparatus of </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT> may be used to embed fiber in either a resin or a viscoelastic material, the term &ldquo;carrier&rdquo; may be generically applied to describe the support structure carrying the fiber.</PDAT></PTEXT></PARA>
<PARA ID="P-00185" LVL="0"><PTEXT><PDAT>The control of rotation of the tow ring </PDAT><HIL><BOLD><PDAT>202</PDAT></BOLD></HIL><PDAT> and movement of the workpiece W may be achieved by means of input device </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>a</PDAT></ITALIC></HIL><PDAT>, control system </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>a</PDAT></ITALIC></HIL><PDAT>, mechanical linkages </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>a</PDAT></ITALIC></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>122</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>a </PDAT></ITALIC></HIL><PDAT>and drive mechanisms as shown. Position sensors </PDAT><HIL><BOLD><PDAT>134</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>a </PDAT></ITALIC></HIL><PDAT>connected to control system </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>a </PDAT></ITALIC></HIL><PDAT>along lines </PDAT><HIL><BOLD><PDAT>136</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>a </PDAT></ITALIC></HIL><PDAT>may also be utilized in a similar manner as done in FIG. </PDAT><HIL><BOLD><PDAT>7</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00186" LVL="0"><PTEXT><PDAT>Another method for practicing an embodiment of the invention is shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 10. A</PDAT></FGREF><PDAT> fiber tow </PDAT><HIL><BOLD><PDAT>302</PDAT></BOLD></HIL><PDAT>, matrix material </PDAT><HIL><BOLD><PDAT>304</PDAT></BOLD></HIL><PDAT> and viscoelastic material </PDAT><HIL><BOLD><PDAT>306</PDAT></BOLD></HIL><PDAT> are laid over an existing fiber containing composite </PDAT><HIL><BOLD><PDAT>308</PDAT></BOLD></HIL><PDAT> such as the pre-preg made in accordance with FIG. </PDAT><HIL><BOLD><PDAT>7</PDAT></BOLD></HIL><PDAT>. Alternately, instead of using a pre-preg as composite </PDAT><HIL><BOLD><PDAT>308</PDAT></BOLD></HIL><PDAT>, one may utilize paper to serve as the initial substrate onto which the tow </PDAT><HIL><BOLD><PDAT>302</PDAT></BOLD></HIL><PDAT>, matrix material </PDAT><HIL><BOLD><PDAT>304</PDAT></BOLD></HIL><PDAT> and viscoelastic material </PDAT><HIL><BOLD><PDAT>306</PDAT></BOLD></HIL><PDAT> are deposited. The substrate </PDAT><HIL><BOLD><PDAT>308</PDAT></BOLD></HIL><PDAT> may also be formed from a layer of viscoelastic material on a paper support. In the latter two example, the paper support is preferably later removed. In general, paper as used in this connection means any backing material which can be removed prior to or during use. In some cases, paper may be removed and a clear plastic backing placed thereon instead. In certain applications, the backing may be retained in place even on the final CWCV structure. Further, the substrate </PDAT><HIL><BOLD><PDAT>308</PDAT></BOLD></HIL><PDAT> may be formed from a previously made combination of fiber tow, resin and viscoelastic material made during a previous cycle through the fabrication steps shown in FIG. </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT>. In this manner, the output of </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 10</PDAT></FGREF><PDAT> serves as the input to a second cell for performing the identical steps as illustrated in FIG. </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT>. The structure of the machine has been removed for clarity.</PDAT></PTEXT></PARA>
<PARA ID="P-00187" LVL="0"><PTEXT><PDAT>The continuous fiber tow </PDAT><HIL><BOLD><PDAT>302</PDAT></BOLD></HIL><PDAT> is fed into the machine from a series of spools with tension adjusters (not shown), and the fibers are uniformly arranged and flattened by rollers (not shown). The fiber tow </PDAT><HIL><BOLD><PDAT>302</PDAT></BOLD></HIL><PDAT> is then pulled through a set of pinch rollers </PDAT><HIL><BOLD><PDAT>310</PDAT></BOLD></HIL><PDAT> which place enough compression on the fiber tow </PDAT><HIL><BOLD><PDAT>302</PDAT></BOLD></HIL><PDAT> to prevent slippage of the fiber upon axial movement of the pinch rollers </PDAT><HIL><BOLD><PDAT>310</PDAT></BOLD></HIL><PDAT> for producing a fiber wave pattern. The pinch rollers </PDAT><HIL><BOLD><PDAT>310</PDAT></BOLD></HIL><PDAT> may be made of metals, hard rubber, or metal with a thin compliant material coating depending on the characteristics of the fiber. For carbon fiber, metal rollers with a thin compliant coating can be used to prevent chopping or breakage of the fiber.</PDAT></PTEXT></PARA>
<PARA ID="P-00188" LVL="0"><PTEXT><PDAT>The fiber tow </PDAT><HIL><BOLD><PDAT>302</PDAT></BOLD></HIL><PDAT> is combined with one or more matrix materials, such as a polymer matrix, coated, paper-backed sheet </PDAT><HIL><BOLD><PDAT>304</PDAT></BOLD></HIL><PDAT> as it is pulled over a second set of roller(s) </PDAT><HIL><BOLD><PDAT>312</PDAT></BOLD></HIL><PDAT>. In the illustrated example, matrix coated paper sheet </PDAT><HIL><BOLD><PDAT>304</PDAT></BOLD></HIL><PDAT> is pressed down onto the fiber tow </PDAT><HIL><BOLD><PDAT>302</PDAT></BOLD></HIL><PDAT> by the roller </PDAT><HIL><BOLD><PDAT>312</PDAT></BOLD></HIL><PDAT>. The matrix coated paper sheet </PDAT><HIL><BOLD><PDAT>304</PDAT></BOLD></HIL><PDAT> has a thin coating of uncured polymer matrix </PDAT><HIL><BOLD><PDAT>304</PDAT></BOLD></HIL><PDAT> which is thick and tacky at room temperature. In the illustrated example, the tackiness of the polymer matrix sheet </PDAT><HIL><BOLD><PDAT>304</PDAT></BOLD></HIL><PDAT> is sufficient to &ldquo;lock&rdquo; the fiber tow </PDAT><HIL><BOLD><PDAT>302</PDAT></BOLD></HIL><PDAT> in position upon contact without the addition of heat or other chemicals. Use of other materials may require the addition of heat and/or chemicals to lock the pattern into place.</PDAT></PTEXT></PARA>
<PARA ID="P-00189" LVL="0"><PTEXT><PDAT>The fiber containing matrix material (e.g., polymer, matrix coated, paper-backed sheet </PDAT><HIL><BOLD><PDAT>304</PDAT></BOLD></HIL><PDAT>) is then passed under one or more rollers </PDAT><HIL><BOLD><PDAT>314</PDAT></BOLD></HIL><PDAT> which cause complete commingling of the matrix material and fiber tow </PDAT><HIL><BOLD><PDAT>302</PDAT></BOLD></HIL><PDAT>. In the example using a polymer matrix containing a carbon fiber tow, the roller(s) </PDAT><HIL><BOLD><PDAT>314</PDAT></BOLD></HIL><PDAT> are heated enough to cause complete wicking of the matrix material into the fiber tow </PDAT><HIL><BOLD><PDAT>302</PDAT></BOLD></HIL><PDAT>, but not enough to cure the material. Following this step in the process, the paper backing </PDAT><HIL><BOLD><PDAT>305</PDAT></BOLD></HIL><PDAT> is removed in preparation for laying another layer of viscoelastic material </PDAT><HIL><BOLD><PDAT>306</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00190" LVL="0"><PTEXT><PDAT>Next, a paper-backed layer of viscoelastic material </PDAT><HIL><BOLD><PDAT>306</PDAT></BOLD></HIL><PDAT> on a paper sheet </PDAT><HIL><BOLD><PDAT>307</PDAT></BOLD></HIL><PDAT> is laid on the fiber containing matrix, and paper backing </PDAT><HIL><BOLD><PDAT>307</PDAT></BOLD></HIL><PDAT> is removed by another set of rollers </PDAT><HIL><BOLD><PDAT>316</PDAT></BOLD></HIL><PDAT> which can be heated or cooled if necessary to promote adhesion.</PDAT></PTEXT></PARA>
<PARA ID="P-00191" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 10</PDAT></FGREF><PDAT> illustrates one &ldquo;cell&rdquo; of a larger machine of plural cells which lays multiple layers of fiber-matrix-viscoelastic combinations on a mold, panel, truss, or other large structure. It can also represent one cell of a continuous extrusion machine which, produces, shapes, and cures structural members.</PDAT></PTEXT></PARA>
<PARA ID="P-00192" LVL="0"><PTEXT><PDAT>In the embodiment of </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 10</PDAT></FGREF><PDAT>, the viscoelastic material and the resin are pressed together around the fiber tow so as to produce at least some co-mingling of the viscoelastic, matrix and fiber at the boundary of the matrix and the viscoelastic material.</PDAT></PTEXT></PARA>
<PARA ID="P-00193" LVL="0"><PTEXT><PDAT>Although a carbon fiber tow contained in a polymer matrix, and a viscoelastic adhesive have been used as an example, other materials (e.g. fibers and/or matrix) may require addition of heat, controlled pressure, chemicals, or other processes to finish the production of the material, including shaping, curing, and/or cutting to final dimensions.</PDAT></PTEXT></PARA>
<PARA ID="P-00194" LVL="0"><PTEXT><PDAT>Again, a key to the process is the differential movement of the two (or more) sets of rollers </PDAT><HIL><BOLD><PDAT>310</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>312</PDAT></BOLD></HIL><PDAT>. In this example the orientation angle of the fiber tow </PDAT><HIL><BOLD><PDAT>302</PDAT></BOLD></HIL><PDAT> with respect to the direction of composite advance is set by computer control where the lateral movement of the fiber tow pinch rollers </PDAT><HIL><BOLD><PDAT>310</PDAT></BOLD></HIL><PDAT> is tied algorithmically to the rotary movement of the combination roller(s) </PDAT><HIL><BOLD><PDAT>312</PDAT></BOLD></HIL><PDAT>. A similar or identical apparatus as described in connection with </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT> may be employed in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 10</PDAT></FGREF><PDAT>, and corresponding elements to </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT> are labeled in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 10</PDAT></FGREF><PDAT> with a suffix &ldquo;b&rdquo; to indicate their correspondence. In </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 10</PDAT></FGREF><PDAT>, the axial movement of pinch rollers </PDAT><HIL><BOLD><PDAT>310</PDAT></BOLD></HIL><PDAT> are controlled by means of the control system with the roller </PDAT><HIL><BOLD><PDAT>312</PDAT></BOLD></HIL><PDAT> preferably remaining fixed against axial movement. As in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT>, a rotational position sensor may be used to sense the rotation of roller </PDAT><HIL><BOLD><PDAT>312</PDAT></BOLD></HIL><PDAT> and the axial (transverse) movement of roller </PDAT><HIL><BOLD><PDAT>310</PDAT></BOLD></HIL><PDAT> may be adjusted to give the desired variable period, amplitude or shape to the waveform.</PDAT></PTEXT></PARA>
<PARA ID="P-00195" LVL="0"><PTEXT><PDAT>There are a host of ways to implement the mechanical/electrical controls including but not limited to cams, linkages, mechanical devices, and including various methods of sensing, position control, and computer control. In this example, computer control was used because it could be combined with optimization, drafting, analysis, design, and other computer programs, to create a concept-to-production capability.</PDAT></PTEXT></PARA>
<PARA ID="P-00196" LVL="0"><PTEXT><PDAT>Yet another method for practicing an embodiment of the invention is shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 11</PDAT></FGREF><PDAT> which illustrates the steps of a composite machine that deposits thin layers of matrix and/or viscoelastic material using spray deposition methods.</PDAT></PTEXT></PARA>
<PARA ID="P-00197" LVL="0"><PTEXT><PDAT>As compared with </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 10</PDAT></FGREF><PDAT>, the rollers </PDAT><HIL><BOLD><PDAT>314</PDAT></BOLD></HIL><PDAT>,</PDAT><HIL><BOLD><PDAT>316</PDAT></BOLD></HIL><PDAT> used to deposit matrix </PDAT><HIL><BOLD><PDAT>304</PDAT></BOLD></HIL><PDAT> and viscoelastic material </PDAT><HIL><BOLD><PDAT>306</PDAT></BOLD></HIL><PDAT> are eliminated and replaced by sprayers </PDAT><HIL><BOLD><PDAT>414</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>416</PDAT></BOLD></HIL><PDAT>, or other devices for depositing a thin layer of materials directly onto a fiber tow </PDAT><HIL><BOLD><PDAT>402</PDAT></BOLD></HIL><PDAT>. </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 11</PDAT></FGREF><PDAT> shows an example of laying a fiber tow </PDAT><HIL><BOLD><PDAT>402</PDAT></BOLD></HIL><PDAT> on a substrate </PDAT><HIL><BOLD><PDAT>408</PDAT></BOLD></HIL><PDAT> which may take the form of a previous laid viscoelastic adhesive layer. In the illustrated example, the fiber pattern of the fiber tow </PDAT><HIL><BOLD><PDAT>402</PDAT></BOLD></HIL><PDAT> is &ldquo;locked&rdquo; in as soon as the fiber tow </PDAT><HIL><BOLD><PDAT>402</PDAT></BOLD></HIL><PDAT> is forced onto the viscoelastic layer </PDAT><HIL><BOLD><PDAT>408</PDAT></BOLD></HIL><PDAT> by pressure roller </PDAT><HIL><BOLD><PDAT>412</PDAT></BOLD></HIL><PDAT>. A heated resin matrix is then deposited by sprayer </PDAT><HIL><BOLD><PDAT>414</PDAT></BOLD></HIL><PDAT> onto the upper layer of fiber tow </PDAT><HIL><BOLD><PDAT>402</PDAT></BOLD></HIL><PDAT> to further lock the fiber pattern in place. Another layer of viscoelastic adhesive is then deposited by sprayer </PDAT><HIL><BOLD><PDAT>416</PDAT></BOLD></HIL><PDAT> on top of the resin matrix and the process is repeated.</PDAT></PTEXT></PARA>
<PARA ID="P-00198" LVL="0"><PTEXT><PDAT>Substrate </PDAT><HIL><BOLD><PDAT>408</PDAT></BOLD></HIL><PDAT> may also take the form of a composite of fiber, resin and viscoelastic material made from a previous use of the fabrication steps illustrated in FIG. </PDAT><HIL><BOLD><PDAT>11</PDAT></BOLD></HIL><PDAT>. Alternately, the substrate </PDAT><HIL><BOLD><PDAT>408</PDAT></BOLD></HIL><PDAT> may be the pre-preg material of </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT>, a layer of viscoelastic material on a paper support, or just a form of paper to give support to the fiber tow, resin and viscoelastic material deposited thereon.</PDAT></PTEXT></PARA>
<PARA ID="P-00199" LVL="0"><PTEXT><PDAT>The use of heated resin matrix and viscoelastic adhesives are a practical means of &ldquo;thinning&rdquo; the mixtures to allow even deposition. As they cool, they become more tacky and help to hold the fiber patterns in place. However, chemical interaction between fiber (and any fiber coatings), matrix material, and/or viscoelastic materials could be used to accomplish the same purpose. These and any other methods which can be modified to deposit matrix and/or viscoelastic materials and lock the fiber pattern in place can produce any desired fiber pattern.</PDAT></PTEXT></PARA>
<PARA ID="P-00200" LVL="0"><PTEXT><PDAT>As shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 11</PDAT></FGREF><PDAT>, a single layer of fiber, resin matrix, and viscoelastic adhesive were laid down on substrate </PDAT><HIL><BOLD><PDAT>408</PDAT></BOLD></HIL><PDAT> which may be formed from a previously made similar combination during a preceding similar process stage. It is also possible to lay different combinations of layers in like manner where different thickness and/or patterns of fiber and/or matrix and/or viscoelastic adhesive are desired. using as an example a common resin matrix and viscoelastic adhesives, two fiber containing resin matrices could be laid down for every three layers of viscoelastic adhesives which are deposited. According to this example, </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 11</PDAT></FGREF><PDAT> would be modified to illustrate an additional set of tow fibers </PDAT><HIL><BOLD><PDAT>402</PDAT></BOLD></HIL><PDAT>, pinch rollers </PDAT><HIL><BOLD><PDAT>410</PDAT></BOLD></HIL><PDAT>, pressure roller </PDAT><HIL><BOLD><PDAT>412</PDAT></BOLD></HIL><PDAT>, and matrix sprayer </PDAT><HIL><BOLD><PDAT>414</PDAT></BOLD></HIL><PDAT> in tandem, followed by three viscoelastic adhesive sprayers </PDAT><HIL><BOLD><PDAT>416</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00201" LVL="0"><PTEXT><PDAT>As in the embodiment shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT>, the embodiment of </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 11</PDAT></FGREF><PDAT> may use a control system and mechanical linkage to axially move rollers </PDAT><HIL><BOLD><PDAT>410</PDAT></BOLD></HIL><PDAT> with roller </PDAT><HIL><BOLD><PDAT>412</PDAT></BOLD></HIL><PDAT> held stationary against axial movement. Thus, a similar or identical apparatus as described in connection with </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT> may be employed in FIG. </PDAT><HIL><BOLD><PDAT>11</PDAT></BOLD></HIL><PDAT>. In </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 11</PDAT></FGREF><PDAT>, the axial movement of pinch rollers </PDAT><HIL><BOLD><PDAT>410</PDAT></BOLD></HIL><PDAT> are controlled by means of the control system with the roller </PDAT><HIL><BOLD><PDAT>412</PDAT></BOLD></HIL><PDAT> remaining fixed against axial movement. As in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT>, a rotational position sensor may be used to sense the rotation of roller </PDAT><HIL><BOLD><PDAT>412</PDAT></BOLD></HIL><PDAT> and the axial (transverse) movement of roller </PDAT><HIL><BOLD><PDAT>410</PDAT></BOLD></HIL><PDAT> may be adjusted to give the desired variable period, amplitude or shape to the waveform.</PDAT></PTEXT></PARA>
<PARA ID="P-00202" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 12</PDAT></FGREF><PDAT> illustrates a method of practicing an embodiment of the invention in which a composite machine deposits thin layers of matrix and/or viscoelastic material using pressurized deposition methods (i.e., forcing resin through tiny holes in a cylinder). The extrusion machine shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 10</PDAT></FGREF><PDAT> may be modified as an example, but the concept is equally applicable to any of the above basic wave machines.</PDAT></PTEXT></PARA>
<PARA ID="P-00203" LVL="0"><PTEXT><PDAT>Instead of using paper coated with resin matrix or viscoelastic adhesive, rollers are used to deposit matrix and viscoelastic material in thin layers directly onto the fiber tow. As shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 12</PDAT></FGREF><PDAT>, the fiber tow </PDAT><HIL><BOLD><PDAT>502</PDAT></BOLD></HIL><PDAT> axially moved by pinch rollers </PDAT><HIL><BOLD><PDAT>510</PDAT></BOLD></HIL><PDAT> so that a desired pattern or waveform is laid on a substrate </PDAT><HIL><BOLD><PDAT>508</PDAT></BOLD></HIL><PDAT>. Substrate </PDAT><HIL><BOLD><PDAT>508</PDAT></BOLD></HIL><PDAT> may take the form of a previous made combination of fiber tow, resin and viscoelastic material; a layer of viscoelastic material on a paper support; a pre-preg; or simply a paper support. In the illustrated example, the pattern of the fiber tow </PDAT><HIL><BOLD><PDAT>502</PDAT></BOLD></HIL><PDAT> is &ldquo;locked&rdquo; in as soon as the fiber tow </PDAT><HIL><BOLD><PDAT>502</PDAT></BOLD></HIL><PDAT> is forced onto the substrate </PDAT><HIL><BOLD><PDAT>508</PDAT></BOLD></HIL><PDAT> by pressure roller </PDAT><HIL><BOLD><PDAT>512</PDAT></BOLD></HIL><PDAT>. A heated resin matrix is then deposited onto the upper layer of fiber tow </PDAT><HIL><BOLD><PDAT>502</PDAT></BOLD></HIL><PDAT> through tiny holes in the pressure roller </PDAT><HIL><BOLD><PDAT>512</PDAT></BOLD></HIL><PDAT>. A layer of viscoelastic adhesive is then deposited on top of the resin matrix by pressure roller </PDAT><HIL><BOLD><PDAT>516</PDAT></BOLD></HIL><PDAT>. The process may be repeated by feeding the output (from roller </PDAT><HIL><BOLD><PDAT>520</PDAT></BOLD></HIL><PDAT>) to another set of rollers identical to those shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 12</PDAT></FGREF><PDAT> with another input tow </PDAT><HIL><BOLD><PDAT>502</PDAT></BOLD></HIL><PDAT>. The use of heated resin matrix and viscoelastic adhesives is a practical means of &ldquo;thinning&rdquo; the mixtures to allow even deposition. Cooling the resin matrix and viscoelastic adhesives may be expedited with optional cooling rollers </PDAT><HIL><BOLD><PDAT>518</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>520</PDAT></BOLD></HIL><PDAT>. As the resin matrix and viscoelastic adhesives cool, they become more tacky and help to hold the fiber patterns in place. However, use of chemical interaction between fiber (and any fiber coatings), matrix material, and/or viscoelastic materials may also be used to accomplish the same purpose. These and any other methods which can be used to deposit matrix and/or viscoelastic materials and lock the fiber pattern in place will produce the desired pattern.</PDAT></PTEXT></PARA>
<PARA ID="P-00204" LVL="0"><PTEXT><PDAT>In the example illustrated in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 12</PDAT></FGREF><PDAT>, a single layer of fiber, resin matrix, and viscoelastic adhesive were laid down on a previous laid similar combination. It is also possible to lay different combinations of layers in like manner where different thickness and/or patterns of fiber and/or matrix and/or viscoelastic adhesive are desired. As an example, using a common resin matrix and viscoelastic adhesives, two layers of fiber resin matrix could be laid down for every three layers of viscoelastic adhesive. According to this example, </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 12</PDAT></FGREF><PDAT> would be modified to include an additional set of tow fibers </PDAT><HIL><BOLD><PDAT>502</PDAT></BOLD></HIL><PDAT>, pinch rollers </PDAT><HIL><BOLD><PDAT>510</PDAT></BOLD></HIL><PDAT>, and matrix pressure roller </PDAT><HIL><BOLD><PDAT>512</PDAT></BOLD></HIL><PDAT> in tandem followed by three viscoelastic adhesive rollers </PDAT><HIL><BOLD><PDAT>516</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00205" LVL="0"><PTEXT><PDAT>As in the embodiment shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT>, the embodiment of </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 11</PDAT></FGREF><PDAT> may use a control system and mechanical linkage to axially move rollers </PDAT><HIL><BOLD><PDAT>410</PDAT></BOLD></HIL><PDAT> with roller </PDAT><HIL><BOLD><PDAT>412</PDAT></BOLD></HIL><PDAT> held stationary against axial movement. Thus, a similar or identical apparatus as described in connection with </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT> may be employed in FIG. </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>. In </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 12</PDAT></FGREF><PDAT>, the axial movement of pinch rollers </PDAT><HIL><BOLD><PDAT>510</PDAT></BOLD></HIL><PDAT> are controlled by means of the control system with the roller </PDAT><HIL><BOLD><PDAT>512</PDAT></BOLD></HIL><PDAT> remaining fixed against axial movement. As in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT>, a rotational position sensor may be used to sense the rotation of roller </PDAT><HIL><BOLD><PDAT>512</PDAT></BOLD></HIL><PDAT> and the axial (transverse) movement of roller </PDAT><HIL><BOLD><PDAT>510</PDAT></BOLD></HIL><PDAT> may be adjusted to give the desired variable period, amplitude or shape to the waveform.</PDAT></PTEXT></PARA>
<PARA ID="P-00206" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIGS. 9-11</PDAT></FGREF><PDAT> may be modified to eliminate the application of the viscoelastic material and the resulting apparatus is suitable for making a pre-preg using only the apparatus associated with the fibers and the resinous material. For example, in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 10</PDAT></FGREF><PDAT>, one merely needs to retain elements </PDAT><HIL><BOLD><PDAT>310</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>312</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>314</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>304</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>305</PDAT></BOLD></HIL><PDAT> in order to make a resin matrix/fiber pre-preg. The starting material </PDAT><HIL><BOLD><PDAT>308</PDAT></BOLD></HIL><PDAT> in this embodiment of the invention could simply be a paper substrate. Similarly, in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 11</PDAT></FGREF><PDAT>, one need only retain elements </PDAT><HIL><BOLD><PDAT>408</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>410</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>402</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>412</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>414</PDAT></BOLD></HIL><PDAT> for fabrication of the pre-preg. In </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 12</PDAT></FGREF><PDAT>, only elements </PDAT><HIL><BOLD><PDAT>508</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>502</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>510</PDAT></BOLD></HIL><PDAT>, and </PDAT><HIL><BOLD><PDAT>512</PDAT></BOLD></HIL><PDAT> need only be used. As in the case of </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT>, a paper substrate may be used for elements </PDAT><HIL><BOLD><PDAT>408</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>508</PDAT></BOLD></HIL><PDAT> of </PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 9 and 11</PDAT></FGREF><PDAT> respectively.</PDAT></PTEXT></PARA>
<PARA ID="P-00207" LVL="0"><PTEXT><PDAT>In </PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 9-11</PDAT></FGREF><PDAT>, it is also generally possible to interchange the order of applying the resinous matrix and the viscoelastic material especially if there is some tackiness to the viscoelastic material so as to provide some resistance to movement of the waveform produced by the relatively axially movable rollers. In the event that the viscoelastic material is part of the resinous matrix, only a single application step is needed. In this latter case, the combined viscoelastic/resin matrix material is applied as a single step. Thus, in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 10</PDAT></FGREF><PDAT>, element </PDAT><HIL><BOLD><PDAT>304</PDAT></BOLD></HIL><PDAT> would comprise a paper-backed viscoelastic/resin matrix material and elements </PDAT><HIL><BOLD><PDAT>306</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>316</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>307</PDAT></BOLD></HIL><PDAT> would not be needed. Similarly, in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 11</PDAT></FGREF><PDAT> element </PDAT><HIL><BOLD><PDAT>416</PDAT></BOLD></HIL><PDAT> may be omitted (the spray of element </PDAT><HIL><BOLD><PDAT>414</PDAT></BOLD></HIL><PDAT> would contain both the viscoelastic and resin matrix material so that both are applied at the same time); and in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 12</PDAT></FGREF><PDAT> element </PDAT><HIL><BOLD><PDAT>516</PDAT></BOLD></HIL><PDAT> may be omitted as the viscoelastic material is applied together with the resin matrix using the single application roller </PDAT><HIL><BOLD><PDAT>512</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00208" LVL="0"><PTEXT><PDAT>Ideally, instead of using a separate viscoelastic layer, a CWC material with viscoelastic properties could be combined with another CWC (preferably but not necessarily with an opposite pattern) wherein the other CWC also preferably (but not necessarily) has viscoelastic properties. Such an arrangement would obviate the need for a separate viscoelastic layer or would at least permit any intermediate viscoelastic layer to be thinner. In the case that the adjacent CWC materials have viscoelastic properties, the &ldquo;interface&rdquo; layer between the adjacent laminae would have a thin layer of pure viscoelastic matrix naturally created during the curing process. Some current research indicates that stiffer or thinner viscoelastic layers would require much shorter wave periods.</PDAT></PTEXT></PARA>
<PARA ID="P-00209" LVL="0"><PTEXT><PDAT>It should further be noted that while the carbon fiber polymer type matrix is widely used and discussed above in connection with the various embodiments of the invention, one may also utilize metal matrix and ceramic base materials for high temperature applications without departing from the essential features of the invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00210" LVL="0"><PTEXT><PDAT>Additional advantages and modifications will readily occur to those skilled in the art. Therefore, the invention in its broader aspects is not limited to the specific details, and the representative devices, shown and described herein. Accordingly, various modifications may be made without departing from the spirit and scope of the general inventive concept as defined by the appended claims and their equivalents.</PDAT></PTEXT></PARA>
</BTEXT>
</DETDESC>
</SDODE>
<SDOCL>
<H LVL="1"><STEXT><PDAT>What is claimed is: </PDAT></STEXT></H>
<CL>
<CLM ID="CLM-00001">
<PARA ID="P-00211" LVL="0"><PTEXT><PDAT>1. Apparatus for controlling the fiber angle of a fiber tow embedded in a carrier comprising:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>a first pair of rollers including a first and second roller, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>at least a third roller, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>said fiber tow pressed between the first and second rollers and passing adjacent said third roller for movement along a first direction due to rotation of the first, second and third rollers, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a first drive mechanism for rotating said first, second and third rollers, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a second drive mechanism connected to at least one of said first pair of rollers and said third roller, said second drive mechanism responsive to control signals for displacing said at least one of said first pair of rollers and said third roller axially along the rotation axis of said at least one of said first pair of rollers and said third roller, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>an electronic controller connected to said second drive mechanism for generating said control signals to control the amount of axial displacement of said at least one of said first pair of rollers and said third roller; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein said carrier comprises a matrix material in the form of a rolled sheet and said apparatus further comprising at least one support roller for securing said matrix material, said at least one support roller positioned for feeding said matrix material for contact with said third roller level with said fiber tow for at least partially securing said fiber tow in place within said matrix material. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00002">
<PARA ID="P-00212" LVL="0"><PTEXT><PDAT>2. Apparatus as recited in </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT> wherein said electronic controller comprises a digital computer programmed to generate said control signals as a function of at least one of distance along said first direction and time.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00003">
<PARA ID="P-00213" LVL="0"><PTEXT><PDAT>3. Apparatus for controlling the fiber angle of a fiber tow embedded in a carrier comprising:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>a first pair of rollers including a first and second roller, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>at least a third roller, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>said fiber tow pressed between the first and second roller and passing adjacent said third roller for movement along a first direction due to rotation of the first, second and third rollers, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a first dirve mechanism for rotating said first, second and third rollers, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a second drive mechanism connected to at least one of said first pair of rollers and said third roller, said second drive mechanism responsive to control signals for displacing said at least one of said first pair of rollers and said third roller axially along the rotation axis of said at least one of said first pair of rollers and said third roller, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>an electronic controller connected to said second drive mechanism for generating said control signals to control the amount of axial displacement of said at least one of said first pair of rollers and said third roller, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a fourth roller positioned adjacent said third roller to form a second pair of rollers, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>said fiber tow passing between said third and fourth rollers, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>at least a first and second support roller and a first and second sheet of matrix material, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>said first support roller supporting said first sheet of matrix material and said second support roller supporting said second sheet of matrix material, and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>said first support roller positioned for feeding said matrix material of said first sheet between one of said third and fourth rollers and said fiber tow, and said second support roller positioned for passing said matrix material of said second sheet between the other of said third and fourth rollers and said fiber tow. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00004">
<PARA ID="P-00214" LVL="0"><PTEXT><PDAT>4. Apparatus as recited in </PDAT><CLREF ID="CLM-00003"><PDAT>claim 3</PDAT></CLREF><PDAT> wherein said matrix material comprises an uncured polymer and said apparatus further comprising heating elements downstream of said second pair of rollers, in reference to said first direction, for causing wicking of said fibers with said uncured polymer matrix.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00005">
<PARA ID="P-00215" LVL="0"><PTEXT><PDAT>5. Apparatus as recited in </PDAT><CLREF ID="CLM-00003"><PDAT>claim 3</PDAT></CLREF><PDAT> wherein said carrier comprises a viscoelastic material in the form of a rolled sheet and said apparatus further comprising at least one support roller for securing said viscoelastic material, said at least one support roller positioned for feeding said viscoelastic material for contact with said third roller and with said fiber tow.</PDAT></PTEXT></PARA>
</CLM>
</CL>
</SDOCL>
<SDODR ID="DRAWINGS">
<EMI ID="EMI-D00000" ALT="embedded image" FILE="US06467521-20021022-D00000.TIF"/>
<EMI ID="EMI-D00001" ALT="embedded image" FILE="US06467521-20021022-D00001.TIF"/>
<EMI ID="EMI-D00002" ALT="embedded image" FILE="US06467521-20021022-D00002.TIF"/>
<EMI ID="EMI-D00003" ALT="embedded image" FILE="US06467521-20021022-D00003.TIF"/>
<EMI ID="EMI-D00004" ALT="embedded image" FILE="US06467521-20021022-D00004.TIF"/>
<EMI ID="EMI-D00005" ALT="embedded image" FILE="US06467521-20021022-D00005.TIF"/>
<EMI ID="EMI-D00006" ALT="embedded image" FILE="US06467521-20021022-D00006.TIF"/>
<EMI ID="EMI-D00007" ALT="embedded image" FILE="US06467521-20021022-D00007.TIF"/>
<EMI ID="EMI-D00008" ALT="embedded image" FILE="US06467521-20021022-D00008.TIF"/>
<EMI ID="EMI-D00009" ALT="embedded image" FILE="US06467521-20021022-D00009.TIF"/>
<EMI ID="EMI-D00010" ALT="embedded image" FILE="US06467521-20021022-D00010.TIF"/>
<EMI ID="EMI-D00011" ALT="embedded image" FILE="US06467521-20021022-D00011.TIF"/>
<EMI ID="EMI-D00012" ALT="embedded image" FILE="US06467521-20021022-D00012.TIF"/>
<EMI ID="EMI-D00013" ALT="embedded image" FILE="US06467521-20021022-D00013.TIF"/>
<EMI ID="EMI-D00014" ALT="embedded image" FILE="US06467521-20021022-D00014.TIF"/>
</SDODR>
</PATDOC>

<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PATDOC SYSTEM "ST32-US-Grant-025xml.dtd" [
<!ENTITY US06468531-20021022-D00001.TIF SYSTEM "US06468531-20021022-D00001.TIF" NDATA TIF>
<!ENTITY US06468531-20021022-D00002.TIF SYSTEM "US06468531-20021022-D00002.TIF" NDATA TIF>
<!ENTITY US06468531-20021022-D00003.TIF SYSTEM "US06468531-20021022-D00003.TIF" NDATA TIF>
<!ENTITY US06468531-20021022-D00004.TIF SYSTEM "US06468531-20021022-D00004.TIF" NDATA TIF>
<!ENTITY US06468531-20021022-D00005.TIF SYSTEM "US06468531-20021022-D00005.TIF" NDATA TIF>
<!ENTITY US06468531-20021022-D00006.TIF SYSTEM "US06468531-20021022-D00006.TIF" NDATA TIF>
<!ENTITY US06468531-20021022-D00007.TIF SYSTEM "US06468531-20021022-D00007.TIF" NDATA TIF>
<!ENTITY US06468531-20021022-D00008.TIF SYSTEM "US06468531-20021022-D00008.TIF" NDATA TIF>
<!ENTITY US06468531-20021022-D00009.TIF SYSTEM "US06468531-20021022-D00009.TIF" NDATA TIF>
<!ENTITY US06468531-20021022-D00010.TIF SYSTEM "US06468531-20021022-D00010.TIF" NDATA TIF>
]>
<PATDOC DTD="2.5" STATUS="Build 20020918">
<SDOBI>
<B100>
<B110><DNUM><PDAT>06468531</PDAT></DNUM></B110>
<B130><PDAT>B1</PDAT></B130>
<B140><DATE><PDAT>20021022</PDAT></DATE></B140>
<B190><PDAT>US</PDAT></B190>
</B100>
<B200>
<B210><DNUM><PDAT>08303026</PDAT></DNUM></B210>
<B211US><PDAT>08</PDAT></B211US>
<B220><DATE><PDAT>19940908</PDAT></DATE></B220>
</B200>
<B500>
<B510>
<B511><PDAT>A61K 39395</PDAT></B511>
<B512><PDAT>A61K 3900</PDAT></B512>
<B512><PDAT>C07K 1628</PDAT></B512>
<B516><PDAT>7</PDAT></B516>
</B510>
<B520>
<B521><PDAT>4241431</PDAT></B521>
<B522><PDAT>4241311</PDAT></B522>
<B522><PDAT>4241331</PDAT></B522>
<B522><PDAT>4241411</PDAT></B522>
<B522><PDAT>4241521</PDAT></B522>
<B522><PDAT>4241721</PDAT></B522>
<B522><PDAT>5303872</PDAT></B522>
<B522><PDAT>5303873</PDAT></B522>
<B522><PDAT>5303882</PDAT></B522>
<B522><PDAT>53038822</PDAT></B522>
<B522><PDAT>5303889</PDAT></B522>
<B522><PDAT>5303891</PDAT></B522>
</B520>
<B540><STEXT><PDAT>Method of promoting cellular function</PDAT></STEXT></B540>
<B560>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4699880</PDAT></DNUM>
<DATE><PDAT>19871000</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Goldstein</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>4351722</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4849413</PDAT></DNUM>
<DATE><PDAT>19890700</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>della Valle et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>514 54</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5144010</PDAT></DNUM>
<DATE><PDAT>19920900</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Erlanger et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>5303872</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5279966</PDAT></DNUM>
<DATE><PDAT>19940100</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Jessell et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>4353201</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B562><NCIT><STEXT><PDAT>Goldstein et al., Scientific Amer, 255:74-83, 1986.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>T.M. Jessell, &ldquo;Reactions of Neurons to Injury&rdquo;, from: &ldquo;Principles of Neural Science Third Edition&rdquo;, Ed. E.R. Kandel et al., Elsevier, 1991, pp. 258-269.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Borrebaeck et al., Imm. Today, 14:477-479, 1997.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Edgington, Bio/Technology, 10:383-386, 388, 389, 1992.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Waldmann, Science, 252:1657-1662, 1991.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Harris et al., Tibtech, 11:42-44.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Guillet et al., PNAS, 82:1781-84, 1985.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Bradley, Chapter 10, pp. 235-238, from: &ldquo;Selected Methods in Cellular Immunology&rdquo;, ed. B. B. Mishell et al., W. H. Freeman and Co., 1980.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Bailey et al, &ldquo;The influence of fibronectin and laminin during Schwann cell migration and peripheral nerve regeneration through silicon chambers&rdquo;, Journal of Neurocytology 22:176 (1993). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Lundborg et al, &ldquo;Nerve Regeneration in Silicone Chambers: Influence of Gap Length and of Distal Stump Components&rdquo;, Experimental Neurology 76:361 (1982). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Lungborg et al, &ldquo;In Vivo Regeneration of Cut Nerves Encased in Silicone Tubes&rdquo;, Journal of Neuropathology and Experimental Neurology 41(4):412 (1982). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Neugebauer et al, &ldquo;Cell-surface regulation of &bgr;</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-integrin activity on developing retinal neurons&rdquo;, Nature 350:68 (1991). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Boucheix et al, &ldquo;Characteristics of platelet aggregation induced by the monoclonal antibody ALB</PDAT><HIL><SB><PDAT>6 </PDAT></SB></HIL><PDAT>(acute lymphoblastic leukemia antigen p 24)&rdquo; FEBS 161(2):289 (1983). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Griffith et al, &ldquo;Platelet Activation by Immobilized Monoclonal Antibody: Evidence for a CD9 Proximal Signal&rdquo;, Blood 78(7):1753 (1991). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Matthew et al, &ldquo;Cyclophosphamide treatment used to manipulate the immune response for the production of monoclonal antibodies&rdquo;, Journal of Immunological Methods 100:73 (1987). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>&ldquo;Science and Business&rdquo;, Scientific American pp. 101-103, Jul. 1993. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Sharon et al, &ldquo;Carbohydrates in Cell Recognition&rdquo;, Scientific American pp. 82-89, Jan. 1993. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>The Genesis Report&trade; /Rx, &ldquo;Business Implications of Technology Innovation in Pharmaceuticals&rdquo; 1(2):1-3 (1992). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Hodgson, &ldquo;Carbohydrate-Based Therapeutics&rdquo;, Bio/Technology 9:609 (1991). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Schreiber et al, Proc. Natl. Acad. Sci. USA 78(12):7535-7539 (1981). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Sege et al, Proc. Natl. Acad. Sci. USA 75(5):2443-2447 (1978). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Haynes et al, Int. J. Dev. Neurosci. 7(6):623-632 (1989) (Abstract thereof). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Buttke et al, &ldquo;Oxidative stress as a mediator of apoptosis&rdquo;, Immunol. Today 15:7-10 (1994). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Deng et al, &ldquo;Amyotrophic Lateral Sclerosis and Structural Defects in Cu,Zn Superoxide Dismutase&rdquo;, Science 261:1047-1051 (1993). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Coyle et al, &ldquo;Oxidative Stress, Glutamate, and Neurodegenerative Disorders&rdquo;, Science 262:689-695 (1993).</PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
</B560>
<B570>
<B577><PDAT>4</PDAT></B577>
<B578US><PDAT>2</PDAT></B578US>
</B570>
<B580>
<B582><PDAT>4241311</PDAT></B582>
<B582><PDAT>4241331</PDAT></B582>
<B582><PDAT>4241411</PDAT></B582>
<B582><PDAT>4241431</PDAT></B582>
<B582><PDAT>4241521</PDAT></B582>
<B582><PDAT>4241721</PDAT></B582>
<B582><PDAT>4241751</PDAT></B582>
<B582><PDAT>4352401</PDAT></B582>
<B582><PDAT>435327</PDAT></B582>
<B582><PDAT>435334</PDAT></B582>
<B582><PDAT>435345</PDAT></B582>
<B582><PDAT>5303872</PDAT></B582>
<B582><PDAT>5303873</PDAT></B582>
<B582><PDAT>5303882</PDAT></B582>
<B582><PDAT>53038822</PDAT></B582>
<B582><PDAT>5303889</PDAT></B582>
<B582><PDAT>5303891</PDAT></B582>
</B580>
<B590><B595><PDAT>10</PDAT></B595><B596><PDAT>23</PDAT></B596></B590>
</B500>
<B600>
<B630><B632><PARENT-US><CDOC><DOC><DNUM><PDAT>08/303026</PDAT></DNUM></DOC></CDOC><PDOC><DOC><DNUM><PDAT>08/123851</PDAT></DNUM><DATE><PDAT>19930909</PDAT></DATE><CTRY><PDAT>US</PDAT></CTRY><KIND><PDAT>00</PDAT></KIND></DOC></PDOC><PSTA><PDAT>03</PDAT></PSTA></PARENT-US></B632></B630>
</B600>
<B700>
<B720>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>William D.</PDAT></FNM><SNM><STEXT><PDAT>Matthew</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Durham</PDAT></CITY>
<STATE><PDAT>NC</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Marcia J.</PDAT></FNM><SNM><STEXT><PDAT>Riggott</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Durham</PDAT></CITY>
<STATE><PDAT>NC</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Eva S.</PDAT></FNM><SNM><STEXT><PDAT>Anton</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Hamden</PDAT></CITY>
<STATE><PDAT>CT</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
</B720>
<B730>
<B731>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Duke University</PDAT></STEXT></ONM></NAM>
<ADR><CITY><PDAT>Durham</PDAT></CITY><STATE><PDAT>NC</PDAT></STATE></ADR>
</PARTY-US>
</B731>
<B732US>
<PDAT>02</PDAT>
</B732US>
</B730>
<B740>
<B741>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Nixon &amp; Vanderhye P.C.</PDAT></STEXT></ONM></NAM>
</PARTY-US>
</B741>
</B740>
<B745>
<B746>
<PARTY-US>
<NAM><FNM><PDAT>Ronald B.</PDAT></FNM><SNM><STEXT><PDAT>Schwadron</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B746>
<B748US><PDAT>1644</PDAT></B748US>
</B745>
</B700>
</SDOBI>
<SDOAB>
<BTEXT>
<PARA ID="P-00001" LVL="0"><PTEXT><PDAT>The present invention relates, in general, to a method of producing a therapeutic effect and, in particular, to a method of using antibodies to promote cellular function, to antibodies suitable for use in such a method and to compositions comprising same.</PDAT></PTEXT></PARA>
</BTEXT>
</SDOAB>
<SDODE>
<RELAPP>
<BTEXT>
<PARA ID="P-00002" LVL="0"><PTEXT><PDAT>This application is a continuation-in-part of Application No. 08/123,851, filed Sep. 9, 1993, now abandoned the entire contents of which are incorporated herein by reference.</PDAT></PTEXT></PARA>
</BTEXT>
</RELAPP>
<GOVINT>
<BTEXT>
<PARA ID="P-00003" LVL="0"><PTEXT><PDAT>This invention was made with Government support under Grant No. BNS-90-06752 awarded by the National Science Foundation. The Government has certain rights in the invention.</PDAT></PTEXT></PARA>
</BTEXT>
</GOVINT>
<BRFSUM>
<BTEXT>
<H LVL="1"><STEXT><PDAT>TECHNICAL FIELD</PDAT></STEXT></H>
<PARA ID="P-00004" LVL="0"><PTEXT><PDAT>The present invention relates, in general, to a method of producing a therapeutic effect and, in particular, to a method of using antibodies to promote cellular function, to antibodies suitable for use in such a method and to compositions comprising same.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>BACKGROUND</PDAT></STEXT></H>
<PARA ID="P-00005" LVL="0"><PTEXT><PDAT>To date, the use of immunoglobulins for therapy has been guided by the premise that antibodies neutralize antigens and block function or that antibodies can kill cells. The use of immunoglobulins for such purposes is well grounded in practice and research. Immunological therapies have been used to treat malignant tumors (Miller et al, New Eng. J. Med. 9:517 (1982)), to reduce allograft rejection (Bluestone et al, Immunol. Rev. 90:5 (1986)), and to prepare vaccines against viral infections (Finberg and Ertl, Immunol. Rev. 90:129 (1986)). The feasibility of using antibodies as therapeutics has been greatly improved by the development of technology to humanize rodent monoclonal antibodies and thereby render them non-immunogenic in humans (Hardman et al, J. Biol. Markers 7:203 (1992); Carter et al, Proc. Natl. Acad. Sci. USA 89:4285 (1992); Routledge et al, Eur. J. Immunol. 21:2717 (1991); Gussow and Seemann Meth. Enzyme 203:99 (1991)). Although humanized antibodies have certain side effects, such effects can generally be kept at therapeutically acceptable levels.</PDAT></PTEXT></PARA>
<PARA ID="P-00006" LVL="0"><PTEXT><PDAT>In contrast to the traditional use of immunoglobulins as agents to inhibit or neutralize function, the present invention is based on the realization that immunoglobulins can also be used as agonists to facilitate function. Neugebauer et al (Nature 350:68 (1991) disclose anantibody that promotes adhesion but no reference is made to inducing cell signalling or facilitating a cellular function, such as motility). Antibodies suitable for use in the present invention, designated &ldquo;agonist antibodies&rdquo;, include those that are mirror images of a particular epitope. One method of generating such antibodies involves the manipulation of the immune system so as to prevent the normal suppression of the system that is responsible for preventing auto-immunity (Matthew &amp; Sandrock, J. Immunol. Methods 100:73 (1987)). The immune system can thus be permitted to produce idiotypic antibodies that are directed to the original antigen and anti-idiotypic antibodies that are directed to the newly circulating antibodies (Jerne, Ann. Immunol. 125C:373 (1974); Matthew, Soc. for Neurosci. Short Course, Anaheim, Calif. (1992)). Anti-idiotypic antibodies can thereby be produced that mimic molecules (e.g. growth factors) that interact with cell surface receptors. In accordance with the present invention, such antibodies can be used as therapeutics to replace or supplement biologically active molecules in facilitating biological function.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>OBJECTS AND SUMMARY OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00007" LVL="0"><PTEXT><PDAT>It is a general object of the invention to provide antibodies that promote cellular functions such as survival, growth and motility.</PDAT></PTEXT></PARA>
<PARA ID="P-00008" LVL="0"><PTEXT><PDAT>It is a specific object of the invention to provide antibodies that mimic molecules that interact with cell surface receptors and thereby facilitate cellular functions.</PDAT></PTEXT></PARA>
<PARA ID="P-00009" LVL="0"><PTEXT><PDAT>It is another object of the invention to provide antibodies for use in promoting neuronal cell growth and glial migration.</PDAT></PTEXT></PARA>
<PARA ID="P-00010" LVL="0"><PTEXT><PDAT>It is a further object of the invention to provide methods of treating injuries and diseases, particularly those of the peripheral and central nervous system.</PDAT></PTEXT></PARA>
<PARA ID="P-00011" LVL="0"><PTEXT><PDAT>In one embodiment, the present invention relates to a method of facilitating a biological function of a cell. The method comprises contacting the cell with an antibody, or binding fragment thereof, that mimics an agent that binds to a receptor on the surface of the cell and thereby facilitates the function. The contacting is effected under conditions such that the antibody binds to the receptor and thereby facilitates the function.</PDAT></PTEXT></PARA>
<PARA ID="P-00012" LVL="0"><PTEXT><PDAT>In another embodiment, the present invention relates to a method of stimulating migration of a Schwann cell. The method comprises contacting the cell with an antibody, or binding fragment thereof, that binds to a receptor on the surface of the cell that regulates migration of the cell. The contacting is effected under conditions such that the antibody binds to the receptor so that migration is thereby stimulated.</PDAT></PTEXT></PARA>
<PARA ID="P-00013" LVL="0"><PTEXT><PDAT>In a further embodiment, the present invention relates to a method of treating a de-myelinating disease. The method comprises administering to a patient in need thereof an antibody, or binding fragment thereof, that binds to a receptor on the surface of Schwann cells of the patient that regulates migration of the Schwann cells. The amount administered is sufficient to stimulate migration of the Schwann cells.</PDAT></PTEXT></PARA>
<PARA ID="P-00014" LVL="0"><PTEXT><PDAT>In yet another embodiment, the present invention relates to a method of regulating calcium homeostasis of a mammal in need thereof. The method comprises administering to the mammal an amount of a GM1 anti-idiotypic antibody sufficient to effect the regulation.</PDAT></PTEXT></PARA>
<PARA ID="P-00015" LVL="0"><PTEXT><PDAT>In further embodiments, the present invention relates to an isolated GM1 anti-idiotypic antibody and an isolated antibody specific for a Schwann cell surface antigen that potentiates Schwann cell migration.</PDAT></PTEXT></PARA>
<PARA ID="P-00016" LVL="0"><PTEXT><PDAT>In yet another, embodiment, the present invention relates to a method of protecting a mammalian cell from a toxic effect of a free radical. The method comprises contacting the cell with an anti-idiotypic GM1 antibody under conditions such that the protection is effected.</PDAT></PTEXT></PARA>
<PARA ID="P-00017" LVL="0"><PTEXT><PDAT>Further objects and advantages of the present invention will be clear from the Description that follows.</PDAT></PTEXT></PARA>
</BTEXT>
</BRFSUM>
<DRWDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BRIEF DESCRIPTION OF THE DRAWINGS</PDAT></STEXT></H>
<PARA ID="P-00018" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>: Anti-idiotypic antibodies share structural homology with the antigen and can bind the functional sites of antigen receptors.</PDAT></PTEXT></PARA>
<PARA ID="P-00019" LVL="0"><PTEXT><PDAT>FIGS. </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT>A and </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT>B: Embryonic day 18 hippocampal cells were grown on normal sciatic nerve tissue sections. Cells grown in NS1 conditioned medium do not adhere to the tissue section but remain as unattached aggregates. In the presence of antibody 4, cells adhere to and extend processes on the nerve substrate.</PDAT></PTEXT></PARA>
<PARA ID="P-00020" LVL="0"><PTEXT><PDAT>FIGS. </PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT>A-</PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT>E: Embryonic day 18 hippocampal cells were grown on CELL-TAK (Collaborative Biomedical) in the presence of NS1 conditioned medium or antibodies. Although cells adhered in all cases, neurite outgrowth was strongly facilitated by the anti-idiotypic antibodies to GM1.</PDAT></PTEXT></PARA>
<PARA ID="P-00021" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>4</PDAT></BOLD></HIL><PDAT>: Images obtained from hippocampal neurons grown on CELL-TAK (as described below with reference to </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 3</PDAT></FGREF><PDAT>) were collected on the IMAGE 1 system. The neurite lengths were traced and measured for 35 neurons. The mean &plusmn; standard deviation of neurite length is indicated for neurons grown in the presence of antibodies 4, 5, 20 and 58 or NS1 conditioned medium. The neuritic length for neurons grown in the presence of NS1 conditioned medium was significantly different from those grown in the presence of anti-idiotypic antibodies to GM1. Statistical significance was tested using a two-tailed t-test assuming equal variance at P&lt;0.05.</PDAT></PTEXT></PARA>
<PARA ID="P-00022" LVL="0"><PTEXT><PDAT>FIGS. </PDAT><HIL><BOLD><PDAT>5</PDAT></BOLD></HIL><PDAT>A-</PDAT><HIL><BOLD><PDAT>5</PDAT></BOLD></HIL><PDAT>C: Enhancement of Schwann cell migration by antibodies 216C and 21. DRGs were explanted onto a cryostat section of normal sciatic nerve and cultured in the presence of antibodies (117E, 21, or 216C) for 72 hours. Photographs are of carboxy fluorescein labeled Schwann cells migrating out of the DRG explant on to the nerve substrate in the presence of (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 5A</PDAT></FGREF><PDAT>) 117E, (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 5B</PDAT></FGREF><PDAT>) 216C, and (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 5C</PDAT></FGREF><PDAT>) 21 after 72 hours in culture. Scale bar&equals;100 &mgr;m.</PDAT></PTEXT></PARA>
<PARA ID="P-00023" LVL="0"><PTEXT><PDAT>FIGS. </PDAT><HIL><BOLD><PDAT>6</PDAT></BOLD></HIL><PDAT>A-</PDAT><HIL><BOLD><PDAT>6</PDAT></BOLD></HIL><PDAT>D: Exposure to migration-modulating antibodies leads to changes in Schwann cell shape and activity. After recording 45 minutes of baseline activity (FIGS. </PDAT><HIL><BOLD><PDAT>6</PDAT></BOLD></HIL><PDAT>A,B), primary Schwann cell cultures were perfused with either antibody 21 or 131C. Antibody 21 led to enhanced lamellapodial activity at the bipolar ends of the Schwann cells (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 6C</PDAT></FGREF><PDAT>) and increased cell movement. Only the lamellapodia that are projecting at an angle are clearly visible. Exposure to antibody 131C led to gradual withdrawal of the bipolar processes and rounding up of cells (FIG. </PDAT><HIL><BOLD><PDAT>6</PDAT></BOLD></HIL><PDAT>D). Images in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 6C and D</PDAT></FGREF><PDAT> were taken approximately 45 minutes after antibody perfusion.</PDAT></PTEXT></PARA>
<PARA ID="P-00024" LVL="0"><PTEXT><PDAT>FIGS. </PDAT><HIL><BOLD><PDAT>7</PDAT></BOLD></HIL><PDAT>A-</PDAT><HIL><BOLD><PDAT>7</PDAT></BOLD></HIL><PDAT>D: Exposure to migration-modulating antibodies leads to changes in cytosolic calcium levels. Fluo-3 loaded Schwann cells were perfused with antibodies 21 and 131C. Exposure to 21, a migration-promoting antibody, increased calcium levels (FIG. </PDAT><HIL><BOLD><PDAT>7</PDAT></BOLD></HIL><PDAT>A-baseline, </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7B-</PDAT></FGREF><PDAT>18 minutes after exposure to 21) whereas exposure to 131C, a migration-inhibitory antibody, lead to a drop in calcium levels (FIG. </PDAT><HIL><BOLD><PDAT>7</PDAT></BOLD></HIL><PDAT>C-baseline, </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7D-</PDAT></FGREF><PDAT>30 minutes after exposure to 131C). IMAGE 1 uses a color spectrum to code fluorescent signals, highest calcium is assigned red, lower concentrations are assigned violet.</PDAT></PTEXT></PARA>
<PARA ID="P-00025" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>8</PDAT></BOLD></HIL><PDAT>: Exposure to antibodies leads to tyrosine phosphorylation of Schwann cell substrates. Primary Schwann cells were cultured for 45 minutes in RPMI/10% FCS medium (control) or in medium containing antibodies (117E, 21, 131C, 216C). Schwann cells were then harvested and probed with anti-phosphotyrosine antibodies. The major protein substrates phosphorylated by the antibodies are marked with arrows. 216C, 21, and 131C induced phosphorylation of 170 kDa, 54 kDa, and 58 kDa proteins, respectively. Antibody 117E did not induce phosphorylation.</PDAT></PTEXT></PARA>
<PARA ID="P-00026" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>9</PDAT></BOLD></HIL><PDAT>: GM1-agonist antibodies protect mouse Schwannoma cells against hydrogen peroxide toxicity.</PDAT></PTEXT></PARA>
<PARA ID="P-00027" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT>: GM1-agonist antibodies protect human neuroblastoma cells against hydrogen peroxide toxicity.</PDAT></PTEXT></PARA>
</BTEXT>
</DRWDESC>
<DETDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>DETAILED DESCRIPTION OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00028" LVL="0"><PTEXT><PDAT>The present invention relates to a method of inducing a therapeutic effect in an animal, for example, a mammal, and derives from the realization that antibodies can be used to facilitate, rather than inhibit or block, the biological functions necessary for achieving the effect sought. Key to at least one embodiment of the present invention are the facts that growth factors and other biological molecules that interact with cell surface receptors can be mimicked by antibodies and that such antibodies can be used in therapy to replace or supplement the biologically active molecule that they mimic. The present invention thus relates to a novel method of using immunoglobulins as agonists. In view of the immense potential of the mammalian immune system to produce immunoglobulins (more than 100 million being possible), the invention should find application in virtually all fields of medical science.</PDAT></PTEXT></PARA>
<PARA ID="P-00029" LVL="0"><PTEXT><PDAT>Antibodies suitable for use in the present invention include anti-idiotypic antibodies, that is, antibodies that recognize the binding site of another antibody, the idiotype. An anti-idiotype, which is complementary to the idiotypic binding site, has structural homology to the original epitope on the antigen against which the idiotype is raised (FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00030" LVL="0"><PTEXT><PDAT>The present invention results, at least in part, from the observation that anti-idiotypic monoclonal antibodies to the ganglioside GM1 are capable of inducing effects that mimic those associated with GM1. GM1 is known to enhance neuronal survival and axon growth, to provide protection from ischemia, glutamate toxicity, trauma and stroke, and to facilitate the action of various neurotropic factors and adhesion molecules. Although the mechanism by which GM1 exerts its effects is uncertain, one possibility is that GM1 binds to membrane protein receptors which, in turn, leads to second messenger activation.</PDAT></PTEXT></PARA>
<PARA ID="P-00031" LVL="0"><PTEXT><PDAT>The GM1 anti-idiotypic antibodies of the invention mimic GM1 in that they bind to and activate GM1 receptors and, through activation of a tyrosine kinase second messenger system, facilitate neuronal survival, adhesion and neurite growth.</PDAT></PTEXT></PARA>
<PARA ID="P-00032" LVL="0"><PTEXT><PDAT>The anti-idiotypic antibodies of the invention, including GM1 anti-idiotypic antibodies, can be produced using the method of Matthew and Sandrock (J. Immunol. Methods 100:73 (1987)). When a host is immunized with an antigen, advantageously, a simple antigen, and treated with cyclophosphamide as described by Matthew and Sandrock, the normal immune response is altered because those lymphocytes (B and T cells) that have been stimulated to divide are killed. It is the killing of T suppressor cells that, presumably, is responsible for the high frequency production of anti-idiotypic antibodies in animals treated with cyclophosphamide. That is, T suppressor cell killing results in the production of autoimmune responses, both to the antigen and to the newly elicited idiotypic antibodies. When spleen cells from such animals are immortalized, both idiotypic and anti-idiotypic antibodies are obtained. Antigens suitable for use in generating appropriate idiotypes using this system are, preferably, relatively simple, containing a limited number of epitopes. If a complex antigen possessing many non-functional epitopes is used, only a small number of idiotypic antibodies are successful at eliciting anti-idiotypes capable of binding the functional site of the antigen-binding protein. Simple carbohydrate structures (ranging from 2 to 6 saccharides) are preferred since the idiotypic response is essentially monoclonal in nature and most anti-idiotypic antibodies mimic the carbohydrate structure.</PDAT></PTEXT></PARA>
<PARA ID="P-00033" LVL="0"><PTEXT><PDAT>As noted above, GM1 has been shown to have very broad effects on neuronal growth and a variety of signaling mechanisms have been proposed to explain these effects. GM1 regulation of calcium homeostasis, either by influencing calcium channels, pumps or internal stores, is one possible explanation for the breadth of these effects. Accordingly, the present invention contemplates the use of anti-idiotypic antibodies of the type described herein to regulate calcium homeostasis which is fundamental to a variety of treatment regimens. Traumatic or ischemic brain injury is surrounded by an area, referred to as the area penumbra, of striking metabolic change. There are many changes that occur within the area penumbra, including an elevation in glutamate, glycine, GABA, amines, free radicals, and the products of arachidonic acid metabolism (Manev et al, FASEB J. 4:1789 (1990)). It is expected that those cellular responses to injury that can be regulated by GM1 can also be regulated by the GM1 anti-idiotypic antibodies of the invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00034" LVL="0"><PTEXT><PDAT>In addition to the above, it is also expected that the GM1 agonist antibodies of the invention can be used to control the effects of glutamate toxicity in neurons. Glutamate depolarizes many types of neurons, opening voltage dependent and transmitter gated calcium channels, which increases intraneuronal calcium levels. In addition, glutamate can further increase calcium levels by activating receptors coupled to phosphatidylinositol. Such receptors increase inositol triphosphate which regulates internal calcium stores. By activating glutamate receptors and increasing post-synaptic calcium, the formation of arachidonic acid and and nitric oxide is activated (Manev et al., Acta Neurobiol. Exper. 50:475 (1990); Kiedrowski et al., J. Neurochom. 58:335 (1992)). Thus, some of the toxic effects of glutamate can be interpreted as being caused by persistent elevation of intraneuronal calcium levels leading to neuronal cell death. The ability of GM1 to provide protection against glutamate toxicity has been tested in vitro (Manev et al., Acta Neurobiol. Exper. 50:475 (1990); Nakamura et al., Methods Enzymol. 179:241 (1992); Manev, In: Bridging Basic anc Clinical Neuroscience, Georgetown Univ. Press (1993); Skaper et al., Dev. Brain Res. 71:1 (1993)) and in vivo (Lipartiti et al., Neuroreport 3:919 (1992)). In both sets of experiments, GM1 provides protection from toxicity. That GM1 regulation of calcium homeostasis is the basis for its broad effects on neuron growth is supported by experiments showing that GM1 affects calcium levels in neurons (Guerold et al., J. Neurosci. Res. 32:110 (1992); Hilbush and Levine, J. Biol. Chem. 267:24789 (1992)) and that GM1 modulates neurite outgrowth by regulating calcium (Spoerri et al., Dev. Brain Res. 56:177 (1990)). Precedent for GM1 regulation of calcium levels has been seen outside the nervous system where gangliosides inhibit platelet-derived growth factor-stimulated increases in intracellular calcium in fibroblasts (Guan et al., Biochim. Biophys. Acta 1136:315 (1991); Yates et al., Exp. Cell Res. 204:38 (1993)). The ability of GM1 agonist antibodies to regulate calcium homeostasis and provide protection against glutamate toxicity, makes possible many clinical uses for such antibodies, both within and beyond the nervous system.</PDAT></PTEXT></PARA>
<PARA ID="P-00035" LVL="0"><PTEXT><PDAT>Elevated levels of intracellular calcium can be toxic to neural as well as non-neural cells. Such toxicity can sometimes be controlled using calcium antagonists. Most notably, calcium antagonists can be used to inhibit the calcium toxicity in arterial hypertension and arteriosclerosis (Hansson, Acta Anaesthesiologica Scandinavica-Supplementum, 99:26-8, (1993)); Fleckenstein-Grun et al, Drugs, 44 Suppl 1:23-30, (1992)). Calcium antagonists significantly lower systolic and diastolic blood pressure (Fetkovska et al, American Journal of Hypertension, 6(3 Pt 2):98S-101S, (1993)). The effectiveness of anti-idiotypic antibodies to GM1 in regulating intracellular calcium levels, can be expected to make possible the treatment of a variety of diseases currently treated with calcium antagonists.</PDAT></PTEXT></PARA>
<PARA ID="P-00036" LVL="0"><PTEXT><PDAT>There is now extensive evidence for the early appearance and pathological importance of oxygen radical formation and cell membrane lipid peroxidation in the injured nervous system (Hall et al, Cell. Molec. Neuro. 13:415-432 (1993)). Furthermore, peroxide accumulation may lead to protein oxidation during aging (Stadtman, Science 257:1220 (1992)) which may be particularly toxic to individuals predisposed to neurodegenerative diseases. In addition, the neurodegenerative disorder, familial amyotrophic lateral sclerosis (ALS), has been shown to be associated with a mutation in superoxide dismutase (SOD), an enzyme responsible for eliminating free radicals in tissues (Marx, Science 261:956 (1993), Deng et al, Science 261:1047 (1993), Coyle et al, Science 262:689 (1993)). The GM1-agonist antibodies of the present invention afford protection against hydrogen peroxide toxicity and in a dose-dependent manner. (GM1, acting through GM1-binding proteins, can thus be expected to alter peroxide metabolism and protect neurons from oxygen free radicals (Dalia et al, J. Neurosci. 13:3104 (1993); Lai et al, Biochem. Pharm. 45:927 (1993)).) The agonist antibodies of the invention (eg the GM1-agonist antibodies) thus provide therapeutics for the treatment of tissue trauma, such as occurs in reperfusion injury, and for the treatment of oxidative-stress related diseases, including ALS, cancer, autoimmune diseases and AIDS (see Buttke et al, Immunol. Today 15:7 (1994)). The antibodies of the present invention are particularly advantageous for use in eliminating free radicals when long term treatments are required since such antibodies have long in vivo half lives. In the case of local tissue trauma or surgical procedure, agonist antibodies can be applied locally. For other purposes, the antibodies can be delivered intravenously.</PDAT></PTEXT></PARA>
<PARA ID="P-00037" LVL="0"><PTEXT><PDAT>The present invention also results from the observation that monoclonal antibodies can be produced that bind to Schwann cell surface molecules and, in so doing, stimulate tyrosine phosphorylation of specific protein substrates and dramatically facilitate cell migration. Schwann cells migrate extensively during development and regeneration of peripheral nerves. Thus, it is expected that antibodies against the Schwann cell membrane antigens can be used to enhance the therapeutic usefulness of Schwann cells following peripheral and central nervous system injuries where migration of Schwann cells promotes recovery.</PDAT></PTEXT></PARA>
<PARA ID="P-00038" LVL="0"><PTEXT><PDAT>Antibodies that potentiate Schwann cell migration can be produced using the immunosuppressant drug cyclophosphamide to tolerize the host to fibroblast membranes so that Schwann cell specific surface antigens can then be targeted (see Matthew and Sandrock, J. Immunol. Methods 100:73 (1987)). Schwann cells appear to follow certain molecular signals that govern their migration, thus they can be expected to possess specific surface receptors. Besides targeting the immune response in a subtractive scheme, cyclophosphamide can elicit autoimmune reactions (discussed above) and therefore success can be gained by the drug&apos;s ability to eliminate suppressive mechanisms. Mouse antibodies to a mouse Schwann cell line used in immunization are obtained even though it is extremely difficult to generate antibodies to mouse cell lines because the mouse is tolerant to these surface antigens. Therefore, a host treated with cyclophosphamide is susceptible to developing autoimmune reactions to normally non-immunogenic epitopes.</PDAT></PTEXT></PARA>
<PARA ID="P-00039" LVL="0"><PTEXT><PDAT>Schwann cell migration on biologically relevant tissue sections, and the effect of putative migration-modulating molecules (e.g. antibodies) thereon, can be studied using an in vitro bioassay. Briefly, dorsal root ganglia (DRG) from neonatal rats are explanted onto cryostat sections of either a normal sciatic nerve or a distal stump of previously transected sciatic nerve. Culture media suitable for use in the assay (for example, consisting of medium with fetal calf serum but without nerve growth factor) do not support significant neurite growth, but avidly support Schwann cell migration. The ganglionic Schwann cells that migrate on this substrate are visualized, for example, with the vital dye carboxyfluorescein di-acetate succinimydyl ester. The maximum distance migrated can be measured using an image analyzing program.</PDAT></PTEXT></PARA>
<PARA ID="P-00040" LVL="0"><PTEXT><PDAT>Numerous Schwann cells migrate extensively over sciatic nerve tissue substrates, mostly starting from 40 hours in culture. Assays are typically kept in culture for 72 hours in order to allow significant levels of Schwann cell migration to occur. Immunolabeling with a Schwann cell specific marker, S100, and counter staining with a nuclear marker, bis-benzamide, can be used to show whether all of the cells that migrate out of the DRG are Schwann cells. Typically, only occasional fibroblasts are seen among migrating Schwann cells. In some cases, a few neurofilament positive neurites are observed in the immediate region of the explant, far behind the migrating Schwann cells. Interestingly, Schwann cells migrate farther on a denervated sciatic nerve substrate than on a normal sciatic nerve substrate (for example, by 41%).</PDAT></PTEXT></PARA>
<PARA ID="P-00041" LVL="0"><PTEXT><PDAT>Various sources of Schwann cells have been tested in this assay system. Schwann cells from one day old superior cervical ganglia, sympathetic chain ganglia, coeliac ganglia (parasympathetic), neonatal sciatic nerve explants, and adult DRGs behave similarly in the assay. It is noteworthy that Schwann cells from sciatic nerve explants behave the same as Schwann cells from DRGs. The sciatic nerve explants do not contain neurons and therefore the bioassays provide a good model of Schwann cell behavior independent of neuronal influences.</PDAT></PTEXT></PARA>
<PARA ID="P-00042" LVL="0"><PTEXT><PDAT>One day old DRGs are used as the primary source of Schwann cells in the Examples that follow. They are easily obtained in large numbers and provide consistent results. Neonatal sciatic nerve explants are also used to verify results obtained with DRGs. As detailed in the Examples, following removal from one day old animals, sciatic nerves are cut into pieces and cultured for 48 hours in RPMI/10% FCS. Approximately 70% of the cells that migrate out during this period are fibroblasts. At the end of 48 hours, nerve pieces are explanted onto experimental nerve substrates and &gt;95% of the cells that migrate out are Schwann cells (based on S100 staining). The advantage of such explants is that they lack neurons and contain mostly Schwann cells. However, unlike DRGs, it can be difficult to consistently obtain sciatic nerve explants that contain approximately equal numbers of Schwann cells. Therefore, it is advantageous to use DRGs for routine assays and to use sciatic nerve explants for verification.</PDAT></PTEXT></PARA>
<PARA ID="P-00043" LVL="0"><PTEXT><PDAT>The bioassay system described herein above provides an excellent strategy for screening antibodies (and other molecules) for their ability to influence Schwann cell migration and has the following advantages: 1) Schwann cells display their capacity to migrate differentially in response to different molecular environments, 2) this bioassay utilizes biologically relevant substrata and 3) it is simple enough that a large number of antibodies (or growth factors) can be easily tested for effects, 4) the predominant biological feature of this assay is Schwann cell migration, not fibroblast migration or neurite extension.</PDAT></PTEXT></PARA>
<PARA ID="P-00044" LVL="0"><PTEXT><PDAT>The in vitro bioassay described above mimics Schwann cell migration on extracellular matrix and basement membrane components. However, Schwann cells also migrate on axons during the development and regeneration of peripheral nerves. Described below are two different assays in which Schwann cells are sensitive to the activities of the molecules present on axonal surfaces.</PDAT></PTEXT></PARA>
<PARA ID="P-00045" LVL="0"><PTEXT><PDAT>In the first assay, neonatal DRGs are cultured on cryostat sections of adult trout olfactory nerve. Trout olfactory nerve is primarily made up of bundles of naked axons (Kreutzberg and Gross, Cell Tissue Res. 181:443 (1977)). An extremely high density of axonal packing is observed in this nerve and, in general, the ratio of axonal plasma membrane to glial plasma membrane in this nerve exceeds 7:1. Thus, Schwann cells migrating out of the DRG explant have the opportunity to migrate on axonal surfaces in this assay. Typically, greater than 95% of the cells that migrate out of the DRG are Schwann cells. The average distance of Schwann cell migration after 72 hours in culture is 428&plusmn;13 &mgr;m. Other sources of pure axonal surfaces have been tested, such as, monolayers of a sensory neuronal cell line (E3H5B1), PC12 cells, and postnatal day 0 corpus callosum. Trout olfactory nerve is the preferred substrata for the purposes of this assay. This assay does, however, have certain limitations. Apart from the species origin of this substrate, the majority of the axons in a trout olfactory nerve do not seem to interact with glial cells during their development. These may, thus, contain certain molecular cues that signal fish glial cells to avoid them.</PDAT></PTEXT></PARA>
<PARA ID="P-00046" LVL="0"><PTEXT><PDAT>Schwann cell migration on axonal surfaces can also be studied using a second assay. In this assay, adult DRGs (L4, L5, L6) are removed two days after a sciatic nerve crush, dissociated, and cultured at low density on laminin coated plates in culture medium, for example, F1 5/10% horse serum. The dissociation procedure results in small neuron-Schwann cell clumps of similar size (&tilde;70 &mgr;m in diameter). Observation of cultures at, for example, 5, 16, 24, and 36 hours, indicates that by about 10 to 16 hours in culture, neurons in the clump establish extensive neurite networks. Following this, Schwann cells in the neuron-Schwann cell clump begin to migrate along these neurites. Schwann cells are easily identified based on their classical bipolar morphology. Almost all of the Schwann cells seen on neurites must originate from the neuron-Schwann cell clump, since only occasional Schwann cells are observed outside neuron-Schwann cell clumps during the early time points in culture. Time-lapse recordings of these cultures show that Schwann cells migrate exclusively along neurites and these cells always originate from the aggregate. Migration is not unidirectional but Schwann cells can change direction and migrate back towards the aggregate.</PDAT></PTEXT></PARA>
<PARA ID="P-00047" LVL="0"><PTEXT><PDAT>The major advantage of this assay is that it provides an optimal system to monitor the migration of Schwann cells on living neurites in real time. Moreover, some of the secondary events associated with changes in the migratory state of Schwann cells (e.g., filopodia extension or collapse) and changes in neurite growth and morphology can also be characterized in this assay. The ability of various agonist antibodies (and other molecules) to modulate these biological phenomena can be easily tested in this assay by including them in the culture media. One skilled in the art will appreciate that these assays can be used in combination to screen for antibodies (and other molecules) that modulate axon-Schwann cell interactions.</PDAT></PTEXT></PARA>
<PARA ID="P-00048" LVL="0"><PTEXT><PDAT>Although the Examples set forth below relate specifically to antibodies that bind Schwann cell surface molecules and facilitate cell migration and to antibodies to GM1 binding proteins that promote neuronal growth, the invention has much broader applicability. For example, antibodies can be produced in accordance with the invention that facilitate wound repair. For tissue and skin to recover from either wounds or burns, specific cell types must migrate to replace the damaged tissues. The availability of agonist antibodies that facilitate the migration of skin cells is clearly of advantage for use in treating tissue damage. Antibodies that facilitate Schwann cell migration can be expected to be suitable for use in promoting skin cell migration. Alternatively, antibodies that promote skin cell migration can be produced by targeting skin cell specific antigens in the manner described above for Schwann cell surface antigens.</PDAT></PTEXT></PARA>
<PARA ID="P-00049" LVL="0"><PTEXT><PDAT>The invention also contemplates agonist antibodies that stimulate the function of specific immune cells compromised by, for example, HIV infection. In this regard, it is expected that immune cell function can be promoted by using agonist antibodies that mimic lymphokines. The anti-idiotypic strategy can be employed to develop agonist antibodies by identifying the functional site of the lymphokine. Alternatively, antibodies can be generated to the lymphokine receptor that are capable of mimicking the lymphokine.</PDAT></PTEXT></PARA>
<PARA ID="P-00050" LVL="0"><PTEXT><PDAT>Agonist antibodies of the invention also include those that mimic the function of growth factors. That is, agonist antibodies can be used that bind and activate growth factor receptors. For example, an agonist antibody for the insulin receptor can be used in place of insulin. Neurotrophic factors can be mimicked with antibodies and thereby provide therapies for motor neuron disease and Alzheimer&apos;s disease. Furthermore, it is expected that essentially any pharmaceutical that acts at the cell surface can be mimicked with an agonist antibody of the invention. Such pharmaceuticals include manufactured drugs as well as endogenous agents that promote cellular functions. In each case, the antibody is targeted to the functional active site of the receptor. Difficulties in applying this approach, in terms of targeting the antibody to the appropriate site on the receptor protein, can be expected to be resolved by using the anti-idiotypic method to target the functional recognition site on the receptor. The use of anti-idiotypic antibodies directed to the functional domains of proteins are ideal for this purpose, since such antibodies mimic the structure of the ligand, not the structure of the binding protein.</PDAT></PTEXT></PARA>
<PARA ID="P-00051" LVL="0"><PTEXT><PDAT>While the present approach is applicable to any ligand (small ligands being preferred), carbohydrate-binding proteins are particularly preferred targets for therapeutic agonist antibodies. Carbohydrate drug development is being sought for a wide variety of diseases: AIDs, arthritis, cardiovascular disease, diarrhea, infections, anti-inflammatory, autoimmune disease, diabetes, and wound healing (The Genesis Report, Vol. 1, number 2 (1992)). The intent in these efforts is to develop specific carbohydrates that interact with carbohydrate-binding proteins. The major dilemma continues to be the production of pure carbohydrates in large quantities. This dilemma can be resolved by developing anti-idiotypic antibodies to the carbohydrate of interest and using the antibody to mimic the carbohydrate structure in the manner described above for GM1 and the GM1 receptor.</PDAT></PTEXT></PARA>
<PARA ID="P-00052" LVL="0"><PTEXT><PDAT>Agonist antibodies of the invention that are preferred for use in humans can be designed using approaches such as those that follow. Chimeric antibodies can be made where variable regions from mouse agonist antibodies are spliced to human constant regions. Alternatively, those regions of mouse agonist antibodies comprising the binding site can be grafted into human antibodies. The latter is typically referred to as a &ldquo;humanized&rdquo; antibody. In both cases, because the constant region of the immunoglobulin is responsible for eliciting an immune response, the antibodies are relatively non-immunogenic in humans. Either chimeras or humanized murine antibodies can be produced by cloning the cDNA for the antibody and genetically engineering the recombinant immunoglobulin molecules (Mountain and Adair, Biotech. Genetic Engin. Rev. 10:1-142 (1992); Singer et al, J. Immun. 150:2844-57 (1993); Hardman et al, Inter. J. Biol. Markers 7:203-9 (1992); Carter et al, P.N.A.S. 89:4285-9 (1992)). Another, more simple approach, is to use Fab fragments of mouse antibodies (Hudson and Hay, Practical Immunology, Blackwell Sci. Pub. (1989)). In this case, the majority of the constant region is removed by proteolysis. This yields a protein with the ability to bind antigen but one that is incapable of activating complement. This approach is preferred since agonist antibodies of the invention are used to signal cells through receptors, not to activate complement and kill cells.</PDAT></PTEXT></PARA>
<PARA ID="P-00053" LVL="0"><PTEXT><PDAT>The agonist antibodies of the invention are preferable to most pharmaceuticals and peptides in that they are long-lived in the body. Immunoglobulins turn over in vivo with half lives of approximately 30 days. By comparison, the half life of GM1 in vivo ranges from 6 to 24 hours. In addition to a prolonged half life, antibodies of the invention that have a high affinity for their respective binding partners can be more effective than the molecules they mimic.</PDAT></PTEXT></PARA>
<PARA ID="P-00054" LVL="0"><PTEXT><PDAT>The mode of delivery of an antibody of the invention depends on the nature of the antibody and the therapeutic effect to be achieved. For applications relating to peripheral nerve regeneration, the delivery of antibody is relatively straightforward. Delivery of antibodies of the invention to the brain can, however, also be effected and without compromising the blood brain barrier. The barrier is not absolute, but typically reduces the concentration of serum proteins by three orders of magnitude. A high affinity, potent agonist antibody might have an effect within the brain at such titers. In cases of tissue trauma, either within the nervous system or peripheral injuries, like wounds, an agonist antibody of the invention that promotes cell survival, growth or migration can be applied locally, for example, by the surgeon during surgery to reconstruct the cord or eliminate hemorrhaging. Agonist antibodies that promote neuron growth can be directly applied to the site of surgery. In addition, canuli left in place to drain the lesion can be used to deliver therapeutic agents. Antibodies can also be delivered into the cerebral spinal fluid using standard techniques.</PDAT></PTEXT></PARA>
<PARA ID="P-00055" LVL="0"><PTEXT><PDAT>In the case of burns or wounds, agonist antibodies can again be applied locally. For other purposes, the antibodies can be delivered intravenously. Doses of agonist antibodies that are effective but that do not cause secondary complications can be experimentally determined.</PDAT></PTEXT></PARA>
<PARA ID="P-00056" LVL="0"><PTEXT><PDAT>Since agonist antibodies are designed to facilitate the survival, growth and migration of certain cell types, they will be valuable tools for supplementing currently available therapeutics. For example, it is expected that agonist antibodies can be developed that potentiate the activity of certain growth factors and that these two reagents can be employed in combination.</PDAT></PTEXT></PARA>
<PARA ID="P-00057" LVL="0"><PTEXT><PDAT>Certain aspects of the present invention are described in greater detail in the non-limiting Examples that follow.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE I</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Promotion of Neuron Growth by Antibodies to GM-1 Binding Proteins</PDAT></STEXT></H>
<PARA ID="P-00058" LVL="7"><PTEXT><PDAT>I.a. Generation of Antibodies to GM1-binding Proteins:</PDAT></PTEXT></PARA>
<PARA ID="P-00059" LVL="0"><PTEXT><PDAT>GM1 (3.5 mg) was solubilized in 0.5 ml of absolute ethanol and added to 0.7 mg of glutaraldhyde-activated beads (Affinity Adsorbent, 665-525, Boehringer Mannheim). The ethanol was evaporated under a stream of nitrogen gas and the beads were suspended in 7.0 ml RPMI-1640 culture medium. Female BALB/c mice, 8 weeks old, received a 1 ml volume of bead suspension i.p. containing 0.5 mg of ganglioside. Cyclophosphamide (2 mg/ml in saline) was given i.p. at dosages of 100 mg/kg and/or 150 mg/kg. A final dose of 0.5 mg of GM1 was given two weeks after the initial immunization. Spleens were removed 2-4 days later for fusion. Spleen cells of immunized mice were fused with NS1 myeloma cells as described (Matthew and Sandrock, J. Immunol. Methods 100:73 (1987); Dunbar and Skinner, Methods Enzymol. 182:670 (1990)).</PDAT></PTEXT></PARA>
<PARA ID="P-00060" LVL="0"><PTEXT><PDAT>The antibodies were screened in ELISA&apos;s (Ausubel et al, Current Portocols in Molecular Biology, Vols. 1 and 2, John Wiley &amp; Sons (1990); Matthew and Sandrock, J. Immunol. Methods 100:73 (1987); Miyoshi et al, J. Biochem. 92:89 (1982)) for their ability to bind to purified GM1, GM2, GD1b, a mixture of gangliosides that includes GM1, galactocerebroside (the ganglioside backbone with only a galactose sugar moiety rather than the full complement of carbohydrates), and the &bgr; subunit of cholera toxin. Gangliosides and galactocerebroside were solubilized in methanol at a concentration of 10 &mgr;g/ml. Fifty &mgr;1 was pipetted into each well of a 96 well ELISA plate and the solvent evaporated in a fume hood. Cholera toxin (beta-subunit) was diluted to 5 &mgr;g/ml; 50 &mgr;l was pipetted into each well of a 96 well ELISA plate and allowed to adsorb to the plastic for 2 hours at room temperature or overnight at 4&deg; C. The plates were washed with 1% PVP/TBS and 50 &mgr;l of hybridoma supernatant or NS1 conditioned media was added to each well. After a one hour incubation, the wells were washed and incubated with biotinylated anti-mouse IgG and IgM&apos;s. The biotinylated secondary antibodies were incubated with avidin-HRP (Vectastain ABC kit, Vector Labs). The complex was visualized as a diaminobenzidine reaction product (Ausubel et al, Current Protocols in Molecular Biology, Vols. 1 and 2, John Wiley &amp; Sons (1990)).</PDAT></PTEXT></PARA>
<PARA ID="P-00061" LVL="0"><PTEXT><PDAT>Using seven different immunization schedules, 1467 hybridomas were produced. Twenty hybridomas were selected from each fusion to be screened for antibody specificity. Of these 140 hybridomas, 44 produced antibody secreting hybridomas. Of the 44, 16 were identified as putative anti-idiotypic antibodies based on their ability to bind cholera toxin. Two doses of cyclophosphamide produced the greatest number of hybridomas secreting ganglioside or cholera toxin binding antibodies. In this series of fusions, 36.4% of the antibody-secreting hybridomas produced antibodies specific for the beta-subunit of cholera toxin. This binding was blocked competitively by GM1.</PDAT></PTEXT></PARA>
<PARA ID="P-00062" LVL="7"><PTEXT><PDAT>I.b. Spatial and Temporal Distribution of Antigens:</PDAT></PTEXT></PARA>
<PARA ID="P-00063" LVL="0"><PTEXT><PDAT>ELISA assays: Homogenates of brain tissue from rats aged embryonic day 18, postnatal days 0 and 7 and adult were prepared in TBS. The protein contained in each of the 4 homogenates was determined with a Biorad protein assay and the homogenates were each diluted to a final protein concentration of 32 mg/ml. Fifty &mgr;l of homogenate was added to each ELISA well and allowed to adsorb for 2 hours at room temperature or overnight at 4&deg; C. The ELISA assay was performed as described by Matthew and Sandrock (J. Immunol. Methods 100:73 (1987)) and Miyoshi et al (J. Biochem. 92:89 (1982)).</PDAT></PTEXT></PARA>
<PARA ID="P-00064" LVL="0"><PTEXT><PDAT>Labeling tissue sections: Neonatal rats (aged 0-10 days) were anesthetized in the cold and adult rats were anesthetized with a combination of ketamine (100 mg/kg), xylazine (5.2 mg/kg) and acepromozine (1 mg/kg) and perfused in 2-4% paraformaldehyde in phosphate buffered saline with 2% sucrose. Tissue was removed and frozen to a cryostat chuck with OCT embedding media. Fifteen micrometer sections were cut at &minus;18&deg; C. onto subbed glass slides. Sections were washed and blocked in 1% PVP/TBS or 2.5% calf serum/TBS and primary and fluorescently labeled secondary antibodies applied for 1 hour each at room temperature.</PDAT></PTEXT></PARA>
<PARA ID="P-00065" LVL="0"><PTEXT><PDAT>Culture methods for dissociated hippocampal cells: Hippocampi were dissected from embryonic day 18 rats. The meninges are removed and the cells are incubated at 37&deg; C. in Ca&plus;&plus;, Mg&plus;&plus; free Hank&apos;s buffered salt solution (fHBSS) with 0.005% (w/v) trypsin for 15 minutes. The cells are washed in DMEM/F12 media with 5% horse serum and 2.5% calf serum and triturated. The cells were spun and resuspended to a final concentration of 50-200K cells/ml (adapted from Banker and Cowan, Brain Res. 126:397 (1977); Banker and Goslin, Culturing Nerve Cells, MIT Press, Cambridge, Mass., pp. 177-206 and 251-282 (1991)).</PDAT></PTEXT></PARA>
<PARA ID="P-00066" LVL="0"><PTEXT><PDAT>Labeling cells in culture: Dissociated cells were plated onto glass chamber slides coated with poly-L-lysine, laminin, or on a monolayer of astrocytes. The cells were allowed to grow until neurites formed (3-5 days). Cultures were fixed with 4% paraformaldehye and permeabilized with 0.3% TRITON (a non-ionic detergent)-X-100. Coverslips were rinsed with medium, incubated with hybridoma supernatant for 30 minutes, washed with 1 PVP/TBS or 2.5% calf serum in tris buffered saline pH 7.4 (CS/TBS), incubated with fluorescein coupled goat anti-mouse Ig (Antibodies Inc.) for 30 minutes, washed with CS/TBS and then viewed using a fluorescence microscope. Neurons were identified with an anti-neurofilament monoclonal antibody, astrocytes were identified with anti-glial fibrillary acidic protein, oligodendrocytes were identified using anti-galactocerebroside monoclonal antibody and fibroblasts were identified by labeling with antibodies to fibronectin.</PDAT></PTEXT></PARA>
<PARA ID="P-00067" LVL="0"><PTEXT><PDAT>The 16 antibodies referenced in I.a. above that bound the beta subunit of cholera toxin were screened for their ability to bind to.brain homogenates in ELISA assays, cultured embryonic hippocampal cells and sections of CNS and PNS tissue. All of these antibodies bound to tissue homogenates from developing brains in the ELISA&apos;s. These antibodies were then used to label tissue sections and cultured cells, as described above. Ten of these antibodies labeled tissue sections and 5 labeled cultured cells.</PDAT></PTEXT></PARA>
<PARA ID="P-00068" LVL="7"><PTEXT><PDAT>I.c. In Vitro Axon Outgrowth Bioassay on Cryostat Sections:</PDAT></PTEXT></PARA>
<PARA ID="P-00069" LVL="0"><PTEXT><PDAT>Bioassays: Dissociated cells were plated at 20-35 k cells/cm</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>onto substrates of increasing complexity: poly-L-lysine (Banker and Cowan, Brain Res. 126:397 (1977)), CELL-TAK cryostat sections of E18 brain and spinal cord (Tuttle and Matthew, J. Neuro Sci. Methods 39:193 (1991)), adult normal sciatic nerve and the distal stump of a degenerating sciatic nerve (Sandrock and Matthew, Proc. Natl. Acad. Sci. USA 84:6934 (1987)) in the presence of hybridoma supernatant or NS1 conditioned media. Living cells were visualized with fluorescence microscopy following incorporation of the vital dye 6-carboxyfluorescein diacetate succinimidyl ester (Bronner-Fraser, J. Cell Biol. 101:610 (1985)); Rotman and Papermaster, Proc. Natl. Acad. Sci. USA 55:134 (1966)).</PDAT></PTEXT></PARA>
<PARA ID="P-00070" LVL="0"><PTEXT><PDAT>Measuring the degree of neurite outgrowth: The total length of neurite outgrowth was measured from cells whose processes were at least as long as the diameter of the cell body. All the processes measured in this study were single unbranched neurites. When the processes were bipolar, the length of both processes were added to give a total neuritic length.</PDAT></PTEXT></PARA>
<PARA ID="P-00071" LVL="0"><PTEXT><PDAT>Four of 10 antibodies from I.a. above that were tested (designated 4, 5, 20 and 58) were successful in manipulating cell attachment and neurite outgrowth in in vitro bioassays (see </PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 2A</PDAT></FGREF><PDAT>, </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT>B, </PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT>A-</PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT>C and </PDAT><HIL><BOLD><PDAT>4</PDAT></BOLD></HIL><PDAT>). All of these antibodies promoted cell adhesion and promoted process outgrowth to brain sections. In only 5% of the control bioassays, did cells attach to brain sections. Only 1 antibody was successful in promoting attachment to embryonic spinal cord. All of these antibodies promoted cell adhesion to the normal sciatic nerve. In 7 of these bioassays, attached cells exhibited processes. In control bioassays, cells never attached to the normal sciatic nerve. Cells always adhered to the distal stump of a degenerating sciatic nerve in control and antibody treated bioassays.</PDAT></PTEXT></PARA>
<PARA ID="P-00072" LVL="0"><PTEXT><PDAT>Antibodies that bind to cholera toxin thus have the ability to promote cell adhesion and neurite outgrowth on nonpermissive substrates. Embryonic hippocampal cells were plated onto: a) E18 brain, b) E18 spinal cord, c) adult normal sciatic nerve, and d) distal stump of a transected sciatic nerve. Cells adhere to permissive and nonpermissive substrates when they are cultured in the presence of the anti-idiotypic antibodies.</PDAT></PTEXT></PARA>
<PARA ID="P-00073" LVL="0"><PTEXT><PDAT>Further studies demonstrated that the anti-idiotypic antibodies actually enhanced the ability of the cells to adhere to and survive on permissive and nonpermissive substrates rather than merely covering inhibitory sites on the substrates. Specifically, the cells were grown on simple substrates like poly-L-lysine or CELL-TAK in the presence of antibody or NS1 conditioned media. In these assays, cells adhere readily to CELL-TAK and extend processes. After 3 days in culture, cells grown in the presence of antibody had extended single or bipolar unbranched neurites the total neuritic length of which was 50-75% longer than those grown in the presence of NS1 conditioned media (see FIG. </PDAT><HIL><BOLD><PDAT>4</PDAT></BOLD></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00074" LVL="7"><PTEXT><PDAT>I.d. Determination of Proteins that are Phosphorylated at Tyrosine Residues in Response to Antibody Treatment:</PDAT></PTEXT></PARA>
<PARA ID="P-00075" LVL="0"><PTEXT><PDAT>Dissociated embryonic hippocampal cells were prepared. Five hundred &mgr;l of cells at 200K cells/ml were incubated for 45 minutes in the presence of 500 &mgr;l of various hybridoma supernatants, 0.5 or 0.1 &mgr;g of cholera toxin, 2 or 20 &mgr;g of GM1, the phosphatase inhibitor vanadate (0.5 mM) or kinase inhibitor genestein (0.5 mM), and NS1 conditioned media. These growth factors represent two major classes of growth factors that act in the nervous system (Cockram et al, Sem. in Dev. Biol. 1:421-435 (1990); Maisonpierre et al, Sci. 247:1446-1451 (1990); Unsicker et al, PNAS 84:5459-5463 (1987); Walicke et al, PNAS 83:3012-3016 (1986)). The cells were pelleted and the supernatant aspirated with a 27 gauge needle. Hot SDS-PAGE sample buffer containing 0.5 mM vanadate was added and the samples were frozen at &minus;20&deg; C. until use. The samples were boiled and centrifuged; 30 &mgr;l was added to each well of a 10% gel and run at 40 mA. The proteins were blotted onto nitrocellulose, blocked with 4% calf serum containing vanadate and then 10% calf serum in tris buffered saline (pH 7.4) overnight at 4&deg; C. Bands of protein containing phosphorylated tyrosine were identified using an anti-phosphotyrosine antibody (Sigma, P-3300) diluted 1:750 in 10% calf serum. Positive bands were visualized with an anti-mouse VECTASTAIN ABC-HRP kit as a diaminobenzidine reaction product.</PDAT></PTEXT></PARA>
<PARA ID="P-00076" LVL="0"><PTEXT><PDAT>As shown by Western blotting, embryonic hippocampal cells treated with anti-idiotypic antibodies that promote cell adhesion and neurite outgrowth induced tyrosine phosphorylation of bands at approximately 65-75 and 48-52 Kd. The bands of tyrosine phosphorylation were not observed in samples treated with nonfunctional antibodies, NS1 conditioned media, 0.5 mM genestein, 0.5 mM vanadate. Proteins that are known to be phosphorylated in neurons are as follows. For the 75 kD band: 80 kD synapsin 1 (synaptic vesicle protein), 72 kD protein phosphorylated at serine in response to GQ1b (Nakamura et al, J.N.R. 31:724 (1992)), 70 kD paxillin (a protein in focal adhesions, substrate for the tyrosine kinase pp60src), the 69 kD laminin receptor, 68 kD neurofilament protein, or 59 kD vimentin. For the 50 kD band: 45 kD NGF activated MAP2 kinase, 42-44 MAP kinase (ERK), 46 kD talin, 45 kD laminin binding protein, 43 kD actin, 36-42 kD proteins of rat brain P2 subcellular fraction, P in response to GD1b (Bassi et al, J. Neurochem. 57:1207-1211 (1991).</PDAT></PTEXT></PARA>
<PARA ID="P-00077" LVL="7"><PTEXT><PDAT>I.e. Molecular Identity of Antigens Recognized by the Anti-idiotypic Antibodies:</PDAT></PTEXT></PARA>
<PARA ID="P-00078" LVL="0"><PTEXT><PDAT>Embryonic hippocampal cells or PC12 cells were solubilized with SDS and mercaptoethanol. The material was separated by SDS-PAGE and electrophoretically transferred to nitrocellulose paper. The blot was blocked with 1% PVP/TBS, incubated with hybridoma supernatant, washed with CS/TBS and incubated with biotinylated anti-mouse IgM. The bound antibody was detected using a VECTASTAIN AIBC-HRP kit and the complex was visualized as a diaminobenzidine reaction product (Ausubel et al, Current Protocols in Molecular Biology, Vols. 1 and 2, John Wiley &amp; Sons, N.Y. (1990)).</PDAT></PTEXT></PARA>
<PARA ID="P-00079" LVL="0"><PTEXT><PDAT>Western blotting of the embryonic hippocampal and PC12 cells revealed bands at approximately 45 and 57 kD that are recognized by the anti-idiotypic antibodies that enhanced adhesion and neurite outgrowth in bioassays. These bands were recognized regardless of whether the cells had been cultured in the presence of growth factors. The antibodies tested appeared to show differential affinity for cholera toxin, beta-subunit, in the ELISA assays, and also showed varied affinities for the proteins on the blot. In all cases, the 45 kD band was recognized more strongly than the 57 kD band.</PDAT></PTEXT></PARA>
<PARA ID="P-00080" LVL="0"><PTEXT><PDAT>In order to determine whether the antibodies were binding to the carbohydrate portion of the protein, three experiments were performed. Western blots showed that antibody binding was not blocked by preincubating the antibodies with the appropriate carbohydrates, that samples treated with glycosidases continue to be labeled with the.antibodies, and the antigen could be recognized by antibodies in PC12 cells grown in the presence of tunicamycin which inhibits protein glycosylation. In each case, recognition of the 45 and 57 kD bands on the Western blot indicated that the antibodies did not bind to the carbohydrate portion of a protein.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE II</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Modulation of Schwann Cell Migration by Antibodies Against Schwann Cell Membrane Antigens</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>I In Vitro Bioassays</PDAT></STEXT></H>
<PARA ID="P-00081" LVL="7"><PTEXT><PDAT>I.a) In Vitro Bioassay for Schwann Cell Migration on Cryostat Tissue Sections:</PDAT></PTEXT></PARA>
<PARA ID="P-00082" LVL="0"><PTEXT><PDAT>In this assay, neonatal peripheral ganglia are cultured on cryostat sections of sciatic nerve and migration of Schwann cells from the peripheral ganglia onto the nerve substrate is assessed. The assay provides an in vitro system where the primary biological event is Schwann cell migration on extracellular matrix and cell surfaces, not neurite extension or fibroblast migration. Neurite outgrowth is minimal when a simple culture medium is used (RPMI/10% FCS or DMEM/10% FCS, lacking exogenous additives like NGF). The extent of Schwann cell migration, neurite outgrowth, and fibroblast migration has been evaluated by first immunostaining the cultures with Schwann cell and neuron specific markers such as S100 and GAP-43 and then counterstaining them with cresyl violet or bis-benzamide.</PDAT></PTEXT></PARA>
<PARA ID="P-00083" LVL="0"><PTEXT><PDAT>Method: Twenty two micron thick longitudinal cryostat sections of adult sciatic and optic nerves are dried on to glass coverslips and then washed briefly in DMEM. DRGs from one day old rats are removed, treated with 0.25% trypsin and 200 units/ml collagenase in DMEM for 20 minutes, rinsed with 0.1% anti-trypsin and 0.01% DNAse in DMEM/10% FCS for 10 minutes, and then explanted onto the cryostat sections. Cultures are maintained in DMEM/10% FCS from one to three days. At the end of incubation, a vital dye, 5-6 carboxyfluorescein diacetate succinimydyl ester, is used to visualize cells and neurites. Images of these living cultures are recorded. Following the vital dye treatment and image acquisition, cultures are fixed in 4% parafornmaldehye and stained with antibodies to S100 and neurofilament either the peroxidase-anti-peroxidase method or the immunofluorescence method (Hudson and Hay, Practical Immunology, Blackwell Sci. Pub. 1989). Depending on the histochemical procedure used, cultures are counterstained with either cresyl violet or bis benzamide. In addition to DRGs, parasympathetic ganglia, sympathetic chain ganglia and sensory ganglia from different points along the rostrocaudal axis (at least one antigen differs along the rostrocaudal axis among Schwann cells&mdash;see: Suzue et al, Neuron 5:421 (1990)) have been tested in this assay as possible sources of Schwann cells and to ascertain any differences in their capacity to migrate. Sciatic nerves from different age rats (embryonic day 14 to adult) have been cut into 2 mm segments and explanted onto tissue sections.</PDAT></PTEXT></PARA>
<PARA ID="P-00084" LVL="0"><PTEXT><PDAT>The IMAGE I (Universal Imaging Inc.) program is used to measure the extent of Schwann cell migration in this assay. A rectangular grid divided into several 100 square micrometer squares is pasted to the image and the distance between the edges of the DRG and the leading Schwann cells is measured. An average of these measurements indicates the mean distance Schwann cells have migrated on a particular substrate from a particular DRG explant. These measurements are analyzed using a statistics software program, EXSTATICS.</PDAT></PTEXT></PARA>
<PARA ID="P-00085" LVL="7"><PTEXT><PDAT>I.b.) In Vitro Bioassay to Study Schwann Cell Migration on Axonal Surfaces:</PDAT></PTEXT></PARA>
<PARA ID="P-00086" LVL="0"><PTEXT><PDAT>In the assays that follow, Schwann cells are sensitive to the activities of molecules present on axonal surfaces. In the first assay, cryostat sections of a nerve (trout olfactory nerve) that is primarily made up of naked axons are used as substrates for Schwann cell migration. In the second assay, living axons are used as substrates. In both cases, migrating Schwann cells interact primarily with axonal surfaces.</PDAT></PTEXT></PARA>
<PARA ID="P-00087" LVL="0"><PTEXT><PDAT>Culture methods for dissociated dorsal root ganglion (DRG) cells: Neonatal rats were anesthetized in the cold and decapitated. DRG were removed and incubated at 37&deg; C. in 0.25% collaganase type 11 in F14 media with N1 additives for 1.5 hours. DRG were then triturated and 0.025% (w/v) trypsin 80 g/ml DNAase and 100 g/ml soybean trypsin inhibitor is added. Following one round of gentle trituration, the cells are suspended in 15 ml of F14 media with 10% horse serum and spun. The pellet is resuspended to 50-200K cells/ml and incubated or plated on poly-L-lysine ((0.1 mg/ml) or laminin (10 mg/ml) coated glass coverslips.</PDAT></PTEXT></PARA>
<PARA ID="P-00088" LVL="0"><PTEXT><PDAT>Culture methods for dissociated superior cervical ganglion cells: Ganglia were dissected from 2-3 day old mice, and the capsule is removed. The ganglia were incubated at 37&deg; C. in Ca&plus;&plus;, Mg&plus;&plus; free Hank&apos;s buffered salt solution (fHBSS) with 0.25% (w/v) trypsin for 30 minutes. The cells are transferred to L-15 media with 1 mg/ml BSA, washed twice, and triturated. The cells are spun and resuspended to a final concentration of 50-200K cells/ml (adapted from Banker and Goslin, Culturing Nerve Cells, MIT Press, Cambridge, Mass., pp. 177-206 and 251-282 (1991)) and plated onto poly-L-lysine coated coverslips.</PDAT></PTEXT></PARA>
<PARA ID="P-00089" LVL="0"><PTEXT><PDAT>Assay: In the first assay, Schwann cell migration on 22 &mgr;m thick trout olfactory nerve substrates was studied in a manner analogous to that described above for Schwann cell migration on cryostat sections of sciatic nerve. For the study of Schwann cell migration on living neurites, sciatic nerves of adult Sprague-Dawley rats were crushed two days prior to the removal of corresponding DRGs (L4, L5, and L6). Following removal, DRGs were incubated at 37&deg; C. in 0.25% collagenase type II (in F14 media with N1 additives) for 1.5 hours. At the end of this incubation, DRGs were triturated (16 passages) with a fire polished glass pipette and 0.025% trypsin was added to the cell suspension. After 15 minutes at room temperature, 80 &mgr;g/ml DNAse and 100 &mgr;g/ml soybean trypsin inhibitor were added to the suspension. Following one round of gentle trituration, cells were suspended in 15 ml of F14/10% horse serum (HS) media and spun for 10 minutes at 500 g. The cell pellet was resuspended in a desired volume of F14/10% HS and plated on laminin (10 &mgr;g/ml) coated 24 well plates. In general, the cells from one DRG were plated into 32 wells. Cultures were maintained for 36 hours and then stained with 5-6 carboxyfluorescein diacetate succinimidyl ester and bis benzamide. Carboxyfluorescein labels all living cells and their processes. Bis benzamide was used to stain the cell nuclei. Images of cultures stained as above could be used to analyze the extent of neurite outgrowth and neuron-Schwann cell association. Instead of labeling with carboxyfluorescein and bis-benzamide, migration of Schwann cells on neurites has also been monitored in real time in cultures using time lapse microscopy.</PDAT></PTEXT></PARA>
<PARA ID="P-00090" LVL="7"><PTEXT><PDAT>I.c.) Assay to Determine Whether Schwann Cells from Dystrophic Mice Differ in Their Ability to Migrate and Whether Dystophic Nerve Substrates Differ in Their Ability to Support Schwann Cell Migration:</PDAT></PTEXT></PARA>
<PARA ID="P-00091" LVL="0"><PTEXT><PDAT>In the spinal nerve roots of dystrophic mice, substantial numbers of axons are without ensheathment and are not separated by Schwann cell processes or extracellular matrix. In these regions, Schwann cells are present but they remain on the perimeter of the bundled axons. These observations imply a deficit in Schwann cell migration during development. Therefore, the migratory behavior of dystrophic Schwann cells and the molecular differences between normal and dystrophic nerve substrates can be analyzed as follows.</PDAT></PTEXT></PARA>
<PARA ID="P-00092" LVL="0"><PTEXT><PDAT>Method: Cryostat sections of sciatic nerves from dystrophic mice and littermates are used as substrates. DRGs from normal and dystrophic mice are explanted on to these substrates. Migration of normal Schwann cells on dystrophic nerve substrate, dystrophic Schwann cells on normal nerve substrate, and dystrophic Schwann cells on dystrophic nerve substrate are assessed as described above. Relevant growth factors and antibodies are tested in these assays for their ability to alleviate the deficits in Schwann cell migration. Cryostat sections of sciatic nerves from dystrophic and normal mice are screened by immunocytochemistry with relevant antibodies.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>II Preparation of Monoclonal Antibodies and Potentiation of Schwann Cell Migration</PDAT></STEXT></H>
<PARA ID="P-00093" LVL="7"><PTEXT><PDAT>II.a.) Antibodies Prepared to Schwann Cell Molecules:</PDAT></PTEXT></PARA>
<PARA ID="P-00094" LVL="0"><PTEXT><PDAT>The cyclophosphamide protocol of Matthew and Sandrock (J. Immunol. Methods 100:73 (1987)) was used to isolate monoclonal antibodies that recognize antigens expressed by Schwann cells. Briefly, mice were tolerized first with whole cell extracts from fibroblast cell line (3T3) and then immunized with whole cell extracts from the Schwann cell line B1.1, a cell line generated by infecting primary mouse Schwann cells with a transforming retrovirus. Cell lines were used since large quantities of pure, homogeneous populations could be generated efficiently.</PDAT></PTEXT></PARA>
<PARA ID="P-00095" LVL="0"><PTEXT><PDAT>About 90 antibodies were identified that recognize antigens expressed in B1.1 cells but not in 3T3 cells. These 90 antibodies also recognize Schwann cell associated antigens in cryostat tissue sections of sciatic nerve and primary Schwann cells. Immunostaining of sciatic nerve sections indicate that 60 of the antibodies recognize extracellular matrix or myelin associated antigens. Sixteen others recognize Schwann cell membrane associated antigens and fourteen antibodies bind Schwann cell cytoplasmic antigens. These antibodies are referred to as S series antibodies.</PDAT></PTEXT></PARA>
<PARA ID="P-00096" LVL="7"><PTEXT><PDAT>II.b. Potentiation of Schwann Cell Migration in Vitro by Monoclonal Antibodies:</PDAT></PTEXT></PARA>
<PARA ID="P-00097" LVL="0"><PTEXT><PDAT>All of the antibodies that were raised against B1.1 cell line were screened in the in vitro bioassay for Schwann cell migration on cryostat sections of normal and denervated sciatic nerve, as described above. The antibodies that modulated Schwann cell migration in this assay were further screened for their ability to modulate Schwann cell migration on trout olfactory nerve sections and living neurites using the assays set forth above. Time lapse recordings permit measurements of true neurite growth and Schwann cell migration rates in the assays to evaluate Schwann cell migration on living axons. In light of the large numbers of antibodies to be screened, only the changes in the number of Schwann cells associated with living neurites and the extent of neurites in the presence or absence of the antibodies were evaluated. Any modulation of axon-Schwann cell interactions by the antibodies is expected to be reflected in these two phenomena. Primary Schwann cells and fibroblasts were stained with these antibodies in order to identify the cellular location of the corresponding antigens. Furthermore, these antibodies were also isotyped and tested in dot blots for their ability to recognize extracellular matrix molecules, laminin, and fibronectin. Listed in Table 1 are antibodies that were found to potentiate Schwann cell migration and antibodies that were found to inhibit Schwann cell migration (note that antibody 21 (IgG1) was obtained from a fusion different from the fusion that resulted in the other antibodies listed).</PDAT></PTEXT></PARA>
<CWU>
<TABLE-US ID="TABLE-US-00001">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="259pt" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" rowsep="1"><PTEXT><PDAT>TABLE 1</PDAT></PTEXT></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry><PTEXT><PDAT>RESULTS OF BIOASSAYS &amp; PRELIMINARY BINDING CHARACTERISTICS</PDAT></PTEXT></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="offset" colwidth="42pt" align="left"/>
<colspec colname="1" colwidth="84pt" align="center"/>
<colspec colname="2" colwidth="133pt" align="left"/>
<tbody valign="top">
<row>
<entry></entry>
<entry><PTEXT><PDAT>Bioassay &num;:</PDAT></PTEXT></entry>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="offset" colwidth="42pt" align="left"/>
<colspec colname="1" colwidth="21pt" align="left"/>
<colspec colname="2" colwidth="21pt" align="left"/>
<colspec colname="3" colwidth="42pt" align="left"/>
<colspec colname="4" colwidth="133pt" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry><PTEXT><PDAT>&num;1</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&num;2</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&num;3</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Binding to:</PDAT></PTEXT></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="13">
<colspec colname="1" colwidth="42pt" align="left"/>
<colspec colname="2" colwidth="21pt" align="left"/>
<colspec colname="3" colwidth="21pt" align="left"/>
<colspec colname="4" colwidth="14pt" align="left"/>
<colspec colname="5" colwidth="14pt" align="left"/>
<colspec colname="6" colwidth="14pt" align="left"/>
<colspec colname="7" colwidth="21pt" align="left"/>
<colspec colname="8" colwidth="14pt" align="left"/>
<colspec colname="9" colwidth="21pt" align="left"/>
<colspec colname="10" colwidth="14pt" align="left"/>
<colspec colname="11" colwidth="14pt" align="left"/>
<colspec colname="12" colwidth="21pt" align="left"/>
<colspec colname="13" colwidth="28pt" align="left"/>
<tbody valign="top">
<row>
<entry><PTEXT><PDAT>Antibody</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>NS</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>DS</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>TN</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&num;4</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&num;5</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>SC</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>FB</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>EM</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>LN</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>FN</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>MYL</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Ig clas</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="13" align="center" rowsep="1"></entry>
</row>
<row>
<entry><PTEXT><PDAT>S131C</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M &plus; G2</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S122B</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;/&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S113G</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>G1</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S159H</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S216B</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S139G</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>A</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S224G</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;&minus;&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;&minus;&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S135C</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M &plus; G1</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S1410H</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;&minus;&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;&minus;&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S147C</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>G2a</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S212A</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;/&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S143C</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>nd.</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>nd.</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>nd.</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M &plus; G1</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S138E</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M &plus; G2</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S241D</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;/&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M &plus; G1</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S1211G</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;,&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S222H</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M &plus; G1</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S112B</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;/&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S122C</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>G1 &plus; M</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S113D</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S126B</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M &plus; G1</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S1410G</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M &plus; G1</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S237E</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;,&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S119H</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S131B</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M &plus; 2b</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S126E</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>nd.</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S137G</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M &plus; G1</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S119C</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M &plus; G1</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S135E</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S2110B</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>G1</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>S216C</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>nd.</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>A</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>21*</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>nd.</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>nd.</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>nd.</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&minus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>G1</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>4,5,20,58**</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;&plus;&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&bull;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>nd.</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>nd.</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>nd.</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&plus;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>nd.</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>nd.</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>nd.</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>nd.</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>nd.</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>all M&apos;s</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="13" align="center" rowsep="1"></entry>
</row>
<row>
<entry namest="1" nameend="13" align="left"><PTEXT><FOO ID="FOO-00001"><PTEXT><PDAT>BIOASSAY &num;1: EVALUATION OF SCHWANN CELL MIGRATION ON CRYOSTAT SECTIONS OF NORMAL SCIATIC NERVE (NS). </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="13" align="left"><PTEXT><FOO ID="FOO-00002"><PTEXT><PDAT>BIOASSAY &num;2: EVALUATION OF SCHWANN CELL MIGRATION ON CRYOSTAT SECTIONS OF DENERVATED SCIATIC NERVE (DS). </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="13" align="left"><PTEXT><FOO ID="FOO-00003"><PTEXT><PDAT>BIOASSAY &num;3: EVALUATION OF SCHWANN CELL MIGRATION ON CRYOSTAT SECTIONS OF TROUT OLFACTORY NERVE (TN). </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="13" align="left"><PTEXT><FOO ID="FOO-00004"><PTEXT><PDAT>BIOASSAY &num;4: EVALUATION OF NUMBER OF SCHWANN CELLS ASSOCIATED WITH NEUTRITES FROM DISSOCIATED ADULT DRG CULTURES. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="13" align="left"><PTEXT><FOO ID="FOO-00005"><PTEXT><PDAT>BIOASSAY &num;5: EVALUATION OF NEURITE GROWTH FROM ADULT DRG CULTURES (EXTENT OF NEURITE GROWTH AND BRANCHING). </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="13" align="left"><PTEXT><FOO ID="FOO-00006"><PTEXT><PDAT>ANTIBODY EFFECTS ON BIOASSAYS: </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="13" align="left"><PTEXT><FOO ID="FOO-00007"><PTEXT><PDAT>&bull;: SAME AS CONTROL </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="13" align="left"><PTEXT><FOO ID="FOO-00008"><PTEXT><PDAT>&minus; OR &plus;: 25%-50% ENHANCEMENT(&plus;) OR REDUCTION(&minus;) </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="13" align="left"><PTEXT><FOO ID="FOO-00009"><PTEXT><PDAT>&minus;&minus; OR &plus;&plus;: 50%-75% ENHANCEMENT OR REDUCTION </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="13" align="left"><PTEXT><FOO ID="FOO-00010"><PTEXT><PDAT>&minus;&minus;&minus; OR &plus;&plus;&plus;: ABOVE 75% ENHANCEMENT OR REDUCTION </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="13" align="left"><PTEXT><FOO ID="FOO-00011"><PTEXT><PDAT>ND: NOT DETERMINED </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="13" align="left"><PTEXT><FOO ID="FOO-00012"><PTEXT><PDAT>BINDING: BINDING TO SCHWANN CELLS(SC) AND FIBROBLASTS(FB) REPORTS IMMUNOHISTOCHEMICAL RESULTS FROM STAINING PRIMARY CULTURES OF SCHWANN CELLS AND FIBROBLASTS. BINDING TO EHS SARCOMA MATRIGEL EXTRACELLULAR MATRIX(EM), EHS LAMININ(LN), HUMAN PLASMA FIBRONECTIN(FN), PREPARATIONS OF PERIPHERAL AND CENTRAL MYELIN(MYL) ASSAYED BY DOT BLOT AND ELISA ASSAYS. THE TOW ANTIBODIES THAT BIND MYELIN BIND BOTH CNS AND PNS MYELIN PREPARATIONS. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="13" align="left"><PTEXT><FOO ID="FOO-00013"><PTEXT><PDAT>IMMUNOGLOBULIN(IG) CLASS DETERMINED USING A HYCLONE ISOTYPING KIT. ONLY SOME CELL LINES HAVE BEEN SUBCLONED AND SOME SUPERNATANTS CONTAIN MORE THAN ONE CLASS OF IG. THIS ALMOST CERTAINLY REPRESENTS ANTIBODIES WITH DIFFERENT SPECIFICITIES AND THESE LINES WILL DEFINITELY NEED TO BE CLONED SEVERAL TIMES, AS WILL ANY HYBRIDOMA LINE CHOSEN FOR RIGOROUS CHARACTERIZATION. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="13" align="left"><PTEXT><FOO ID="FOO-00014"><PTEXT><PDAT>*OBTAINED FROM A DIFFERENT, BUT VERY SIMILAR IMMUNIZATION PARADIGM. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="13" align="left"><PTEXT><FOO ID="FOO-00015"><PTEXT><PDAT>**ANTI-IDIOTYPES TO GM1. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<PARA ID="P-00098" LVL="0"><PTEXT><PDAT>All of the antibodies that enhanced Schwann cell migration were screened in dot blots for their ability to recognize CNS and PNS myelin. Two of the enhancing antibodies (S237E and S1211G) recognized molecules in both CNS and PNS myelin. PNS myelin may thus contain some inhibitory molecules in common with CNS myelin. The only growth inhibitory molecules characterized thus far in the nervous system are found only in the CNS myelin (Schwab et al, Mental Neurology 109:2 (1990)). Furthermore, all of the enhancing antibodies were screened for their ability to potentiate Schwann cell migration on CNS tissue substrates (i.e., optic nerve substrates). Antibody S2110B, potentiated Schwann cell migration on adult optic nerve substrates.</PDAT></PTEXT></PARA>
<PARA ID="P-00099" LVL="0"><PTEXT><PDAT>Many of the antibodies in Table 1 effect Schwann cell migration by binding cells and activating second messenger cascades; hence they function as agonist antibodies. In the studies described below, representative experiments used to characterize these antibodies are illustrated. Antibody 21, a migration promoting antibody, and antibody 131C, an inhibitor, i.e., an antagonist, are highlighted. However, many of the antibodies in Table 1 have the characteristics of agonist antibodies.</PDAT></PTEXT></PARA>
<PARA ID="P-00100" LVL="0"><PTEXT><PDAT>The first in vitro bioassay used to screen the panel of antibodies was an assessment of Schwann cell migration from a sensory ganglion explant onto a cryostat section of sciatic nerve. It is noteworthy that the migrating cells are definitely Schwann cells and, once committed to migration, cells do not divide. </PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 5A-5C</PDAT></FGREF><PDAT> illustrate two antibodies that potentiate Schwann cell migration and one antibody that recognizes a Schwann cell membrane protein but has no functional activity in this assay. The agonist antibodies cited above recognize antigens that are present on Schwann cell membranes as well as on rat sciatic nerve sections&mdash;the substrate employed in this migration bioassay. There are several ways in which these antibodies could regulate Schwann cell migration in this assay. For example, these antibodies could produce their effects by binding to Schwann cell surface molecules, including receptors and adhesion molecules, and thus modulate the cellular machinery involved in cell movement; this would be true for agonist antibodies. Alternatively, they may bind to and mask inhibitory or attractive molecules that are present on nerve substrates and thus influence Schwann cell migration by modifying the environment in which they migrate.</PDAT></PTEXT></PARA>
<PARA ID="P-00101" LVL="0"><PTEXT><PDAT>Many of the antibodies directly modulate Schwann cell migration by binding to their respective antigens on Schwann cell membranes. In the cryostat section assay, enhancement is dependent on the presence of antibody in the culture media. Pre-treating the nerve substrate with the concentrated antibody alone does not affect the rate of Schwann cell migration, thus indicating a direct effect of the antibody on Schwann cells. The most compelling argument is made by experiments using only plastic as a substrate for migration. In time-lapse recordings of primary Schwann cells cultured on plastic, addition of migration-promoting antibodies leads to enhanced lamellipodial activity and increased movement of Schwann cells, whereas exposure to inhibitory antibodies results in the gradual withdrawal of the bipolar leading edges and the eventual rounding of Schwann cells (FIGS. </PDAT><HIL><BOLD><PDAT>6</PDAT></BOLD></HIL><PDAT>A-</PDAT><HIL><BOLD><PDAT>6</PDAT></BOLD></HIL><PDAT>D).</PDAT></PTEXT></PARA>
<PARA ID="P-00102" LVL="0"><PTEXT><PDAT>The apparent direct modulation of Schwann cell shape and motility by these antibodies is likely to involve second messenger cascades such as Ca&plus;&plus; level changes and protein phosphorylation. Thus, the intracellular change in calcium levels in Schwann cells was monitored following antibody exposure by using a fluorescent Ca&plus;&plus; indicator, Fluo 3-AM.</PDAT></PTEXT></PARA>
<PARA ID="P-00103" LVL="0"><PTEXT><PDAT>Method: The methods for calcium imaging are as previously described (Jahromi et al., Neuron 8:1069-1077 (1992)) for Schwann cells. Primary cultures are established on coverslips. Cells are washed in 10 mM HEPES-buffered balanced salt and the incubated with 1 ml HEPES-buffered balanced salt containing 10 &mgr;M Fluo-3 acetoxymethyl ester (AM) (Molecular Probes Inc.) and the non-ionic detergent pluronic acid F127 0.5 mg/ml. Heavy metals that might bind to Fluo-3 and interfere with its calcium sensitivity are chelated by adding 10 &mgr;M Tetrakis (2-pyridyl methyl)ethylenediamine (TPEN) to the incubation medium. Cells are loaded with dye for 2 hours at room temperature. The cultures are washed and placed onto a 37&deg; C. stage on a Zeiss IM microscope. The chamber is then perfused at a rate of 2 ml/min with either control agents or antibodies. Images are collected every minute using the IMAGE 1 system, a SIT camera, a computer controlled shutter on the UV light source and an optical recorder. After 15 minutes of base-line recording, medium with pure agonist antibody is perfused and the fluorescent changes induced in neuronal cell somas by antibody stimulation are measured. The calculation: &lcub;(Flourescence with antibody&minus;Fluorescence baseline)/Fluorescence baseline&rcub;, can be directly related to calcium changes. As controls, other nonfunctional antibodies are tested as is a calcium ionophore.</PDAT></PTEXT></PARA>
<PARA ID="P-00104" LVL="0"><PTEXT><PDAT>Exposure to antibody 21 led to 81&plusmn;7% (n&equals;9) increase in Fluo-3 fluorescence in Schwann cell soma, indicating an increase in intracellular Ca&plus;&plus;. In contrast, exposure to antibody 131C leads to a decrease in intracellular calcium (FIGS. </PDAT><HIL><BOLD><PDAT>7</PDAT></BOLD></HIL><PDAT>A-</PDAT><HIL><BOLD><PDAT>7</PDAT></BOLD></HIL><PDAT>D). This reduction in calcium levels precedes changes in cell shape observed in time lapse movies. The calcium increase in response to antibody 21 began approximately 10 to 15 minutes after antibody exposure and remained elevated in most of the cells for the duration of the recording (another 15 minutes). In a few cells, Ca&plus;&plus; levels returned to near basal levels after 7-10 Minutes. The slow rate of calcium level change suggests that it is most likely due to the release of calcium from intracellular stores rather than from extracellular Ca&plus;&plus; influx through channels on Schwann cell surfaces. Change in calcium precedes changes in cell motility, since in time lapse movies significant changes in motility were seen only after about 30-45 minutes exposure to antibodies.</PDAT></PTEXT></PARA>
<PARA ID="P-00105" LVL="0"><PTEXT><PDAT>The effect of antibodies on tyrosine, serine, and threonine phosphorylation of intracellular protein substrates was analyzed. Exposure to antibody 21 resulted in tyrosine phosphorylation of 54 kD, 48 kD, and 42 kD substrates (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 8</PDAT></FGREF><PDAT>, other antibodies lead to the phosphorylation of different molecular weight substrates) serine phosphorylation of 54 kD and 50 kD substrates, and threonine phosphorylation of the 54 kD substrate within 45 minutes. Antibody 131C promotes the phosphorylation of a 58 kD substrate. Some of these substrates may be proteins already known to be phosphorylated during changes in cell adhesion and motility. Candidate proteins include: 115-130 kD complex called pp130, 80/85 kD contactin, 70 kD paxillin, 69 kD laminin receptor, 68 kD neurofilament, 59 kD vimentin, 45 kD MAP kinase, 42-44 kD MAP kinase, 46 kD talin, 45 kD laminin binding protein, and 43 kD actin.</PDAT></PTEXT></PARA>
<PARA ID="P-00106" LVL="0"><PTEXT><PDAT>Changes in cytosolic calcium concentrations and phosphorylation of specific cellular proteins has been previously shown to influence the activity of actin-binding contractile proteins, the onset of cell migration, and the degree of cell-cell adhesion of various cell types including the precursors of Schwann cells, the neural crest cells (Forscher, Trends in Neurosci. 12:468-474 (1989); Newgreen and Gooday, J. Comp. Neurol. 259:330-347 (1985); Doherty et al, Cell 67:21-33 (1991)) and is likely to influence Schwann cell motility similarly.</PDAT></PTEXT></PARA>
<PARA ID="P-00107" LVL="0"><PTEXT><PDAT>The above observations indicate that binding of agonist antibodies, like 21, to their antigens on Schwann cell surfaces activates second messenger cascades such as protein phosphorylation and changes in intacellular calcium levels, leading eventually to cytoskeletal reorganization and thus changes in Schwann cell motility.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE III</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>GM1-Agonist Antibodies Protect Mammalian Cells Against Hydrogen Peroxide Toxicity</PDAT></STEXT></H>
<PARA ID="P-00108" LVL="0"><PTEXT><PDAT>To determine whether anti-idiotypic GM1 antibodies protect against cytotoxicity induced by hydrogen peroxide exposure, the mouse B1.1 Schwannoma cell line was preincubated in NS1 CM (control) or anti-idiotypic GM1 agonist antibody 4, 5 or 20. Following treatment with hydrogen peroxide at 0, 25 &mgr;M, 50 AM, 100 &mgr;M and 500 &mgr;M, cell viability was determined using a Promega Cell Titer 96 Aqueous cell toxicity assay (Promega Corp, 2800 Woods Hollow Road, Madison Wis. 53711). The results presented in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 9</PDAT></FGREF><PDAT> demonstrate that the antibodies protect against the toxic effects of hydrogen peroxide (optical density is a measure of the number of live cells).</PDAT></PTEXT></PARA>
<PARA ID="P-00109" LVL="0"><PTEXT><PDAT>GM1 is known to protect against cell death following growth factor deprivation or glutamate exposure. SKNSH human neuroblastoma cells (Helson et al, Cancer Res. 35:2594 (1975); Biedler et al, J. Natl. Can. Inst. 57:683 (1976)) were preincubated in NS1 CM (control), a nonfunctional antibody of the same immunoglobulin class, or anti-idiotypic GM1 agonist antibody 4, 5 or 20. Following treatment with hydrogen peroxide at 200 &mgr;M, 350 &mgr;M or 500 &mgr;M, cell viability was determined using a Promega Cell Titer 96 Aqueous cell toxicity assay. The results presented in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 10</PDAT></FGREF><PDAT> demonstrate that the antibodies protect against the toxic effects of the hydrogen peroxide (optical density is proportional to the number of live cells).</PDAT></PTEXT></PARA>
<PARA ID="P-00110" LVL="0"><PTEXT><PDAT>Murine hybridomas 5-GM and 21-S were deposited with the American Type Culture Collection, 12301 Parklawn Drive, Rockville, Md. 20852 USA, under on Aug. 19, 1993 the terms of the Budapest Treaty and were assigned deposit numbers ATCC 11439 and ATCC 11440, respectively.</PDAT></PTEXT></PARA>
<PARA ID="P-00111" LVL="0"><PTEXT><PDAT>All documents cited hereinabove are incorporated in their entirety by reference.</PDAT></PTEXT></PARA>
<PARA ID="P-00112" LVL="0"><PTEXT><PDAT>While the invention has been described with respect to what is presently regarded as the most practical embodiments thereof, it will be understood by those of ordinary skill in the art that various alterations and modifications may be made which nevertheless remain within the scope of the invention as defined by the claims which follow.</PDAT></PTEXT></PARA>
</BTEXT>
</DETDESC>
</SDODE>
<SDOCL>
<H LVL="1"><STEXT><PDAT>What is claimed is: </PDAT></STEXT></H>
<CL>
<CLM ID="CLM-00001">
<PARA ID="P-00113" LVL="0"><PTEXT><PDAT>1. A method of facilitating growth of a nerve cell comprising contacting said cell with an antibody, or fragment thereof that binds antigen, that mimics an agent that binds to a receptor on the surface of said cell and thereby facilitates said growth, wherein said contacting is effected under conditions such that said antibody, or said fragment, binds to said receptor and thereby facilitates said growth,</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein said antibody is produced by a hybridoma having ATCC deposit number 11439. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00002">
<PARA ID="P-00114" LVL="0"><PTEXT><PDAT>2. A method of facilitating growth of a nerve cell comprising contacting said cell with an antibody, or fragment thereof that binds antigen, that mimics an agent that binds to a receptor on the surface of said cell and thereby facilitates said growth, wherein said contacting is effected under conditions such that said antibody, or said fragment, binds to said receptor and thereby facilitates said growth,</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein binding of said antibody to said receptor activates protein phosphorylation. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00003">
<PARA ID="P-00115" LVL="0"><PTEXT><PDAT>3. The method according to </PDAT><CLREF ID="CLM-00002"><PDAT>claim 2</PDAT></CLREF><PDAT> wherein said phosphorylation occurs at a tyrosine residue.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00004">
<PARA ID="P-00116" LVL="0"><PTEXT><PDAT>4. The method according to </PDAT><CLREF ID="CLM-00002"><PDAT>claim 2</PDAT></CLREF><PDAT> wherein said phosphorylation is of a 65-75 kD or 48-52 kD substrate.</PDAT></PTEXT></PARA>
</CLM>
</CL>
</SDOCL>
<SDODR ID="DRAWINGS">
<EMI ID="EMI-D00001" ALT="embedded image" FILE="US06468531-20021022-D00001.TIF"/>
<EMI ID="EMI-D00002" ALT="embedded image" FILE="US06468531-20021022-D00002.TIF" TYPE="HALFTONE"/>
<EMI ID="EMI-D00003" ALT="embedded image" FILE="US06468531-20021022-D00003.TIF" TYPE="HALFTONE"/>
<EMI ID="EMI-D00004" ALT="embedded image" FILE="US06468531-20021022-D00004.TIF"/>
<EMI ID="EMI-D00005" ALT="embedded image" FILE="US06468531-20021022-D00005.TIF" TYPE="HALFTONE"/>
<EMI ID="EMI-D00006" ALT="embedded image" FILE="US06468531-20021022-D00006.TIF" TYPE="HALFTONE"/>
<EMI ID="EMI-D00007" ALT="embedded image" FILE="US06468531-20021022-D00007.TIF" TYPE="HALFTONE"/>
<EMI ID="EMI-D00008" ALT="embedded image" FILE="US06468531-20021022-D00008.TIF" TYPE="HALFTONE"/>
<EMI ID="EMI-D00009" ALT="embedded image" FILE="US06468531-20021022-D00009.TIF"/>
<EMI ID="EMI-D00010" ALT="embedded image" FILE="US06468531-20021022-D00010.TIF"/>
</SDODR>
</PATDOC>

<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PATDOC SYSTEM "ST32-US-Grant-025xml.dtd" [
<!ENTITY US06468657-20021022-M00001.NB SYSTEM "US06468657-20021022-M00001.NB" NDATA NB>
<!ENTITY US06468657-20021022-M00001.TIF SYSTEM "US06468657-20021022-M00001.TIF" NDATA TIF>
<!ENTITY US06468657-20021022-D00000.TIF SYSTEM "US06468657-20021022-D00000.TIF" NDATA TIF>
<!ENTITY US06468657-20021022-D00001.TIF SYSTEM "US06468657-20021022-D00001.TIF" NDATA TIF>
<!ENTITY US06468657-20021022-D00002.TIF SYSTEM "US06468657-20021022-D00002.TIF" NDATA TIF>
<!ENTITY US06468657-20021022-D00003.TIF SYSTEM "US06468657-20021022-D00003.TIF" NDATA TIF>
<!ENTITY US06468657-20021022-D00004.TIF SYSTEM "US06468657-20021022-D00004.TIF" NDATA TIF>
]>
<PATDOC DTD="2.5" STATUS="Build 20020918">
<SDOBI>
<B100>
<B110><DNUM><PDAT>06468657</PDAT></DNUM></B110>
<B130><PDAT>B1</PDAT></B130>
<B140><DATE><PDAT>20021022</PDAT></DATE></B140>
<B190><PDAT>US</PDAT></B190>
</B100>
<B200>
<B210><DNUM><PDAT>09206084</PDAT></DNUM></B210>
<B211US><PDAT>09</PDAT></B211US>
<B220><DATE><PDAT>19981204</PDAT></DATE></B220>
</B200>
<B500>
<B510>
<B511><PDAT>B32B  516</PDAT></B511>
<B512><PDAT>A61L  5103</PDAT></B512>
<B512><PDAT>G01N 3353</PDAT></B512>
<B516><PDAT>7</PDAT></B516>
</B510>
<B520>
<B521><PDAT>428403</PDAT></B521>
<B522><PDAT>427  211</PDAT></B522>
<B522><PDAT>427  214</PDAT></B522>
<B522><PDAT>427217</PDAT></B522>
<B522><PDAT>427220</PDAT></B522>
<B522><PDAT>428404</PDAT></B522>
<B522><PDAT>428407</PDAT></B522>
<B522><PDAT>428699</PDAT></B522>
<B522><PDAT>428701</PDAT></B522>
<B522><PDAT>428702</PDAT></B522>
<B522><PDAT>435  71</PDAT></B522>
<B522><PDAT>435  77</PDAT></B522>
<B522><PDAT>435  78</PDAT></B522>
<B522><PDAT>435  79</PDAT></B522>
<B522><PDAT>4352879</PDAT></B522>
<B522><PDAT>436 72</PDAT></B522>
<B522><PDAT>436 73</PDAT></B522>
<B522><PDAT>436 80</PDAT></B522>
<B522><PDAT>436120</PDAT></B522>
<B522><PDAT>436127</PDAT></B522>
<B522><PDAT>436501</PDAT></B522>
<B522><PDAT>514495</PDAT></B522>
<B522><PDAT>514499</PDAT></B522>
<B522><PDAT>514501</PDAT></B522>
<B522><PDAT>514706</PDAT></B522>
<B522><PDAT>514770</PDAT></B522>
</B520>
<B540><STEXT><PDAT>Controllable ion-exchange membranes</PDAT></STEXT></B540>
<B560>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4246091</PDAT></DNUM>
<DATE><PDAT>19810100</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Murayama et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4652356</PDAT></DNUM>
<DATE><PDAT>19870300</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Oda et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>204283</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4871427</PDAT></DNUM>
<DATE><PDAT>19891000</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Kolesar, Jr.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>204  1 T</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4872958</PDAT></DNUM>
<DATE><PDAT>19891000</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Suzuki et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>204 98</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4931498</PDAT></DNUM>
<DATE><PDAT>19900600</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Pidgeon</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>525 541</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4964972</PDAT></DNUM>
<DATE><PDAT>19901000</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Sagiv et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>204418</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5328847</PDAT></DNUM>
<DATE><PDAT>19940700</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Case et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>435291</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5472881</PDAT></DNUM>
<DATE><PDAT>19951200</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Beebe et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>436 94</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5660892</PDAT></DNUM>
<DATE><PDAT>19970800</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Robbins et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>427537</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5728431</PDAT></DNUM>
<DATE><PDAT>19980300</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Bergbreiter et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>4273881</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5919576</PDAT></DNUM>
<DATE><PDAT>19990700</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Hui et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>428545</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5922550</PDAT></DNUM>
<DATE><PDAT>19990700</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Everhart et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>435  721</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5942388</PDAT></DNUM>
<DATE><PDAT>19990800</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Willner et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>435  6</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5942397</PDAT></DNUM>
<DATE><PDAT>19990800</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Tarlov et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>435  6</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>6013855</PDAT></DNUM>
<DATE><PDAT>20000100</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>McPherson et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>623 11</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B562><NCIT><STEXT><PDAT>Elmidaoui et al., &ldquo;Synthesis and Characterization of New Ion-Exchange Membranes&rdquo; </PDAT><HIL><ITALIC><PDAT>J. App. Polym Sci. </PDAT></ITALIC></HIL><PDAT>42:2551-2561 (1991). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Breitbach et al., &ldquo;Heterogeneous functionalizing of polysulfone membranes&rdquo; </PDAT><HIL><ITALIC><PDAT>Angew Makromol. Chem. </PDAT></ITALIC></HIL><PDAT>184:183-196 (1991). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Menon et al., &ldquo;Fabrication and Evaluation of Nanoelectrode Ensembles&rdquo; </PDAT><HIL><ITALIC><PDAT>Anal. Chem. </PDAT></ITALIC></HIL><PDAT>67:1920-1928 (1995). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Nishizawa et al., &ldquo;Metal Nanotubule Membranes with Electrochemically Switchable Ion-Transport Selectivity&rdquo; </PDAT><HIL><ITALIC><PDAT>Science </PDAT></ITALIC></HIL><PDAT>268:700-702 (1995). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Jirage et al., &ldquo;Nanotubule-Based Molecular-Filtration Membranes&rdquo; </PDAT><HIL><ITALIC><PDAT>Science </PDAT></ITALIC></HIL><PDAT>278:655-658 (1997). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Yu et al., &ldquo;Electochemical Behavior of Azobenzene Self -Assembled Monolayers on Gold&rdquo; </PDAT><HIL><ITALIC><PDAT>Langmuir </PDAT></ITALIC></HIL><PDAT>12:2843-2848 (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Kumano et al., &ldquo;Photoresponsive Permeation Characteristics of a Ternary Composite Membrane of Polymer/Artificial Lipid/Azobenzene Derivative&rdquo; </PDAT><HIL><ITALIC><PDAT>Polymer J. </PDAT></ITALIC></HIL><PDAT>16(6):461-470 (1984). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Seki et al., &ldquo;&lsquo;Command Surfaces&rsquo; of Langmuir&mdash;Blodgett Films. Photoregulations of Liquid Crystal Alignment by Molecularly Tailored Surface Azobenzene Layers&rdquo; </PDAT><HIL><ITALIC><PDAT>Langmuir </PDAT></ITALIC></HIL><PDAT>9:211-218 (1993). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Sekkat et al., &ldquo;A &lsquo;Smart&rsquo; Ultrathin Photochromic Layer&rdquo; </PDAT><HIL><ITALIC><PDAT>Langmuir </PDAT></ITALIC></HIL><PDAT>11:2856-2859 (1995). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Lakshmi et al., &ldquo;Enantioseparation using apoenzymes immobilized in a porous polymeric membrane&rdquo; </PDAT><HIL><ITALIC><PDAT>Nature </PDAT></ITALIC></HIL><PDAT>388:758-760 (1997). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Noble et al., &ldquo;Facilitated Transport Membrane Systems&rdquo; </PDAT><HIL><ITALIC><PDAT>Chem. Eng. Progr. </PDAT></ITALIC></HIL><PDAT>85:58-70 (1989). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Noble, &ldquo;Generalized microscopic mechanism of facilitated transport in fixed site carrier membranes&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Membr. Sci. </PDAT></ITALIC></HIL><PDAT>75:121-129 (1992).</PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
</B560>
<B570>
<B577><PDAT>71</PDAT></B577>
<B578US><PDAT>1</PDAT></B578US>
</B570>
<B580>
<B582><PDAT>428403</PDAT></B582>
<B582><PDAT>428404</PDAT></B582>
<B582><PDAT>428407</PDAT></B582>
<B582><PDAT>428450</PDAT></B582>
<B582><PDAT>428457</PDAT></B582>
<B582><PDAT>428699</PDAT></B582>
<B582><PDAT>428701</PDAT></B582>
<B582><PDAT>428702</PDAT></B582>
<B582><PDAT>427  211</PDAT></B582>
<B582><PDAT>427  214</PDAT></B582>
<B582><PDAT>427217</PDAT></B582>
<B582><PDAT>427220</PDAT></B582>
<B582><PDAT>435  71</PDAT></B582>
<B582><PDAT>435  77</PDAT></B582>
<B582><PDAT>435  78</PDAT></B582>
<B582><PDAT>435  79</PDAT></B582>
<B582><PDAT>4352871</PDAT></B582>
<B582><PDAT>4352872</PDAT></B582>
<B582><PDAT>4352879</PDAT></B582>
<B582><PDAT>436 73</PDAT></B582>
<B582><PDAT>436 72</PDAT></B582>
<B582><PDAT>436 80</PDAT></B582>
<B582><PDAT>436120</PDAT></B582>
<B582><PDAT>436127</PDAT></B582>
<B582><PDAT>436501</PDAT></B582>
<B582><PDAT>514495</PDAT></B582>
<B582><PDAT>514499</PDAT></B582>
<B582><PDAT>514501</PDAT></B582>
<B582><PDAT>514706</PDAT></B582>
<B582><PDAT>514770</PDAT></B582>
</B580>
<B590><B595><PDAT>4</PDAT></B595><B596><PDAT>6</PDAT></B596><B597US/>
</B590>
</B500>
<B700>
<B720>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Zhizhong</PDAT></FNM><SNM><STEXT><PDAT>Hou</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Davis</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Pieter</PDAT></FNM><SNM><STEXT><PDAT>Stroeve</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Davis</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Nicholas</PDAT></FNM><SNM><STEXT><PDAT>Abbott</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Madison</PDAT></CITY>
<STATE><PDAT>WI</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
</B720>
<B730>
<B731>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>The Regents of the University of California</PDAT></STEXT></ONM></NAM>
<ADR><CITY><PDAT>Oakland</PDAT></CITY><STATE><PDAT>CA</PDAT></STATE></ADR>
</PARTY-US>
</B731>
<B732US>
<PDAT>02</PDAT>
</B732US>
</B730>
<B740>
<B741>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Townsend and Townsend and Crew LLP</PDAT></STEXT></ONM></NAM>
</PARTY-US>
</B741>
</B740>
<B745>
<B746>
<PARTY-US>
<NAM><FNM><PDAT>Hoa T.</PDAT></FNM><SNM><STEXT><PDAT>Le</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B746>
<B748US><PDAT>1773</PDAT></B748US>
</B745>
</B700>
</SDOBI>
<SDOAB>
<BTEXT>
<PARA ID="P-00001" LVL="0"><PTEXT><PDAT>Multilayered porous materials are formed by coating a porous substrate with a metal and adsorbing an organic layer comprising a recognition moiety onto the metal film. The recognition moiety interacts with an analyte of interest allowing for its detection, purification, etc. Suitable recognition moieties can be selected from a range of species including, small molecules, polymers and biomolecules and the like. The novel porous materials of the invention can be utilized in an array of methods including, ion-exchange, ion-selective ion-exchange, assays, affinity dialysis, size exclusion dialysis and the like.</PDAT></PTEXT></PARA>
</BTEXT>
</SDOAB>
<SDODE>
<RELAPP>
<BTEXT>
<H LVL="1"><STEXT><PDAT>CROSS-REFERENCE TO RELATED APPLICATIONS</PDAT></STEXT></H>
<PARA ID="P-00002" LVL="0"><PTEXT><PDAT>This application is related to U.S. patent application Ser. No. 09/205,750, filed on an even date, the teachings of which are incorporated herein by reference for all purposes.</PDAT></PTEXT></PARA>
</BTEXT>
</RELAPP>
<GOVINT>
<BTEXT>
<H LVL="1"><STEXT><PDAT>STATEMENT AS TO RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT</PDAT></STEXT></H>
<PARA ID="P-00003" LVL="0"><PTEXT><PDAT>This work was partially supported by the National Science Foundation MRSEC Program, (DMR-9400354) and the CAREER Program (CTS-9410147). Support was also received from the Office of Naval Research, Presidential Early Career Award for Science and Engineering (N00014-97-1-0703).</PDAT></PTEXT></PARA>
</BTEXT>
</GOVINT>
<BRFSUM>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BACKGROUND OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00004" LVL="0"><PTEXT><PDAT>Ion-exchange membranes play an important role in separation and purification processes. These membranes generally consist of either highly swollen gels or microporous structures with fixed charges derived from ionizable functional groups localized at the pore walls (Strathmann, H., In </PDAT><HIL><ITALIC><PDAT>Synthetic Membranes: Science, Engineering and Applications; </PDAT></ITALIC></HIL><PDAT>Bungay, P. M.; Lonsdale, H. K.; de Pinho, M. N., Eds.; NATO ASI Series C: Mathematical and Physical Sciences Vol. 181; D. Reidel Publishing Company: Dordrecht, Holland, (1986), pp 1-37). A membrane that contains fixed positive charges is called an anion-exchange membrane, and a membrane bearing fixed negative charges is called a cation-exchange membrane. The general purpose of ion-exchange membranes is not to exchange ions but to transmit them in a controlled way (Meares, P., In </PDAT><HIL><ITALIC><PDAT>Mass Transfer and Kinetics of Ion Exchange; </PDAT></ITALIC></HIL><PDAT>Liberti, L.; Helffefich, F. G., Eds.; NATO ASI Series E: Applied Science No. 71; Martinus Nijhoff Publishers, The Hague, The Netherlands, (1983); pp 329-366). Co-ions (i.e., ions with the same charges as the fixed charges) are excluded from the pores, whereas counterions (i.e., ions with opposite charges to the fixed charges) selectively transport across the membrane. Ion-exchange membranes have been used in the following processes, classified by the driving forces of transport of ions (Meares, P., In </PDAT><HIL><ITALIC><PDAT>Mass Transfer and Kinetics of Ion Exchange; </PDAT></ITALIC></HIL><PDAT>Liberti, L.; Helffefich, F. G., Eds.; NATO ASI Series E: Applied Science No. 71; Martinus Nijhoff Publishers, The Hague, The Netherlands, (1983); pp 329-366): (a) for electrical driving forces, desalination, demineralization, concentration of solutions, exchange of ions, and oxidation-reduction (e.g., chlor-alkali processes); (b) for driving forces of concentration gradient, diffusion dialysis, solid electrolytes in batteries, and ion-selective electrodes, (c) for driving forces of pressure, reverse osmosis and piezodialysis.</PDAT></PTEXT></PARA>
<PARA ID="P-00005" LVL="0"><PTEXT><PDAT>The most common functional groups in cation-exchange membranes are sulfonic acid (SO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>H) and carboxylic acid (&mdash;COOH) groups. The Nafion brand perfluorosulfonated polymer membranes (Meares, P., In </PDAT><HIL><ITALIC><PDAT>Mass Transfer and Kinetics of Ion Exchange; </PDAT></ITALIC></HIL><PDAT>Liberti, L.; Helffefich, F. G., Ed.; NATO ASI Series E: Applied Science No. 71; Martinus Nijhoff Publishers, The Hague, The Netherlands, (1983); pp 329-366; Yeager, H. L. et al., In </PDAT><HIL><ITALIC><PDAT>Perfluorinated Ionomer Membranes; </PDAT></ITALIC></HIL><PDAT>Yeager, H. L.; Eisenberg, Eds.; ACS Symposium Series 180; American Chemical Society: Washington, D.C., (1982); pp 1-6) are an example of the first type. These membranes were developed by E. I. du Pont de Nemours &amp; CO. during the 1960&apos;s and are still extensively used in industry. The perfluoro-sulfonic acid is ionized at normal pH values because of their low pK</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>values (&lt;1) (Seko, M. et al., ibid.; pp 365-410). In the seventies some Japanese companies (Asahi Chemical Co., Asahi Glass Co., and Tokuyama Soda Co.) developed perfluorocarboxylated membranes that contain carboxylic acid groups (Seko, M. et al., ibid.; pp 365-410; Sata, T. et al., ibid.; pp 411-425; Ukihastfi, H. et al., ibid.; pp 427-451; Sato, K. et al., </PDAT><HIL><ITALIC><PDAT>PolymerJ., </PDAT></ITALIC></HIL><PDAT>23, 1991, 531-540). Although the perfluorocarboxylic acid has a higher pK</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>(2-3), it can be nearly completely ionized even in weakly acidic environments. Other functional groups such as phosphonic acid (&mdash;PO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) and sulfonamide (&mdash;SO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) are sometimes used but are less practical.</PDAT></PTEXT></PARA>
<PARA ID="P-00006" LVL="0"><PTEXT><PDAT>The functional groups in anion-exchange membranes are usually quaternary ammonium &lsqb;&mdash;N</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>&rsqb; and to a lesser extent quaternary phosphonium &lsqb;&mdash;P</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>&rsqb; and tertiary sulfonium &lsqb;&mdash;S</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&rsqb;. Anion-exchange membranes are frequently less stable than cation-exchange membranes because the basic groups are inherently less stable than the acidic groups (Strathmann, H. In </PDAT><HIL><ITALIC><PDAT>Synthetic Membranes: Science, Engineering and Applications; </PDAT></ITALIC></HIL><PDAT>Bungay, P. M.; Lonsdale, H. K.; de Pinho, M. N., Eds.; NATO ASI Series C: Mathematical and Physical Sciences Vol. 181; D. Reidel Publishing Company: Dordrecht, Holland, (1986); pp 1-37).</PDAT></PTEXT></PARA>
<PARA ID="P-00007" LVL="0"><PTEXT><PDAT>Conventional ion-exchange membranes are generally produced by: (a) polymerization (condensation or addition) of ionogenic monomers; (b) introduction of ionizable groups into a polymer film by grafting and/or chemical treatment; or (c) heterogeneously dispersing an ion exchange material into a binder polymer matrix.</PDAT></PTEXT></PARA>
<PARA ID="P-00008" LVL="0"><PTEXT><PDAT>The Nafion perfluorosulfonated membranes are copolymers of tetrafluoroethylene and perfluorovinyl ethers containing sulfonic acid groups (Yeager, H. L. et al., In </PDAT><HIL><ITALIC><PDAT>Perfluorinated Ionomer Membranes; </PDAT></ITALIC></HIL><PDAT>Yeager, H. L.; Eisenberg, Eds.; ACS Symposium Series 180; American Chemical Society: Washington, DC, (1982); pp 1-6). Synthesis of perfluorocarboxylated membranes is similar, but the sulfonic acid groups in perfluorovinyl ethers are replaced by carboxylic acid groups (Seko, M. et al., ibid.; pp 365-410; Sata, T. et al., ibid.; pp 411-425; Ukihastfi, H. et al., ibid.; pp 427451; Sato, K. et al., </PDAT><HIL><ITALIC><PDAT>PolymerJ., </PDAT></ITALIC></HIL><PDAT>23, 1991, 531-540).</PDAT></PTEXT></PARA>
<PARA ID="P-00009" LVL="0"><PTEXT><PDAT>Perfluorinated ionomer (i.e., ion-containing polymer) membranes constitute a significant portion of ion-exchange membranes and are extensively used in the chlor-alkali industry (Dotson, R. et al., In </PDAT><HIL><ITALIC><PDAT>Perfluorinated Ionomer Membranes; </PDAT></ITALIC></HIL><PDAT>Yeager, H. L. Eisenberg, Eds.; ACS Symposium Series 180; American Chemical Society: Washington, D.C., 1982, pp 311-364). Composite membranes are sometimes utilized to improve the separation performance. An exemplary composite membrane has layers of both sulfonic acid and carboxylic acid polymers bound together to improve permselectivity (Sato, K. et al., </PDAT><HIL><ITALIC><PDAT>PolymerJ., </PDAT></ITALIC></HIL><PDAT>23, 1991, 531-540). Composite layers having a layer of polyanion adsorbed onto a cation-exchange membrane have been prepared. Such membranes could prevent the precipitation of hydroxides and simplify the control of membrane fouling (Meares, P., In </PDAT><HIL><ITALIC><PDAT>Mass Transfer and Kinetics of Ion Exchange; </PDAT></ITALIC></HIL><PDAT>Liberti, L.; Helffefich, F. G., Eds,; NATO ASI Series E: Applied Science No. 71; Martinus Nijhoff Publishers, The Hague, The Netherlands, (1983); pp 329-366). Recent development in synthesis of ion-exchange membranes focus on new polymerization processes, such as radiation induced grafting (Chakravorty, B. et al., </PDAT><HIL><ITALIC><PDAT>Membr. Sci. </PDAT></ITALIC></HIL><PDAT>1989, 41, 155-161; Gineste, J.-L. et al., </PDAT><HIL><ITALIC><PDAT>Polym. Sci.: </PDAT></ITALIC></HIL><PDAT>Part A: </PDAT><HIL><ITALIC><PDAT>Polym. Chem. </PDAT></ITALIC></HIL><PDAT>1993, 31, 2969-2975) and copolymerization, (,G. K. et al., </PDAT><HIL><ITALIC><PDAT>Membr. Sci. </PDAT></ITALIC></HIL><PDAT>1992, 68, 133-140) plasma polymerization of ionomer films (Brumlik, C. J. et al., </PDAT><HIL><ITALIC><PDAT>Electrochem. Soc. </PDAT></ITALIC></HIL><PDAT>1994, 141, 2273-2279), deposition of thin polymer film by plasma polymerization (Osada, Y. In </PDAT><HIL><ITALIC><PDAT>Membrane Science and Technology; </PDAT></ITALIC></HIL><PDAT>Osada, Y.; Nakagawa, T., Eds.; Marcel Dekker, Inc.: New York, 1992; pp 167-201), and grafting of functional groups on polymers treated by ozonization Elmidaoui, A. et al., </PDAT><HIL><ITALIC><PDAT>Appl. Polym. Sci. </PDAT></ITALIC></HIL><PDAT>1991, 42, 2551-2561).</PDAT></PTEXT></PARA>
<PARA ID="P-00010" LVL="0"><PTEXT><PDAT>In conventional ion-exchange membranes prepared by polymer chemistry, ion transport operates in a gel phase formed by sorption of water and swelling of the membrane due to the hydrophilic functional groups on the polymer backbone (Leddy, J. J. In </PDAT><HIL><ITALIC><PDAT>Synthetic Membranes; </PDAT></ITALIC></HIL><PDAT>Chenowetb, M. B., Ed.; MMI Press Symposium Series; Harwood Academic Publishers: London, 1986; pp 119-128). The size of pores, however, is difficult to control and there can be undesired transport of water and co-ions across the membrane, leading to poor perm-selectivity. Perfluorocarboxylated membranes are believed to have higher permselectivity than the Nafion membranes due to less uptake of water by the carboxylic groups than by the sulfonic groups (Sato, K. et al., </PDAT><HIL><ITALIC><PDAT>PolymerJ., </PDAT></ITALIC></HIL><PDAT>23, 1991, 531-540).</PDAT></PTEXT></PARA>
<PARA ID="P-00011" LVL="0"><PTEXT><PDAT>Ion-exchange membranes with a porous structure were recently prepared by several techniques to offer membranes with both suitable pore sizes and good ion exchange capacity. These techniques include oxidative etching of gel-like ion-exchange membranes (Mizutani, Y. et al., </PDAT><HIL><ITALIC><PDAT>J. Appl. Polym. Sci. </PDAT></ITALIC></HIL><PDAT>1990, 39, 1087-1100), chemical modification of preformed ultrafiltration membranes (Breitbach, L. et al., </PDAT><HIL><ITALIC><PDAT>Angew. Makromol. Chem. </PDAT></ITALIC></HIL><PDAT>1991, 184, 183-196), and removal of inorganic fillers from a polymer blend and modification of the polymer matrix (Bryjak, M. et al., </PDAT><HIL><ITALIC><PDAT>Angew. Makromol. Chem. </PDAT></ITALIC></HIL><PDAT>1992, 200, 93-108). Using those techniques, however, it is not flexible to introduce various functional groups and the pore sizes of the membranes are usually not uniform.</PDAT></PTEXT></PARA>
<PARA ID="P-00012" LVL="0"><PTEXT><PDAT>Martin et al. recently reported electroless deposition of gold onto the pore walls in polycarbonate track-etched (PCTE) filtration membranes (Menon, V. P. et al., </PDAT><HIL><ITALIC><PDAT>Anal. Chem. </PDAT></ITALIC></HIL><PDAT>1995, 67, 1920-1928; Nishizawa, M. et al., </PDAT><HIL><ITALIC><PDAT>Science </PDAT></ITALIC></HIL><PDAT>1995, 268, 700-702; Jirage, K. B. et al., </PDAT><HIL><ITALIC><PDAT>Science </PDAT></ITALIC></HIL><PDAT>1997, 278, 655-658). Such gold-coated membranes have unique properties. Application of a positive or a negative electrical potential to gold resulted in anion or cation selectivity, respectively and the ion selectivity was reversibly altered by manipulation of the applied electrical potential (Nishizawa, M. et al., </PDAT><HIL><ITALIC><PDAT>Science </PDAT></ITALIC></HIL><PDAT>1995, 268, 700-702).</PDAT></PTEXT></PARA>
<PARA ID="P-00013" LVL="0"><PTEXT><PDAT>Self-assembled monolayers formed with &ohgr;-substituted alkanethiols on the surface of gold have been used as model surfaces in a number of past studies of the interactions of proteins with surfaces (Spinke et al., </PDAT><HIL><ITALIC><PDAT>Langumuir, </PDAT></ITALIC></HIL><PDAT>9: 1821 (1993); Willner et al., </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc., </PDAT></ITALIC></HIL><PDAT>114: 10965 (1992); Song et al., </PDAT><HIL><ITALIC><PDAT>J. Phys, Chem., </PDAT></ITALIC></HIL><PDAT>97: 6564 (1993); Mrksich et al., </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc., </PDAT></ITALIC></HIL><PDAT>117: 12009 (1995)). For example, multilayer systems based on biotinylated alkanethiols and streptavidin have been used in schemes for the immobilization of Fab fragments of antibodies on surfaces (Spinke et al., </PDAT><HIL><ITALIC><PDAT>Langumuir, </PDAT></ITALIC></HIL><PDAT>9: 1821 (1993)), and SAMs formed from NHS-activated disulfidies have been used to form enzyme-based electrodes by covalent immobilization of glutathione reductase (Willner et al., </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc., </PDAT></ITALIC></HIL><PDAT>114: 10965 (1992)). Cytochrome c, when adsorbed to SAMs formed from mercaptoundecanoic acid, has also been shown to be active and to possess a formal potential nearly identical to that of cytochrome c bound to physiological membranes (Song et al., </PDAT><HIL><ITALIC><PDAT>J. Phys, Chem., </PDAT></ITALIC></HIL><PDAT>97: 6564 (1993)).</PDAT></PTEXT></PARA>
<PARA ID="P-00014" LVL="0"><PTEXT><PDAT>Whereas, investigations such as those described above have firmly established the use of SAMs for studies of specific interactions between proteins and surfaces, mixed SAMs formed from hydrophobic (methyl-terminated) and hydrophilic (hydroxyl-, oligo(ethylene glycol)-terminated) alkanethiols have also been used as model surfaces in studies of non-specific adsorption of proteins onto surfaces. Whitesides and coworkers, for example, have reported a study of the non-specific adsorption of fibrinogen, lysozyme, pyruvate kinase and RNAse to mixed SAMs (Prime et al., </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc., </PDAT></ITALIC></HIL><PDAT>115: 10714 (1993); Prime et al., </PDAT><HIL><ITALIC><PDAT>Science, </PDAT></ITALIC></HIL><PDAT>252: 1164 (1991)). By using ellipsometry, SAMs formed from oligo(ethylene glycol)-terminated alkanethiols were shown to resist irreversible adsorption of these proteins.</PDAT></PTEXT></PARA>
<PARA ID="P-00015" LVL="0"><PTEXT><PDAT>Surfaces prepared by the chemisorption of organosulfur compounds on evaporated films of gold are not limited to the alkanethiols. Self-assembled monolayers formed from perfluorinated organosulfur compounds have also been reported. See, Lenk et al., </PDAT><HIL><ITALIC><PDAT>Langmuir, </PDAT></ITALIC></HIL><PDAT>10: 4610 (1994); Drawhorn et al., </PDAT><HIL><ITALIC><PDAT>J. Phys. Chem., </PDAT></ITALIC></HIL><PDAT>99: 16511 (1995). These surfaces, too, can be highly ordered, although, interestingly, the origin of the order within the monolayer is largely intramolecular and contrasts, therefore, to monolayers formed from alkanethiols (where the order largely reflects the cohesive intermolecular dispersion force). Steric interactions between adjacent fluorine atoms of a perfluorinated chain cause the chain to twists itself into a rigid, helical conformation. That is, an isolated perfluoro chain is stiff, as compared to an aliphatic chain. Because perfluorinated chains have larger cross-sectional areas than alkanethiols, monolayers formed on gold from perfluorinated thiols are not tilted from the normal to the same degree as alkanethiols. See, Drawhorn et al., </PDAT><HIL><ITALIC><PDAT>J. Phys. Chem., </PDAT></ITALIC></HIL><PDAT>99: 16511 (1995). Estimates by IR studies place the tilt of the perfluorinated chains at 0&tilde;10&deg;. Because perfluorinated chains within SAMs on Au(111) are not tilted to the same degree as the alkanethiols, their surfaces are not expected to possess domains formed from regions of monolayer with different tilt directions (as occurs with monolayers formed from alkanethiols).</PDAT></PTEXT></PARA>
<PARA ID="P-00016" LVL="0"><PTEXT><PDAT>Gold-coated PCTE membranes were recently reported. See, Nishizawa, M. et al., </PDAT><HIL><ITALIC><PDAT>Science </PDAT></ITALIC></HIL><PDAT>1995, 268, 700-702). These membranes were derivatized with 1-propanethiol to protect the gold from adventitious binding of anions (such as Cl</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>, Br</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>, and I</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>) presented in external solutions. These workers, however, did not investigate whether 1-propanethiol (or any alkanethiol) formed close-packed monolayers on the electroless gold coated membrane under the conditions used to prepare the membranes. Further, no suggestion was made to derivatize the 1-propanethiol layer with ionic or other groups to impart functionality and recognition properties to the membranes.</PDAT></PTEXT></PARA>
<PARA ID="P-00017" LVL="0"><PTEXT><PDAT>Easily prepared and characterized membranes that are capable of presenting a wide range of recognition groups (ionic groups, metal, complexing agents, biomolecules, and the like), pore sizes, surface charges and surface hydrophilicity/hydrophobicity would represent a significant advance in membrane science. Quite surprisingly, the present invention provides such membranes and methods of making and using these membranes.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>SUMMARY OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00018" LVL="0"><PTEXT><PDAT>It has now been discovered that membranes coated with metal films can be functionalized with SAMs (mixed and homogeneous) formed from organic groups bearing recognition moieties. Because a wide range of recognition moieties can be easily introduced onto surfaces by these methods, these membranes are useful for a range of purification methods and assays.</PDAT></PTEXT></PARA>
<PARA ID="P-00019" LVL="0"><PTEXT><PDAT>Thus, in a first aspect, the present invention provides a multilayered material comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00020" LVL="2"><PTEXT><PDAT>(a) a porous substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00021" LVL="2"><PTEXT><PDAT>(b) a metal film adhered onto said porous substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00022" LVL="2"><PTEXT><PDAT>(c) an organic layer attached to said metal film, said organic layer comprising a recognition moiety.</PDAT></PTEXT></PARA>
<PARA ID="P-00023" LVL="0"><PTEXT><PDAT>In a second aspect, the invention provides a multilayered material comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00024" LVL="2"><PTEXT><PDAT>(a) a polycarbonate track-etched substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00025" LVL="2"><PTEXT><PDAT>(b) a metal film adhered onto said substrate; and</PDAT></PTEXT></PARA>
<PARA ID="P-00026" LVL="2"><PTEXT><PDAT>(c) an organosulfur layer attached to said metal film, said organosulfur layer comprising a recognition moiety.</PDAT></PTEXT></PARA>
<PARA ID="P-00027" LVL="0"><PTEXT><PDAT>In a third aspect, the present invention provides an ion exchange medium comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00028" LVL="2"><PTEXT><PDAT>(a) a porous substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00029" LVL="2"><PTEXT><PDAT>(b) a metal film adhered onto said substrate; and</PDAT></PTEXT></PARA>
<PARA ID="P-00030" LVL="2"><PTEXT><PDAT>(c) an organic layer attached to said metal film, said organic layer comprising a recognition moiety that interacts with said ion.</PDAT></PTEXT></PARA>
<PARA ID="P-00031" LVL="0"><PTEXT><PDAT>In a fourth aspect, the present invention provides a method for removing an ion from a fluid, said method comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00032" LVL="2"><PTEXT><PDAT>(a) contacting said fluid with an ion exchange medium comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00033" LVL="3"><PTEXT><PDAT>(i) a porous substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00034" LVL="3"><PTEXT><PDAT>(ii) a metal film adhered onto said substrate; and</PDAT></PTEXT></PARA>
<PARA ID="P-00035" LVL="3"><PTEXT><PDAT>(iii) an organic layer attached to said metal film, said organic layer comprising a recognition moiety that interacts with said ion.</PDAT></PTEXT></PARA>
<PARA ID="P-00036" LVL="0"><PTEXT><PDAT>In a fifth aspect, the present invention provides a method for isolating a molecule from other molecules by affinity dialysis comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00037" LVL="2"><PTEXT><PDAT>(a) contacting the molecule with a multilayered porous material comprising;</PDAT></PTEXT></PARA>
<PARA ID="P-00038" LVL="3"><PTEXT><PDAT>a porous substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00039" LVL="3"><PTEXT><PDAT>a metal film adhered onto the substrate; and</PDAT></PTEXT></PARA>
<PARA ID="P-00040" LVL="3"><PTEXT><PDAT>an organic layer attached to the metal film, the organic layer comprising a recognition moiety.</PDAT></PTEXT></PARA>
<PARA ID="P-00041" LVL="2"><PTEXT><PDAT>(b) forming a complex between the recognition moiety and the molecule.</PDAT></PTEXT></PARA>
<PARA ID="P-00042" LVL="0"><PTEXT><PDAT>In a sixth aspect, the present invention provides a method of isolating a first molecule from a second molecule by size exclusion dialysis, comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00043" LVL="2"><PTEXT><PDAT>(a) contacting the first and second molecule with a multilayered porous material comprising;</PDAT></PTEXT></PARA>
<PARA ID="P-00044" LVL="3"><PTEXT><PDAT>a porous substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00045" LVL="3"><PTEXT><PDAT>a metal film layered onto the substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00046" LVL="3"><PTEXT><PDAT>a hydrophilic polymer attached to the metal film; and</PDAT></PTEXT></PARA>
<PARA ID="P-00047" LVL="3"><PTEXT><PDAT>passing the first molecule through the porous material while the second molecule is substantially retained thereby.</PDAT></PTEXT></PARA>
<PARA ID="P-00048" LVL="0"><PTEXT><PDAT>In a seventh aspect, the present invention provides a method for determining the presence or amount of an analyte in a test sample comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00049" LVL="2"><PTEXT><PDAT>(a) contacting the test sample with a multilayered porous material comprising;</PDAT></PTEXT></PARA>
<PARA ID="P-00050" LVL="3"><PTEXT><PDAT>a porous substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00051" LVL="3"><PTEXT><PDAT>a metal film layered onto the substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00052" LVL="3"><PTEXT><PDAT>an organic layer adhered to the metal film, the organic layer comprising a recognition moiety;</PDAT></PTEXT></PARA>
<PARA ID="P-00053" LVL="2"><PTEXT><PDAT>(b) forming a complex between the recognition moiety and the analyte; and</PDAT></PTEXT></PARA>
<PARA ID="P-00054" LVL="2"><PTEXT><PDAT>(c) detecting the analyte.</PDAT></PTEXT></PARA>
<PARA ID="P-00055" LVL="0"><PTEXT><PDAT>In an eighth aspect, the invention provides a method of producing a multilayered porous material comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00056" LVL="2"><PTEXT><PDAT>(a) contacting a porous substrate with a metal plating means to form a porous substrate having a metal film adhered thereto;</PDAT></PTEXT></PARA>
<PARA ID="P-00057" LVL="2"><PTEXT><PDAT>(b) contacting said porous substrate having a metal film adhered thereto with a plurality of organic molecules that associate with said metal film, wherein at least a portion of said plurality of organic molecules comprise a member selected from the group consisting of recognition moieties, reactive groups, protected reactive groups and combinations thereof.</PDAT></PTEXT></PARA>
<PARA ID="P-00058" LVL="0"><PTEXT><PDAT>In a ninth aspect, the present invention provides a drug delivery device comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00059" LVL="2"><PTEXT><PDAT>(a) a porous substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00060" LVL="2"><PTEXT><PDAT>(b) a metal film adhered onto said substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00061" LVL="2"><PTEXT><PDAT>(c) an organic layer attached to said metal film, said organic layer containing a recognition moiety; and</PDAT></PTEXT></PARA>
<PARA ID="P-00062" LVL="2"><PTEXT><PDAT>(d) a drug moiety reversibly associated with said recognition moiety.</PDAT></PTEXT></PARA>
<PARA ID="P-00063" LVL="0"><PTEXT><PDAT>Additional objects and advantages of the invention will be apparent to those of skill in the art from the detailed description and the examples that follow.</PDAT></PTEXT></PARA>
</BTEXT>
</BRFSUM>
<DRWDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BRIEF DESCRIPTION OF THE FIGURES</PDAT></STEXT></H>
<PARA ID="P-00064" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> is a schematic illustration of the membrane prepared by electroless deposition of gold on a PCTE membrane followed by self-assembly of functionalized thiols.</PDAT></PTEXT></PARA>
<PARA ID="P-00065" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT> is a diagram of a diffusion cell incorporating a membrane of the invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00066" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 3</PDAT></FGREF><PDAT> is a display of the changes in concentration of MnO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> in the sink at different external pH values during diffusion experiments using the membranes carboxylic acid groups (except the dashed line). The concentration of MnO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> in the reservoir is 1 mM.</PDAT></PTEXT></PARA>
<PARA ID="P-00067" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 4</PDAT></FGREF><PDAT> is a plot of the flux of MnO4&mdash; across the membrane bearing carboxylic acid groups as a function of external pH. The concentration of MnO4&mdash; in the reservoir is 1 mM.</PDAT></PTEXT></PARA>
<PARA ID="P-00068" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 5</PDAT></FGREF><PDAT> is a schematic illustration of a light-controllable membrane: (a) configuration change of a azobenzene group embedded in a chain; (b) light-responsive adjustment of the size of the pore with SAMs formed from azobenzene-containing functionalized molecules onto the pore wall.</PDAT></PTEXT></PARA>
</BTEXT>
</DRWDESC>
<DETDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>DETAILED DESCRIPTION OF THE INVENTION AND THE PREFERRED EMBODIMENTS</PDAT></STEXT></H>
<PARA ID="P-00069" LVL="7"><PTEXT><PDAT>Abbreviations and Definitions</PDAT></PTEXT></PARA>
<PARA ID="P-00070" LVL="0"><PTEXT><PDAT>SAM, self assembled monolayer.</PDAT></PTEXT></PARA>
<PARA ID="P-00071" LVL="0"><PTEXT><PDAT>The term &ldquo;attached,&rdquo; as used herein encompasses interactions including, but not limited to, covalent bonding, ionic bonding, chemisorption, physisorption and combinations thereof.</PDAT></PTEXT></PARA>
<PARA ID="P-00072" LVL="0"><PTEXT><PDAT>The term &ldquo;fluid&rdquo; refers to pure liquids, solutions, suspensions, colloids, gases, vapors, mixtures of two or more of these &ldquo;fluids&rdquo; and the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00073" LVL="0"><PTEXT><PDAT>The term &ldquo;independently selected&rdquo; is used herein to indicate that the groups so described can be identical or different.</PDAT></PTEXT></PARA>
<PARA ID="P-00074" LVL="0"><PTEXT><PDAT>The term &ldquo;alkyl&rdquo; is used herein to refer to a branched or unbranched, saturated or unsaturated, monovalent hydrocarbon radical having from 1-30 carbons and preferably, from 4-20 carbons and more preferably from 6-18 carbons. When the alkyl group has from 1-6 carbon atoms, it is referred to as a &ldquo;lower alkyl.&rdquo; Suitable alkyl radicals include, for example, structures containing one or more methylene, methine and/or methyne groups. Branched structures have a branching motif similar to i-propyl, t-butyl, i-butyl, 2-ethylpropyl, etc. As used herein, the term encompasses &ldquo;substituted alkyls.&rdquo;</PDAT></PTEXT></PARA>
<PARA ID="P-00075" LVL="0"><PTEXT><PDAT>&ldquo;Substituted alkyl&rdquo; refers to alkyl as just described including one or more functional groups such as lower alkyl, aryl, acyl, halogen (i.e., alkylhalos, e.g., CF</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>), hydroxy, amino, alkoxy, alkylamino, acylamino, thioamido, acyloxy, aryloxy, aryloxyalkyl, mercapto, thia, aza, oxo, both saturated and unsaturated cyclic hydrocarbons, heterocycles and the like. These groups may be attached to any carbon of the alkyl moiety. Additionally, these groups may be pendent from, or integral to, the alkyl chain.</PDAT></PTEXT></PARA>
<PARA ID="P-00076" LVL="0"><PTEXT><PDAT>The term &ldquo;aryl&rdquo; is used herein to refer to an aromatic substituent which may be a single aromatic ring or multiple aromatic rings which are fused together, linked covalently, or linked to a common group such as a methylene or ethylene moiety. The common linking group may also be a carbonyl as in benzophenone. The aromatic ring(s) may include phenyl, naphthyl, biphenyl, diphenylmethyl and benzophenone among others. The term &ldquo;aryl&rdquo; encompasses &ldquo;arylalkyl.&rdquo;</PDAT></PTEXT></PARA>
<PARA ID="P-00077" LVL="0"><PTEXT><PDAT>The term &ldquo;arylalkyl&rdquo; is used herein to refer to a subset of &ldquo;aryl&rdquo; in which the aryl group is attached to another nucleus by an alkyl group as defined herein.</PDAT></PTEXT></PARA>
<PARA ID="P-00078" LVL="0"><PTEXT><PDAT>&ldquo;Substituted aryl&rdquo; refers to aryl as just described including one or more functional groups such as lower alkyl, acyl, halogen, alkylhalos (e.g. CF</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>), hydroxy, amino, alkoxy, alkylamino, acylamino, acyloxy, phenoxy, mercapto and both saturated and unsaturated cyclic hydrocarbons which are fused to the aromatic ring(s), linked covalently or linked to a common group such as a methylene or ethylene moiety. The linking group may also be a carbonyl such as in cyclohexyl phenyl ketone. The term &ldquo;substituted aryl&rdquo; encompasses &ldquo;substituted arylalkyl.&rdquo;</PDAT></PTEXT></PARA>
<PARA ID="P-00079" LVL="0"><PTEXT><PDAT>&ldquo;Substituted arylalkyl&rdquo; defines a subset of &ldquo;substituted aryl&rdquo; wherein the substituted aryl group is attached to another nucleus by an alkyl group as defined herein.</PDAT></PTEXT></PARA>
<PARA ID="P-00080" LVL="0"><PTEXT><PDAT>The term &ldquo;acyl&rdquo; is used to describe a ketone substituent, &mdash;C(O)R, where R is alkyl or substituted alkyl, aryl or substituted aryl as defined herein.</PDAT></PTEXT></PARA>
<PARA ID="P-00081" LVL="0"><PTEXT><PDAT>The term &ldquo;halogen&rdquo; is used herein to refer to fluorine, bromine, chlorine and iodine atoms.</PDAT></PTEXT></PARA>
<PARA ID="P-00082" LVL="0"><PTEXT><PDAT>The term &ldquo;hydroxy&rdquo; is used herein to refer to the group &mdash;H.</PDAT></PTEXT></PARA>
<PARA ID="P-00083" LVL="0"><PTEXT><PDAT>The term &ldquo;amino&rdquo; is used to describe primary amines, R&mdash;NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00084" LVL="0"><PTEXT><PDAT>The term &ldquo;alkoxy&rdquo; is used herein to refer to the &mdash;OR group, where R is a lower alkyl, substituted lower alkyl, aryl, substituted aryl, arylalkyl or substituted arylalkyl wherein the alkyl, aryl, substituted aryl, arylalkyl and substituted arylalkyl groups are as described herein. Suitable alkoxy radicals include, for example, methoxy, ethoxy, phenoxy, substituted phenoxy, benzyloxy, phenethyloxy, t-butoxy, etc.</PDAT></PTEXT></PARA>
<PARA ID="P-00085" LVL="0"><PTEXT><PDAT>The term &ldquo;alkylamino&rdquo; denotes secondary and tertiary amines wherein the alkyl groups may be either the same or different and are as described herein for &ldquo;alkyl groups.&rdquo;</PDAT></PTEXT></PARA>
<PARA ID="P-00086" LVL="0"><PTEXT><PDAT>As used herein, the term &ldquo;acylamino&rdquo; describes substituents of the general formula RC(O)NR&prime;, wherein R&prime; is a lower alkyl group and R represents another organic radical.</PDAT></PTEXT></PARA>
<PARA ID="P-00087" LVL="0"><PTEXT><PDAT>The term &ldquo;acyloxy&rdquo; is used herein to describe an organic radical derived from an organic acid by the removal of the acidic hydrogen. Simple acyloxy groups include, for example, acetoxy, and higher homologues derived from carboxylic acids such as ethanoic, propanoic, butanoic, etc. The acyloxy moiety may be oriented as either a forward or reverse ester (i.e. RC(O)OR&prime; or R&prime;OC(O)R, respectively, wherein R comprises the portion of the ester attached either directly or through an intermediate hydrocarbon chain to another nucleus.</PDAT></PTEXT></PARA>
<PARA ID="P-00088" LVL="0"><PTEXT><PDAT>As used herein, the term &ldquo;aryloxy&rdquo; denotes aromatic groups which are linked to another nucleus directly through an oxygen atom. This term encompasses &ldquo;substituted aryloxy&rdquo; moieties in which the aromatic group is substituted as described above for &ldquo;substituted aryl.&rdquo;</PDAT></PTEXT></PARA>
<PARA ID="P-00089" LVL="0"><PTEXT><PDAT>As used herein &ldquo;aryloxyalkyl&rdquo; defines aromatic groups attached, through an oxygen atom to an alkyl group, as defined herein. The term &ldquo;aryloxyalkyl&rdquo; encompasses &ldquo;substituted aryloxyalkyl&rdquo; moieties in which the aromatic group is substituted as described for &ldquo;substituted aryl.&rdquo;</PDAT></PTEXT></PARA>
<PARA ID="P-00090" LVL="0"><PTEXT><PDAT>As used herein, the term &ldquo;mercapto&rdquo; defines moieties of the general structure R&mdash;S&mdash;R&prime; wherein R and R&prime; are the same or different and are alkyl, aryl or heterocyclic as described herein.</PDAT></PTEXT></PARA>
<PARA ID="P-00091" LVL="0"><PTEXT><PDAT>The term &ldquo;saturated cyclic hydrocarbon&rdquo; denotes groups such as the cyclopropyl, cyclobutyl, cyclopentyl, etc., and substituted analogues of these structures. These cyclic hydrocarbons can be single- or multi-ring structures.</PDAT></PTEXT></PARA>
<PARA ID="P-00092" LVL="0"><PTEXT><PDAT>The term &ldquo;unsaturated cyclic hydrocarbon&rdquo; is used to describe a monovalent non-aromatic group with at least one double bond, such as cyclopentene, cyclohexene, etc. and substituted analogues thereof. These cyclic hydrocarbons can be single- or multi-ring structures.</PDAT></PTEXT></PARA>
<PARA ID="P-00093" LVL="0"><PTEXT><PDAT>The term &ldquo;heteroaryl&rdquo; as used herein refers to aromatic rings in which one or more carbon atoms of the aromatic ring(s) are substituted by a heteroatom such as nitrogen, oxygen or sulfur. Heteroaryl refers to structures which may be a single aromatic ring, multiple aromatic ring(s), or one or more aromatic rings coupled to one or more non-aromatic ring(s). In structures having multiple rings, the rings can be fused together, linked covalently, or linked to a common group such as a methylene or ethylene moiety. The common linking group may also be a carbonyl as in phenyl pyridyl ketone. As used herein, rings such as thiophene, pyridine, isoxazole, phthalimide, pyrazole, indole, furan, etc. or benzo-fused analogues of these rings are defined by the term &ldquo;heteroaryl.&rdquo;</PDAT></PTEXT></PARA>
<PARA ID="P-00094" LVL="0"><PTEXT><PDAT>&ldquo;Heteroarylalkyl&rdquo; defines a subset of &ldquo;heteroaryl&rdquo; wherein an alkyl group, as defined herein, links the heteroaryl group to another nucleus.</PDAT></PTEXT></PARA>
<PARA ID="P-00095" LVL="0"><PTEXT><PDAT>&ldquo;Substituted heteroaryl&rdquo; refers to heteroaryl as just described wherein the heteroaryl nucleus is substituted with one or more functional groups such as lower alkyl, acyl, halogen, alkylhalos (e.g. CF</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>), hydroxy, amino, alkoxy, alkylamino, acylamino, acyloxy, mercapto, etc. Thus, substituted analogues of heteroaromatic rings such as thiophene, pyridine, isoxazole, phthalimide, pyrazole, indole, furan, etc. or benzo-fused analogues of these rings are defined by the term &ldquo;substituted heteroaryl.&rdquo;</PDAT></PTEXT></PARA>
<PARA ID="P-00096" LVL="0"><PTEXT><PDAT>&ldquo;Substituted heteroarylalkyl&rdquo; refers to a subset of &ldquo;substituted heteroaryl&rdquo; as described above in which an alkyl group, as defined herein, links the heteroaryl group to another nucleus.</PDAT></PTEXT></PARA>
<PARA ID="P-00097" LVL="0"><PTEXT><PDAT>The term &ldquo;heterocyclic&rdquo; is used herein to describe a monovalent saturated or unsaturated non-aromatic group having a single ring or multiple condensed rings from 1-12 carbon atoms and from 1-4 heteroatoms selected from nitrogen, sulfur or oxygen within the ring. Such heterocycles are, for example, tetrahydrofuran, morpholine, piperidine, pyrrolidine, etc.</PDAT></PTEXT></PARA>
<PARA ID="P-00098" LVL="0"><PTEXT><PDAT>The term &ldquo;substituted heterocyclic&rdquo; as used herein describes a subset of &ldquo;heterocyclic&rdquo; wherein the heterocycle nucleus is substituted with one or more functional groups such as lower alkyl, acyl, halogen, alkylhalos (e.g. CF</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>), hydroxy, amino, alkoxy, alkylamino, acylamino, acyloxy, mercapto, etc.</PDAT></PTEXT></PARA>
<PARA ID="P-00099" LVL="0"><PTEXT><PDAT>The term &ldquo;heterocyclicalkyl&rdquo; defines a subset of &ldquo;heterocyclic&rdquo; wherein an alkyl group, as defined herein, links the heterocyclic group to another nucleus.</PDAT></PTEXT></PARA>
<PARA ID="P-00100" LVL="0"><PTEXT><PDAT>&ldquo;Organosulfur,&rdquo; as used herein, encompasses, organo-thiols, -sulfides, and -disulfides.</PDAT></PTEXT></PARA>
<PARA ID="P-00101" LVL="0"><PTEXT><PDAT>&ldquo;Alkylsulfur,&rdquo; as used herein, encompasses, thiols, sulfides, disulfides and derivatives of these compounds wherein the alkyl group is substituted as described above for &ldquo;substituted alkyl.&rdquo;</PDAT></PTEXT></PARA>
<PARA ID="P-00102" LVL="7"><PTEXT><PDAT>A. Introduction</PDAT></PTEXT></PARA>
<PARA ID="P-00103" LVL="0"><PTEXT><PDAT>The present invention provides a broad range of novel materials. The materials are porous materials such as membranes that, unlike presently available membranes, have a structure that allows many of their properties to be tailored by variations in the components used at the various stages of assembly of these materials. In addition to providing the materials themselves, the present invention provides methods for using and making these novel materials.</PDAT></PTEXT></PARA>
<PARA ID="P-00104" LVL="0"><PTEXT><PDAT>Thus, in a first aspect, the present invention provides a multilayered material comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00105" LVL="0"><PTEXT><PDAT>a multilayered porous material comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00106" LVL="2"><PTEXT><PDAT>(a) a porous substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00107" LVL="2"><PTEXT><PDAT>(b) a metal film adhered onto said porous substrate; and</PDAT></PTEXT></PARA>
<PARA ID="P-00108" LVL="2"><PTEXT><PDAT>(c) an organic layer attached to said metal film, said organic layer comprising a recognition moiety.</PDAT></PTEXT></PARA>
<PARA ID="P-00109" LVL="0"><PTEXT><PDAT>Metals can be plated onto membrane substrates using sputtering, controlled vapor deposition or electroless plating techniques to produce membranes with a metal layer substantially coating the membrane surface. The metal coating generally comprises a metal that forms a bond or intimate association (e.g., chemisorption, physisorption) with an organic molecule, such as an organosulfur (e.g., alkylthiol, sulfide, disulfide) with which the metal coated membranes are surface-functionalized.</PDAT></PTEXT></PARA>
<PARA ID="P-00110" LVL="0"><PTEXT><PDAT>The organic layer comprises a recognition moiety, which is a molecule or portion of a molecule that interacts with an analyte. The interaction can be either attractive or repulsive. In an exemplary attractive interaction, the recognition moiety will assist the entry of the analyte into the pores of the porous material. In an exemplary repulsive interaction, the analyte will be excluded from the pores of the porous material. Useful recognition moieties can be, for example, biomolecules (e.g., antibodies, antigens, carbohydrates, nucleic acids, peptides, enzymes and receptors), organic groups (e.g., amines, carboxylic acids, drugs, chelating agents, crown ethers, cyclodextrins and combinations thereof), metal chelates and organometallic moieties. In addition to the molecule bearing the recognition moiety, the organic layer can be mixed with other species that do not bear recognition moieties.</PDAT></PTEXT></PARA>
<PARA ID="P-00111" LVL="0"><PTEXT><PDAT>Certain commercially-available, well-characterized membranes have excellent properties and provide a good entry point for developing new membranes with useful characteristics.</PDAT></PTEXT></PARA>
<PARA ID="P-00112" LVL="0"><PTEXT><PDAT>Thus, in a second aspect, the invention provides a multilayered material comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00113" LVL="0"><PTEXT><PDAT>a multilayered porous material comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00114" LVL="2"><PTEXT><PDAT>(a) a polycarbonate track-etched substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00115" LVL="2"><PTEXT><PDAT>(b) a metal film adhered onto the substrate; and</PDAT></PTEXT></PARA>
<PARA ID="P-00116" LVL="2"><PTEXT><PDAT>(c) an organosulfur layer attached to said metal film, the organosulfur layer comprising a recognition moiety.</PDAT></PTEXT></PARA>
<PARA ID="P-00117" LVL="0"><PTEXT><PDAT>Although the porous materials of the invention can bear any of a range of recognition moieties, certain useful materials will bear recognition moieties that are useful for ion-exchange or ion-selective ion-exchange of charged species. The materials of the invention are ideally structures for such uses.</PDAT></PTEXT></PARA>
<PARA ID="P-00118" LVL="0"><PTEXT><PDAT>Thus, in a third aspect, the present invention provides an ion exchange medium comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00119" LVL="2"><PTEXT><PDAT>(a) a porous substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00120" LVL="2"><PTEXT><PDAT>(b) a metal film adhered onto said substrate; and</PDAT></PTEXT></PARA>
<PARA ID="P-00121" LVL="2"><PTEXT><PDAT>(c) an organic layer attached to said metal film, said organic layer comprising a recognition moiety that interacts with said ion.</PDAT></PTEXT></PARA>
<PARA ID="P-00122" LVL="0"><PTEXT><PDAT>In addition to new materials and useful methods utilizing these materials, the present invention provides straight-forward methods for assembling these materials. Solution-phase metal plating methods can be used to coat porous membrane substrates with films consisting of single metals, alloys and composites. The film coated membranes are functionalized with an organic layer, generally formed from substituted organosulfur molecules, however, any organic layer that attaches to the film can be used. At least one component of the organic layer will bear a recognition moiety that interacts with a molecule of interest, referred to herein as an &ldquo;analyte.&rdquo; Because a wide range of recognition moieties can be easily introduced onto surfaces by a wide range of methods, these membranes are useful for a range of purification methods and assays.</PDAT></PTEXT></PARA>
<PARA ID="P-00123" LVL="0"><PTEXT><PDAT>The materials, methods, additional aspects and preferred embodiments of the present invention are discussed in greater detail in the sections that follow.</PDAT></PTEXT></PARA>
<PARA ID="P-00124" LVL="7"><PTEXT><PDAT>Porous Substrates</PDAT></PTEXT></PARA>
<PARA ID="P-00125" LVL="0"><PTEXT><PDAT>Porous substrates that are useful in practicing the present invention can be made of practically any physicochemically stable material. Substrates can be selected from the group consisting of optically opaque substrates, optically transparent substrates, insulating substrates, conducting substrates, semiconducting substrates, magnetic substrates and combinations thereof.</PDAT></PTEXT></PARA>
<PARA ID="P-00126" LVL="0"><PTEXT><PDAT>Useful porous substrates are not limited to a pore size or range of pore sizes. The choice of an appropriate pore size for a given application will be apparent to those of skill in the art. In certain preferred embodiments, the substrate has a pore diameter of from about 0.005 micrometer to about 25 micrometers. In other preferred embodiments, the substrate has a diameter of from about 0.01 micrometer to about 1 micrometer.</PDAT></PTEXT></PARA>
<PARA ID="P-00127" LVL="0"><PTEXT><PDAT>Exemplary substrate materials include, but are not limited to, inorganic crystals, inorganic glasses, inorganic oxides, metals, organic polymers and combinations thereof.</PDAT></PTEXT></PARA>
<PARA ID="P-00128" LVL="0"><PTEXT><PDAT>In a presently preferred embodiment, the substrate is track-etched.</PDAT></PTEXT></PARA>
<PARA ID="P-00129" LVL="7"><PTEXT><PDAT>B.1. Inorganic Crystals and Glasses</PDAT></PTEXT></PARA>
<PARA ID="P-00130" LVL="0"><PTEXT><PDAT>Inorganic crystals and inorganic glasses that are appropriate for substrate materials include, for example, LiF, NaF, NaCl, KBr, KI, CaF</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, MgF</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, HgF</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, BN, AsS</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, ZnS, Si</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>and the like. The crystals and glasses can be prepared by art standard techniques. See, for example, Goodman, Crystal Growth Theory and Techniques, Plenum Press, New York, 1974. Alternatively, the crystals and glasses can be purchased commercially (e.g., Fischer Scientific, Duke Scientific Corporation, Palo Alto, Calif.). The crystals and glasses can be the sole component of the substrate or they can be coated with one or more additional substrate components. Thus, it is within the scope of the present invention to utilize crystals and/or glasses coated with, for example one or more metal films or a metal film and an organic polymer. Additionally, a crystal and/or glass can constitute a portion of a substrate that contacts another portion of the substrate made of a different material, or a different physical form (e.g., a glass) of the game material. Other useful substrate configurations utilizing inorganic crystals and/or glasses will be apparent to those of skill in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00131" LVL="7"><PTEXT><PDAT>B.2. Inorganic Oxides</PDAT></PTEXT></PARA>
<PARA ID="P-00132" LVL="0"><PTEXT><PDAT>Inorganic oxides can also form a substrate of the device of the present invention. Inorganic oxides of use in the present invention include, for example, Cs</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, Mg(OH)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, TiO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, ZrO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, CeO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, Y</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, Cr</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, Fe</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, NiO, ZnO, Al</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, SiO</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(glass), silica, quartz, In</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, SnO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, PbO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, silicone polymers and the like. The inorganic oxides can be utilized in a variety of physical forms such as powders, glasses, crystals, resins, plastics and the like. A substrate can consist of a single inorganic oxide or a composite of more than one inorganic oxide. For example, a composite of inorganic oxides can have a layered structure (i.e., a second oxide deposited on a first oxide) or two or more oxides can be arranged in a contiguous non-layered structure. In addition, one or more oxides can be admixed and deposited on a support such as a porous glass, polymer or metal sheet. Further, a layer of one or more inorganic oxides can be intercalated between two other substrate layers (e.g., metal-oxide-metal, metal-oxide-crystal). Appropriate inorganic oxide materials can be prepared or, alternatively, they can be purchased from commercial sources (e.g., Duke Scientific Corporation, Palo Alto, Calif.).</PDAT></PTEXT></PARA>
<PARA ID="P-00133" LVL="0"><PTEXT><PDAT>Inorganic oxides membranes are resistant to aggressive chemicals like acids, alkalines and solvents. These membranes are also resistant to abrasive suspensions and temperature fluctuations. Methods of making inorganic oxide membranes are known to those of skill in the art. Additionally, appropriate membranes are available commercially from sources such as Schumacher Umwelt- und Trenntechnik GmbH (Crailsheim, Germany). The membranes are available in pore sizes between 0.005-1.2 micrometers and in at least eight different geometries.</PDAT></PTEXT></PARA>
<PARA ID="P-00134" LVL="0"><PTEXT><PDAT>In a preferred embodiment, the inorganic oxide is a member selected from the group ZnO, TiO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, Fe</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, Al</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, ZrO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, ZrO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>/TiO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, CeO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, SnO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, CuO, Cr</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, SiO</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>and combinations thereof.</PDAT></PTEXT></PARA>
<PARA ID="P-00135" LVL="7"><PTEXT><PDAT>B.3. Metals</PDAT></PTEXT></PARA>
<PARA ID="P-00136" LVL="0"><PTEXT><PDAT>Metals are also of use as porous substrates in the present invention. The metal can be used as a crystal or an amorphous material, such as a powder. When a powder is used, it will preferably have been formed into a desired configuration by a method such as casting, pressing, molding and the like. Appropriate metal membranes are available from a variety of sources such as Alternburger electronic GmbH (Seelbach, Germany). As most of the surface characteristics of the metal membrane will be masked by its metallic coating layer, there are essentially no limitations on the types identity of metal that can be used in the present invention. The metal membranes can be selected for desirable physical properties such as density, magnetic characteristics, conducting or insulating characteristics, heat capacity and the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00137" LVL="0"><PTEXT><PDAT>In preferred embodiments, the metal substrate is a member selected from the group of nickel, copper, silver, gold, platinum, palladium and combinations thereof.</PDAT></PTEXT></PARA>
<PARA ID="P-00138" LVL="7"><PTEXT><PDAT>B.4. Organic Polymers</PDAT></PTEXT></PARA>
<PARA ID="P-00139" LVL="0"><PTEXT><PDAT>Organic polymers that form useful substrates include, for example, polyalkenes (e.g., polyethylene, polyisobutene, polybutadiene), polyacrylics (e.g., polyacrylate, polymethyl methacrylate, polycyanoacrylate), polyvinyls (e.g., polyvinyl alcohol, polyvinyl acetate, polyvinyl butyral, polyvinyl chloride), polystyrenes, polycarbonates, polyesters, polyurethanes, polyamides, polyimides, polysulfone, polysiloxanes, polyheterocycles, cellulose derivative (e.g., methyl cellulose, cellulose acetate, nitrocellulose), polysaccharides (e.g., dextran derivatives), polysilanes, fluorinated polymers, epoxies, polyethers and phenolic resins.</PDAT></PTEXT></PARA>
<PARA ID="P-00140" LVL="0"><PTEXT><PDAT>Many commercially available polymer- or resin-based membranes can also be used in practicing the present invention. Moreover, commercially available membranes having well-defined pore sizes are available over a wide pore size range and composed of a number of different materials.</PDAT></PTEXT></PARA>
<PARA ID="P-00141" LVL="0"><PTEXT><PDAT>Presently preferred polymer- or resin-based membranes include those constructed of polymers selected from the group of polypropylene, nylon, fluorocarbon, polyester, polyethylene, polysulfone, polyether sulfone, cellulose, cellulose ester, ethyl vinyl acetate, polycarbonate, polyaramide, polyimide and combinations thereof.</PDAT></PTEXT></PARA>
<PARA ID="P-00142" LVL="7"><PTEXT><PDAT>C. Metal Coatings</PDAT></PTEXT></PARA>
<PARA ID="P-00143" LVL="0"><PTEXT><PDAT>Metals that are presently preferred as coatings for particulate substrates include, but are not limited to, gold, silver, platinum, palladium, nickel and copper. Silver and gold are preferred, gold being particularly preferred. Other useful metal coatings are composite materials that form an association with the sulfur atom(s) of thiols, sulfides and/or disulfides (e.g., ZnSe).</PDAT></PTEXT></PARA>
<PARA ID="P-00144" LVL="0"><PTEXT><PDAT>The metal coating can be either continuous or discontinuous. Further, the thickness of the metal layer can remain constant or it can vary over the surface of the porous substrate. In one embodiment, more than one metal is used. The more than one metal can be present as an alloy, they can be formed into a layered &ldquo;sandwich&rdquo; structure, or they can be laterally adjacent to one another. In a preferred embodiment, where more than one metal layer is used, the outermost metal is gold. In a particularly preferred embodiment the metal used is gold layered on silver, more preferably gold layered on silver which has been layered onto a membrane activated by the adsorption of tin.</PDAT></PTEXT></PARA>
<PARA ID="P-00145" LVL="0"><PTEXT><PDAT>A wide range of art-recognized techniques leading to the deposition of a metal layer onto a substrate are appropriate for use in practicing the present invention, including sputtering, controlled-vapor deposition and electroless plating. In a preferred embodiment, the metal is deposited by an electroless plating method.</PDAT></PTEXT></PARA>
<PARA ID="P-00146" LVL="0"><PTEXT><PDAT>Metals can be plated onto membranes using electroless plating techniques to produce membranes with a metal layer substantially coating the membrane surface. In a particularly preferred embodiment, the metal coating comprises a metal that forms a bond or intimate association (e.g., chemisorption, physisorption) with an organic molecule, such as an organosulfur (e.g., alkylthiol, sulfide, disulfide). The metal coated membranes can be surface-functionalized with SAMs (mixed and homogeneous) formed from organosulfur moieties.</PDAT></PTEXT></PARA>
<PARA ID="P-00147" LVL="0"><PTEXT><PDAT>Due to the extensive literature on their synthesis and characterization and the commercial availability of many species having useful structures and properties, &ohgr;-substituted alkylsulfur compounds are preferred as components of the organic layer.</PDAT></PTEXT></PARA>
<PARA ID="P-00148" LVL="7"><PTEXT><PDAT>D. Organic Layers</PDAT></PTEXT></PARA>
<PARA ID="P-00149" LVL="0"><PTEXT><PDAT>A wide variety of organic layers are useful in practicing the present invention. These organic layers can comprise monolayers, bilayers and multilayers. Furthermore, the organic layers can be attached by covalent bonds, ionic bonds, coordinating bonds, physisorption, chemisorption and the like, including, but not limited to, hydrophobic interactions, hydrophilic interactions, van der Waals interactions and the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00150" LVL="0"><PTEXT><PDAT>In a presently preferred embodiment, organic layer components which form self-assembled monolayers are used.</PDAT></PTEXT></PARA>
<PARA ID="P-00151" LVL="0"><PTEXT><PDAT>In the discussion that follows, self-assembled monolayers are utilized as an exemplary organic layer. This use is not intended to be limiting. It will be understood that the various configurations of the self-assembled monolayers and their methods of synthesis, binding properties and other characteristics are equally applicable to each of the organic layers of use in the present invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00152" LVL="7"><PTEXT><PDAT>D.1 Self-Assembled Monolayers (&ldquo;SAMs&rdquo;)</PDAT></PTEXT></PARA>
<PARA ID="P-00153" LVL="0"><PTEXT><PDAT>Self-assembled monolayers are generally depicted as an assembly of organized, closely packed linear molecules. There are two widely-used methods to deposit molecular monolayers on solid substrates; Langmuir-Blodgett transfer and self-assembly. Additional methods include techniques such as depositing a vapor of the monolayer precursor onto a substrate surface. Each of these methods is appropriate for use in practicing the present invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00154" LVL="0"><PTEXT><PDAT>The composition of a SAM useful in the present invention, can be varied over a wide range of compound structures and molar ratios. In one embodiment, the SAM is formed from only one compound. In a presently preferred embodiment, the SAM is formed from two or more compounds. In another preferred embodiment, the organic layer comprises a plurality of compounds, each compound comprising a moiety that associates with the metal film.</PDAT></PTEXT></PARA>
<PARA ID="P-00155" LVL="0"><PTEXT><PDAT>In preferred embodiments, the organic layer and/or the recognition moiety undergoes a change in state upon being exposed to certain conditions. In general, the change of state will alter the pore size or the species selectivity of the pores to, for example, exclude a previously allowed species from the pores or vice-versa. Organic layer and/or recognition moiety states that can undergo alteration include, for example, steric bulk, polarity, conformation and redox potential. Conditions that can be manipulated to produce these and other changes in state include, for example, fluid redox potential, fluid ionic strength, fluid pH, application of external fields (electrical, magnetic, etc.), light (UV, IR, etc.).</PDAT></PTEXT></PARA>
<PARA ID="P-00156" LVL="0"><PTEXT><PDAT>In one exemplary embodiment, the organic layer and/or recognition moiety comprises an azobenzene or other group that undergoes a change of state under the influence of external conditions such as changes in pH, ionic strength, temperature and incident light. In other embodiments, the group undergoes a change of state in response to applied electrical or magnetic fields.</PDAT></PTEXT></PARA>
<PARA ID="P-00157" LVL="0"><PTEXT><PDAT>In yet a further preferred embodiment, the organic layer comprises a group having the structure:</PDAT></PTEXT></PARA>
<PARA ID="P-00158" LVL="0"><PTEXT><F><PTEXT><PDAT>&mdash;SR</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>(X</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL></PTEXT></F></PTEXT></PARA>
<PARA ID="P-00159" LVL="7"><PTEXT><PDAT>wherein R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a linking group between sulfur and X</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>; X</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a member selected from the group consisting of H, halogen, recognition moieties, hydrophilic polymers and combinations thereof; and n is a number between 1 and 50.</PDAT></PTEXT></PARA>
<PARA ID="P-00160" LVL="0"><PTEXT><PDAT>In a preferred embodiment, the SAM component bearing X</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is attached directly and essentially irreversibly via a &ldquo;stable bond&rdquo; to the surface of the substrate. A &ldquo;stable bond&rdquo;, as used herein, is a bond which maintains its chemical integrity over a wide range of conditions (e.g., amide, carbamate, carbon-carbon, ether, etc.). In another preferred embodiment the SAM component bearing the recognition moiety comprises a &ldquo;cleaveable bond&rdquo;. A &ldquo;cleaveable bond,&rdquo; as used herein, is a bond which undergoes scission under conditions which do not degrade other bonds in the recognition moiety-analyte complex. Cleaveable bonds include, but are not limited to, disulfide, imine, carbonate and ester bonds.</PDAT></PTEXT></PARA>
<PARA ID="P-00161" LVL="0"><PTEXT><PDAT>Exemplary applications wherein it is preferred that the molecule (&ldquo;analyte&rdquo;) that interacts with X</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>remains tethered to the surface include, but are not limited to, quantitating or measuring a property of the analyte while it is tethered to the surface. Alternatively, the material of the invention can be used to remove an analyte from a fluid such as a liquid or vapor mixture to purify or partially purify that mixture or the analyte. Many other applications wherein the analyte remains tethered to the surface will be apparent to those of skill in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00162" LVL="0"><PTEXT><PDAT>Preferred R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>groups with &ldquo;stable&rdquo; bonds include R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>groups which are members selected from the group consisting of alkyl, substituted alkyl, aryl, arylalkyl, substituted aryl, substituted arylalkyl, saturated cyclic hydrocarbon, unsaturated cyclic hydrocarbon, heteroaryl, heteroarylalkyl, substituted heteroaryl, substituted heteroarylalkyl, heterocyclic, substituted heterocyclic and heterocyclicalkyl groups. Further preferred stable R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>groups are members selected from the group consisting of alkyl and substituted alkyl groups.</PDAT></PTEXT></PARA>
<PARA ID="P-00163" LVL="0"><PTEXT><PDAT>Exemplary applications wherein the analyte or X</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>-analyte complex is removable from the surface include, but are not limited to, purification of an analyte, synthesis of a molecule on the material of the invention and regeneration of the material of the invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00164" LVL="0"><PTEXT><PDAT>Many cleaveable groups are known in the art. See, for example, Jung et al., </PDAT><HIL><ITALIC><PDAT>Biochem. Biophys. Acta, </PDAT></ITALIC></HIL><PDAT>761: 152-162 (1983); Joshi et al., </PDAT><HIL><ITALIC><PDAT>J. Biol. Chem., </PDAT></ITALIC></HIL><PDAT>265: 14518-14525 (1990); Zarling et al., </PDAT><HIL><ITALIC><PDAT>J. Immunol., </PDAT></ITALIC></HIL><PDAT>124: 913-920 (1980); Bouizar et al., </PDAT><HIL><ITALIC><PDAT>Eur. J. Biochem., </PDAT></ITALIC></HIL><PDAT>155: 141-147 (1986); Park et al., </PDAT><HIL><ITALIC><PDAT>J. Biol. Chem., </PDAT></ITALIC></HIL><PDAT>261: 205-210 (1986); Browning et al., </PDAT><HIL><ITALIC><PDAT>J. Immunol., </PDAT></ITALIC></HIL><PDAT>143: 1859-1867 (1989). Exemplary cleaveable moieties can be cleaved using light, heat or reagents such as thiols, hydroxylamine, bases, periodate and the like. Preferred cleaveable groups comprise a cleaveable moiety which is a member selected from the group consisting of disulfide, ester, imide, carbonate, nitrobenzyl, phenacyl and benzoin groups.</PDAT></PTEXT></PARA>
<PARA ID="P-00165" LVL="0"><PTEXT><PDAT>When two or more structurally distinct moieties are used as components of the SAMs, the components can be contacted with the substrate as a mixture of SAM components or, alternatively, the components can be added sequentially. In those embodiments in which the SAM components are added as a mixture, the mole ratio of a mixture of the components in solution generally results in the same ratio in the mixed SAM. Depending on the manner in which the SAM is assembled, the two components do not phase segregate into islands. See, Bain et al., </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc., </PDAT></ITALIC></HIL><PDAT>111: 7164 (1989). This feature of SAMs can be used to immobilize recognition moieties or bulky modifying groups in such a manner that certain interactions, such as steric hindrance, between these molecules is minimized.</PDAT></PTEXT></PARA>
<PARA ID="P-00166" LVL="0"><PTEXT><PDAT>The individual components of the SAMs can also be bound to the substrate in a sequential manner. Thus, in one embodiment, a first SAM component is attached to the substrate&apos;s surface by &ldquo;underlabeling&rdquo; the surface functional groups with less than a stoichiometric equivalent of the first component. The first component can be a SAM component linked to a reactive group or recognition group, a spacer arm or a monovalent moiety. Subsequently, the second component is contacted with the substrate. This second component can either be added in stoichiometric equivalence, stoichiometric excess or can again be used to underlabel to leave sites open for yet a third component. It is also possible to displace some fraction of the first adsorbed species by a second species, thereby forming a mixture on the surface.</PDAT></PTEXT></PARA>
<PARA ID="P-00167" LVL="0"><PTEXT><PDAT>In certain preferred embodiments, the organic layer comprises:</PDAT></PTEXT></PARA>
<PARA ID="P-00168" LVL="0"><PTEXT><F><PTEXT><PDAT>X</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>Q</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>C(CQ</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>(Z</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>)</PDAT><HIL><SB><PDAT>o</PDAT></SB></HIL><PDAT>(CQ</PDAT><HIL><SP><PDAT>2</PDAT></SP></HIL><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>S&mdash;</PDAT></PTEXT></F></PTEXT></PARA>
<PARA ID="P-00169" LVL="7"><PTEXT><PDAT>wherein, X</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>is a member selected from the group consisting of H, halogen and recognition moieties; Q, Q</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>and Q</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>are independent members selected from the group consisting of H and halogen; Z</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a member selected from the group consisting of &mdash;CQ</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&mdash;, &mdash;CQ</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&mdash;, &mdash;CQ</PDAT><HIL><SP><PDAT>2</PDAT></SP></HIL><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&mdash;, &mdash;O&mdash;, &mdash;S&mdash;, &mdash;NR</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>&mdash;, &mdash;C(O)NR</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>NC(O)&mdash;, in which; R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a member selected from the group consisting of H, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl and heterocyclic groups; m is a number between 0 and 40; and n is a number between 0 and 40 and o is a number between 0 and 5.</PDAT></PTEXT></PARA>
<PARA ID="P-00170" LVL="0"><PTEXT><PDAT>In yet a further preferred embodiment, Q, Q</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>and Q</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>are independently members selected from the group consisting of H and fluorine. In a further preferred embodiment, R</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>is a member selected from H and CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>. In yet another preferred embodiment u is a number between 5 and 20.</PDAT></PTEXT></PARA>
<PARA ID="P-00171" LVL="0"><PTEXT><PDAT>When the organic layer is formed from a halogenated organosulfur compound, the organic layer can comprise a single halogenated compound or more than one halogenated compound having different structures. Additionally, these layers can comprise both non-halogenated and halogenated organosulfur compounds.</PDAT></PTEXT></PARA>
<PARA ID="P-00172" LVL="0"><PTEXT><PDAT>In certain preferred embodiment of this aspect of the invention, the organosulfur layer comprises a member selected from the group consisting of &mdash;S(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>OH, &mdash;S(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>COOH, &mdash;S(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, HOCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>S&mdash; and combinations thereof; m is an integer between 2 and 50; and n is an integer between 1 and 25. In a still further preferred embodiment, n is an integer between 5 and 15. In certain embodiments, the organic layer will include only these molecules, while in others one or more of these species will be mixed with one or more additional species.</PDAT></PTEXT></PARA>
<PARA ID="P-00173" LVL="0"><PTEXT><PDAT>Although, each of the components of the organic layer discussed herein are appropriate for practicing this aspect of the invention, in preferred embodiments, the organosulfur layer further comprises &mdash;S(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>X</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>, wherein X</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a recognition moiety; and m is an integer from 1 to 25. In another preferred embodiment, m is an integer from 5 to 15.</PDAT></PTEXT></PARA>
<PARA ID="P-00174" LVL="7"><PTEXT><PDAT>D.2 Hydrophilic Polymers</PDAT></PTEXT></PARA>
<PARA ID="P-00175" LVL="0"><PTEXT><PDAT>In a preferred embodiment, the organic layer includes a hydrophilic polymer. The hydrophilic polymer can optionally comprise an X</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>. A number of hydrophilic polymers are useful in practicing the present invention. Both charged and uncharged polymers are of use, however, uncharged polymers are preferred. Suitable uncharged polymers include, but are not limited to, polyethylene glycol (PEG), poly(vinylalcohol), poly(propyleneglycol) (PPG)-PEG co-polymers PEG-PPG co-block polymers and similar polymers. In a preferred embodiment, these polymers are derivatized with at least one sulfur-containing moiety. PEG-thiols of various molecular weights are commercially available (Shearwater Polymers, Huntsville, Ala.). The choice of an appropriate polymer and its modification for a particular purpose will be apparent and readily accessible to those of skill in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00176" LVL="0"><PTEXT><PDAT>In a further preferred embodiment, R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a poly(ethyleneglycol) moiety. Polyethylene glycol (PEG) use in biotechnology and biomedical applications continuing to expand and has been reviewed (Poly(ethylene glycol) Chemisrty: Biotechnical and Biomedical Applications, J. M. Harris, Ed., Plenum Press, New York, 1992). Modification of enzymes (Chiu et al., </PDAT><HIL><ITALIC><PDAT>J. Bioconjugate Chem., </PDAT></ITALIC></HIL><PDAT>4: 290-295 (1993)), RGD peptides (Braatz et al., </PDAT><HIL><ITALIC><PDAT>Bioconjugate Chem., </PDAT></ITALIC></HIL><PDAT>4: 262-267 (1993)), liposomes (Zalipsky, S. </PDAT><HIL><ITALIC><PDAT>Bioconjugate Chem., </PDAT></ITALIC></HIL><PDAT>4: 296-299 (1993)), and CD4-IgG glycoprotein (Chamow et al., </PDAT><HIL><ITALIC><PDAT>Bioconjugate Chem., </PDAT></ITALIC></HIL><PDAT>4: 133-140 (1993)) are some of the recent advances in the use of polyethylene glycol. The modification of toxicity, pharmacokinetics, biodistribution and other biofunctions are a number of the promising areas for the use of this simple polymer. Surfaces treated with PEG have been shown to resist protein deposition and have improved resistance to thrombogenicity when coated on blood contacting biomaterials (Merrill, &ldquo;Poly(ethylene oxide) and Blood Contact: A Chronicle of One Laboratory,&rdquo; in Poly(ethylene glycol) Chemistry: Biotechnical and Biomedical Applications, Harris, Ed., Plenum Press, New York, (1992), pp. 199-220). Accordingly, application of PEG based coatings to multilayered porous materials would be very useful for chromatography, analytical and medical devices. In the present invention, hydrophilic polymers such as PEG can be used to engineer preselected pore sizes and characteristics by the judicious choice of the size of the PEG(s) chosen as constituents of the organic layer.</PDAT></PTEXT></PARA>
<PARA ID="P-00177" LVL="0"><PTEXT><PDAT>Poly(ethyleneglycol) is known to impart hydrophilicity and protein adsorption resistance and to reduce the immunogenicity and antigenicity of materials to which it is bound. See, for example, Abuchowski et al., Enzymes as Drugs, Holcenberg et al., Eds., John Wiley &amp; Sons, N.Y., (1981), pp. 367-383. Many methods are available in the art for attaching poly(ethyleneglycol) moieties to other molecules. Generally, to effect covalent attachment of polyethylene glycol (PEG) to another molecule, for example, a protein, the hydroxyl end-groups of the polymer are first converted into reactive functional groups. This process is frequently referred to as &ldquo;activation&rdquo; and the product is called &ldquo;activated PEG&rdquo;.</PDAT></PTEXT></PARA>
<PARA ID="P-00178" LVL="0"><PTEXT><PDAT>Many activated derivatives of poly(ethyleneglycol) are available commercially and in the literature. It is well within the abilities of one of skill to choose, and synthesize if necessary, an appropriate activated PEG derivative. At present, the most common form of activated PEG used for preparation of protein conjugates is poly(ethylene glycol) succinoyl-N-hydroxysuccinimide ester (SS-PEG). This derivative reacts quickly with proteins (30 min) under mild conditions yielding active yet extensively modified conjugates and, thus, is appropriate for use in practicing the present invention. See, Abuchowski et al. </PDAT><HIL><ITALIC><PDAT>Cancer Biochem. Biophys., </PDAT></ITALIC></HIL><PDAT>7: 175-186 (1984). In addition, many other activated PEG groups can be used in the present invention. Some of these are detailed below.</PDAT></PTEXT></PARA>
<PARA ID="P-00179" LVL="0"><PTEXT><PDAT>Activation of PEG has been reported to be accomplished by the use of reactive functional groups including cyanurylate (Abuchowski et al., </PDAT><HIL><ITALIC><PDAT>J. Biol. Chem., </PDAT></ITALIC></HIL><PDAT>252: 3582-3586 (1977); Jackson et al., </PDAT><HIL><ITALIC><PDAT>Anal. Biochem., </PDAT></ITALIC></HIL><PDAT>165: 114-127 (1987); Koide et al., </PDAT><HIL><ITALIC><PDAT>Biochem Biophys. Res. Commun., </PDAT></ITALIC></HIL><PDAT>111: 659-667 (1983)), tresylate (Nilsson et al., </PDAT><HIL><ITALIC><PDAT>Methods Enzymol., </PDAT></ITALIC></HIL><PDAT>104: 56-69 (1984); Delgado et al., </PDAT><HIL><ITALIC><PDAT>Biotechnol. Appl. Biochem., </PDAT></ITALIC></HIL><PDAT>12: 119-128 (1990)); N-hydroxysuccinimide derived active esters (Buckmann et al., </PDAT><HIL><ITALIC><PDAT>Makromol. Chem., </PDAT></ITALIC></HIL><PDAT>182: 1379-1384 (1981); Joppich et al., </PDAT><HIL><ITALIC><PDAT>Makromol. Chem., </PDAT></ITALIC></HIL><PDAT>180: 1381-1384 (1979); Abuchowski et al., </PDAT><HIL><ITALIC><PDAT>Cancer Biochem. Biophys., </PDAT></ITALIC></HIL><PDAT>7: 175-186 (1984); Katreet al. </PDAT><HIL><ITALIC><PDAT>Proc. Natl. Acad. Sci. U.S.A., </PDAT></ITALIC></HIL><PDAT>84: 1487-1491 (1987); Kitamura et al., </PDAT><HIL><ITALIC><PDAT>Cancer Res., </PDAT></ITALIC></HIL><PDAT>51: 4310-4315 (1991); Boccu et al., </PDAT><HIL><ITALIC><PDAT>Z. Naturforsch., </PDAT></ITALIC></HIL><PDAT>38C: 94-99 (1983), carbonates (Zalipsky et al., Poly(ethylene glycol) Chemistry: Biotechnical and Biomedical Applications, Harris, Ed., Plenum Press, New York, 1992, pp. 347-370; Zalipsky et al., </PDAT><HIL><ITALIC><PDAT>Biotechnol. Appl. Biochem., </PDAT></ITALIC></HIL><PDAT>15: 100-114 (1992); Veronese et al., </PDAT><HIL><ITALIC><PDAT>Appl. Biochem. Biotech., </PDAT></ITALIC></HIL><PDAT>11: 141-152 (1985)), imidazolyl formates (Beauchamp et al., </PDAT><HIL><ITALIC><PDAT>Anal. Biochem., </PDAT></ITALIC></HIL><PDAT>131: 25-33 (1983); Berger et al., </PDAT><HIL><ITALIC><PDAT>Blood, </PDAT></ITALIC></HIL><PDAT>71: 1641-1647 (1988)), 4-dithiopyridines (Woghiren et al., </PDAT><HIL><ITALIC><PDAT>Bioconjugate Chem., </PDAT></ITALIC></HIL><PDAT>4: 314-318 (1993)), isocyanates (Byun et al., </PDAT><HIL><ITALIC><PDAT>ASAIO Journal, </PDAT></ITALIC></HIL><PDAT>M649-M-653 (1992)) and epoxides (U.S. Pat. No. 4,806,595, issued to Noishiki et al., (1989). Other linking groups include the urethane linkage between amino groups and activated PEG. See, Veronese, et al., </PDAT><HIL><ITALIC><PDAT>Appl. Biochem. Biotechnol., </PDAT></ITALIC></HIL><PDAT>11: 141-152 (1985).</PDAT></PTEXT></PARA>
<PARA ID="P-00180" LVL="0"><PTEXT><PDAT>Various activated polyethylene glycols (PEG) have been effectively used in such fields as protein modification (Abuchowski &amp; Davis, 1981, supra), peptide chemistry (Zalipsky, et al., </PDAT><HIL><ITALIC><PDAT>Int, J. Peptide Protein Res., </PDAT></ITALIC></HIL><PDAT>30: 740-783 (1987)) and preparation of conjugates with biologically active materials (Zalipsky, et al., </PDAT><HIL><ITALIC><PDAT>Eur. Polym. J., </PDAT></ITALIC></HIL><PDAT>19: 1177-1183 (1983) and Zalipsky et al., </PDAT><HIL><ITALIC><PDAT>Polymer Preprints, Am. Chem. Soc. Div. Polym. Chem., </PDAT></ITALIC></HIL><PDAT>27(1): 1-2 (1986)).</PDAT></PTEXT></PARA>
<PARA ID="P-00181" LVL="0"><PTEXT><PDAT>Also of use in the present invention are succinidyl carbonate activated PEGs, namely, poly(ethylene glycol)-succinidyl carbonate (SC-PEG). These materials react to yield attachment through stable urethane linkages. The reactivity of these agents, are comparable to the conventionally used SS-PEG. Thus, high degrees of modification are achievable in mild conditions (aqueous buffers, pH 5.8-11, preferably pH 7.0-9.5) within about 30-60 min. and moderate temperatures (4&deg;-40&deg; C). Additionally, the agents are soluble in a variety of organic solvents, thus being useful and important in the coupling of low molecular weight, partially protected peptides and other biologically useful ligands. See, U.S. Pat. No. 5,122,614, issued Jun. 16, 1992 to Zalipsky.</PDAT></PTEXT></PARA>
<PARA ID="P-00182" LVL="0"><PTEXT><PDAT>PEG useful in practicing the present invention does not have to be of a particular molecular weight, but it is preferred that the molecular weight be between 500 and 40,000; more preferably between 2,000 and 20,000.</PDAT></PTEXT></PARA>
<PARA ID="P-00183" LVL="0"><PTEXT><PDAT>In other preferred embodiments, the PEG does not have an X</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>group at a terminus and the organic layer comprises:</PDAT></PTEXT></PARA>
<PARA ID="P-00184" LVL="7"><PTEXT><PDAT>&emsp;R</PDAT><HIL><SP><PDAT>2</PDAT></SP></HIL><PDAT>OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>u</PDAT></SB></HIL><PDAT>S&mdash;,</PDAT></PTEXT></PARA>
<PARA ID="P-00185" LVL="7"><PTEXT><PDAT>in which R</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>is a member selected from the group consisting of H, alkyl and acyl; and u is a number between 1 and 50.</PDAT></PTEXT></PARA>
<PARA ID="P-00186" LVL="7"><PTEXT><PDAT>E. Recognition Moieties</PDAT></PTEXT></PARA>
<PARA ID="P-00187" LVL="0"><PTEXT><PDAT>As used herein, the term &ldquo;recognition moiety&rdquo; refers to molecules which are attached to one or more organic layer components. The recognition moieties can interact with the analyte via either attractive or repulsive mechanisms. In one exemplary embodiment, the analyte and the recognition moiety form an intimately associated pair by, for example, covalent bonding, ionic bonding, ion pairing, van der Waals association and the like. In another exemplary embodiment, the analyte and recognition moiety interact by a repulsive mechanism such as incompatible steric characteristics, charge-charge repulsion, hydrophilic-hydrophobic interactions and the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00188" LVL="0"><PTEXT><PDAT>Recognition moieties can be selected from a wide range of small organic molecules (e.g., drugs, pesticides, toxins, etc.), organic functional groups (e.g., amines, carbonyls, carboxylates, etc.), biomolecules, metals, metal chelates and organometallic compounds.</PDAT></PTEXT></PARA>
<PARA ID="P-00189" LVL="0"><PTEXT><PDAT>When the recognition moiety is an amine, in preferred embodiments, the recognition moiety will interact with a structure on the analyte that is complementary to (e.g., binding, complexing, ion-pairing) with the amine (e.g., carbonyl groups, alkylhalo groups). In another preferred embodiment, the amine is protonated by an acidic moiety on the analyte of interest (e.g., carboxylic acid, sulfonic acid). In still another preferred embodiment, the amine is quaternized and acts as an ion-exchange moiety.</PDAT></PTEXT></PARA>
<PARA ID="P-00190" LVL="0"><PTEXT><PDAT>In certain preferred embodiments, when the recognition moiety is a carboxylic, or other acid, the recognition moiety will interact with the analyte by, for example, complexation (e.g., metal ions) or ion-pairing (e.g., quaternary ammonium cations). In still other preferred embodiments, the carboxylic acid will protonate a basic group on the analyte (e.g. amine).</PDAT></PTEXT></PARA>
<PARA ID="P-00191" LVL="0"><PTEXT><PDAT>In another preferred embodiment, the recognition moiety is a drug moiety. The drug moieties can be agents already accepted for clinical use or they can be drugs whose use is experimental, or whose activity or mechanism of action is under investigation. The drug moieties can have a proven action in a given disease state or can be only hypothesized to show desirable action in a given disease state. In a preferred embodiment, the drug moieties are compounds that are being screened for their ability to interact with an analyte of choice. As such, drug moieties that are useful in practicing the instant invention include drugs from a broad range of drug classes having a variety of pharmacological activities.</PDAT></PTEXT></PARA>
<PARA ID="P-00192" LVL="0"><PTEXT><PDAT>Classes of useful agents include, for example, non-steroidal anti-inflammatory drugs (NSAIDS). The NSAIDS can, for example, be selected from the following categories: (e.g., propionic acid derivatives, acetic acid derivatives, fenamic acid derivatives, biphenylcarboxylic acid derivatives and oxicams); steroidal anti-inflammatory drugs including hydrocortisone and the like; antihistaminic drugs (e.g., chlorpheniramine, triprolidine); antitussive drugs (e.g., dextromethorphan, codeine, carmiphen and carbetapentane); antipruritic drugs (e.g., methidilizine and trimeprizine); anticholinergic drugs (e.g., scopolamine, atropine, homatropine, levodopa); anti-emetic and antinauseant drugs (e.g., cyclizine, meclizine, chlorpromazine, buclizine); anorexic drugs (e.g., benzphetamine, phentermine, chlorphentermine, fenfluramine); central stimulant drugs (e.g., amphetamine, methamphetamine, dextroamphetamine and methylphenidate); antiarrhythmic drugs (e.g., propanolol, procainamide, disopyraminde, quinidine, encainide); &bgr;-adrenergic blocker drugs (e.g., metoprolol, acebutolol, betaxolol, labetalol and timolol); cardiotonic drugs (e.g., milrinone, amrinone and dobutamine); antihypertensive drugs (e.g., enalapril, clonidine, hydralazine, minoxidil, guanadrel, guanethidine);diuretic drugs (e.g., amiloride and hydrochlorothiazide); vasodilator drugs (e.g., diltazem, amiodarone, isosuprine, nylidrin, tolazoline and verapamil); vasoconstrictor drugs (e.g., dihydroergotamine, ergotamine and methylsergide); antiulcer drugs (e.g., ranitidine and cimetidine); anesthetic drugs (e.g., lidocaine, bupivacaine, chlorprocaine, dibucaine); antidepressant drugs (e.g. imipramine, desipramine, amitryptiline, nortryptiline); tranquilizer and sedative drugs (e.g., chlordiazepoxide, benacytyzine, benzquinamide, flurazapam, hydroxyzine, loxapine and promazine); antipsychotic drugs (e.g., chlorprothixene, fluphenazine, haloperidol, molindone, thioridazine and trifluoperazine); antimicrobial drugs (antibacterial, antifungal, antiprotozoal and antiviral drugs).</PDAT></PTEXT></PARA>
<PARA ID="P-00193" LVL="0"><PTEXT><PDAT>Antimicrobial drugs which are preferred for incorporation into the present composition include, for example, pharmaceutically acceptable salts of &bgr;-lactam drugs, quinolone drugs, ciprofloxacin, norfloxacin, tetracycline, erythromycin, amikacin, triclosan, doxycycline, capreomycin, chlorhexidine, chlortetracycline, oxytetracycline, clindamycin, ethambutol, hexamidine isothionate, metronidazole, pentamidine, gentamycin, kanamycin, lineomycin, methacycline, methenamine, minocycline, neomycin, netilmycin, paromomycin, streptomycin, tobramycin, miconazole and amanfadine.</PDAT></PTEXT></PARA>
<PARA ID="P-00194" LVL="0"><PTEXT><PDAT>Other drug moieties of use in practicing the present invention include antineoplastic drugs (e.g., antiandrogens (e.g., leuprolide or flutamide), cytocidal agents (e.g., adriamycin, doxorubicin, taxol, cyclophosphamide, busulfan, cisplatin, &agr;-2-interferon) anti-estrogens (e.g., tamoxifen), antimetabolites (e.g., fluorouracil, methotrexate, mercaptopurine, thioguanine).</PDAT></PTEXT></PARA>
<PARA ID="P-00195" LVL="0"><PTEXT><PDAT>The recognition moiety can also comprise hormones (e.g., medroxyprogesterone, estradiol, leuprolide, megestrol, octreotide or somatostatin); muscle relaxant drugs (e.g., cinnamedrine, cyclobenzaprine, flavoxate, orphenadrine, papaverine, mebeverine, idaverine, ritodrine, dephenoxylate, dantrolene and azumolen); antispasmodic drugs; bone-active drugs (e.g., diphosphonate and phosphonoalkylphosphinate drug compounds); endocrine modulating drugs (e.g., contraceptives (e.g., ethinodiol, ethinyl estradiol, norethindrone, mestranol, desogestrel, medroxyprogesterone), modulators of diabetes (e.g., glyburide or chlorpropamide), anabolics, such as testolactone or stanozolol, androgens (e.g., methyltestosterone, testosterone or fluoxymesterone), antidiuretics (e.g., desmopressin) and calcitonins).</PDAT></PTEXT></PARA>
<PARA ID="P-00196" LVL="0"><PTEXT><PDAT>Also of use in the present invention are estrogens (e.g., diethylstilbesterol), glucocorticoids (e.g., triamcinolone, betamethasone, etc.) and progenstogens, such as norethindrone, ethynodiol, norethindrone, levonorgestrel; thyroid agents (e.g., liothyronine or levothyroxine) or anti-thyroid agents (e.g., methimazole); antihyperprolactinemic drugs (e.g., cabergoline); hormone suppressors (e.g., danazol or goserelin), oxytocics (e.g., methylergonovine or oxytocin) and prostaglandins, such as mioprostol, alprostadil or dinoprostone, can also be employed.</PDAT></PTEXT></PARA>
<PARA ID="P-00197" LVL="0"><PTEXT><PDAT>Other useful recognition moieties include immunomodulating drugs (e.g., antihistamines, mast cell stabilizers, such as lodoxamide and/or cromolyn, steroids (e.g., triamcinolone, beclomethazone, cortisone, dexamethasone, prednisolone, methylprednisolone, beclomethasone, or clobetasol), histamine H</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>antagonists (e.g., famotidine, cimetidine, ranitidine), immunosuppressants (e.g., azathioprine, cyclosporin), etc. Groups with anti-inflammatory activity, such as sulindac, etodolac, ketoprofen and ketorolac, are also of use. Other drugs of use in conjunction with the present invention will be apparent to those of skill in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00198" LVL="0"><PTEXT><PDAT>The above enumerated, and other molecules, can be attached to the organic layer by methods well-known to those of skill in the art. Ample guidance can be found in literature devoted to, for example, the fields of bioconjugate chemistry and drug delivery. For example, one of skill, faced with a drug comprising an available amine will be able to choose from among a variety of amine derivatizing reactions, locate an appropriately functionalized partner (e.g., a carboxylic acid terminated thiol) for the organic layer and react the partners under conditions chosen to effect the desired coupling (e.g., dehydrating agents, e.g., dicyclohexylcarbodiimide). See, for example, Modification of Proteins: Food, Nutritional, and Pharmacological Aspects, Feeney et al., Eds., American Chemical Society, Washington, D.C., 1982, pp. 370-387; Polymeric Drugs and Drug Delivery Systems, Dunn et al., Eds., American Chemical Society, Washington, D.C., 1991.</PDAT></PTEXT></PARA>
<PARA ID="P-00199" LVL="0"><PTEXT><PDAT>When the recognition moiety is a chelating agent, crown ether or cyclodextrin, host-guest chemistry will dominate the interaction between the recognition moiety and the analyte. The use of host-guest chemistry allows a great degree of recognition-moiety-analyte specificity to be engineered into a device of the invention. The use of these compounds to bind to specific compounds is well known to those of skill in the art. See, for example, Pitt et al., &ldquo;The Design of Chelating Agents for the Treatment of Iron Overload,&rdquo; In, Inorganic Chemistry in Biology and Medicine; Martell, Ed., American Chemical Society, Washington, D.C., 1980, pp. 279-312; Lindoy, The Chemistry of Macrocyclic Ligand Complexes; Cambridge University Press, Cambridge,1989; Dugas, Bioorganic Chemistry; Springer-Verlag, New York, 1989, and references contained therein.</PDAT></PTEXT></PARA>
<PARA ID="P-00200" LVL="0"><PTEXT><PDAT>Additionally, a manifold of routes allowing the attachment of chelating agents, crown ethers and cyclodextrins to other molecules is available to those of skill in the art. See, for example, Meares et al., &ldquo;Properties of In Vivo Chelate-Tagged Proteins and Polypeptides.&rdquo; In, Modification of Proteins: Food, Nutritional, and Pharmacological Aspects;&rdquo; Feeney, et al., Eds., American Chemical Society, Washington, D.C., 1982, pp. 370-387; Kasina et al., </PDAT><HIL><ITALIC><PDAT>Bioconjugate Chem., </PDAT></ITALIC></HIL><PDAT>9: 108-117 (1998); Song et al., </PDAT><HIL><ITALIC><PDAT>Bioconjugate Chem., </PDAT></ITALIC></HIL><PDAT>8: 249-255 (1997).</PDAT></PTEXT></PARA>
<PARA ID="P-00201" LVL="0"><PTEXT><PDAT>In another preferred embodiment, the recognition moiety forms an inclusion complex with the analyte of interest. In a particularly preferred embodiment, the recognition moiety is a cyclodextrin or modified cyclodextrin. Cyclodextrins are a group of cyclic oligosaccharides produced by numerous microorganisms. Cyclodextrins have a ring structure which has a basket-like shape. This shape allows cyclodextrins to include many kinds of molecules into their internal cavity. See, for example, Szejtli, Cyclodextrins and Their Inclusion Complexes; Akademiai Klado, Budapest, 1982; and Bender et al., Cyclodextrin Chemistry Springer-Verlag, Berlin, 1978.</PDAT></PTEXT></PARA>
<PARA ID="P-00202" LVL="0"><PTEXT><PDAT>Cyclodextrins are able to form inclusion complexes with an array of organic molecules including, for example, drugs, pesticides, herbicides and agents of war. See, Tenjarla et al., </PDAT><HIL><ITALIC><PDAT>J. Pharm. Sci., </PDAT></ITALIC></HIL><PDAT>87: 425-429 (1998); Zughul et al., </PDAT><HIL><ITALIC><PDAT>Pharm. Dev. Technol., </PDAT></ITALIC></HIL><PDAT>3: 43-53 (1998); and Albers et al., </PDAT><HIL><ITALIC><PDAT>Crit. Rev. Ther. Drug Carrier Syst., </PDAT></ITALIC></HIL><PDAT>12: 311-337 (1995). Importantly, cyclodextrins are able to discriminate between enantiomers of compounds in their inclusion complexes. Thus, in one preferred embodiment, the invention provides for the detection of a particular enantiomer in a mixture of enantiomers. See, Koppenhoefer et al., </PDAT><HIL><ITALIC><PDAT>J. Chromatogr., A </PDAT></ITALIC></HIL><PDAT>793: 153-164 (1998).</PDAT></PTEXT></PARA>
<PARA ID="P-00203" LVL="0"><PTEXT><PDAT>The cyclodextrin recognition moiety can be attached to a SAM component, through a spacer arm or directly to the metal. See, Yamamoto et al., </PDAT><HIL><ITALIC><PDAT>J. Phys. Chem. B, </PDAT></ITALIC></HIL><PDAT>101: 6855-6860 (1997). Methods to attach cyclodextrins to other molecules are well known to those of skill in the chromatographic and pharmaceutical arts. See, Sreenivasan, K. J., </PDAT><HIL><ITALIC><PDAT>Appl. Polym. Sci., </PDAT></ITALIC></HIL><PDAT>60: 2245-2249 (1996).</PDAT></PTEXT></PARA>
<PARA ID="P-00204" LVL="0"><PTEXT><PDAT>In a presently preferred embodiment, the recognition moiety is a polyaminocarboxylate chelating agent such as ethylenediaminetetraacetic acid (EDTA) or diethylenetriaminepentaacetic acid (DTPA). These recognition moieties can be attached to any amine-terminated component of a SAM or a spacer arm, for example, by utilizing the commercially available dianhydride (Aldrich Chemical Co., Milwaukee, Wis.).</PDAT></PTEXT></PARA>
<PARA ID="P-00205" LVL="0"><PTEXT><PDAT>In still further preferred embodiments, the recognition moiety is a biomolecule such as a protein, nucleic acid, peptide or an antibody. Biomolecules useful in practicing the present invention can be derived from any source. The biomolecules can be isolated from natural sources or can be produced by synthetic methods. Proteins can be natural proteins or mutated proteins. Mutations can be effected by chemical mutagenesis, site-directed mutagenesis or other means of inducing mutations known to those of skill in the art. Proteins useful in practicing the instant invention include, for example, enzymes, antigens, antibodies and receptors. Antibodies can be either polyclonal or monoclonal. Peptides and nucleic acids can be isolated from natural sources or can be wholly or partially synthetic in origin.</PDAT></PTEXT></PARA>
<PARA ID="P-00206" LVL="0"><PTEXT><PDAT>In those embodiments wherein the recognition moiety is a protein or antibody, the protein can be tethered to a SAM component or a spacer arm by any reactive peptide residue available on the surface of the protein. In preferred embodiments, the reactive groups are amines or carboxylates. In particularly preferred embodiments, the reactive groups are the &egr;-amine groups of lysine residues. Furthermore, these molecules can be adsorbed onto the surface of the substrate or SAM by non-specific interactions (e.g., chemisorption, physisorption).</PDAT></PTEXT></PARA>
<PARA ID="P-00207" LVL="0"><PTEXT><PDAT>Recognition moieties which are antibodies can be used to recognize analytes which are proteins, peptides, nucleic acids, saccharides or small molecules such as drugs, herbicides, pesticides, industrial chemicals and agents of war. Methods of raising antibodies for specific molecules are well-known to those of skill in the art. See, U.S. Pat. No. 5,147,786, issued to Feng et al. on Sep. 15, 1992; U.S. Pat. No. 5,334,528, issued to Stanker et al. on Aug. 2, 1994; U.S. Pat. No. 5,686,237, issued to Al-Bayati, M. A. S. on Nov. 11, 1997; and U.S. Pat. No. 5,573,922, issued to Hoess et al. on Nov. 12, 1006. Methods for attaching antibodies to surfaces are also known in the art. See, Delamarche et al. </PDAT><HIL><ITALIC><PDAT>Langmuir, </PDAT></ITALIC></HIL><PDAT>12: 1944-1946 (1996).</PDAT></PTEXT></PARA>
<PARA ID="P-00208" LVL="7"><PTEXT><PDAT>E.1 Reactive Groups</PDAT></PTEXT></PARA>
<PARA ID="P-00209" LVL="0"><PTEXT><PDAT>&ldquo;Reactive groups,&rdquo; as used herein refers to a subset of recognition moieties. The members of this subset can be used to attach recognition moieties to SAM components or, alternatively, they can themselves serve as recognition moieties. For example, an amine-bearing SAM component can be used to bind a carboxylic acid-containing recognition moiety onto the SAM, or it can be used to &ldquo;recognize&rdquo; a carboxylic, or other acid, in a solution, vapor and the like. One principle of recognition using reactive groups can be broadly stated; materials having electron deficient (e.g., electrophilic) organic layers can be used to recognize electron rich (e.g., nucleophilic) species and vice-versa. Moreover, acids can be used to recognize bases and vice versa.</PDAT></PTEXT></PARA>
<PARA ID="P-00210" LVL="0"><PTEXT><PDAT>The reactive groups can also be used to tether recognition groups onto the materials of the invention either before or after the organic layer has been deposited onto the metal layer. In certain circumstances, it will be desirable to assemble a batch of the porous material having a reactive group on its surface. The material can be stored and aliquots can be used to bind recognition moieties as the materials are needed. Alternatively, each member of a set of porous substrates having the same organic layer can be reacted with a different recognition preparation of an array of differentially functionalized porous materials. This method is analogous to combinatorial library methods and it can be used to prepare an array of porous materials having different characteristics. These materials can then be screened in operation for desirable properties. Many other variations of and uses for this strategy will be readily apparent to those of skill in the art. The nature of useful reactive groups is discussed in greater detail below.</PDAT></PTEXT></PARA>
<PARA ID="P-00211" LVL="0"><PTEXT><PDAT>The reactive functional groups can be chosen such that they do not participate in, or interfere with, the reaction controlling the assembly of the various SAM components or the attachment of the functionalized SAM component onto the metal film. Alternatively, the reactive functional group can be protected from participating in the reaction by the presence of a protecting group. Those of skill in the art will understand how to protect a particular functional group from interfering with a chosen set of reaction conditions. For examples of useful protecting groups, see Greene et al., Protective Groups in Organic Synthesis, John Wiley &amp; Sons, New York, 1991.</PDAT></PTEXT></PARA>
<PARA ID="P-00212" LVL="0"><PTEXT><PDAT>The discussion that follows focuses on the attachment of a reactive SAM component to the metal film. This focus is for convenience only and one of skill in the art will understand that the discussion is equally applicable to embodiments in which the SAM component-recognition moiety cassette is preformed prior to its attachment to the substrate. As used herein, &ldquo;reactive SAM components&rdquo; refers to components that have a functional group available for reaction with a recognition moiety or other species following the attachment of the component to the substrate.</PDAT></PTEXT></PARA>
<PARA ID="P-00213" LVL="0"><PTEXT><PDAT>Currently favored classes of reactions available with reactive SAM components are those which proceed under relatively mild conditions. These include, but are not limited to nucleophilic substitutions (e.g., reactions of amines and alcohols with acyl halides), electrophilic substitutions (e.g., enamine reactions) and additions to carbon-carbon and carbon-heteroatom multiple bonds (e.g., Michael reaction, Diels-Alder addition). These and other useful reactions are discussed in March, Advanced Organic Chemistry, Third Ed., John Wiley &amp; Sons, New York, 1985.</PDAT></PTEXT></PARA>
<PARA ID="P-00214" LVL="0"><PTEXT><PDAT>According to the present invention, a membrane&apos;s surface can be functionalized with SAM components and other species by attaching a reactive SAM component to the metal film in such a way as to derivative the metal film with a plurality of available reactive functional groups. Reactive groups which can be used in practicing the present invention include, for example, amines, hydroxyl groups, carboxylic acids, carboxylic acid derivatives, alkenes, sulfhydryls, etc.</PDAT></PTEXT></PARA>
<PARA ID="P-00215" LVL="0"><PTEXT><PDAT>In a preferred embodiment, the reactive group is tethered to the metal surface by an agent displaying avidity for that surface. In a presently preferred embodiment, the substrate includes a silver film or a gold film and the group that reacts with the metal surface comprises a thiol, sulfide or disulfide such as:</PDAT></PTEXT></PARA>
<PARA ID="P-00216" LVL="0"><PTEXT><F><PTEXT><PDAT>Y&mdash;S&mdash;R</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>&mdash;X</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL></PTEXT></F></PTEXT></PARA>
<PARA ID="P-00217" LVL="7"><PTEXT><PDAT>wherein R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a linking group between sulfur and X</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>, and X</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>is a reactive group or a protected reactive group. X</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>can also be a recognition moiety as discussed below. Y is a member selected from the group consisting of H, R</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>2</PDAT></SP></HIL><PDAT>&mdash;S&mdash;, wherein R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>are independently selected. When R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>are the same, symmetrical sulfides and disulfides result, and when they are different, asymmetrical sulfides and disulfides result.</PDAT></PTEXT></PARA>
<PARA ID="P-00218" LVL="0"><PTEXT><PDAT>A large number of functionalized thiols, sulfides and disulfides are commercially available (Aldrich Chemical Co., St. Louis). Additionally, those of skill in the art have available to them a manifold of synthetic routes with which to produce additional such molecules. For example, amine-functionalized thiols can be produced from the corresponding halo-amines, halo-carboxylic acids, etc. by reaction of these halo precursors with sodium sulfhydride. See, for example, Reid, Organic Chemistry of Bivalent Sulfur, vol. 1, pp. 21-29, 32-35, vol. 5, pp. 27-34, Chemical Publishing Co., New York, 1958, 1963. Additionally, functionalized sulfides can be prepared via alkylthio-de-halogenation with a mercaptan salt. See, Reid, Organic Chemistry of Bivalent Sulfur, vol. 2, pp. 16-21, 24-29, vol. 3, pp. 11-14, Chemical Publishing Co., New York, 1960. Other methods for producing compounds useful in practicing the present invention will be apparent to those of skill in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00219" LVL="0"><PTEXT><PDAT>Many reactive groups and protected reactive groups of use in the present invention will be apparent to those of skill in the art. One of skill will be able to ascertain and purchase or synthesize the reactive organic layer constituent needed for a particular purpose. Representative reactive functional groups (X</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>) include, but are not limited to:</PDAT></PTEXT></PARA>
<PARA ID="P-00220" LVL="2"><PTEXT><PDAT>(a) carboxyl groups and various derivatives thereof including, but not limited to, N-hydroxysuccinimide esters, N-hydroxybenztriazole esters, acid halides, acyl imidazoles, thioesters, p-nitrophenyl esters, alkyl, alkenyl, alkynyl and aromatic esters;</PDAT></PTEXT></PARA>
<PARA ID="P-00221" LVL="2"><PTEXT><PDAT>(b) hydroxyl groups which can be converted to esters, ethers, aldehydes, etc.</PDAT></PTEXT></PARA>
<PARA ID="P-00222" LVL="2"><PTEXT><PDAT>(c) haloalkyl groups wherein the halide can be later displaced with a nucleophilic group such as, for example, an amine, a carboxylate anion, thiol anion, carbanion, or an alkoxide ion, thereby resulting in the covalent attachment of a new group at the site of the halogen atom;</PDAT></PTEXT></PARA>
<PARA ID="P-00223" LVL="2"><PTEXT><PDAT>(d) dienophile groups which are capable of participating in Diels-Alder reactions such as, for example, maleimido groups;</PDAT></PTEXT></PARA>
<PARA ID="P-00224" LVL="2"><PTEXT><PDAT>(e) aldehyde or ketone groups such that subsequent derivatization is possible via formation of carbonyl derivatives such as, for example, imines, hydrazones, semicarbazones or oximes, or via such mechanisms as Grignard addition or alkyllithium addition;</PDAT></PTEXT></PARA>
<PARA ID="P-00225" LVL="2"><PTEXT><PDAT>(f) sulfonyl halide groups for subsequent reaction with amines, for example, to form sulfonamides;</PDAT></PTEXT></PARA>
<PARA ID="P-00226" LVL="2"><PTEXT><PDAT>(g) thiol groups which can be converted to disulfides or reacted with acyl halides:</PDAT></PTEXT></PARA>
<PARA ID="P-00227" LVL="2"><PTEXT><PDAT>(h) amine or sulfhydryl groups which can be, for example, acylated or alkylated;</PDAT></PTEXT></PARA>
<PARA ID="P-00228" LVL="2"><PTEXT><PDAT>(i) alkenes which can undergo, for example, cycloadditions, acylation, Michael addition, etc.; and</PDAT></PTEXT></PARA>
<PARA ID="P-00229" LVL="2"><PTEXT><PDAT>(i) epoxides which can react with, for example, amines and hydroxyl compounds.</PDAT></PTEXT></PARA>
<PARA ID="P-00230" LVL="7"><PTEXT><PDAT>F. Conjugation</PDAT></PTEXT></PARA>
<PARA ID="P-00231" LVL="0"><PTEXT><PDAT>A recognition moiety can be conjugated to a component of an organic layer by any of a large number of art-known attachment methods. For example, in one preferred embodiment, a reactive SAM component is attached to the substrate and the recognition moiety is subsequently bound to the SAM component via the reactive group on the SAM component and a group of complementary reactivity on the recognition moiety. See, for example, Hegner et al., </PDAT><HIL><ITALIC><PDAT>Biophys. J., </PDAT></ITALIC></HIL><PDAT>70: 2052-2066 (1996). In another preferred embodiment, the recognition moiety is attached to the SAM component prior to immobilizing the SAM component on the substrate surface: the recognition moiety-SAM component cassette is then attached to the substrate. In a still further preferred embodiment, the recognition moiety is attached to the substrate via a displacement reaction. In this embodiment, the SAM is preformed and then a fraction of the SAM components are displaced by a recognition moiety or a SAM component bearing a recognition moiety.</PDAT></PTEXT></PARA>
<PARA ID="P-00232" LVL="0"><PTEXT><PDAT>Peptides and nucleic acids can be attached to a SAM component. Both naturally-derived and synthetic peptides and nucleic acids are of use in conjunction with the present invention. These molecules can be attached to a SAM component by any available reactive group. For example, peptides can be attached through an amine, carboxyl, sulfhydryl, or hydroxyl group. Such a group can reside at a peptide terminus or at a site internal to the peptide chain. Nucleic acids can be attached through a reactive group on a base (e.g., exocyclic amine) or an available hydroxyl group on a sugar moiety (e.g., 3&prime;- or 5&prime;-hydroxyl). The peptide and nucleic acid chains can be further derivatized at one or more sites to allow for the attachment of appropriate reactive groups onto the chain. See, Chrisey et al., </PDAT><HIL><ITALIC><PDAT>Nucleic Acids Res., </PDAT></ITALIC></HIL><PDAT>24: 3031-3039 (1996).</PDAT></PTEXT></PARA>
<PARA ID="P-00233" LVL="0"><PTEXT><PDAT>When the peptide or nucleic acid is a fully or partially synthetic molecule, a reactive group or masked reactive group can be incorporated during the process of the synthesis. Many derivatized monomers appropriate for reactive group incorporation in both peptides and nucleic acids are know to those of skill in the art. See, for example, &ldquo;Special Methods in Peptide Synthesis,&rdquo; In, The Peptides: Analysis, Synthesis, Biology, Vol. 2: Gross, et al., Eds., Academic Press, New York (1980). Many useful monomers are commercially available (Bachem, Sigma, etc.). This masked group can then be unmasked following the synthesis, at which time it becomes available for reaction with a SAM component or a spacer arm.</PDAT></PTEXT></PARA>
<PARA ID="P-00234" LVL="0"><PTEXT><PDAT>In other preferred embodiments, the peptide is attached directly to the metal film. See, Frey et al. </PDAT><HIL><ITALIC><PDAT>Anal. Chem., </PDAT></ITALIC></HIL><PDAT>68: 3187-3193 (1996). In a particularly preferred embodiment, the peptide is attached to a silver or a gold film through a sulfhydryl group on a cysteine residue. In another preferred embodiment, the peptide is attached through a thiol to a spacer arm which terminates in, for example, an iodoacetamide, chloroacetamide, benzyl iodide, benzyl bromide, alkyl iodide or alkyl bromide. Similar immobilization techniques are known to those of skill in the art. See, for example, Zull et al., </PDAT><HIL><ITALIC><PDAT>J. Ind. Microbiol., </PDAT></ITALIC></HIL><PDAT>13: 137-143 (1994).</PDAT></PTEXT></PARA>
<PARA ID="P-00235" LVL="7"><PTEXT><PDAT>G. Spacer Arms</PDAT></PTEXT></PARA>
<PARA ID="P-00236" LVL="0"><PTEXT><PDAT>As used herein, the term &ldquo;spacer arm,&rdquo; refers to constituents of the organic layer that have a different structure than the bulk of the organic layer and which bear either reactive groups, recognition moieties or combinations thereof.</PDAT></PTEXT></PARA>
<PARA ID="P-00237" LVL="0"><PTEXT><PDAT>In certain embodiments, it is advantageous to have the recognition moiety attached to a SAM component having a structure that is different than that of the constituents of the bulk SAM. In this embodiment, the group to which the recognition moiety is bound is referred to as a &ldquo;spacer arm&rdquo; or &ldquo;spacer.&rdquo; Using such spacer arms, the properties of the SAM adjacent to the reactive group and/or recognition moiety can be controlled. Properties that are usefully controlled include, for example, hydrophobicity, hydrophilicity, surface-activity and the distance of the reactive group and/or recognition moiety from the surface of the substrate and/or the SAM. For example, in a SAM composed of alkanethiols, the recognition moiety can be attached to the metal film or a SAM component via an amine terminated poly(ethyleneglycol). Numerous other combinations of spacer arms and SAMs will be apparent, and are accessible, to those of skill in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00238" LVL="0"><PTEXT><PDAT>In addition to the use of hydrophilic polymers, the hydrophilicity of the organic layer can be enhanced by reaction with polar molecules such as amine-, hydroxyl- and polyhydroxyl-containing molecules. Similar strategies can be used to increase hydrophobicity (e.g, use of long-chain fatty acid derivatives) and to enhance the surface activity of the material (e.g., use of detergents, surfactants).</PDAT></PTEXT></PARA>
<PARA ID="P-00239" LVL="0"><PTEXT><PDAT>In another embodiment, the spacer serves to distance the reactive group and/or recognition moiety from the substrate or SAM. Spacers with this characteristic have several uses. For example, a recognition moiety held too closely to the substrate or SAM surface may not react with incoming analyte, or it may react unacceptably slowly. When an analyte is itself sterically demanding, the reaction leading to recognition moiety-analyte complex formation can be undesirably slowed, or not occur at all, due to the monolithic substrate hindering the approach of the two components.</PDAT></PTEXT></PARA>
<PARA ID="P-00240" LVL="7"><PTEXT><PDAT>H. Changes of State</PDAT></PTEXT></PARA>
<PARA ID="P-00241" LVL="0"><PTEXT><PDAT>The membranes of the present invention can be assembled such that the organic layer comprises a switchable group that undergoes a change of state upon being contacted by some external agent or force. The switchable group can be the recognition moiety, a portion of the recognition moiety and/or the group to which the recognition moiety is attached. The change in state can be, for example, an alteration in the conformation, electronic configuration, charge, polarity, dipole moment or steric bulk of the group. The change in the state of the group can be utilized to affect the membrane properties and to assemble membranes that are switchable between at least two different states.</PDAT></PTEXT></PARA>
<PARA ID="P-00242" LVL="0"><PTEXT><PDAT>The change in state can be brought about by a range of external conditions or forces including, for example, changes in fluid pH, ionic strength and/or redox potential. Additionally, changes in state can be brought about by exposing the switchable group to forces such as light, heat, magnetic and electrical fields.</PDAT></PTEXT></PARA>
<PARA ID="P-00243" LVL="0"><PTEXT><PDAT>In a preferred embodiment, the change of state is utilized to alter the availability of a recognition moiety to its binding partner. For example, in a first state, the switchable group can present a recognition moiety in a binding mode. When switched into its second state, the binding moiety becomes unavailable for binding or it binds with less affinity. Thus, by switching between the two states an analyte can be, for example bound to and then expelled from the membrane. Alternatively, the recognition moiety can be maintained in its non-binding conformation until a desired time when the change of state is initiated and the membrane binds the analyte.</PDAT></PTEXT></PARA>
<PARA ID="P-00244" LVL="0"><PTEXT><PDAT>In another preferred embodiment, the switchable group can be used to vary the size or the charge of the pores. Thus, the permselectivity of a membrane can be varied between at least two states utilizing the available states of the switchable group. For example, a group that is switched by a change in pH might exist in both an acidic and a basic form. In one example, the acidic form will be charged (e.g., amine to ammonium cation). In its neutral form, the membrane will allow positively charged analytes of the proper size to pass through the membrane. If the membrane is protonated, however, the positively charged species will be repelled by the similar charges on the membrane.</PDAT></PTEXT></PARA>
<PARA ID="P-00245" LVL="0"><PTEXT><PDAT>In those embodiments wherein the passage of a species through the membrane is influenced by the size of the species, the size of the pores can be switched between a first and a second state. In this embodiment, one of the states will be characterized by a greater steric bulk of the switchable group.</PDAT></PTEXT></PARA>
<PARA ID="P-00246" LVL="0"><PTEXT><PDAT>Switchable groups appropriate for use in conjunction with the present invention include, for example, azobenzene derivatives. Azobenzenes exist in one of two switchable isomers, the &ldquo;trans&rdquo; and the &ldquo;cis&rdquo; isomers. See, for example, Yu et al., </PDAT><HIL><ITALIC><PDAT>Langmuir </PDAT></ITALIC></HIL><PDAT>12: 2843-2848 (1996); Kumano et al., </PDAT><HIL><ITALIC><PDAT>Polymer J. </PDAT></ITALIC></HIL><PDAT>16(6): 461-470 (1984); Seki et al., </PDAT><HIL><ITALIC><PDAT>Langmuir </PDAT></ITALIC></HIL><PDAT>9: 211-217 (1993); and Sekkat et al., </PDAT><HIL><ITALIC><PDAT>Langmuir </PDAT></ITALIC></HIL><PDAT>11: 2855-2859 (1995). Other useful groups include, for example, spiropyrans and related compounds and redox couples such as ferrocene (Chidsey, </PDAT><HIL><ITALIC><PDAT>Science </PDAT></ITALIC></HIL><PDAT>251: 919 (1991)), viologen (DeLong et al., </PDAT><HIL><ITALIC><PDAT>Langmuir </PDAT></ITALIC></HIL><PDAT>6: 709 (1992)), and ruthenium polypyridyl complexes (Finkles et al., </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>114: 3173 (1992)). Other useful switchable groups will be apparent to those of skill in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00247" LVL="0"><PTEXT><PDAT>The switchable membranes are of use in each of the aspects and embodiments of the invention discussed below.</PDAT></PTEXT></PARA>
<PARA ID="P-00248" LVL="7"><PTEXT><PDAT>I. Methods</PDAT></PTEXT></PARA>
<PARA ID="P-00249" LVL="0"><PTEXT><PDAT>In addition to the novel materials detailed above, the present invention also includes methods for using and manufacturing these materials. The methods include purification strategies (e.g., ion exchange, dialysis) and assays.</PDAT></PTEXT></PARA>
<PARA ID="P-00250" LVL="7"><PTEXT><PDAT>I.1. Ion Exchange</PDAT></PTEXT></PARA>
<PARA ID="P-00251" LVL="0"><PTEXT><PDAT>Ion-exchange is an ubiquitous technique in which cations or anions in a fluid are either removed from, or concentrated by the ion exchange membrane. Although, many different types of ion exchange membranes are known in the art, they are generally based on an organic polymer structure. For example, in U.S. Pat. No. 3,884,885, a fluorinated polymer containing pendent, ion-exchange groups in the form of &mdash;SO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>H or &mdash;SO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>is disclosed. Further, preparation of fluorocarbon cation-exchange polymer membranes by reaction of a cation-exchange membrane carrying as its ion-exchange radical a sulfonic acid radical with primary to tertiary monoamines or, alternatively, with quaternary ammonium salts is disclosed in U.S. Pat. No. 4,246,091. Additionally, many ion-exchange membranes are commercially available (e.g., Bio-Rad Laboratories, Richmond, Calif.).</PDAT></PTEXT></PARA>
<PARA ID="P-00252" LVL="0"><PTEXT><PDAT>Ion-exchange membranes have been put to a number of uses on both laboratory and industrial scales. For example separation of organic liquids utilizing an ion-exchange membrane is disclosed by Pasternak et al. in U.S. Pat. Nos. 4,798,674; 4,877,529; 4,952,318; and in U.S. Pat. No. 5,006,576. Additionally, ion-exchange devices have been used in water treatment, food processing, pharmaceutical manufacturing, chemical purification, hydrometallurgy, metal processing, waste treatment, gas absorption and as catalysts.</PDAT></PTEXT></PARA>
<PARA ID="P-00253" LVL="0"><PTEXT><PDAT>In spite of their useful properties, the straight-forward assembly of membranes specific for certain ions or classes of ions or having certain desirable properties remains a somewhat elusive goal. Two approaches for assembling ion-exchange membranes are prevalent in the art; the polymerization of monomers bearing ion-exchange moieties and the modification of polymeric membranes with ion-exchange moieties. Both of these methods are limited in the identities of ion-exchange moieties that can be incorporated into the membranes and in the morphology of the membranes produced.</PDAT></PTEXT></PARA>
<PARA ID="P-00254" LVL="0"><PTEXT><PDAT>The materials of the present invention can be tailored for a particular ion-exchange application by a straight-forward attachment of a selected recognition moiety to the organic layer of the membranes of the invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00255" LVL="0"><PTEXT><PDAT>Thus, in a fourth aspect, the present invention provides a method for removing an ion from a fluid, said method comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00256" LVL="2"><PTEXT><PDAT>(a) contacting said fluid with an ion exchange medium comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00257" LVL="3"><PTEXT><PDAT>(i) a porous substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00258" LVL="3"><PTEXT><PDAT>(ii) a metal film adhered onto said substrate; and</PDAT></PTEXT></PARA>
<PARA ID="P-00259" LVL="3"><PTEXT><PDAT>(iii) an organic layer attached to said metal film, said organic layer comprising a recognition moiety that interacts with said ion.</PDAT></PTEXT></PARA>
<PARA ID="P-00260" LVL="0"><PTEXT><PDAT>The interaction between the recognition moiety and the ion can be either attractive or repulsive. In those embodiments, wherein the interaction is attractive, the ion can be bound to the ion-exchange membrane and physically removed from the solution by removing the membrane from the solution. In a preferred embodiment, the method further comprises passing the ion through the ion exchange medium. In yet another preferred embodiment, the interaction is repulsive and the ion cannot pass through or bind to the membrane.</PDAT></PTEXT></PARA>
<PARA ID="P-00261" LVL="0"><PTEXT><PDAT>The recognition moiety can comprise any group having ion-exchange capabilities, however, in a preferred embodiment, the recognition moiety is a member selected from the group of amines, quaternary amines, heterocyclic amines, sulfonamides, quaternary phosphonium, tertiary sulfonium, acids, chelating agents, crown ethers, cyclodextrins and combinations thereof.</PDAT></PTEXT></PARA>
<PARA ID="P-00262" LVL="0"><PTEXT><PDAT>The method of the invention can be used to separate a single ion or more than one ion from other species in a mixture. As with conventional ion exchange methods, the present method can be used to separate ions having dissimilar charges. Additionally, in a preferred embodiment, the method of the invention can be used to separate selectively two ions having identical charges. Ions with identical charges can be separated by, for example, controlling the size of the pores such that a smaller ion is preferentially transported across the membrane.</PDAT></PTEXT></PARA>
<PARA ID="P-00263" LVL="0"><PTEXT><PDAT>The materials of the invention can be used for methods in which the separation is achieved by passive diffusion across the membrane. Such processes are referred to as &ldquo;diffusion dialysis&rdquo; processes. Diffusion dialysis is a simple ion exchange membrane process that separates ionic, non-ionic or colloidal species from an aqueous acid, base, or salt solution based on differences in diffusion rates. This method utilizes a concentration difference across the membrane as the driving force. Examples include acid dialysis and base dialysis.</PDAT></PTEXT></PARA>
<PARA ID="P-00264" LVL="0"><PTEXT><PDAT>Acid diffusion dialysis can be used for a range of purposes, including purification and/or analysis of organic and inorganic molecules, recovery of acids such as HCl, HNO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, HF and H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>SO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>from spent pickling baths, recovery of acids from metal finishing baths, recovery of mineral acids from battery waste and recovery of hydrochloric acid from uranium processing. Base diffusion dialysis can be used, inter alia, for the purification and/or analysis of organic and inorganic materials, in the recovery of caustic and aluminum from aluminum chemical milling, anodizing, aluminum surface finishing baths, recovery of caustic from, for example, photographic baths and electronic component processing (Aqualytics, Inc.).</PDAT></PTEXT></PARA>
<PARA ID="P-00265" LVL="0"><PTEXT><PDAT>A typical diffusion dialysis apparatus comprises at least one permselective diffusion membrane (either cationic or anionic). The membrane divides a dialysis vessel into two or more compartments. The feed fluid is on one side of the membrane at the beginning of the process. Typically, a free acid or base will diffuse across the membrane into the product compartment of the vessel. Alternatively, one of these components can be repelled by the membrane and concentrated in the feed fluid.</PDAT></PTEXT></PARA>
<PARA ID="P-00266" LVL="0"><PTEXT><PDAT>In addition, to methods in which the ion-exchange or other separation is effected by passive diffusion, he membranes of the present invention, due to the conductive metallic layer can be used in processes such as electrodialysis. Electrodialysis is an electrically driven separation modality utilizing an ion exchange membrane. This technique is capable of separating, concentrating and purifying selected ions from aqueous mixtures. Electrodialysis is similar to evaporation or reverse osmosis. It can be used, for example, to recover pure water from a salt solution or concentrate the total dissolved solids in a waste stream.</PDAT></PTEXT></PARA>
<PARA ID="P-00267" LVL="0"><PTEXT><PDAT>Electrodialysis utilizes a system in which ions migrate through the membrane from a less concentrated to a more concentrated solution as a result of the ions&apos; respective attractions to a positive electrode (anode) and a negative electrode (cathode), created by direct electric current. Application of a current causes cations to migrate toward the cathode, and anions to migrate toward the anode. Upon contacting an ion exchange membrane surface, the membrane properties (i.e., charge and pore size) determine whether the ion is repelled or allowed to pass through it.</PDAT></PTEXT></PARA>
<PARA ID="P-00268" LVL="0"><PTEXT><PDAT>Electrodialysis has been used for a number of applications including, desalting and purification of organic acids and solvents including glycol and amines, desalting of foods such as whey, soy sauce, vinegar, hydrolyzed vegetable protein, sugars and wine, deacidification of foods, concentration of dilute acid, base and salt streams, recovery of salts, acids, or alkali from industrial rinse waters, mineral acid separation, phosphoric acid recovery, drinking water nitrate reduction, synthesis of organic and amino acids, waste water minimization, potable water production from brackish water.</PDAT></PTEXT></PARA>
<PARA ID="P-00269" LVL="7"><PTEXT><PDAT>I.2. Affinity-Based Membrane Separations</PDAT></PTEXT></PARA>
<PARA ID="P-00270" LVL="0"><PTEXT><PDAT>Affinity-based purification methods, such as affinity chromatography enable the efficient isolation of species such as biological molecules or biopolymers by utilizing their recognition sites for certain supported chemical/biological structures with a high degree of selectivity. Previous affinity-based methods have been predominantly chromatographic, utilizing materials of varying chemical structure as supports. For example, agarose gels and cross-linked agarose gels have been the most widely used support materials. Although their hydrophilicity makes them relatively free of nonspecific binding, their compressibility makes them less attractive as carriers in large scale processing, such as in manufacturing. Controlled-pore glass (CPG) beads have also been used in affinity chromatography. Although high throughputs can be obtained with columns packed with CPG, this carrier is even more expensive than agarose beads. Cellulose particles have also been used by immunochemists for synthetic affinity sorbents. However, compared to agarose gels, cellulose particles are formed with more difficulty and therefore, have received less attention in the preparation of affinity sorbents for enzymes.</PDAT></PTEXT></PARA>
<PARA ID="P-00271" LVL="0"><PTEXT><PDAT>A review of current affinity chromatographic matrices, leads to the conclusion that there exists a need for materials and method useful both for ion exchange and affinity-based purifications which will have high stability, high porosity, low non-specific adsorption, high through-put, non-compressibility, and which will be useful for both laboratory and industrial-scale biological separations. It is at the industrial level of manufacturing, especially, where the aforementioned drawbacks of the prior art have had their most important effect and where this need is the strongest.</PDAT></PTEXT></PARA>
<PARA ID="P-00272" LVL="0"><PTEXT><PDAT>Large-scale membrane-mediated purifications are well-known in processes, such as the purification of organic chemicals, pharmaceuticals, waste-water and gas separations. Thus, a membrane-based affinity separation material and method is an attractive alternative for chromatographic processes.</PDAT></PTEXT></PARA>
<PARA ID="P-00273" LVL="0"><PTEXT><PDAT>The affinity of a membrane-bound recognition moiety for an analyte can be exploited to purify that analyte. In this embodiment of the present invention, the materials of the invention are broadly analogous to affinity chromatography matrices. The methods are similarly analogous to affinity chromatographic methods. Although the materials of the invention can be used in a range of affinity purification protocols, two methodologies are currently preferred. In the first of these, the porous material is incubated with a fluid containing the analyte. Following the period of incubation, the membrane is removed from the fluid and the analyte is freed from the membrane. In a second embodiment, the organic layer comprises a recognition moiety that, because of its affinity for the analyte, facilitates the transport of the analyte across the membrane.</PDAT></PTEXT></PARA>
<PARA ID="P-00274" LVL="0"><PTEXT><PDAT>Thus, in a fifth aspect, the present invention provides a method for isolating a molecule from other molecules by affinity dialysis comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00275" LVL="2"><PTEXT><PDAT>(a) contacting the molecule with a multilayered porous material comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00276" LVL="3"><PTEXT><PDAT>a porous substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00277" LVL="3"><PTEXT><PDAT>a metal film adhered onto the substrate; and</PDAT></PTEXT></PARA>
<PARA ID="P-00278" LVL="3"><PTEXT><PDAT>an organic layer attached to the metal film, the organic layer comprising a recognition moiety</PDAT></PTEXT></PARA>
<PARA ID="P-00279" LVL="2"><PTEXT><PDAT>(c) forming a complex between the recognition moiety.</PDAT></PTEXT></PARA>
<PARA ID="P-00280" LVL="0"><PTEXT><PDAT>In a preferred embodiment, after the membrane and a fluid containing the molecule are contacted and incubated together, the membrane is removed from the fluid and the method further comprises;</PDAT></PTEXT></PARA>
<PARA ID="P-00281" LVL="2"><PTEXT><PDAT>(d) washing the membrane-molecule complexes with a solvent for the other molecules.</PDAT></PTEXT></PARA>
<PARA ID="P-00282" LVL="0"><PTEXT><PDAT>Following the purification, it will often be desirable to remove the purified molecule from the membrane. Thus, in a preferred embodiment, the method of the invention further comprises disrupting the complex between the recognition moiety and the molecule, thereby separating the molecule from the membrane.</PDAT></PTEXT></PARA>
<PARA ID="P-00283" LVL="0"><PTEXT><PDAT>In another preferred embodiment, the molecule undergoing affinity separation interacts with the recognition moiety and is transported across the membrane at a rate higher than that at which other molecules in the fluid are transported. In this embodiment, the method further comprises;</PDAT></PTEXT></PARA>
<PARA ID="P-00284" LVL="2"><PTEXT><PDAT>(d) disrupting the membrane-molecule complexes, thereby passing the molecule through the membrane.</PDAT></PTEXT></PARA>
<PARA ID="P-00285" LVL="0"><PTEXT><PDAT>The membrane-molecule complex can of a transient nature and easily disrupted by normal kinetic/thermodynamic processes (e.g., low binding affinity, concentration gradients, diffusion, etc.). Alternatively, the complex can be disrupted by a change in the fluid conditions (e.g., ionic strength, pH, temperature, etc.). In general, the formation of the complex will facilitate the transport of the analyte across the membrane.</PDAT></PTEXT></PARA>
<PARA ID="P-00286" LVL="0"><PTEXT><PDAT>The concept of facilitated transport across membranes is recognized in the art. See, for example, Lakshmi et al., </PDAT><HIL><ITALIC><PDAT>Nature </PDAT></ITALIC></HIL><PDAT>388(21), 758-760 (1997); Noble, </PDAT><HIL><ITALIC><PDAT>Chem. Eng. Progr. </PDAT></ITALIC></HIL><PDAT>85: 58-70 (1989); Noble et al., </PDAT><HIL><ITALIC><PDAT>J. Membr. Sci. </PDAT></ITALIC></HIL><PDAT>75: 121-129 (1992). Briefly, the concept of facilitated transport involves the conjugation to a membrane of a species selective for an analyte. The membrane-conjugated species recognizes the analyte and binds to or otherwise forms a complex with the analyte. Thus, the present invention provides materials and methods for achieving the affinity purification of species through a facilitated transport mechanism.</PDAT></PTEXT></PARA>
<PARA ID="P-00287" LVL="0"><PTEXT><PDAT>Although it is within the scope of the present invention to utilize membrane-based affinity separation methods for the purification of any member of any class of molecules, in a preferred embodiment, the molecule being purified is a biomolecule. In further preferred embodiments, the biomolecule is a member selected from the group consisting of peptides, enzymes, enzyme substrates, carbohydrates, nucleic acids, antibodies, antigens and combinations thereof.</PDAT></PTEXT></PARA>
<PARA ID="P-00288" LVL="0"><PTEXT><PDAT>The choice of appropriate recognition groups for performing a particular affinity chromatographic separation will be apparent to those of skill in the art, however, in preferred embodiments, the recognition moiety is a member selected from the group consisting of biomolecules, organic groups, metal chelates, organometallic moieties and combinations thereof. In preferred embodiments, the recognition moiety does not react with the analyte to convert it to another species. Thus, recognition moieties, such as apoenzymes, receptors and antibodies are currently preferred.</PDAT></PTEXT></PARA>
<PARA ID="P-00289" LVL="0"><PTEXT><PDAT>The literature is replete with articles, monographs, and books on the subject of affinity chromatography, including such topics as affinity chromatography supports, crosslinking members, ligands and their preparation and use. A sampling of those references includes, &ldquo;Affinity chromatography: general methods,&rdquo; </PDAT><HIL><ITALIC><PDAT>Methods Enzymol., </PDAT></ITALIC></HIL><PDAT>182: 357-71 (1990); &ldquo;Novel affinity-based processes for protein purification,&rdquo; Ferment, </PDAT><HIL><ITALIC><PDAT>Bioeng., </PDAT></ITALIC></HIL><PDAT>70(3): 199-209 (1990). &ldquo;Applications of preparative high-performance liquid chromatography to the separation and purification of peptides and proteins,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Chromatogr., </PDAT></ITALIC></HIL><PDAT>492: 431-69 (1989); &ldquo;Purification of enzymes by heparin-Sepharose affinity chromatography,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Chromatogr., </PDAT></ITALIC></HIL><PDAT>184(3): 335-45 (1980), &ldquo;Principles of multi-enzyme purification by affinity chromatography,&rdquo; </PDAT><HIL><ITALIC><PDAT>Enzyme Eng., </PDAT></ITALIC></HIL><PDAT>4: 441-2 (1978); &ldquo;General ligand affinity chromatography in enzyme purification; Ligands, affinity chromatography, enzyme purification,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Macromol. Sci., Chem., </PDAT></ITALIC></HIL><PDAT>A10(1-2): 15-52 (1976); &ldquo;Affinity purification of enzymes,&rdquo; </PDAT><HIL><ITALIC><PDAT>Chem. Technol., </PDAT></ITALIC></HIL><PDAT>5(9): 564-71 (1975); &ldquo;Bioaffinity chromatography,&rdquo; </PDAT><HIL><ITALIC><PDAT>Pract. High Perform. Liq. Chromatogr., </PDAT></ITALIC></HIL><PDAT>193-206 (1976); &ldquo;Affinity chromatography of plasma proteins-an overview,&rdquo; </PDAT><HIL><ITALIC><PDAT>Proc. Int., Workshop Technol. Protein Sep. Improv. Blood Plasma Fractionation, </PDAT></ITALIC></HIL><PDAT>422-35; (1977) &ldquo;Affinity chromatography of enzymes,&rdquo; </PDAT><HIL><ITALIC><PDAT>Affinity Chromatogr., Proc. Int. Symp. </PDAT></ITALIC></HIL><PDAT>25-38, (1977) (Pub. 1978); &ldquo;Protein immobilization and affinity chromatography,&rdquo; </PDAT><HIL><ITALIC><PDAT>Biotechnol. Appl. Proteins Enzymes. Pap. Conf., </PDAT></ITALIC></HIL><PDAT>83-102 (1976) (Pub. 1977); &ldquo;Use of affinity chromatography in protein structure studies,&rdquo; </PDAT><HIL><ITALIC><PDAT>Pept., Proc. Eur. Pept. Symp., </PDAT></ITALIC></HIL><PDAT>11th, 203-22 (1971) (Pub. 1973); &ldquo;Affinity chromatography of enzymes,&rdquo; </PDAT><HIL><ITALIC><PDAT>Fed. Eur. Biochem. Soc. Meet., </PDAT></ITALIC></HIL><PDAT>&lsqb;Proc&rsqb; 30 (1974); and Affinity Chromatography: A Practival Approach, IRL Press Limited, Oxford England (1985). It is within the abilities of those of skill in the art to modify methods appropriate for preparing and utilizing affinity chromatographic media such that they can be used in conjunction with the porous materials of the invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00290" LVL="0"><PTEXT><PDAT>To better illustrate this aspect of the invention, the following discussion, focusing on enzyme purification, is offered. The use of enzyme purification is intended to be illustrative and not limiting.</PDAT></PTEXT></PARA>
<PARA ID="P-00291" LVL="0"><PTEXT><PDAT>The starting point for designing an affinity matrix for removal of specific enzymes is to examine the structure of the enzyme and, particularly, the structure of the inhibitors of the enzymes. The complex formed between an enzyme and its inhibitor provides the best picture of how the enzyme may interact with the specific protein structure. Enzyme inhibition is always competitive and reversible as expressed by the following equation:</PDAT></PTEXT></PARA>
<PARA ID="P-00292" LVL="7"><PTEXT><PDAT>&emsp;E(enzyme)&plus;I(inhibitor)&equals;EI complex</PDAT></PTEXT></PARA>
<PARA ID="P-00293" LVL="0"><PTEXT><PDAT>In affinity dialysis, this reaction between enzyme and the membrane-bound inhibitor or substrate is used to selectively extract the enzyme from crude solutions, either as a batch or continuous process. In preferred embodiments, after washing away the contaminating proteins, the enzyme is freed from the membrane by introducing free ligand, which competes with the membrane for binding of the enzyme. The enzyme is then freed of inhibitor by dialysis or ultrafiltration techniques, or in the case of potent inhibitors by chemical processes that interfere with binding to the inhibitor.</PDAT></PTEXT></PARA>
<PARA ID="P-00294" LVL="0"><PTEXT><PDAT>The dialysis feed solution can contain a buffer solution which is preferably at neutral pH. Any nonreactive compound with a pKa near neutrality is satisfactory. Quite often a buffer such as N-&lsqb;2-hydroxyethyl&rsqb;piperazineN&prime;-&lsqb;2-ethanesulfonic acid&rsqb; (HEPES) proves to be satisfactory. Other components can be included in the buffer, such as sucrose, 3-&lsqb;3-cholamidopropyl)dimethylammonio&rsqb;-1-propanesulfonate (CHAPS) to slow the rate of dissociation of enzyme having multiple subunits to inactive monomers. Other useful buffer solutions and additives for a given purpose will be apparent to those of skill in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00295" LVL="0"><PTEXT><PDAT>The flow rate through the membrane can vary over a wide range. An important consideration in the choice of flow rates is the rate constant for association and dissociation of the inhibitor and the enzyme. When the rates of association are slower than normal, slow flow rates are generally used. Methods of controlling the flow include manipulating the concentration gradient of the enzyme and varying the pore size of the membrane.</PDAT></PTEXT></PARA>
<PARA ID="P-00296" LVL="0"><PTEXT><PDAT>Following its immobilization on the membrane, the bound enzyme is generally washed with buffer, or continuously dialyzed against fresh buffer, to remove the last traces of contaminating proteins.</PDAT></PTEXT></PARA>
<PARA ID="P-00297" LVL="0"><PTEXT><PDAT>After washing, the enzyme is removed from the membrane by including the free ligand, or another inhibitor or substrate for the enzyme in the wash buffer. Again, the rate constants for equilibration with particular inhibitors require special consideration. The half-life for dissociation of the inhibitor or substrate can be used as a guide for ascertaining appropriate flow rates or incubation times. If the rates are too slow to use continuous flow to remove the enzyme, removal is accomplished in a batch process, in which the membrane is flooded with free ligand and then incubated for a period (e.g., overnight) to allow the exchange to reach equilibrium.</PDAT></PTEXT></PARA>
<PARA ID="P-00298" LVL="0"><PTEXT><PDAT>Lastly, purified enzyme must be separated from the E-I complex. At this point, the purified enzyme is complexed with the eluting ligand. Removal of the ligand and reactivation of the enzyme is classically accomplished by dialysis or diafiltration. Similar methods are available for purification of other biomolecules.</PDAT></PTEXT></PARA>
<PARA ID="P-00299" LVL="0"><PTEXT><PDAT>In a variation on this method, the enzymes, or their apoenzyme analogues, can be utilized as components of the affinity membrane to isolate the components to which they bind.</PDAT></PTEXT></PARA>
<PARA ID="P-00300" LVL="0"><PTEXT><PDAT>Of particular interest is the immobilization of enzymes such as hydrolases, isomerases, proteases, amylases, and the like. These immobilized enzymes can then be used in biochemical reactors, as is otherwise well known in the art. In a preferred embodiment, the starting material does not pass through the membrane, however, the product will pass through the membrane and into a collection vessel on the other side of the membrane.</PDAT></PTEXT></PARA>
<PARA ID="P-00301" LVL="0"><PTEXT><PDAT>Antibodies can be similarly isolated by the use of a membrane having bound thereto one or more species recognized by the antibody. Alternatively, antibodies can be used in an affinity membrane to isolate the targets (e.g. antigen, receptor or receptor subunits) to which they bind. Briefly, in one embodiment, affinity dialysis involves immobilizing (e.g. on the porous material of the invention) one or more species of antibodies. A fluid containing the molecules (e.g., small molecular drugs, peptides, peptide mimetics, nucleic acids, etc.), cells, cellular lysate, or cellular homogenate are then contacted with the immobilized antibody which then binds to its cognate ligand. The remaining material is then washed away and the bound/isolated cognate ligand can then be released from the antibody for farther use. Adaptations of art-recognized methods for performing affinity chromatography are well within the abilities of those of skill in the art (see, e.g., U.S. Pat. Nos. 5,710,254; 5,491,096; 5,278,061; 5,110,907; 4,985,144; 4,385,991; 3,983,001, etc.).</PDAT></PTEXT></PARA>
<PARA ID="P-00302" LVL="0"><PTEXT><PDAT>It is now known that for the coupling of a biomolecule or a ligand to a solid matrix to present the coupled species with maximum affinity for its binding partner it is important that the ligand or biomolecule retain its active conformation after coupling to the matrix. For example, antibody molecules exist in their active forms only in a small number of conformations. The functional affinities vary widely upon coupling to a solid surface. Thus, the noncovalent interactions between the membrane and ligand with forces such as hydrogen bonding and hydrophobic interactions have manifest influence on antibody conformations. Since antibodies are bulky in structure, the physical character of the membrane, such as surface area and pore distribution, also is a consideration from a steric hindrance point of view. For example, it has been found that above the level of about 3-4 mg/gm of IgG bound to Sepharose&trade;, additional bound IgG is ineffective as a ligand. Apparently, as higher levels of IgG are coupled to the Sepharose&trade;, antibody activity actually diminishes due to crowding of IgG, preventing the action of the antibody. As a solution to this problem, the present invention provides a material in which the concentration and spacing of the bound antibody, or other molecule, can be rationally controlled and varied to optimize the separation parameters.</PDAT></PTEXT></PARA>
<PARA ID="P-00303" LVL="0"><PTEXT><PDAT>Typical ligands of use in this aspect of the invention include, but are not limited to, DNA blood type antigen, anti-alpha feto protein, C1Q, protein A, protein G, polylysine, mucopolysaccharides such as heparin, methylated albumin, tryptophan, phenylalanine, concavaline A, and the like. For removal of proteolytic enzymes from IgG, episilonaminoacrylic acid, lysine, methyl-p-aminocyclohexane carboxylic acid, and trasylol, potential inhibitors, are preferred. For removal of mucopoly-saccharides such as heparin, low molecular weight basic proteins (protamines) such as protamine sulfate are preferred. For removal of kallikrein and PKA, benzamidine is effective. For removal of endotoxins, polymyxin-B-sulfate is preferred.</PDAT></PTEXT></PARA>
<PARA ID="P-00304" LVL="0"><PTEXT><PDAT>As will be recognized by one skilled in the art, ligands suitable for the practice of the present invention include all ligands which may be immobilized by the affinity membrane and still maintain biological activity, such ligands being represented by, but not limited to, the following general classes amino acids; avidin-biotins; carbohydrates; glutathiones; hydrophobic matrices; immunoglobulins; insoluble proteins; lectins; nucleotides; polyamino and polynucleic acids; and specialty ligands.</PDAT></PTEXT></PARA>
<PARA ID="P-00305" LVL="0"><PTEXT><PDAT>Typical amino acids suitable as affinity ligands include L-alanine, L-arginine, L-asparagine, L-aspartic acid, L-cysteine, L-cystine, L-glutamic acid, L-glutamine, glycine, L-histidine, L-isoleucine, L-lysine, L-methionine, L-phenylalanine, L-proline, L-serine, L-threonine, L-thyroxine, D-tryptophan, L-tryptophan, L-tyrosine and L-valine.</PDAT></PTEXT></PARA>
<PARA ID="P-00306" LVL="0"><PTEXT><PDAT>Typical avidin-biotin ligands include avidin, biotin, desthiobiotin, diaminobiotin, and 2-iminobiotin.</PDAT></PTEXT></PARA>
<PARA ID="P-00307" LVL="0"><PTEXT><PDAT>Typical carbohydrates include the glucosamines, the glycopryranoses, the lactosamines, the fucosamines, the fucopyranosylamines, the galactosylamines, the glycopyranosides, and the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00308" LVL="0"><PTEXT><PDAT>Typical glutathione ligands include glutathione, hexylglutathione, and sulfobromophthalein-S-glutathione.</PDAT></PTEXT></PARA>
<PARA ID="P-00309" LVL="0"><PTEXT><PDAT>Typical hydrophobic matrices include amino allyl, butyl, decyl, dodecyl, ethyl, hexyl, methyl, octyl, pentyl, phenyl and propyl.</PDAT></PTEXT></PARA>
<PARA ID="P-00310" LVL="0"><PTEXT><PDAT>Typical immunoglobulins include the IgG&apos;s, including anti-goat IgG, anti-human IgG, anti-mouse IgG, anti-rabbit IgG, goat IgG, human IgG, rabbit IgG, and anti-glucose-6-phosphate dehydrogenase.</PDAT></PTEXT></PARA>
<PARA ID="P-00311" LVL="0"><PTEXT><PDAT>Typical proteins include factor VIII von Willebrand factor complex (VIII:C/VII:RP complex); factor VIII procoagulant activity protein (VIII:C); von Willebrand factor (VIII:RP) (see, U.S. Pat. No. Re. 32,011); factor IX; vitamin K dependent clotting factors such as X, VII, II, protein C, and protein S; antithrombin III; tissue factor inhibitor; plasminogen activator inhibitor; tissue plasminogen activator; erythropoietin; colony stimulating factors; growth factors; protein C inhibitor; interleukins; labeled proteins; DNA probes; interferons; hepatitis vaccine; lipocordons; or any protein, peptide, or fragment to which a monoclonal antibody can be made or bound. The source of proteins such as VIII:C, VIII:RP and factor IX may be plasma or a recombinant source.</PDAT></PTEXT></PARA>
<PARA ID="P-00312" LVL="0"><PTEXT><PDAT>Typical insoluble proteins include aprotinin, fetuin, gelatin, globin, glycophorin, hemoglobin, insulin, lactalbumin, parvalbumin, protamine, protein-A, protein-G, ribose-binding protein, and trypsin inhibitor.</PDAT></PTEXT></PARA>
<PARA ID="P-00313" LVL="0"><PTEXT><PDAT>Typical lactins, include </PDAT><HIL><ITALIC><PDAT>Arachis hypogaea, </PDAT></ITALIC></HIL><PDAT>concanavalin A, </PDAT><HIL><ITALIC><PDAT>Dolichos biflorus, </PDAT></ITALIC></HIL><PDAT>glycine max, </PDAT><HIL><ITALIC><PDAT>Lens culinaris, Phytolacca americana, Pisum sativum, </PDAT></ITALIC></HIL><PDAT>and the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00314" LVL="0"><PTEXT><PDAT>Typical nucleotides include the adenosine mono- and diphosphates, the cytidine di- and triphosphates, flavin mononucleotide, the guanosine mono-, di-, and triphosphates, and the uridine mono-, di-, and triphosphates.</PDAT></PTEXT></PARA>
<PARA ID="P-00315" LVL="0"><PTEXT><PDAT>Typical polyamino and polynucleic acids include DNA, polyadenylic acid, polycytidylic acid, polylysine, polyriboadinylic, polyribocytidylic, polyriboguanylic, polyriboinosinic acid, and polyuridylic.</PDAT></PTEXT></PARA>
<PARA ID="P-00316" LVL="0"><PTEXT><PDAT>In those embodiments in which the affinity membranes of the invention are configured within a device, a membrane of the invention will generally divide the device into two or more vessels appropriate for holding a fluid. Many materials that can be isolated using conventional affinity chromatography support materials can be isolated using the method of the present invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00317" LVL="7"><PTEXT><PDAT>I.3. Size Exclusion Dialysis</PDAT></PTEXT></PARA>
<PARA ID="P-00318" LVL="0"><PTEXT><PDAT>In a sixth aspect, the invention provides a method of isolating a first molecule from a second molecule by size exclusion dialysis, comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00319" LVL="2"><PTEXT><PDAT>(a) contacting the first and second molecule with a multilayered porous material comprising;</PDAT></PTEXT></PARA>
<PARA ID="P-00320" LVL="3"><PTEXT><PDAT>a porous substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00321" LVL="3"><PTEXT><PDAT>a metal film layered onto the substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00322" LVL="3"><PTEXT><PDAT>a hydrophilic polymer attached to the metal film; and</PDAT></PTEXT></PARA>
<PARA ID="P-00323" LVL="2"><PTEXT><PDAT>(b) passing the first molecule through the porous material while the second molecule is substantially retained thereby.</PDAT></PTEXT></PARA>
<PARA ID="P-00324" LVL="0"><PTEXT><PDAT>Any hydrophilic polymer known in the art can be used in this aspect of the invention. The hydrophilic polymers can be either charged or neutral compounds. In a presently preferred embodiment of this aspect of the invention, the hydrophilic polymer comprises poly(ethyleneglycol).</PDAT></PTEXT></PARA>
<PARA ID="P-00325" LVL="0"><PTEXT><PDAT>Size exclusion dialysis is a well-known methodology for separating molecules on the basis of differences in molecular size and/or weight. This form of dialysis is generally non-interactive, The membrane consists essentially of a porous network in which solute molecules are either retained by or passed through based on their hydrodynamic volumes; that is their size and shape. See, for example, Yau et al., Modern Size Exclusion Chromatography, Wiley-Interscience, New York, 1979.</PDAT></PTEXT></PARA>
<PARA ID="P-00326" LVL="0"><PTEXT><PDAT>As a sample passes through the size dialysis membrane, the solute molecules below the molecular weight cut-off are passed through the membrane by the pores in the membrane. Large molecules that cannot enter the pores do not pass through the membrane.</PDAT></PTEXT></PARA>
<PARA ID="P-00327" LVL="0"><PTEXT><PDAT>In this aspect of the invention, the porous network is formed from hydrophilic polymers. The pore size and the density of the network on the membrane material can be adjusted by varying the size and the amount of the hydrophilic polymer bound to the surface. Because organosulfur monolayers on metal surfaces typically form without an &ldquo;islanding&rdquo; effect when more than one compound is used, an array of homogeneous matrices with novel structures and useful properties can be formed by mixing varying concentrations of, for example, thiol-PEGs of different lengths (i.e., molecular weights). Further, a polymer mixture including hydrophilic polymers of different structure and/or different molecular weights can be used to vary the characteristics of the matrix. The choice of appropriate membrane characteristics will be apparent, and easily accessible, to one of skill in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00328" LVL="7"><PTEXT><PDAT>I.4. Assays</PDAT></PTEXT></PARA>
<PARA ID="P-00329" LVL="0"><PTEXT><PDAT>Assays based on specific binding reactions have been used for detecting a wide variety of components such as drugs, hormones, enzymes, proteins, antibodies, and infectious agents in various biological fluids and tissue samples. In general, the assays consist of an analyte, a binding substance for the analyte, and a means of detection such as a detectable label. Immunological assays involve reactions between immunoglobulins (antibodies) which are capable of binding with specific antigenic determinants of various compounds and materials (antigens). Other types of reactions include binding between avidin and biotin, protein A and immunoglobulins, lectins and sugar moieties and the like. See, for example, U.S. Pat. No. 4,313,734, issued to Leuvering; U.S. Pat. No. 4,435,504, issued to Zuk; U.S. Pat. Nos. 4,452,901 and 4,960,691, issued to Gordon; and U.S. Pat. No. 3,893,808, issued to Campbell.</PDAT></PTEXT></PARA>
<PARA ID="P-00330" LVL="0"><PTEXT><PDAT>These assay techniques provide the ability to detect both the presence and amount of small quantities of analytes and are useful in, for example medical diagnostics and forensic applications.</PDAT></PTEXT></PARA>
<PARA ID="P-00331" LVL="0"><PTEXT><PDAT>Thus, in an seventh aspect, the present invention provides a method for determining the presence or amount of an analyte in a test sample comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00332" LVL="2"><PTEXT><PDAT>(a) contacting the test sample with a multilayered porous material comprising;</PDAT></PTEXT></PARA>
<PARA ID="P-00333" LVL="3"><PTEXT><PDAT>a porous substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00334" LVL="3"><PTEXT><PDAT>a metal film layered onto the substrate,</PDAT></PTEXT></PARA>
<PARA ID="P-00335" LVL="3"><PTEXT><PDAT>an organic layer adhered to the metal film, the organic layer comprising a recognition moiety;</PDAT></PTEXT></PARA>
<PARA ID="P-00336" LVL="2"><PTEXT><PDAT>(b) forming a complex between the recognition moiety and the analyte; and</PDAT></PTEXT></PARA>
<PARA ID="P-00337" LVL="2"><PTEXT><PDAT>(c) detecting the analyte.</PDAT></PTEXT></PARA>
<PARA ID="P-00338" LVL="0"><PTEXT><PDAT>Assays of any format can be used in conjunction with the present invention. In an exemplary embodiment, the porous material of the invention is used as an assay substrate on which the assay is performed. Assay formats appropriate to this embodiment include sandwich assays, agglutination assays, competitive assays and immunoassays. Alternatively, the material of the invention can be used to distinguish between the analyte and another substance. For example, if the analyte is contaminated with an interfering substance, the material of the invention can facilitate the assay by excluding the interfering substance from the detection step.</PDAT></PTEXT></PARA>
<PARA ID="P-00339" LVL="0"><PTEXT><PDAT>In yet another embodiment, the analyte is bound to the membrane. The analyte is subsequently released from the membrane on contacting a binding partner having greater avidity for the analyte than that of the membrane.</PDAT></PTEXT></PARA>
<PARA ID="P-00340" LVL="0"><PTEXT><PDAT>In another exemplary embodiment, the material of the invention selectively transports the analyte across the membrane and into the apparatus utilized for detection. For example, if the analyte is negatively charged and the interfering is positively charged, a material having a positively charged recognition moiety will facilitate the transport of the analyte across the membrane.</PDAT></PTEXT></PARA>
<PARA ID="P-00341" LVL="0"><PTEXT><PDAT>When the membrane is used to transport or exclude a species, a presently preferred assay format is equilibrium dialysis. Equilibrium dialysis provides a method to determine ligand binding and association constants from measured and plotted ligand binding data. In a typical experimental apparatus, a porous material of the invention divides a vessel into two chambers. The functionality of the porous material will determine those molecules that will pass through the membrane and those that will be retained by the membrane. In a preferred embodiment, the membrane will allow a ligand to pass through the membrane, but will retain the ligand-binding partner (e.g., antibody, enzyme, etc.). In a typical equilibrium dialysis experiment utilizing an antibody, the same concentration of antibody is placed into one compartment of several dialysis vessels. Differing concentrations of ligands are placed in the other compartment and the system is allowed to come to equilibrium.</PDAT></PTEXT></PARA>
<PARA ID="P-00342" LVL="0"><PTEXT><PDAT>After the system has come to equilibrium, there will be an equal amount of free ligand in each compartment of the vessel. If the antibody binds the ligand, there will also be a population of bound ligand in the antibody-containing compartment. This will afford a correspondingly higher concentration of ligand in the antibody-containing compartment relative to the ligand only compartment. Therefore, by determining the total ligand each side of the container, the free ligand concentration can be determined and, by subtraction the concentration of the bound ligand can be determined. By constructing a bound/free versus bound plot, the K</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>for the can be determined. Additionally, by dividing the ligand bound at saturation by the total concentration of antibody used, the number of ligand binding sites on the antibody can be determined.</PDAT></PTEXT></PARA>
<PARA ID="P-00343" LVL="0"><PTEXT><PDAT>The format of an assay for extracting affinity data for two molecules can be understood by reference to an embodiment in which a ligand that is known to bind to a receptor is displaced by an antagonist to that receptor. Other variations on this format will be apparent to those of skill in the art. The competitive format is well known to those of skill in the art. See, for example, U.S. Pat. Nos. 3,654,090 and 3,850,752.</PDAT></PTEXT></PARA>
<PARA ID="P-00344" LVL="0"><PTEXT><PDAT>Many other analysis formats can be utilized with the materials of the invention. The choice of assay format and the appropriate material and detection means to carry out the assay will be apparent to those of skill in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00345" LVL="0"><PTEXT><PDAT>Competition binding data can be analyzed by a number of techniques, including nonlinear least-squares curve fitting procedure. When the ligand is an antagonist for the receptor, this method provides the IC50 of the antagonist (concentration of the antagonist which inhibits specific binding of the ligand by 50% at equilibrium). The IC50 is related to the equilibrium dissociation constant (Ki) of the antagonist based on the Cheng and Prusoff equation: Ki&equals;IC50/(1&plus;L/Kd), where L is the concentration of the ligand used in the competitive binding assay, and Kd is the dissociation constant of the ligand as determined by Scatchard analysis. These assays are described, among other places, in Maddox et al., </PDAT><HIL><ITALIC><PDAT>J. Exp Med., </PDAT></ITALIC></HIL><PDAT>158: 1211 (1983); Hampton et al., Serological Methods, A Laboratory Manual APS Press, St. Paul, Minn., 1990. Other assay formats utilizing the material of the invention will be apparent to those of skill in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00346" LVL="0"><PTEXT><PDAT>Methods of detecting can utilize any art-recognized method of detecting the presence of a compound or a binding interaction including, but not limited to, optical, non-optical, coulometeric, potentiometric, fluorescent, chromophoric, luminescent and the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00347" LVL="0"><PTEXT><PDAT>Exemplary optical detection means include interference enhanced reflection (IER) and surface plasmon resonance (SPR). In case of employing interference enhanced reflection as a detection means in the chemical substance detector of the present invention, it is particularly preferable since sensitivity is further increased.</PDAT></PTEXT></PARA>
<PARA ID="P-00348" LVL="0"><PTEXT><PDAT>Non-optical detection means can also be employed, as exemplified by electrical means and detection means that uses a crystal oscillator.</PDAT></PTEXT></PARA>
<PARA ID="P-00349" LVL="0"><PTEXT><PDAT>Interference enhanced reflection (IER) is a method that utilizes the reflection characteristic of a polymer film on a highly reflective substrate. Light reflected from the surface of a polymer film will interfere with light reflected at the interface between the polymer film and the substrate. The intensity of reflected light is largely dependent on the thickness and refractive index of the polymer film. Thus, the change in either the thickness of the polymer or its refractive index or the changes in both factors will appear as the change in the intensity of reflected light. Even in the case where a plurality of swollen polymer films behave differently, the degrees of swelling of the respective polymer films can be easily identified on the basis of the changes in the intensity of reflected light from the films. In short, the physical changes that occur in the chemical substance detecting film and which are used in IER are the changes in film thickness and refractive index.</PDAT></PTEXT></PARA>
<PARA ID="P-00350" LVL="0"><PTEXT><PDAT>Surface plasmon resonance (SPR) is a method in which light is incident on the metal-dielectric interface at the critical angle in such a way that the momentum and energy of photons at the interface will coincide with those of surface plasmons, whereby the metal-dielectric interface of interest can be excited optically. As a result, the energy of photons will couple with surface plasmons, causing a sharp drop in the intensity of reflected light. The efficiency of coupling with surface plasmons is greatly influenced not only by the thickness of the metal film but also by the characteristics of the dielectric on one side of the metal film. In short, the physical changes that occur in the chemical substance detecting film and which are used in SPR are also the changes in film thickness and refractive index.</PDAT></PTEXT></PARA>
<PARA ID="P-00351" LVL="0"><PTEXT><PDAT>In a preferred embodiment, the analyte or the substance that binds the analyte is labeled with a detectable label. The detectable label is often necessary because the results of specific binding reactions are frequently not directly observable. A variety of detectable labels have been devised for determining the presence of a reaction. Detectable labels have involved well known techniques including radiolabeling and the use of chromophores, fluorophores and enzyme labels. Radiolabels can be detected by radiation detectors. Chromophores and fluorophores have been detected by use of spectrophotometers or the naked eye. Redox active groups can be detected by electroanalytical methods. Biotin can be detected by its well-know binding to avidin or strepavidin. The avidin or strepavidin can itself be labeled with any of the labels described herein. Where members of a specific binding pair are tagged with an enzyme label, their presence may be detected by the enzymatic activation of a reaction system wherein a compound such as a dyestuff, is activated to produce a detectable signal.</PDAT></PTEXT></PARA>
<PARA ID="P-00352" LVL="0"><PTEXT><PDAT>Thus, in preferred embodiments, the label is a member selected from the group consisting of fluorescent groups, chromophoric groups, radioactive groups, redox active groups, biotin, enzyme labels and combinations thereof.</PDAT></PTEXT></PARA>
<PARA ID="P-00353" LVL="0"><PTEXT><PDAT>The labels in the present invention can be primary labels (where the label comprises an element which is detected directly) or secondary labels (where the detected label binds to a primary label, e.g., as is common in immunological labeling). An introduction to labels, labeling procedures and detection of labels is found in Polak et al., Introduction to Immunocytochemistry, 2</PDAT><HIL><SP><PDAT>nd </PDAT></SP></HIL><PDAT>Ed., Springer Verlag, N.Y., (1977), and in Haugland, Handbook of Fluorescent Probes and Research Chemicals, a combined handbook and catalogue Published by Molecular Probes, Inc., Eugene, Oreg. (1996).</PDAT></PTEXT></PARA>
<PARA ID="P-00354" LVL="0"><PTEXT><PDAT>Primary and secondary labels can include undetected elements as well as detected elements. Useful primary and secondary labels in the present invention can include spectral labels such as fluorescent dyes (e.g., fluorescein and derivatives such as fluorescein isothiocyanate (FITC) and Oregon Greene&trade;, rhodamine and derivatives (e.g., Texas red, tetrarhodimine isothiocynate (TRITC), etc.), dixogenin, biotin, phycoerythrin, AMCA, CyDyes&trade;, and the like), radiolabels (e.g., </PDAT><HIL><SP><PDAT>3</PDAT></SP></HIL><PDAT>H, </PDAT><HIL><SP><PDAT>125</PDAT></SP></HIL><PDAT>I, </PDAT><HIL><SP><PDAT>35</PDAT></SP></HIL><PDAT>S, </PDAT><HIL><SP><PDAT>14</PDAT></SP></HIL><PDAT>C, </PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P, </PDAT><HIL><SP><PDAT>33</PDAT></SP></HIL><PDAT>P, etc.), enzymes (e.g., horse-radish peroxidase, alkaline phosphatase etc.) spectral colorimetric labels such as colloidal gold or colored glass or plastic (e.g. polystyrene, polypropylene, latex, etc.) beads. The label can be coupled directly or indirectly to a component of the detection assay (e.g., a nucleic acid) according to methods well known in the art. As indicated above, a wide variety of labels can be used, with the choice of label depending on sensitivity required, ease of conjugation with the compound, stability requirements, available instrumentation, and disposal provisions.</PDAT></PTEXT></PARA>
<PARA ID="P-00355" LVL="0"><PTEXT><PDAT>In general, a detector which monitors an analyte is adapted to the particular label which is used. Typical detectors include spectrophotometers, phototubes and photodiodes, potentiostats, microscopes, scintillation counters, cameras, film and the like, as well as combinations thereof. Examples of suitable detectors are widely available from a variety of commercial sources known to persons of skill. Commonly, an optical image of an analyte comprising bound label is digitized for subsequent computer analysis.</PDAT></PTEXT></PARA>
<PARA ID="P-00356" LVL="0"><PTEXT><PDAT>Preferred labels include those which utilize 1) chemiluminescence (using, for example, Horseradish Peroxidase and/or Alkaline Phosphatase with substrates that produce photons as breakdown products) with kits being available, e.g., from Molecular Probes, Amersham, Boehringer-Mannheim, and Life Technologies/ Gibco BRL; 2) color production &lsqb;using both Horseradish Peroxidase and/or Alkaline Phosphatase with substrates that produce a colored precipitate&rsqb; &lsqb;kits available from Life Technologies/Gibco BRL, and Boehringer-Mannheim&rsqb;; 3) hemifluorescence using, e.g., Alkaline Phosphatase and the substrate AttoPhos &lsqb;Amersham&rsqb; or other substrates that produce fluorescent products, 4) fluorescence &lsqb;e.g., using Cy-5 &lsqb;Amersham&rsqb;, fluorescein, and other fluorescent tags&rsqb;; 5) radioactivity using, for example, kinase enzymes or other end-labeling approaches, nick translation, random priming, or PCR to incorporate radioactive molecules into the labeling nucleic acid; 6) redox labels using, for example, amino drugs labeled with cationic cobalocenium, procationic ferrocene or nitroxide groups (Limoges et al., </PDAT><HIL><ITALIC><PDAT>J. Electroanal. Chem. </PDAT></ITALIC></HIL><PDAT>402: 175 (1996)), antibodies or enzymes labeled with ferrocene by reaction of n-(2-ferroceneethyl)maleimide with cysteine groups (Digleria et al. </PDAT><HIL><ITALIC><PDAT>FEBS Lett. </PDAT></ITALIC></HIL><PDAT>390: 142 (1996), or 5-aminosalicylic acid as a redox-mediator for amperometric detection of enzymes labeled with horseradish peroxidase (Abdelhamid et al., </PDAT><HIL><ITALIC><PDAT>Electroanalysis </PDAT></ITALIC></HIL><PDAT>10: 758 (1998). Other methods for labeling and detection will be readily apparent to one skilled in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00357" LVL="0"><PTEXT><PDAT>Fluorescent labels are highly preferred labels, having the advantage of requiring fewer precautions in handling, and being amenable to high-throughput visualization techniques (optical analysis including digitization of the image for analysis in an integrated system comprising a computer). Preferred labels are typically characterized by one or more of the following: high sensitivity, high stability, low background, low environmental sensitivity and high specificity in labeling. Fluorescent moieties, which are incorporated into the labels of the invention, are generally known, including Texas red, dixogenin, biotin, 1- and 2-aminonaphthalene, p,p&prime;-diaminostilbenes, pyrenes, quaternary phenanthridine salts, 9-aminoacridines, p,p&prime;-diaminobenzophenone imines, anthracenes, oxacarbocyanine, merocyanine, 3-aminoequilenin, perylene, bis-benzoxazole, bis-p-oxazolyl benzene, 1,2-benzophenazin, retinol, bis-3-aminopyridinium salts, hellebrigenin, tetracycline, sterophenol, benzimidazolylphenylamine, 2-oxo-3-chromen, indole, xanthen, 7-hydroxycoumarin, phenoxazine, calicylate, strophanthidin, porphyrins, triarylmethanes, flavin and many others. Many fluorescent tags are commercially available from the SIGMA chemical company (Saint Louis, Mo.), Molecular Probes, R&amp;D systems (Minneapolis, Minn.), Pharmacia LKB Biotechnology (Piscataway, N.J.), CLONTECH Laboratories, Inc. (Palo Alto, Calif.), Chem Genes Corp., Aldrich Chemical Company (Milwaukee, Wis.), Glen Research, Inc., GIBCO BRL Life Technologies, Inc. (Gaithersburg, Md.), Fluka Chemica-Biochemika Analytika (Fluka Chemie AG, Buchs, Switzerland), and Applied Biosystems (Foster City, Calif.), as well as many other commercial sources known to one of skill.</PDAT></PTEXT></PARA>
<PARA ID="P-00358" LVL="0"><PTEXT><PDAT>Most typically, the amount of analyte present is measured by quantitating the amount of label fixed to the material of the invention following a binding event. Alternatively, the amount of material in the fluid can be quantitated. Means of detecting and quantitating labels are well known to those of skill in the art. Thus, for example, where the label is a radioactive label, means for detection include a scintillation counter or photographic film as in autoradiography. Where the label is optically detectable, typical detectors include microscopes, cameras, phototubes and photodiodes. Many other detection systems are widely available.</PDAT></PTEXT></PARA>
<PARA ID="P-00359" LVL="0"><PTEXT><PDAT>Immunological assays are of three general types. In competitive binding assays, labeled reagents and unlabeled analyte compounds compete for binding sites on a binding material such as that provided by the present invention. After an incubation period, unbound materials are washed off and the amount of labeled reagent bound to the site is compared to reference amounts for determination of the analyte concentration in the sample solution.</PDAT></PTEXT></PARA>
<PARA ID="P-00360" LVL="0"><PTEXT><PDAT>A second type of immunological assay is known as a sandwich assay and generally involves contacting an analyte sample solution to a surface, such as that of a material of the invention, comprising a first binding material immunologically specific for that analyte. A second solution comprising a labeled binding material of the same type (antigen or antibody) as the first binding material is then added to the assay. The labeled binding material will bind to any analyte which is bound to the first binding material. The assay system is then subjected to a wash step to remove labeled binding material which failed to bind with the analyte and the amount of labeled material remaining is ordinarily proportional to the amount of bound analyte.</PDAT></PTEXT></PARA>
<PARA ID="P-00361" LVL="0"><PTEXT><PDAT>A third type of immunological assay technique involves agglutination reaction techniques and is exemplified by well-known assays for blood antigens and serum types. Immunological cross-reactivity between antibodies within serum and antigens presented on red blood cell surfaces is indicated by the formation of a three dimensional cross-linked network of red blood cells and antibodies. The agglutination of the serum/red blood cell mixture results in the formation of a pellet which can be visible to the naked eye. The materials of the invention can be utilized, for example, to present the antibodies or the erythrocyte antigens.</PDAT></PTEXT></PARA>
<PARA ID="P-00362" LVL="0"><PTEXT><PDAT>These assay procedures, enumerated above, were originally performed according to liquid phase immunochemistry techniques wherein enzymes and radiolabeled reactions were carried out in liquid solution in apparatus such as microtiter plates. More recently, techniques and procedures have been adapted for carrying out &ldquo;solid&rdquo; phase assays wherein enzymatic and immunological reactions are carried out in solution on immobilizing substrates. The porous materials of the invention are well suited for use as an immobilizing substrate. Alternatively, the liquid phase immunochemical methods can be readily adapted to incorporate a material of the invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00363" LVL="7"><PTEXT><PDAT>I. 5. Chiral Separations</PDAT></PTEXT></PARA>
<PARA ID="P-00364" LVL="0"><PTEXT><PDAT>The separation of enantiomeric mixtures into individual optical isomers is one of the most challenging problems in analytical and preparative chemistry, reflecting practical considerations important in many areas of science, particularly the pharmaceutical and agricultural industries.</PDAT></PTEXT></PARA>
<PARA ID="P-00365" LVL="0"><PTEXT><PDAT>The pharmaceutically active site of many drugs is &ldquo;chiral,&rdquo; meaning that the active site is not identical to a mirror image of the site. However, many pharmaceutical formulations marketed today are racemic mixtures of the desired compound and its &ldquo;mirror image.&rdquo; One optical form (or enantiomer) of a racemic mixture may be medicinally useful, while the other optical form may be inert or even harmful, as has been reported to be the case for thalidomide.</PDAT></PTEXT></PARA>
<PARA ID="P-00366" LVL="0"><PTEXT><PDAT>Chiral drugs are now extensively evaluated prior to large scale manufacturing, both to examine their efficacy, and to minimize undesirable effects attributable to one enantiomer or to the interaction of enantiomers in a racemic mixture. The United States Food and Drug Administration has recently issued new regulations governing the marketing of chiral drugs.</PDAT></PTEXT></PARA>
<PARA ID="P-00367" LVL="0"><PTEXT><PDAT>Separating optical isomers often requires considerable time, effort, and expense, even when state-of-the-art chiral separation techniques are used. There is a continuing and growing need for improved chiral separation techniques.</PDAT></PTEXT></PARA>
<PARA ID="P-00368" LVL="0"><PTEXT><PDAT>Early chiral separation methods used naturally occurring chiral species in otherwise standard separation protocols. For example, natural chiral polymeric adsorbents such as cellulose, other polysaccharides, and wool were used as early as the 1920&apos;s. Later strategies used other proteins and naturally occurring chiral materials. These early strategies gave some degree of success. However, the poor mechanical and chromatographic properties of naturally occurring materials often complicated the separations. Although naturally occurring chiral materials continue to be used for chiral separations, efforts have increasingly turned to synthesizing chiral materials having better mechanical and chromatographic properties. See, Armstrong, </PDAT><HIL><ITALIC><PDAT>Anal. Chem. </PDAT></ITALIC></HIL><PDAT>59: 84A-91A 1987) gives a review of methods that have been used for chiral separations in liquid chromatography.</PDAT></PTEXT></PARA>
<PARA ID="P-00369" LVL="0"><PTEXT><PDAT>Thus, in an eighth aspect, the present invention provides a method for chiral separation comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00370" LVL="2"><PTEXT><PDAT>(a) contacting the chiral molecule with a multilayered porous material comprising;</PDAT></PTEXT></PARA>
<PARA ID="P-00371" LVL="3"><PTEXT><PDAT>a porous substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00372" LVL="3"><PTEXT><PDAT>a metal film adhered onto the substrate; and</PDAT></PTEXT></PARA>
<PARA ID="P-00373" LVL="3"><PTEXT><PDAT>an organic layer attached to the metal film, the organic layer comprising a recognition moiety.</PDAT></PTEXT></PARA>
<PARA ID="P-00374" LVL="2"><PTEXT><PDAT>(e) forming a complex between the recognition moiety and the chiral molecule.</PDAT></PTEXT></PARA>
<PARA ID="P-00375" LVL="0"><PTEXT><PDAT>The two separation methods most often employed for chiral separations are high performance liquid chromatography and capillary electrophoresis, both of which have high efficiencies. High separation efficiencies are required for chiral separations because the difference in molar free energies of the interactions that discriminate between individual enantiomers is small, typically on the order of 100 calories per mole. The sum of the weighted time averages of these small interactions determines the overall enantioselectivity of a separation technique. High efficiencies are therefore required for chromatographic chiral separations. Separations on the order of 100,000 theoretical plates are readily achievable with capillary electrophoresis. Thus, small chiral selectivities can be magnified using capillary electrophoresis.</PDAT></PTEXT></PARA>
<PARA ID="P-00376" LVL="0"><PTEXT><PDAT>The so-called &ldquo;three point rule&rdquo; is a commonly used rule-of-thumb in many chiral recognition strategies. The &ldquo;three point rule&rdquo; recommends that there be a minimum of three simultaneous interactions between the chiral recognition medium and at least one of the enantiomers to be separated. In addition, at least one of the three interactions must be stereochemically dependent. The three interactions need not be attractive interactions, and may for example employ repulsion due to steric effects. For example, the &ldquo;three point rule&rdquo; was successfully used in 1971 in the design of a chiral stationary phase for the separation of the enantiomers of L-DOPA (L-dihydroxyphenylalanine). See, Baczuk et al., </PDAT><HIL><ITALIC><PDAT>J. Chromatogr. </PDAT></ITALIC></HIL><PDAT>60: 351-361 (1971).</PDAT></PTEXT></PARA>
<PARA ID="P-00377" LVL="0"><PTEXT><PDAT>Until recently, the most common type of synthetic chiral stationary phase used in high performance liquid chromatography (&ldquo;HPLC&rdquo;) was a Pirkle-type (Brush-type) phase. A Pirkle-type phase is based on the &ldquo;three point rule,&rdquo; and usually employs pi-pi interactions (electron donor-acceptor) and intermolecular hydrogen bonding in chiral recognition. Thus, in a presently preferred embodiment, the materials of the invention form a complex with the analyte that is based on pi-pi interactions.</PDAT></PTEXT></PARA>
<PARA ID="P-00378" LVL="0"><PTEXT><PDAT>Another successful approach has used reversible complexes formed of metal ions and chiral complexing agents. This separation method is commonly called ligand-exchange-chromatography (&ldquo;LEC&rdquo;). LEC is usually explained by a model based on multicomponent complexes containing a central metal ion and two chelating chiral molecules. Enantiomers can be separated in LEC either by using chiral mobile phase additives, or by using a chiral stationary phase. In a further preferred embodiment, the materials of the invention form a complex with an analyte through a chiral recognition moiety and/or the method further comprises the use of a chiral additive to the fluid.</PDAT></PTEXT></PARA>
<PARA ID="P-00379" LVL="0"><PTEXT><PDAT>Host-guest enantioselective complexes, in either the mobile phase or the stationary phase, can also be used to separate individual enantiomers. Systems within this general category include those employing chiral crown ethers and cyclodextrins. Compared to crown ethers, cyclodextrins are relatively inexpensive, and are more readily derivatized. See, Gassmann et al., </PDAT><HIL><ITALIC><PDAT>Science </PDAT></ITALIC></HIL><PDAT>230: 813-814 (1985); and Kuhn et al., </PDAT><HIL><ITALIC><PDAT>Chromatographia </PDAT></ITALIC></HIL><PDAT>34: 505-512 (1992). For example, Armstrong et al., </PDAT><HIL><ITALIC><PDAT>Anal. Chem. </PDAT></ITALIC></HIL><PDAT>59: 2237-2241 (1987) disclose the use of an aqueous liquid membrane employing cyclodextrin carriers to perform an enantiomeric enrichment. Additionally, Lakshmi et al., have recently discloses the resolution of a mixture of enantiomers by utilizing an apoenzyme that is selective for one of the enantiomer (Lakshmi et al., </PDAT><HIL><ITALIC><PDAT>Nature </PDAT></ITALIC></HIL><PDAT>388(21), 758-760 (1997).</PDAT></PTEXT></PARA>
<PARA ID="P-00380" LVL="0"><PTEXT><PDAT>Thus, in a preferred embodiment, the present invention utilizes a recognition moiety that forms a complex by host-guest interactions with the analyte. In yet another preferred embodiment, the host-guest recognition moiety is a member selected from the group of crown ethers, cryptands and the like, cyclodextrins and biomolecules.</PDAT></PTEXT></PARA>
<PARA ID="P-00381" LVL="7"><PTEXT><PDAT>I. 6. Preparation of Mulilayered Membranes</PDAT></PTEXT></PARA>
<PARA ID="P-00382" LVL="0"><PTEXT><PDAT>In a ninth aspect, the present invention also provides a method of making the multilayered porous material of the invention. The method comprises,</PDAT></PTEXT></PARA>
<PARA ID="P-00383" LVL="2"><PTEXT><PDAT>(a) contacting a porous substrate with a metal plating solution to form a porous substrate having a metal film adhered thereto;</PDAT></PTEXT></PARA>
<PARA ID="P-00384" LVL="2"><PTEXT><PDAT>(b) contacting the porous substrate having a metal film adhered thereto with a plurality of organic molecules that associate with the metal film, wherein at least a portion of said plurality of organic molecules comprise a member selected from the group consisting of recognition moieties, reactive moieties, protected reactive moieties and combinations thereof.</PDAT></PTEXT></PARA>
<PARA ID="P-00385" LVL="0"><PTEXT><PDAT>Any metal that can be plated, and preferably electrolessly plated, onto a porous substrate is useful in this aspect of the invention. Metals that are presently preferred as coatings include, but are not limited to, gold, silver, platinum, palladium, nickel and copper, more preferably gold and silver, and even more preferably, gold. In one embodiment, more than one metal is used. The more than one metal can be present as an alloy, they can be formed into a layered &ldquo;sandwich&rdquo; structure, or they can be laterally adjacent to one another.</PDAT></PTEXT></PARA>
<PARA ID="P-00386" LVL="0"><PTEXT><PDAT>Any electroless plating solution that can plate a metal onto a substrate can be used in practicing this aspect of the invention, however, solutions having certain characteristics are presently preferred. In a presently preferred embodiment, the plating solution comprises an easily reduced metal salt. In a preferred embodiment, a gold plating solution is utilized and the gold plating solution comprises a reducible gold salt. A presently preferred reducible gold salt is Na</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>Au(SO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00387" LVL="0"><PTEXT><PDAT>In another preferred embodiment, the metal plating solution further comprises a reducing agent. Reducing agents that are useful in this aspect of the invention include, hydroxylamine, oxalic acid, hydrazine, sodium borohydride and formaldehyde. A presently preferred reducing agent is formaldehyde.</PDAT></PTEXT></PARA>
<PARA ID="P-00388" LVL="0"><PTEXT><PDAT>The metal film can be plated directly onto the porous substrate, however, in a preferred embodiment, the method further comprises, prior to step (a), contacting a porous substrate with a sensitizer to form a sensitized porous substrate. In a preferred embodiment, the sensitizer is a transition metal salt. In a still further preferred embodiment, the sensitizer is salt of Sn</PDAT><HIL><SP><PDAT>&plus;2</PDAT></SP></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00389" LVL="0"><PTEXT><PDAT>Sensitizers are desirable for adjusting the surface character of the membranes. Sensitizers can improve the behavior of the substrate surface during plating. For example, it is known that, during the plating process, colloidal silica tends to aggregate or agglomerate when silver is electrolessly deposited. If the silica surface is first coated with, for example a complex oxide or a metal that forms a silicate (e.g., tin), the fine particles do not agglomerate.</PDAT></PTEXT></PARA>
<PARA ID="P-00390" LVL="0"><PTEXT><PDAT>In preferred embodiments, the metal salts used are soluble in water. Thus, salts such as metal chlorides, sulfates, nitrates, acetates and the like are particularly preferred. In other embodiments, the metal ion is complexed with an agent such as EDTA, tartrate and the like. The use of salts that are insoluble in water, but soluble in, for example, organic solvents (e.g. alcohols, DMSO, DMF, ethers, etc.), acids, bases and the like are also within the scope of the present invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00391" LVL="0"><PTEXT><PDAT>In yet another preferred embodiment, when the outermost layer comprises gold, the method further comprises, prior to step (a), contacting the sensitized porous substrate with a silver solution to form a silver coated membrane. A presently preferred silver solution comprises AgNO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>. In a further preferred embodiment, the silver solution further comprises ammonia.</PDAT></PTEXT></PARA>
<PARA ID="P-00392" LVL="0"><PTEXT><PDAT>In certain preferred embodiments, a silver coated membrane is produced which is not then advanced to the gold plating stage. Silver coated membranes are useful when the porous material is used in combination with elevated temperatures, particularly when the organic layer comprises an organosulfur moiety: the silver-sulfur bond has been found to exhibit enhanced stability relative to the gold-sulfur bond at elevated temperatures.</PDAT></PTEXT></PARA>
<PARA ID="P-00393" LVL="0"><PTEXT><PDAT>As discussed above in the context of other aspects and embodiments of the invention, an array of organic layers and organic layer constituents can be used to practice this aspect of the invention. A preferred organic layer comprises an organosulfur moiety. In another preferred embodiment, the organic layer comprises a moiety selected from the group consisting of recognition moieties, reactive moieties, protected reactive moieties and combinations thereof.</PDAT></PTEXT></PARA>
<PARA ID="P-00394" LVL="0"><PTEXT><PDAT>When the organic layer comprises a reactive moiety, in a preferred embodiment, the method further comprises as step (d), reacting the reactive moiety with a recognition moiety. In another preferred embodiment, when the organic layer comprises a protected reactive moiety and the method further comprises, (d) deprotecting the protected reactive moiety to form a reactive moiety; and (e) reacting the reactive moiety with a recognition moiety. Many protecting groups and methods of attaching protecting groups to, and removing them from, reactive groups are known to those of skill in the art and one of skill will be able to ascertain appropriate groups and experimental conditions for a particular application.</PDAT></PTEXT></PARA>
<PARA ID="P-00395" LVL="7"><PTEXT><PDAT>J. Morphology</PDAT></PTEXT></PARA>
<PARA ID="P-00396" LVL="0"><PTEXT><PDAT>The porous materials can be used in a wide range of forms. Because the porous substrates can be shaped, bent molded, etc. into virtually any desired shaped and can be either planar or curved, the materials of the present invention can be produced in a wide range of shapes and sizes. The choice of appropriate shape and size will depend on the particular application for the materials of the invention and is well within the abilities of those of skill in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00397" LVL="0"><PTEXT><PDAT>In addition to size and shape, the pore size and pore density of the membranes can be selected from a wide array of combinations. Many commercially available membranes have appropriate pore sizes and pore densities for use in assembling the materials of the invention. If a porous substrate having a desired pore size and/or pore density is not commercially available, it is well within the abilities of those of skill in the art to prepare the necessary substrate.</PDAT></PTEXT></PARA>
<PARA ID="P-00398" LVL="7"><PTEXT><PDAT>K. Analytes</PDAT></PTEXT></PARA>
<PARA ID="P-00399" LVL="0"><PTEXT><PDAT>As discussed above, the materials and methods of the invention can be used to purify, separate, capture and/or detect any analyte, or class of analytes, which interacts with a recognition moiety. The interaction between the analyte and recognition moiety can be any physicochemical interaction, including covalent bonding, ionic bonding, hydrogen bonding, van der Waals interactions, repulsive electronic interactions, attractive electronic interactions and hydrophobic/hydrophilic interactions. In the following discussion, the materials and methods of the invention are discussed in terms of their ability to detect a substance or class of substances. The focus of this discussion is for reasons of clarity alone: the present materials and methods are equally applicable to purifying, excluding, capturing and assaying the analytes. Additional applications will be apparent to those of skill in the art and are encompassed within the scope of the present invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00400" LVL="0"><PTEXT><PDAT>In a preferred embodiment, the interaction is an ionic interaction. In this embodiment, an acid, base, metal ion or metal ion-binding ligand is the analyte. In a still further preferred embodiment, the interaction is a hydrogen bonding interaction. In a particularly preferred embodiment, the hybridization of an immobilized nucleic acid to a nucleic acid having a complementary sequence is detected. In another preferred embodiment, the interaction is between an enzyme or receptor and a small molecule which binds thereto. One of skill in the art will appreciate that by judicious choice of recognition moiety, an analyte can be captured by, passed through or excluded by the membranes of the invention. For example, a complete strand of a nucleic acid can be separated from failure sequences by using its complementary strand as a recognition moiety. In one embodiment, the medium containing the complete strand is placed in a vessel divided into two compartments by the membrane and equilibrated with the membrane having the complementary strand as a recognition moiety. As the failure sequences will not anneal to the complementary strand with the same level of stability as the complete strand, the failure sequences can be passed through the membrane into the second compartment. After the failure sequences are eliminated, the ionic conditions or the temperature of the dialysis cell can be altered such that the complete strand is separated from the membrane and can be isolated.</PDAT></PTEXT></PARA>
<PARA ID="P-00401" LVL="0"><PTEXT><PDAT>In another embodiment, the analyte competes for the recognition moiety with another agent that has been bound to the recognition moiety prior to introducing the analyte of interest. In this embodiment, it is the process or result of the analyte displacing the pre-bound agent that causes the detectable signal. Suitable combinations of recognition moieties and analytes will be apparent to those of skill in the art. In a preferred embodiment, the displaced species diffuses through the membrane and is detected by an agent that is selective for the displaced species. This embodiment is discussed in greater detail in section I.4, above.</PDAT></PTEXT></PARA>
<PARA ID="P-00402" LVL="0"><PTEXT><PDAT>In presently preferred embodiments, the analyte is a member selected from the group consisting of acids, bases, organic ions, inorganic ions, pharmaceuticals, herbicides, pesticides, chemical warfare agents, noxious gases and biomolecules. Importantly, each of these agents can be purified, captured and/or detected as a gas, vapor or a liquid. These agents can be present as components in mixtures of structurally unrelated compounds, racemic mixtures of stereoisomers, non-racemic mixtures of stereoisomers, mixtures of diastereomers, mixtures of positional isomers or as pure compounds. Within the scope of the invention is a device and a method to purify, capture and/or detect a particular analyte of interest without interference from other substances within a mixture.</PDAT></PTEXT></PARA>
<PARA ID="P-00403" LVL="0"><PTEXT><PDAT>Both organic and inorganic acids can be detected using the device and method of the present invention. In a preferred embodiment, the recognition moiety comprises a group which is protonated by the acid. Alternatively, the recognition moiety can be one that is not protonated by the acid, but is acidic itself and, thus, excludes the acid from the membrane by a repulsive interaction. The use of such repulsive interactions to exclude species from the membrane can be used with substantially all of the analytes with which the present invention can be practiced.</PDAT></PTEXT></PARA>
<PARA ID="P-00404" LVL="0"><PTEXT><PDAT>In another preferred embodiment, the invention provides a material and a method for detecting bases. The methods and methods applicable to bases are substantially similar to those discussed above in the context of acids; the notable exception being that the base will preferably deprotonate a group on a SAM component, spacer arm or metal film. When the base is negatively charged, preferred recongition moieties are positively charged.</PDAT></PTEXT></PARA>
<PARA ID="P-00405" LVL="0"><PTEXT><PDAT>Organic ions which are substantially non-acidic and non-basic (e.g., quaternary alkylammonium salts) can be purified, captured, detected by or excluded from the materials of the invention. For example, a recognition moiety with ion exchange properties is useful in the present invention. A specific example is the exchange of a cation such as dodecyltrimethylammonium cation for a metal ion such as sodium. Recognition moieties that form inclusion complexes with organic ions are also of use. For example, crown ethers and cryptands can be used to form inclusion complexes with organic ions such as quaternary ammonium cations.</PDAT></PTEXT></PARA>
<PARA ID="P-00406" LVL="0"><PTEXT><PDAT>Inorganic ions such as metal ions and complex ions (e.g., SO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;2</PDAT></SP></HIL><PDAT>, PO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;3</PDAT></SP></HIL><PDAT>) can also be detected using the device and method of the invention. Metal ions can be detected, for example, by their complexation or chelation by agents bound to a SAM component, spacer arm or the substrate. In this embodiment, the recognition moiety can be a simple monovalent moiety (e.g., carboxylate, amine, thiol) or can be a more structurally complex agent (e.g., ethylenediaminepentaacetic acid, crown ethers, aza crowns, thia crowns).</PDAT></PTEXT></PARA>
<PARA ID="P-00407" LVL="0"><PTEXT><PDAT>Complex inorganic ions can be detected by their ability to compete with ligands for bound metal ions in ligand-metal complexes. When a ligand bound to a SAM component, a spacer arm or a substrate forms a metal-complex having a thermodynamic stability constant which is less than that of the complex between the metal and the complex ion, the complex ion will cause the dissociation of the metal ion from the immobilized ligand.</PDAT></PTEXT></PARA>
<PARA ID="P-00408" LVL="0"><PTEXT><PDAT>The dissociation of the metal-complex can be used to create a signal in, for example, a chamber of a dialysis vessel, wherein the membrane divides the vessel into two or more chambers. The amount of metal ion displaced from the bound ligand, and hence the magnitude of the signal, will be dependent on the stability constant of the metal-complex and the concentrations of the constituents. Thus, the materials and the methods of the invention can be used to assay a metal-complex for its relevant stability constant(s). Methods of determining stability constants for compounds formed between metal ions and ligands are well known to those of skill in the art. Using these stability constants, membranes and devices which are specific for particular ions can be manufactured. Metal containing species can be detected by, for example, detecting changes in a chromophore or fluorophore. Alternatively, the detection can utilize colorimeteric, potentiometric, coulometric and other methods. See, Martell, A. E., Motekaitis, R. J., Determination and Use of Stability Constants, 2d Ed., VCH Publishers, New York 1992.</PDAT></PTEXT></PARA>
<PARA ID="P-00409" LVL="0"><PTEXT><PDAT>Small molecules such as drugs, pesticides, herbicides, agents of war, and the like can be detected by the use of a number of different recognition moiety motifs. Acidic or basic components can be detected as described above. An agent&apos;s metal binding capability can also be used to advantage, as described above for complex ions. Additionally, if these agents bind to an identified biological structure (e.g., a receptor, antibody, etc.), the receptor can be immobilized on the membrane. Techniques are widely available in the art for raising antibodies that are highly specific for a particular small molecule. Thus, it is within the scope of the present invention to make use of antibodies against small molecules for detection of those molecules.</PDAT></PTEXT></PARA>
<PARA ID="P-00410" LVL="0"><PTEXT><PDAT>In yet another embodiment, a receptor, an enzyme or antibody is located in a chamber of a dialysis vessel. The membrane divides the dialysis vessel into two or more chambers. As a molecule that the antibody binds to passes through the membrane, its binding to the antibody can be detected. Detection methods known in the art as well as those discussed herein are generally applicable to this method as well.</PDAT></PTEXT></PARA>
<PARA ID="P-00411" LVL="0"><PTEXT><PDAT>In a preferred embodiment, the affinity of an analyte for a particular metal ion is exploited by having a membrane labeled with an immobilized metal ion. The metal ion generally must have available at least one empty coordination site to which the analyte can bind. Alternatively, at least one bond between the metal and the metal-immobilizing agent must be sufficiently labile in the presence of the analyte to allow the displacement of at least one bond of the immobilizing reagent by the analyte.</PDAT></PTEXT></PARA>
<PARA ID="P-00412" LVL="0"><PTEXT><PDAT>The binding of this metal ion to the analyte can be detected by a number of methods. In one embodiment, the binding results in a change that is detected electronically (e.g., potentiometrically, etc.).</PDAT></PTEXT></PARA>
<PARA ID="P-00413" LVL="0"><PTEXT><PDAT>In a preferred embodiment, the agent detected by binding to an immobilized metal ion is an organophosphorous compound such as a nucleic acid, an insecticide or an agent of war (e.g., VX, O-ethyl-S-(2-diisopropylaminoethyl)-methylthiophosphonate). Exemplary compounds which exhibit affinity for organophosphorous agents include, but are not limited to, Cu</PDAT><HIL><SP><PDAT>&plus;2</PDAT></SP></HIL><PDAT>-diamine, triethylentetraamine-Cu</PDAT><HIL><SP><PDAT>&plus;2</PDAT></SP></HIL><PDAT>-chloride, tetraethylenediamine-Cu</PDAT><HIL><SP><PDAT>&plus;2</PDAT></SP></HIL><PDAT>-chloride and 2,2&prime;-bipyridine-Cu</PDAT><HIL><SP><PDAT>&plus;2</PDAT></SP></HIL><PDAT>-chloride. See, U.S. Pat. No. 4,549,427, issued to Kolesar, Jr., E. S. on Oct. 29, 1985.</PDAT></PTEXT></PARA>
<PARA ID="P-00414" LVL="0"><PTEXT><PDAT>In another preferred embodiment, antibodies to the particular agents are immobilized on the membrane. Techniques for raising antibodies to herbicides, pesticides and agents of war are known to those of skill in the art. See, Harlow, Lane, Monoclonal Antibodies: A Laboratory Manual, Cold Springs Harbor Laboratory, Long Island, N.Y., 1988.</PDAT></PTEXT></PARA>
<PARA ID="P-00415" LVL="0"><PTEXT><PDAT>In a preferred embodiment, the nucleic acids that are detected include RNA and DNA both as single molecules and as hybrids with one or more complementary strands of another nucleic acid is within the scope of the invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00416" LVL="0"><PTEXT><PDAT>In a preferred embodiment, the herbicides are preferably members of the group consisting of triazines, haloacetanilides, carbamates, toluidines, ureas, plant growth hormones and diphenyl ethers. Included within these broad generic groupings are commercially available herbicides such as phenoxyl alkanoic acids, bipyridiniums, benzonitriles, dinitroanilines, acid amides, carbamates, thiocarbamates, heterocyclic nitrogen compounds including triazines, pyridines, pyridazinones, sulfonylureas, imidazoles, substituted ureas, halogenated aliphatic carboxylic acids, inorganics, organometallics and derivatives of biologically important amino acids.</PDAT></PTEXT></PARA>
<PARA ID="P-00417" LVL="0"><PTEXT><PDAT>In the embodiments discussed above, the preferred agent of war is a member of the group consisting of mustard and related vesicants including the agents known as HD, Q, T, HN1, HN2, HN3, nerve agents, particularly the organic esters of substituted phosphoric acid including tabun, sarin, isopropyl methylphosphonofluoridate, soman pinacolyl methylphosphonofluoridate. Other detectable analytes include incapacitants such as BZ, 3-quinuclidinyl benzilate and irritants such as the riot control compound CS.</PDAT></PTEXT></PARA>
<PARA ID="P-00418" LVL="0"><PTEXT><PDAT>Pesticides preferred for detection using the present invention include bactericides (e.g., formaldehyde), fumigants (e.g., bromomethane), fungicides (e.g., 2-phenylphenol, biphenyl, mercuric oxide, imazalil), acaricides (e.g., abamectin, bifenthrin), insecticides (e.g., imidacloprid, prallethrin, cyphenothrin).</PDAT></PTEXT></PARA>
<PARA ID="P-00419" LVL="0"><PTEXT><PDAT>The present invention also provides a device and a method for detecting noxious gases such as CO, CO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, SO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>SO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>, SO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, NO, NO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>and the like. In a preferred embodiment, membrane includes at least one compound capable of detecting the gas. Useful compounds include, but are not limited to, palladium compounds selected from the group consisting of palladium sulfate, palladium sulfite, palladium pyrosulfite, palladium chloride, palladium bromide, palladium iodide, palladium perchlorate, palladium complexes with organic complexing reagents and mixtures thereof. In a preferred embodiment, the gas is detected by a change in an electrical property of the membrane. Methods of measuring current and/or voltage changes across a metallic surface are well known to those of skill in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00420" LVL="0"><PTEXT><PDAT>Other compounds of use in practicing this embodiment of the present invention include, molybdenum compounds such as silicomolybdic acid, salts of silicomolybdic acid, molybdenum trioxide, heteropolyacids of molybdenum containing vanadium, copper or tungsten, ammonium molybdate, alkali metal or alkaline earth salts of molybdate anion, heteropolymolybdates and mixtures thereof.</PDAT></PTEXT></PARA>
<PARA ID="P-00421" LVL="0"><PTEXT><PDAT>Still further useful gas detecting compounds include, copper salts and copper complexes with an available coordination site. Alpha-cyclodextrin, beta-cyclodextrin, modified alpha- and beta-cyclodextrins, gamma-cyclodextrin and mixtures thereof are of use in practicing the present invention. See, U.S. Pat. No. 5,618,493, issued to Goldstein et al. on Apr. 8, 1997 and U.S. Pat. No. 5,071,526, issued to Pletcher et al. on Dec. 10, 1991.</PDAT></PTEXT></PARA>
<PARA ID="P-00422" LVL="0"><PTEXT><PDAT>In another preferred embodiment, the gas the membrane is derivatized with a compound selected from the group consisting of amorphous hemoglobin, crystalline hemoglobin, amorphous heme, crystalline heme and mixtures thereof. The heme serves as a recognition moiety which is reactive towards the gas. See, U.S. Pat. No. 3,693,327, issued to Scheinberg, I. A. on Sep. 26, 1972.</PDAT></PTEXT></PARA>
<PARA ID="P-00423" LVL="0"><PTEXT><PDAT>When the analyte is a biomolecule, any recognition moiety which interacts with the biomolecule is useful in practicing the present invention. Thus, when the analyte is a nucleic acid, in one embodiment, the recognition moiety is a nucleic acid having a sequence which is at least partially complementary to the recognition moiety sequence. When the recognition moiety is a peptide, an antibody specific for that peptide can be used as the analyte. In another preferred embodiment, a protein, other than an antibody (e.g., enzyme, receptor) is the analyte. The binding of biomolecules to the membrane can be detected by detection methods substantially similar to those discussed herein.</PDAT></PTEXT></PARA>
<PARA ID="P-00424" LVL="0"><PTEXT><PDAT>Other combinations of analytes and recognition moieties and other detection schemes will be apparent to those of skill in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00425" LVL="7"><PTEXT><PDAT>L. Drug Delivery Devices</PDAT></PTEXT></PARA>
<PARA ID="P-00426" LVL="0"><PTEXT><PDAT>Presently there are two types of transdermal drug delivery systems, i.e., passive and iontophoretic. Passive patch systems deliver small and relatively lipophilic drugs through the skin of the patient by diffusion, an example of which would involve the application of a narcotic analgesic patch to provide pain relief. Iontophoresis systems, on the other hand, deliver drug through the skin of the patient through the application of an electromotive force (iontophoresis) to drive ionizable substances (medicament) into the skin so that they can be absorbed by adjacent tissues and blood vessels. Iontophoresis, therefore, allows charged and hydrophilic drugs to be transported across the skin which are poorly deliverable through passive diffusion. Transdermal systems offer advantages clearly not achievable by other modes of administration, such as hypodermic injection which has the associated problem of pain, risk of infection and trauma to the patient. Iontophoresis also has advantages over oral administration in that introduction of the drug through the gastrointestinal tract may result in inactivation of the medicament, food interactions, first pass hepatic metabolism and gastrointestinal side effects.</PDAT></PTEXT></PARA>
<PARA ID="P-00427" LVL="0"><PTEXT><PDAT>Thus, in a ninth aspect, the present invention provides a drug delivery device comprising:</PDAT></PTEXT></PARA>
<PARA ID="P-00428" LVL="2"><PTEXT><PDAT>(a) a porous substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00429" LVL="2"><PTEXT><PDAT>(b) a metal film adhered onto said substrate;</PDAT></PTEXT></PARA>
<PARA ID="P-00430" LVL="2"><PTEXT><PDAT>(c) an organic layer attached to said metal film, said organic layer containing a recognition moiety; and</PDAT></PTEXT></PARA>
<PARA ID="P-00431" LVL="2"><PTEXT><PDAT>(d) a drug moiety reversibly associated with said recognition moiety.</PDAT></PTEXT></PARA>
<PARA ID="P-00432" LVL="0"><PTEXT><PDAT>The devices of the invention can operate by passive diffusion or iontophoresis. In a preferred embodiment, the device operates by ionotphoresis.</PDAT></PTEXT></PARA>
<PARA ID="P-00433" LVL="0"><PTEXT><PDAT>Iontophoretic drug delivery systems, have, in recent years, become an increasingly important means of administering drugs. Iontophoresis, according to Dorland&apos;s Illustrated Medical Dictionary, is defined to be &ldquo;the introduction, by means of electric current, of ions of soluble salts into the tissues of the body for therapeutic purposes.&rdquo; Iontophoretic devices have been known since the early 1900&apos;s. British patent specification 410,009 (1934) describes an iontophoric device which overcame one of the disadvantages of such early devices known to the art at that time, namely the requirement of a special low tension (low voltage) source of current which meant that the patient needed to be immobilized near such source. The device of that British specification was made by forming from the electrodes and the material containing the medicament or drug to be delivered transdermally, a galvanic cell which itself produced the current necessary for iontophoretically delivering the medicament. This ambulatory device thus permitted iontophoretic drug delivery with substantially less interference with the patient&apos;s daily occupation.</PDAT></PTEXT></PARA>
<PARA ID="P-00434" LVL="0"><PTEXT><PDAT>More recently, a number of U.S. patents have issued in the iontophoresis technology, indicating a renewed interest in this mode of drug delivery. For example, U.S. Pat. No. 3,991,755 issued to Jack A. Vernon et al;. U.S. Pat. No. 4,141,359 issued to Stephen C. Jacobson et al;. U.S. Pat. No. 4,398,545 issued to Wilson; U.S. Pat. No. 4,250,878 issued to Jacobsen disclose examples of iontophoretic devices and some applications thereof. The iontophoresis process has been found to be useful in the transdermal administration or introduction of medicaments or drugs including lidocaine hydrochloride, hydrocortisone, acetic acid, fluoride, penicillin, dexamethasone sodium phosphate and many other drugs. Perhaps the widest use of iontophoresis is that of diagnosing cystic fibrosis by using pilocarpine nitrate iontophoresis. The pilocarpine nitrate stimulates sweat production; the sweat is collected and analyzed for its chloride content to detect the presence of the disease.</PDAT></PTEXT></PARA>
<PARA ID="P-00435" LVL="0"><PTEXT><PDAT>Conventional iontophoretic devices, such as those described in U.S. Pat. No. 4,820,263 (Spevak, et al.), U.S. Pat. No. 4,927,408 (Hank, et al.) and U.S. Pat. No. 5,084,008 (Phipps), the disclosures of which are hereby incorporated by reference, provide for delivery of a drug or medicament transdermally through iontophoresis. Basically, conventional iontophoretic devices consist of a power source connected to two electrodes, an anode and a cathode, which are individually in ionic contact with an electrolyte or drug reservoir which is in contact with the skin to be treated by the iontophoretic device. When the current is turned on, electrical energy is used to assist in the transport of ionic molecules into the body through the skin, via ionic conduction.</PDAT></PTEXT></PARA>
<PARA ID="P-00436" LVL="0"><PTEXT><PDAT>The iontophoretic electrode of the invention includes a current distributing member such as the multilayered porous of the materials of the invention which conveys electrical current into iontophoretic reservoirs for the delivery of an ionized substance. The current distributing member is constructed of any of a large variety of electrically conductive materials, including both inert and sacrificial materials.</PDAT></PTEXT></PARA>
<PARA ID="P-00437" LVL="0"><PTEXT><PDAT>Inert conductive materials are those electrically conductive materials which, when employed in the iontophoretic devices of the invention, do not themselves undergo or participate in electrochemical reactions. Thus, an inert material distributes current without being eroded or depleted due to the distribution of current, and conducts current through the generating ions by either reduction or oxidation of water. Inert conductive materials typically include, for example, stainless steel, platinum, gold, and carbon or graphite. The inert conductive material can be a constituent of the porous substrate, the metal film or both of these components. In a preferred embodiment, a metal film is used as the inert conductive component.</PDAT></PTEXT></PARA>
<PARA ID="P-00438" LVL="0"><PTEXT><PDAT>Alternatively, the current distributing member can be constructed from a sacrificial conductive material. A material is considered sacrificial if, when employed as an electrode in an iontophoretic device of the invention, the material is eroded or depleted due to its oxidation or reduction. Such erosion or depletion occurs when the materials and formulations used in the iontophoresis device enable a specific electrochemical reaction, such as when a silver electrode is used with a formulation containing chloride ions. In this situation, the current distributing member would not cause electrolysis of water, but would itself be oxidized or reduced.</PDAT></PTEXT></PARA>
<PARA ID="P-00439" LVL="0"><PTEXT><PDAT>Typically, for anodes, a sacrificial material would include an oxidizable metal such as silver, zinc, copper, etc. In contrast to the hydroxyl and hydronium ions electrochemically generated via an inert material, the ions electrochemically generated via a sacrificial material would include metal cations resulting from oxidation of the metal. Metal/metal salt anodes may also be employed. In such cases, the metal would oxidize to metal ions, which would then be precipitated as an insoluble salt.</PDAT></PTEXT></PARA>
<PARA ID="P-00440" LVL="0"><PTEXT><PDAT>In the device of the invention, the sacrificial layer can be any component of the multilayered material. In a preferred embodiment, the sacrificial material is the porous substrate, a metal film or a combination of the two components.</PDAT></PTEXT></PARA>
<PARA ID="P-00441" LVL="0"><PTEXT><PDAT>In presently known iontophoretic devices, at least two electrodes are generally used. Both these electrodes are disposed so as to be in intimate electrical contact with some portion of the skin of the body. One electrode, called the active electrode, is the electrode from which the ionic substance, medicament, drug precursor or drug is delivered or driven into the body by electrical repulsion. The other electrode, called the indifferent or ground electrode, serves to close the electrical circuit through the body. In conjunction with the patient&apos;s skin contacted by the electrodes, the circuit is completed by connection of the electrodes to a source of electrical energy, e.g., a battery, or appropriately modified household current. For example, if the ionic substance to be driven into the body is positively charged, then the positive electrode (the anode) will be the active electrode and the negative electrode (the cathode) will serve to complete the circuit. If the ionic substance to be delivered is negatively charged, then the negative electrode will be the active electrode and the positive electrode will be the indifferent electrode.</PDAT></PTEXT></PARA>
<PARA ID="P-00442" LVL="0"><PTEXT><PDAT>For cathodes, the current distributing member may be constructed from any electrically conductive material provided an appropriate electrolyte formulation is provided. For example, the cathodic current distributing member may be constructed from a metal/metal salt material. A preferred cathodic material is a silver/silver halide material. In such embodiments, a metal halide salt is preferably employed as the electrolyte. In this case, the device would electrochemically generate halide ions from the electrode as the metal is reduced. Also, accompanying silver ions in a formulation would be reduced to silver metal and would deposit (plate) onto the electrode. In other embodiments, the cathode material may be an intercalation material, an amalgam, or other material which can take electrolyte cations such as sodium out of solution, below the reduction potential of water. In addition, other materials may be used which permit the plating out of a metal from the appropriate electrolyte solution. Thus, metals such as silver, copper, zinc, and nickel, and other materials, such as carbon, may be employed when an appropriate metal salt such as silver nitrate or zinc sulfate is in solution in the electrolyte reservoir. While such materials may develop increased resistivity as a metal plates out during use, they are not eroded or depleted during use as cathodic current distributing members. They are therefore not strictly &ldquo;sacrificial&rdquo; in this context.</PDAT></PTEXT></PARA>
<PARA ID="P-00443" LVL="7"><PTEXT><PDAT>M. Compositions, Kits and Integrated Systems</PDAT></PTEXT></PARA>
<PARA ID="P-00444" LVL="0"><PTEXT><PDAT>The invention provides compositions, kits and integrated systems for practicing the various aspects and embodiments of the present invention, including producing the porous materials and performing the methods.</PDAT></PTEXT></PARA>
<PARA ID="P-00445" LVL="0"><PTEXT><PDAT>The invention provides kits for practicing the methods noted above. The kits can include any of the materials noted above, and optionally further include additional components such as instructions to practice the methods, one or more containers or compartments (e.g., to hold the porous material, nucleic acids, antibodies, inhibitors or the like), or the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00446" LVL="0"><PTEXT><PDAT>The invention also provides integrated systems for performing the methods disclosed herein. For example, in performing assays, in one embodiment, the delivery of individual compounds or compound components is accomplished by means of a robotic armature which transfers fluid from a source to a destination, a controller which controls the robotic armature, a label detector, a data storage unit which records label detection, and an assay component such as a microtiter dish comprising a well comprising the multilayered porous material, or a substrate comprising a fixed multilayered porous material. When a labeled compound is used, it is detected by means of the label detector.</PDAT></PTEXT></PARA>
<PARA ID="P-00447" LVL="0"><PTEXT><PDAT>A number of robotic fluid transfer systems are available, or can easily be made from existing components. For example, a Zymate XP (Zymark Corporation; Hopkinton, Mass.) automated robot using a Microlab 2200 (Hamilton; Reno, Nev.) pipetting station can be used to transfer parallel samples to 96 well microtiter plates to set up several parallel simultaneous ligation reactions.</PDAT></PTEXT></PARA>
<PARA ID="P-00448" LVL="0"><PTEXT><PDAT>Optical images viewed (and, optionally, recorded) by a camera or other recording device (e.g., a photodiode and data storage device) are optionally further processed in any of the embodiments herein, e.g., by digitizing the image and storing and analyzing the image on a computer. A variety of commercially available peripheral equipment and software is available for digitizing, storing and analyzing a digitized video or digitized optical image, e.g., using PC (Intel x86 or Pentium chip- compatible DOS&trade;, OS2&trade; WINDOWS&trade;, WINDOWS NT&trade; or WINDOWS95&trade; based machines), MACINTOSH&trade;, or UNIX based (e.g., SUN&trade; work station) computers.</PDAT></PTEXT></PARA>
<PARA ID="P-00449" LVL="0"><PTEXT><PDAT>One conventional system carries light from the specimen field to a cooled charge-coupled device (CCD) camera, in common use in the art. A CCD camera includes an array of picture elements (pixels). The light from the specimen is imaged on the CCD. Particular pixels corresponding to regions of the specimen (e.g., individual hybridization sites on an array of porous material) are sampled to obtain light intensity readings for each position. Multiple pixels are processed in parallel to increase speed. The apparatus and methods of the invention are easily used for viewing any sample, e.g., by fluorescent or dark field microscopic techniques.</PDAT></PTEXT></PARA>
<PARA ID="P-00450" LVL="0"><PTEXT><PDAT>The materials, methods and devices of the present invention are further illustrated by the examples that follow. These examples are offered to illustrate, but not to limit the claimed invention.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLES</PDAT></STEXT></H>
<PARA ID="P-00451" LVL="0"><PTEXT><PDAT>The procedure for preparation and the structure of an exemplary membrane of the invention is illustrated in FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>. Any kind of filtration membrane with approximately uniform pore sizes and suitable chemical properties can be used as templates. PCTE membranes (Poretics, Inc.) were chosen as an exemplary membrane substrate. These membranes contain cylindrical pores with uniform pore sizes. The pores are nearly perpendicular to the membrane surfaces. Electroless gold was deposited on the pore walls and both faces of the membrane using a procedure similar to that reported by Martinet al. (Menon, V. P. et al., </PDAT><HIL><ITALIC><PDAT>Anal. Chem. </PDAT></ITALIC></HIL><PDAT>1995, 67, 1920-1928). Self-assembled monolayers were then formed from functionalized alkanethiols on the surface of deposited gold to introduce ionizable groups into the membrane. Since the a thickness of gold may not be the same throughout the whole pore (a bottle-neck structure is usually formed near the ends of the pore (Jirage, K. B. et al., </PDAT><HIL><ITALIC><PDAT>Science </PDAT></ITALIC></HIL><PDAT>1997, 278, 655-658).</PDAT></PTEXT></PARA>
<PARA ID="P-00452" LVL="0"><PTEXT><PDAT>After deposition of electroless gold at 0-2&deg; C. for 4.5 hours, the amount of deposited gold was &tilde;0.25 mg per cm</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>of membrane and the apparent pore radius was reduced to 16 nm (measured by water flux). The apparent pore radius was reduced to 14 mn (measured by water flux) after SAMs were formed from HS(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>15</PDAT></SB></HIL><PDAT>COOH onto deposited gold. The 2 nm reduction of pore radius corresponds to the chain length of the adsorbed thiol molecules.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 1</PDAT></STEXT></H>
<PARA ID="P-00453" LVL="7"><PTEXT><PDAT>1.1a Characterization of the Membranes</PDAT></PTEXT></PARA>
<PARA ID="P-00454" LVL="0"><PTEXT><PDAT>The PCTE membrane pore radius was determined by water flux under a pressure drop across the membrane. The pore density of the membranes was determined by SEM images &lsqb;Kim, K. J.,; Stevens, P, V., </PDAT><HIL><ITALIC><PDAT>J Membr. Sci. </PDAT></ITALIC></HIL><PDAT>1997, 123, 303-314&rsqb; is 7.7&plusmn;2.4 pores/&mgr;m</PDAT><HIL><SP><PDAT>2</PDAT></SP></HIL><PDAT>. Since image analysis usually induces systematic errors, the pore density utilized was that provided by the manufacture (6 pores/&mgr;m</PDAT><HIL><SP><PDAT>2</PDAT></SP></HIL><PDAT>) calculations of pore radius from water flux experiments and apparent diffusivities from diffusion experiments.</PDAT></PTEXT></PARA>
<PARA ID="P-00455" LVL="0"><PTEXT><PDAT>The determined value of pore radius (32 nm), however, was more than twice of the value labeled by the manufacturer (15 nm). Similar discrepancy was revealed in a recent report &lsqb;Kim, K. J.; Stevens, P. V., </PDAT><HIL><ITALIC><PDAT>J Membr. Sci. </PDAT></ITALIC></HIL><PDAT>1997, 123, 303-314&rsqb;, where the pore radius measured by water flux under a pressure drop of 100 kPa was more than four times of the labeled value. The discrepancy was attributed to the expansion of pores under stress (by pressure drop). The pressure drop applied in the present experiments (&tilde;2 kPa), however, was much smaller. The larger measured pore radius compared to the manufacturer&apos;s stated value might be caused by deformation of pores due to swelling of polycarbonate in water.</PDAT></PTEXT></PARA>
<PARA ID="P-00456" LVL="7"><PTEXT><PDAT>1.1b Electroless Deposition of Gold</PDAT></PTEXT></PARA>
<PARA ID="P-00457" LVL="0"><PTEXT><PDAT>A PCTE membrane as purchased was first conditioned in a solution of 0.026 M tin (II) chloride and 0.07 M trifluoroacetic acid for 3 minutes. The solvent of this solution was a 1:1 mixture of water and methanol. This step allowed Sn</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> to be adsorbed to the pore walls and the surfaces of the membrane. The tin-sensitized membrane was rinsed thoroughly with methanol and then immersed into an aqueous solution of ammoniacal silver nitrate (0.03 M) for 2 minutes. In this step, a redox reaction leaded to the decoration of the membrane with a layer of silver. The membrane was then rinsed with methanol and subsequently with water. Finally, the silver-decorated membrane was immersed into a gold plating solution containing 7.9 mM Na</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>Au(SO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(diluted from Oromerse Part B, Technic, Inc.), 0.127 M sodium sulfite, and 0.625 M formaldehyde. Deposition of elemental gold was carried out in this solution. The temperature of this solution was maintained around 0-2&deg; C., at which the rate of deposition of gold was estimated to be 4-5 nm/hr. Variation of deposition time resulted in different pore sizes. After deposition was finished, the membrane was thoroughly rinsed with water.</PDAT></PTEXT></PARA>
<PARA ID="P-00458" LVL="7"><PTEXT><PDAT>1.1c Treatment of Electroless Gold</PDAT></PTEXT></PARA>
<PARA ID="P-00459" LVL="0"><PTEXT><PDAT>The gold-coated PCTE membrane was immersed in 25% nitric acid for 12 hours to clean the deposited gold. This treatment was necessary for the formation of close-packed SAMs onto the gold (Hou, Z. et al., </PDAT><HIL><ITALIC><PDAT>Langmuir, </PDAT></ITALIC></HIL><PDAT>in press). The membrane was then thoroughly rinsed with water and air-dried.</PDAT></PTEXT></PARA>
<PARA ID="P-00460" LVL="7"><PTEXT><PDAT>1.1c Formation of SAMS</PDAT></PTEXT></PARA>
<PARA ID="P-00461" LVL="0"><PTEXT><PDAT>The gold-coated PCTE membrane was rinsed with ethanol before immersion in an ethanolic solution of a functionalized alkanethiol (&minus;1 mM) for at least 12 hours. The membrane was then rinsed with ethanol and dried. The pore size of the fabricated membrane could be further reduced by using alkanethiols with long chains.</PDAT></PTEXT></PARA>
<PARA ID="P-00462" LVL="0"><PTEXT><PDAT>We fabricated a pH-responsive ion-exchange membrane beating carboxylic acid groups by electroless deposition of gold on PCTE membrane and self-assembly of 15-mercaptohexadecanoic acid &lsqb;HS(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>15</PDAT></SB></HIL><PDAT>COOH, Aldrich&rsqb; onto deposited gold following the above procedure.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 2</PDAT></STEXT></H>
<PARA ID="P-00463" LVL="0"><PTEXT><PDAT>Example 2 demonstrates the ability of the membranes of the invention to provide ion selective ion transport between two chambers of a diffusion apparatus.</PDAT></PTEXT></PARA>
<PARA ID="P-00464" LVL="0"><PTEXT><PDAT>The membrane described in Example 1, was used to separate two compartments (reservoir and sink) in a diffusion cell (FIG. </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT>). The effective area of the membrane was 1.77 cm</PDAT><HIL><SP><PDAT>2</PDAT></SP></HIL><PDAT>. Before each diffusion experiment started, the reservoir contained a solution (45 ml) of 1 mM potassium permanganate (KMnO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>), while the sink contained a blank solution (45 ml) with no KMnO4. The pH of solutions in both reservoir and sink was adjusted to a desired value by adding the same amount (0-0.04 mM) of sulfuric acid (or potassium hydroxide, 0-0.1 mM) to the solutions in the reservoir and the sink.</PDAT></PTEXT></PARA>
<PARA ID="P-00465" LVL="0"><PTEXT><PDAT>To remove the effect of any change of ionic strength due to variation of pH on electrical double layer forces, the same amount of potassium nitrate was added to the solutions in both the reservoir and the sink to maintain the ionic strength of the solution in the reservoir (&tilde;1.1 mM) and that in the sink (&tilde;0.1 mM) at constant values.</PDAT></PTEXT></PARA>
<PARA ID="P-00466" LVL="0"><PTEXT><PDAT>The membrane had been conditioned in a solution that was the same as the solution in the sink in the subsequent diffusion experiment for at least 1 hour. Vigorous stirring (at the same speed setting) was applied in both compartments in all diffusion experiments by using two magnetic stirrers and a Corning stirring plate (FIG. </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT>). A small amount of solution (&tilde;1 ml) was periodically sampled from the sink and the concentration of MnO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> was determined by absorbance measured at 525 nm. Each sample solution was returned to the sink immediately after measurement (which took 1-2 min). The concentration of MnO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> in the reservoir decreased by less than 0.2% during each diffusion experiment and thus could be considered constant. The flux of MnO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> across the membrane was determined by the change of the concentration of MnO</PDAT><HIL><SB><PDAT>4&minus;</PDAT></SB></HIL><PDAT> in the sink with time: </PDAT>
<CWU>
<MATH-US ID="MATH-US-00001">
<MATHEMATICA ID="MATHEMATICA-00001" ALT="mathematica file" FILE="US06468657-20021022-M00001.NB"/>
<MATHML>
<math>
<mrow>
  <mi>J</mi>
  <mo>=</mo>
  <mfrac>
    <mi>CsV</mi>
    <mrow>
      <mrow>
        <mo>(</mo>
        <mrow>
          <mi>&pi;</mi>
          <mo>&it;</mo>
          <mstyle>
            <mtext>&emsp;</mtext>
          </mstyle>
          <mo>&it;</mo>
          <msup>
            <mi>R</mi>
            <mn>2</mn>
          </msup>
          <mo>&it;</mo>
          <mi>A</mi>
          <mo>&it;</mo>
          <mstyle>
            <mtext>&emsp;</mtext>
          </mstyle>
          <mo>&it;</mo>
          <mi>&delta;</mi>
        </mrow>
        <mo>)</mo>
      </mrow>
      <mo>&it;</mo>
      <mi>t</mi>
    </mrow>
  </mfrac>
</mrow>
</math>
</MATHML>
<EMI ID="EMI-M00001" ALT="embedded image" FILE="US06468657-20021022-M00001.TIF"/>
</MATH-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00467" LVL="7"><PTEXT><PDAT>where C</PDAT><HIL><SB><PDAT>s </PDAT></SB></HIL><PDAT>is the concentration of MnO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>in the sink measured at time t (C</PDAT><HIL><SB><PDAT>s</PDAT></SB></HIL><PDAT>/t was obtained from the plot of Cs against t), V is the volume of solution in the sink, and A is the effective area of the membrane. R, L, and &sgr; are the radius, length, and number density (per unit area of membrane) of the pores, respectively.</PDAT></PTEXT></PARA>
<PARA ID="P-00468" LVL="0"><PTEXT><PDAT>The changes of concentrations of MnO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>in the sink with time observed at different external pH values in the diffusion experiments are shown in FIG. </PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT>. The slope of each line is proportional to the flux of MnO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> passing through the membrane. The dashed line in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 3</PDAT></FGREF><PDAT> was obtained by measuring C</PDAT><HIL><SB><PDAT>s </PDAT></SB></HIL><PDAT>at pH 5.9 before SAMs were on the pore walls. The value of Cs, measured at 40 min when the pH was changed to 3.6 or 8.0 was the same as that at pH 5.9. The slope of this line is larger than those measured after the formation of the SAMS. In the latter case, higher pH values result in smaller fluxes of MnO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>. This phenomenon is consistent with pH dependent ionization of the terminal carboxylic groups in the SAMs and electrostatic interactions between the surface charge on the pore walls and the MnO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> anion. The higher the pH, the larger the density of fixed negative charges due to more ionized carboxylic groups on the pore walls, and consequently the more MnO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> anions are electrically excluded from the pores.</PDAT></PTEXT></PARA>
<PARA ID="P-00469" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 4</PDAT></FGREF><PDAT> gives the flux of MnO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> across the membrane bearing the carboxylic acid groups as a function of the external pH. The value of the flux at pH 3.5 is three times the value at pH 8.2. The flux drops by a factor of 2.5 as the pH changes from 3.5 to 5.5 and decreases slightly when the pH is higher than 6. The pH was changed between high values and low values alternatively. The property of pH-dependent transport of MnO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> did not change during the cumulative time of &tilde;30 hours of diffusion experiments with feeding solutions of 1 mM KMnO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00470" LVL="0"><PTEXT><PDAT>The Debye length corresponding to the ionic strength (&tilde;1.1 mM) of the solution in the reservoir is &tilde;9.1 nm. This is smaller than the pore radius (14 nm). Under the above conditions, the partitioning coefficient of the anion (defined by the ratio of the average concentration of the ion in a pore to that outside the pore) at high external pH values (&gt;8.0) is estimated to be &tilde;0.12. This nonnegligible value of partitioning coefficient may be the reason why the permeation of MnO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>is not completely inhibited even when most of the terminal carboxylic groups are dissociated at high pH values shown in FIG. </PDAT><HIL><BOLD><PDAT>4</PDAT></BOLD></HIL><PDAT>. There should be no effect of association of MnO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> on the flux of MnO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> because the low pK</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>value of MnO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> (&tilde;2.2) ensures that MnO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> is completely dissociated in the whole range of pH shown in FIG. </PDAT><HIL><BOLD><PDAT>4</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00471" LVL="0"><PTEXT><PDAT>It is understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to be persons skilled in the art and are to included within the spirit and purview of this application and are considered within the scope of the appended claims. All publications, patents, and patent applications cited herein are hereby incorporated by reference in their entirety for all purposes.</PDAT></PTEXT></PARA>
</BTEXT>
</DETDESC>
</SDODE>
<SDOCL>
<H LVL="1"><STEXT><PDAT>What is claimed is: </PDAT></STEXT></H>
<CL>
<CLM ID="CLM-00001">
<PARA ID="P-00472" LVL="0"><PTEXT><PDAT>1. A multilayered porous membrane comprising:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>(a) a porous substrate; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>(b) a metal film adhered onto said substrate; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>(c) an organic layer attached to said metal film, said organic layer having a recognition moiety attached thereto, </PDAT></PTEXT></CLMSTEP>
<PARA ID="P-00473" LVL="7"><PTEXT><PDAT>wherein said membrane is porous.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00002">
<PARA ID="P-00474" LVL="0"><PTEXT><PDAT>2. The material according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said substrate is a member selected from the group consisting of optically opaque substrates, optically transparent substrates, insulating substrates, conducting substrates, semiconducting substrates, magnetic substrates and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00003">
<PARA ID="P-00475" LVL="0"><PTEXT><PDAT>3. The material according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said substrate is a member selected from the group consisting of metals, inorganic oxides, inorganic glasses, organic polymers and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00004">
<PARA ID="P-00476" LVL="0"><PTEXT><PDAT>4. The material according to </PDAT><CLREF ID="CLM-00003"><PDAT>claim 3</PDAT></CLREF><PDAT>, wherein said organic polymer is a member selected from the group consisting of polypropylene, nylon, fluorocarbon, polyester, polyethylene, polysulfone, polyether sulfone, cellulose, cellulose ester, ethyl vinyl acetate, polycarbonate, polyaramide, polyimide and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00005">
<PARA ID="P-00477" LVL="0"><PTEXT><PDAT>5. The material according to </PDAT><CLREF ID="CLM-00003"><PDAT>claim 3</PDAT></CLREF><PDAT>, wherein said metal is a member selected from the group consisting of nickel, copper, silver, gold, platinum, palladium and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00006">
<PARA ID="P-00478" LVL="0"><PTEXT><PDAT>6. The material according to </PDAT><CLREF ID="CLM-00003"><PDAT>claim 3</PDAT></CLREF><PDAT>, wherein said inorganic oxide is a member selected from the group consisting of silicon polymers, ZnO, TiO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, Fe</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, Al</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, CeO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, SnO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, CuO, Cr</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, SiO</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00007">
<PARA ID="P-00479" LVL="0"><PTEXT><PDAT>7. The material according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said substrate is track-etched.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00008">
<PARA ID="P-00480" LVL="0"><PTEXT><PDAT>8. The material according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said metal film is a member selected from the group consisting of nickel film, copper film, silver film, gold film, platinum film, palladium film and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00009">
<PARA ID="P-00481" LVL="0"><PTEXT><PDAT>9. The material according to </PDAT><CLREF ID="CLM-00008"><PDAT>claim 8</PDAT></CLREF><PDAT>, wherein said metal film is a gold film.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00010">
<PARA ID="P-00482" LVL="0"><PTEXT><PDAT>10. The material according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said metal film is layered onto said substrate by electroless deposition.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00011">
<PARA ID="P-00483" LVL="0"><PTEXT><PDAT>11. The material according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said organic layer is attached to said metal film through a mechanism which is a member selected from the group consisting of covalent bonding, ionic bonding, coordination, van der Waals interactions, chemisorption, physisorption and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00012">
<PARA ID="P-00484" LVL="0"><PTEXT><PDAT>12. The material according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said organic layer comprises an organosulfur moiety.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00013">
<PARA ID="P-00485" LVL="0"><PTEXT><PDAT>13. The material according to </PDAT><CLREF ID="CLM-00012"><PDAT>claim 12</PDAT></CLREF><PDAT>, wherein said organic layer comprises a group having the structure:</PDAT></PTEXT></PARA>
<PARA ID="P-00486" LVL="0"><PTEXT><F><PTEXT><PDAT>&mdash;SR</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>(X</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n </PDAT></SB></HIL></PTEXT></F></PTEXT></PARA>
<PARA ID="P-00487" LVL="7"><PTEXT><PDAT>wherein</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a linking group between sulfur and X</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>X</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a member selected from the group consisting of H, halogen, recognition moieties, hydrophilic polymers and combinations thereof; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>n is a number between 1 and 50. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00014">
<PARA ID="P-00488" LVL="0"><PTEXT><PDAT>14. The material according to </PDAT><CLREF ID="CLM-00013"><PDAT>claim 13</PDAT></CLREF><PDAT>, wherein R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a member selected from the group consisting of stable linking groups and cleaveable linking groups.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00015">
<PARA ID="P-00489" LVL="0"><PTEXT><PDAT>15. The material according to </PDAT><CLREF ID="CLM-00014"><PDAT>claim 14</PDAT></CLREF><PDAT>, wherein R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a stable linking group which is a member selected from the group consisting of alkyl, substituted alkyl, aryl, arylalkyl, substituted aryl, substituted arylalkyl, saturated cyclic hydrocarbon, unsaturated cyclic hydrocarbon, heteroaryl, heteroarylalkyl, substituted heteroaryl, substituted heteroarylalkyl, heterocyclic, substituted heterocyclic and heterocyclicalkyl groups.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00016">
<PARA ID="P-00490" LVL="0"><PTEXT><PDAT>16. The material according to </PDAT><CLREF ID="CLM-00015"><PDAT>claim 15</PDAT></CLREF><PDAT>, wherein R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a member selected from the group consisting of alkyl and substituted alkyl groups.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00017">
<PARA ID="P-00491" LVL="0"><PTEXT><PDAT>17. The material according to </PDAT><CLREF ID="CLM-00014"><PDAT>claim 14</PDAT></CLREF><PDAT>, wherein R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a cleaveable linking group comprising a cleaveable moiety which is a member selected from group consisting of disulfide, ester, imide, carbonate, nitrobenzyl, phenacyl and benzoin groups.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00018">
<PARA ID="P-00492" LVL="0"><PTEXT><PDAT>18. The material according to </PDAT><CLREF ID="CLM-00013"><PDAT>claim 13</PDAT></CLREF><PDAT>, wherein said organic layer comprises:</PDAT></PTEXT></PARA>
<PARA ID="P-00493" LVL="0"><PTEXT><F><PTEXT><PDAT>X</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>Q</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>C(CQ</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>(Z</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>)</PDAT><HIL><SB><PDAT>o</PDAT></SB></HIL><PDAT>(CQ</PDAT><HIL><SP><PDAT>2</PDAT></SP></HIL><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>S&mdash;</PDAT></PTEXT></F></PTEXT></PARA>
<PARA ID="P-00494" LVL="7"><PTEXT><PDAT>wherein,</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>X</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a member selected from the group consisting of H, OH, halogen and recognition moieties; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>Q, Q</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>and Q</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>are independently members selected from the group consisting of H and halogen; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>Z</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a member selected from the group consisting of &mdash;CQ</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&mdash;, &mdash;CQ</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&mdash;, &mdash;CQ</PDAT><HIL><SP><PDAT>2</PDAT></SP></HIL><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&mdash;, &mdash;O&mdash;, &mdash;S&mdash;, &mdash;NR</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>&mdash;, &mdash;C(O)NR</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>NC(O)&mdash;, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>in which; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a member selected from the group consisting of H, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl and heterocyclic groups; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>m is a number between 0 and 40; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>n is a number between 0 and 40; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>o is a number between 0 and 5. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00019">
<PARA ID="P-00495" LVL="0"><PTEXT><PDAT>19. The material according to </PDAT><CLREF ID="CLM-00018"><PDAT>claim 18</PDAT></CLREF><PDAT>, wherein Q, Q</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>and Q</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>are independently members selected from the group consisting of H and fluorine.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00020">
<PARA ID="P-00496" LVL="0"><PTEXT><PDAT>20. The material according to </PDAT><CLREF ID="CLM-00013"><PDAT>claim 13</PDAT></CLREF><PDAT>, wherein said organic layer comprises:</PDAT></PTEXT></PARA>
<PARA ID="P-00497" LVL="0"><PTEXT><F><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>2</PDAT></SP></HIL><PDAT>OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>u</PDAT></SB></HIL><PDAT>(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>v</PDAT></SB></HIL><PDAT>S&mdash;, </PDAT></PTEXT></F></PTEXT></PARA>
<PARA ID="P-00498" LVL="7"><PTEXT><PDAT>in which</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>is a member selected from the group consisting of H, alkyl, acyl and recognition moieties; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>u is a number between 1 and 50; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>v is a number between 0 and 20. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00021">
<PARA ID="P-00499" LVL="0"><PTEXT><PDAT>21. The material according to </PDAT><CLREF ID="CLM-00020"><PDAT>claim 20</PDAT></CLREF><PDAT>, wherein R</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>is a member selected from H and CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00022">
<PARA ID="P-00500" LVL="0"><PTEXT><PDAT>22. The material according to </PDAT><CLREF ID="CLM-00020"><PDAT>claim 20</PDAT></CLREF><PDAT>, wherein u is a number between 5 and 20.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00023">
<PARA ID="P-00501" LVL="0"><PTEXT><PDAT>23. The material according to </PDAT><CLREF ID="CLM-00013"><PDAT>claim 13</PDAT></CLREF><PDAT>, wherein said organic layer forms a self-assembled monolayer.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00024">
<PARA ID="P-00502" LVL="0"><PTEXT><PDAT>24. The material according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said organosulfur layer comprises a moiety that undergoes a change in state upon exposing said moiety to an external agent.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00025">
<PARA ID="P-00503" LVL="0"><PTEXT><PDAT>25. The material according to </PDAT><CLREF ID="CLM-00024"><PDAT>claim 24</PDAT></CLREF><PDAT>, wherein said external agent is a member selected from the group consisting of light, electrical field, magnetic field, heat, change in fluid pH, change in fluid ionic strength and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00026">
<PARA ID="P-00504" LVL="0"><PTEXT><PDAT>26. The material according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said recognition moiety is a member selected from the group consisting of biomolecules, organic groups, metal chelates and organometallic moieties.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00027">
<PARA ID="P-00505" LVL="0"><PTEXT><PDAT>27. The material according to </PDAT><CLREF ID="CLM-00026"><PDAT>claim 26</PDAT></CLREF><PDAT>, wherein said organic group is a member selected from the group consisting of amines, sulfonamides, quaternary phosphonium, tertiary sulfonium, acids, drugs, chelating agents, crown ethers, cyclodextrins and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00028">
<PARA ID="P-00506" LVL="0"><PTEXT><PDAT>28. The material according to </PDAT><CLREF ID="CLM-00027"><PDAT>claim 27</PDAT></CLREF><PDAT>, wherein said amine is a member selected from the group consisting of quaternary amines, heterocyclic amines and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00029">
<PARA ID="P-00507" LVL="0"><PTEXT><PDAT>29. The material according to </PDAT><CLREF ID="CLM-00027"><PDAT>claim 27</PDAT></CLREF><PDAT>, wherein said acid is a member selected from the group consisting of sulfonic acids, carboxylic acids, phosphonic acids and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00030">
<PARA ID="P-00508" LVL="0"><PTEXT><PDAT>30. The material according to </PDAT><CLREF ID="CLM-00026"><PDAT>claim 26</PDAT></CLREF><PDAT>, wherein said biomolecule is a member selected from the group consisting of antibodies, antigens, carbohydrates, nucleic acids, peptides, enzymes and receptors.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00031">
<PARA ID="P-00509" LVL="0"><PTEXT><PDAT>31. A multilayered porous membrane comprising:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>(a) a porous polycarbonate track-etched substrate; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>(b) a metal film adhered onto said substrate; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>(c) an organic layer attached to said metal film, said organic layer having a recognition moiety attached thereto </PDAT></PTEXT></CLMSTEP>
<PARA ID="P-00510" LVL="7"><PTEXT><PDAT>wherein said membrane is porous.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00032">
<PARA ID="P-00511" LVL="0"><PTEXT><PDAT>32. The material according to </PDAT><CLREF ID="CLM-00031"><PDAT>claim 31</PDAT></CLREF><PDAT>, wherein said metal film is a member selected from the group consisting of nickel film, copper film, silver film, gold film, platinum film, palladium film and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00033">
<PARA ID="P-00512" LVL="0"><PTEXT><PDAT>33. The material according to </PDAT><CLREF ID="CLM-00031"><PDAT>claim 31</PDAT></CLREF><PDAT>, wherein said organic layer comprises a group having the structure:</PDAT></PTEXT></PARA>
<PARA ID="P-00513" LVL="0"><PTEXT><F><PTEXT><PDAT>&mdash;SR</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>(X</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n </PDAT></SB></HIL></PTEXT></F></PTEXT></PARA>
<PARA ID="P-00514" LVL="7"><PTEXT><PDAT>wherein</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a linking group between sulfur and X</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>X</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a recognition moiety; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>n is a number between 1 and 50. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00034">
<PARA ID="P-00515" LVL="0"><PTEXT><PDAT>34. The material according to </PDAT><CLREF ID="CLM-00033"><PDAT>claim 33</PDAT></CLREF><PDAT>, wherein R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a member selected from the group consisting of alkyl and substituted alkyl groups.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00035">
<PARA ID="P-00516" LVL="0"><PTEXT><PDAT>35. The material according to </PDAT><CLREF ID="CLM-00031"><PDAT>claim 31</PDAT></CLREF><PDAT>, wherein said recognition moiety is a member selected from acids and amines.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00036">
<PARA ID="P-00517" LVL="0"><PTEXT><PDAT>36. The material according to </PDAT><CLREF ID="CLM-00035"><PDAT>claim 35</PDAT></CLREF><PDAT>, wherein said amine is a member selected from quaternary amines, heterocyclic amines and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00037">
<PARA ID="P-00518" LVL="0"><PTEXT><PDAT>37. The material according to </PDAT><CLREF ID="CLM-00035"><PDAT>claim 35</PDAT></CLREF><PDAT>, wherein said acid is a member selected from the group consisting of carboxylic acids, sulfonic acids, phosphonic acids and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00038">
<PARA ID="P-00519" LVL="0"><PTEXT><PDAT>38. A multilayered porous ion exchange membrane comprising:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>(a) a porous substrate; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>(b) a metal film adhered onto said substrate; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>(c) an organic layer attached to said metal film, said organic layer comprising a recognition moiety that binds or repels an ion </PDAT></PTEXT></CLMSTEP>
<PARA ID="P-00520" LVL="7"><PTEXT><PDAT>wherein said membrane is porous.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00039">
<PARA ID="P-00521" LVL="0"><PTEXT><PDAT>39. The material according to </PDAT><CLREF ID="CLM-00038"><PDAT>claim 38</PDAT></CLREF><PDAT>, wherein said substrate is a member selected from the group consisting of metals, inorganic oxides, inorganic glasses, organic polymers and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00040">
<PARA ID="P-00522" LVL="0"><PTEXT><PDAT>40. The material according to </PDAT><CLREF ID="CLM-00039"><PDAT>claim 39</PDAT></CLREF><PDAT>, wherein said organic polymer is a member selected from the group consisting of polypropylene, nylon, fluorocarbon, polyester, polyethylene, polysulfone, polyether sulfone, cellulose, cellulose ester, ethyl vinyl acetate, polycarbonate, polyaramide, polyimide and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00041">
<PARA ID="P-00523" LVL="0"><PTEXT><PDAT>41. The material according to </PDAT><CLREF ID="CLM-00039"><PDAT>claim 39</PDAT></CLREF><PDAT>, wherein said metal is a member selected from the group consisting of nickel, copper, silver, gold, platinum, palladium and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00042">
<PARA ID="P-00524" LVL="0"><PTEXT><PDAT>42. The material according to </PDAT><CLREF ID="CLM-00039"><PDAT>claim 39</PDAT></CLREF><PDAT>, wherein said inorganic oxide is a member selected from the group consisting of ZnO, TiO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, Fe</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, Al</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, CeO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, SnO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, CuO, Cr</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, SiO</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00043">
<PARA ID="P-00525" LVL="0"><PTEXT><PDAT>43. The material according to </PDAT><CLREF ID="CLM-00038"><PDAT>claim 38</PDAT></CLREF><PDAT>, wherein said substrate is track-etched.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00044">
<PARA ID="P-00526" LVL="0"><PTEXT><PDAT>44. The material according to </PDAT><CLREF ID="CLM-00038"><PDAT>claim 38</PDAT></CLREF><PDAT>, wherein said metal film is a member selected from the group consisting of nickel film, copper film, silver film, gold film, platinum film, palladium film and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00045">
<PARA ID="P-00527" LVL="0"><PTEXT><PDAT>45. The material according to </PDAT><CLREF ID="CLM-00044"><PDAT>claim 44</PDAT></CLREF><PDAT>, wherein said metal film is a gold film.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00046">
<PARA ID="P-00528" LVL="0"><PTEXT><PDAT>46. The material according to </PDAT><CLREF ID="CLM-00038"><PDAT>claim 38</PDAT></CLREF><PDAT>, wherein said metal film is layered onto said substrate by electroless deposition.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00047">
<PARA ID="P-00529" LVL="0"><PTEXT><PDAT>47. The material according to </PDAT><CLREF ID="CLM-00038"><PDAT>claim 38</PDAT></CLREF><PDAT>, wherein said organic layer is attached to said metal film through a mechanism which is a member selected from the group consisting of covalent bonding, ionic bonding, coordination, van der Waals interactions, chemisorption, physisorption and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00048">
<PARA ID="P-00530" LVL="0"><PTEXT><PDAT>48. The material according to </PDAT><CLREF ID="CLM-00038"><PDAT>claim 38</PDAT></CLREF><PDAT>, wherein said organic layer comprises an organosulfur moiety.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00049">
<PARA ID="P-00531" LVL="0"><PTEXT><PDAT>49. The material according to </PDAT><CLREF ID="CLM-00048"><PDAT>claim 48</PDAT></CLREF><PDAT>, wherein said organosulfur layer comprises a moiety that undergoes a change in conformation upon exposing said moiety to a member selected from the group consisting of light, heat or combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00050">
<PARA ID="P-00532" LVL="0"><PTEXT><PDAT>50. The material according to </PDAT><CLREF ID="CLM-00048"><PDAT>claim 48</PDAT></CLREF><PDAT>, wherein said organic layer comprises a group having the structure:</PDAT></PTEXT></PARA>
<PARA ID="P-00533" LVL="0"><PTEXT><F><PTEXT><PDAT>&mdash;SR</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>(X</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n </PDAT></SB></HIL></PTEXT></F></PTEXT></PARA>
<PARA ID="P-00534" LVL="7"><PTEXT><PDAT>wherein</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a linking group between sulfur and X</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>X</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a recognition moiety; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>n is a number between 1 and 50. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00051">
<PARA ID="P-00535" LVL="0"><PTEXT><PDAT>51. The material according to </PDAT><CLREF ID="CLM-00050"><PDAT>claim 50</PDAT></CLREF><PDAT>, wherein R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a member selected from the group consisting of stable linking groups and cleaveable linking groups.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00052">
<PARA ID="P-00536" LVL="0"><PTEXT><PDAT>52. The material according to </PDAT><CLREF ID="CLM-00051"><PDAT>claim 51</PDAT></CLREF><PDAT>, wherein R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a stable linking group which is a member selected from the group consisting of alkyl, substituted alkyl, aryl, arylalkyl, substituted aryl, substituted arylalkyl, saturated cyclic hydrocarbon, unsaturated cyclic hydrocarbon, heteroaryl, heteroarylalkyl, substituted heteroaryl, substituted heteroarylalkyl, heterocyclic, substituted heterocyclic and heterocyclicalkyl groups.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00053">
<PARA ID="P-00537" LVL="0"><PTEXT><PDAT>53. The material according to </PDAT><CLREF ID="CLM-00052"><PDAT>claim 52</PDAT></CLREF><PDAT>, wherein R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is a member selected from the group consisting of alkyl and substituted alkyl groups.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00054">
<PARA ID="P-00538" LVL="0"><PTEXT><PDAT>54. A method of producing a multilayered porous membrane comprising:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>(a) contacting a porous substrate with a metal plating solution to form a porous substrate having a metal film adhered thereto; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>(b) contacting said metal coated substrate from step (a) with a solution comprising nitric acid, thereby activating said metal film; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>(c) contacting said metal coated substrate from step (b) with a plurality of organic molecules that associate with the activated metal film, thereby forming an organic layer on said particle, wherein at least a portion of said plurality of organic molecules comprise a member selected from the group consisting of recognition moieties, reactive groups, protected reactive groups and combinations thereof </PDAT></PTEXT></CLMSTEP>
<PARA ID="P-00539" LVL="7"><PTEXT><PDAT>wherein said membrane is porous.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00055">
<PARA ID="P-00540" LVL="0"><PTEXT><PDAT>55. The material according to </PDAT><CLREF ID="CLM-00054"><PDAT>claim 54</PDAT></CLREF><PDAT>, wherein said metal plating solution comprises a member selected from the group consisting of nickel, copper, silver, gold, platinum, palladium and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00056">
<PARA ID="P-00541" LVL="0"><PTEXT><PDAT>56. The method according to </PDAT><CLREF ID="CLM-00055"><PDAT>claim 55</PDAT></CLREF><PDAT>, wherein said plating solution comprises a reducible gold salt.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00057">
<PARA ID="P-00542" LVL="0"><PTEXT><PDAT>57. The method according to </PDAT><CLREF ID="CLM-00056"><PDAT>claim 56</PDAT></CLREF><PDAT>, wherein said sensitizer is a transition metal salt.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00058">
<PARA ID="P-00543" LVL="0"><PTEXT><PDAT>58. The method according to </PDAT><CLREF ID="CLM-00057"><PDAT>claim 57</PDAT></CLREF><PDAT>, wherein said transition metal salt is a salt of Sn</PDAT><HIL><SP><PDAT>&plus;2</PDAT></SP></HIL><PDAT>.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00059">
<PARA ID="P-00544" LVL="0"><PTEXT><PDAT>59. The method according to </PDAT><CLREF ID="CLM-00056"><PDAT>claim 56</PDAT></CLREF><PDAT>, wherein said gold plating solution comprises a reducible gold salt.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00060">
<PARA ID="P-00545" LVL="0"><PTEXT><PDAT>60. The method according to </PDAT><CLREF ID="CLM-00059"><PDAT>claim 59</PDAT></CLREF><PDAT>, wherein said gold plating solution further comprises a reducing agent.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00061">
<PARA ID="P-00546" LVL="0"><PTEXT><PDAT>61. The method according to </PDAT><CLREF ID="CLM-00060"><PDAT>claim 60</PDAT></CLREF><PDAT>, wherein said reducing agent is formaldehyde.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00062">
<PARA ID="P-00547" LVL="0"><PTEXT><PDAT>62. The method according to </PDAT><CLREF ID="CLM-00059"><PDAT>claim 59</PDAT></CLREF><PDAT>, wherein said reducible gold salt is Na</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>Au(SO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00063">
<PARA ID="P-00548" LVL="0"><PTEXT><PDAT>63. The method according to </PDAT><CLREF ID="CLM-00054"><PDAT>claim 54</PDAT></CLREF><PDAT>, further comprising, prior to step (a), contacting a particulate substrate with a sensitizer to form a sensitized particulate substrate.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00064">
<PARA ID="P-00549" LVL="0"><PTEXT><PDAT>64. The method according to </PDAT><CLREF ID="CLM-00054"><PDAT>claim 54</PDAT></CLREF><PDAT>, further comprising, prior to step (a), contacting said sensitized particulate substrate with a silver solution to form a silver coated particle.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00065">
<PARA ID="P-00550" LVL="0"><PTEXT><PDAT>65. The method according to </PDAT><CLREF ID="CLM-00064"><PDAT>claim 64</PDAT></CLREF><PDAT>, wherein said silver solution comprises AgNO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00066">
<PARA ID="P-00551" LVL="0"><PTEXT><PDAT>66. The method according to </PDAT><CLREF ID="CLM-00064"><PDAT>claim 64</PDAT></CLREF><PDAT>, wherein said silver solution further comprises ammonia.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00067">
<PARA ID="P-00552" LVL="0"><PTEXT><PDAT>67. The method according to </PDAT><CLREF ID="CLM-00054"><PDAT>claim 54</PDAT></CLREF><PDAT>, wherein said plurality of organic molecules comprises an organosulfur.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00068">
<PARA ID="P-00553" LVL="0"><PTEXT><PDAT>68. The method according to </PDAT><CLREF ID="CLM-00054"><PDAT>claim 54</PDAT></CLREF><PDAT>, wherein said plurality of organic molecules comprises a moiety selected from the group consisting of recognition moieties, reactive moieties, protected reactive moieties and combinations thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00069">
<PARA ID="P-00554" LVL="0"><PTEXT><PDAT>69. The method according to </PDAT><CLREF ID="CLM-00068"><PDAT>claim 68</PDAT></CLREF><PDAT>, wherein said plurality of organic molecules comprises a reactive moiety and said method further comprises:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>(d) reacting said reactive moiety with a recognition moiety. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00070">
<PARA ID="P-00555" LVL="0"><PTEXT><PDAT>70. The method according to </PDAT><CLREF ID="CLM-00068"><PDAT>claim 68</PDAT></CLREF><PDAT>, wherein said plurality of organic molecules comprises a protected reactive moiety and said method further comprises:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>(d) deprotecting said protected reactive moiety to form a reactive moiety; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>(e) reacting said reactive moiety with a recognition moiety. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00071">
<PARA ID="P-00556" LVL="0"><PTEXT><PDAT>71. A drug delivery device comprising:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>(a) a porous substrate; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>(b) a metal film adhered onto said substrate; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>(c) an organic layer attached to said metal film, said organic layer comprising a recognition moiety; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>(d) a drug moiety reversibly associated with said recognition moiety.</PDAT></PTEXT></CLMSTEP>
</CLM>
</CL>
</SDOCL>
<SDODR ID="DRAWINGS">
<EMI ID="EMI-D00000" ALT="embedded image" FILE="US06468657-20021022-D00000.TIF"/>
<EMI ID="EMI-D00001" ALT="embedded image" FILE="US06468657-20021022-D00001.TIF"/>
<EMI ID="EMI-D00002" ALT="embedded image" FILE="US06468657-20021022-D00002.TIF"/>
<EMI ID="EMI-D00003" ALT="embedded image" FILE="US06468657-20021022-D00003.TIF"/>
<EMI ID="EMI-D00004" ALT="embedded image" FILE="US06468657-20021022-D00004.TIF"/>
</SDODR>
</PATDOC>

<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PATDOC SYSTEM "ST32-US-Grant-025xml.dtd" [
<!ENTITY US06468808-20021022-D00001.TIF SYSTEM "US06468808-20021022-D00001.TIF" NDATA TIF>
<!ENTITY US06468808-20021022-D00002.TIF SYSTEM "US06468808-20021022-D00002.TIF" NDATA TIF>
<!ENTITY US06468808-20021022-D00003.TIF SYSTEM "US06468808-20021022-D00003.TIF" NDATA TIF>
<!ENTITY US06468808-20021022-D00004.TIF SYSTEM "US06468808-20021022-D00004.TIF" NDATA TIF>
]>
<PATDOC DTD="2.5" STATUS="Build 20020918">
<SDOBI>
<B100>
<B110><DNUM><PDAT>06468808</PDAT></DNUM></B110>
<B130><PDAT>B1</PDAT></B130>
<B140><DATE><PDAT>20021022</PDAT></DATE></B140>
<B190><PDAT>US</PDAT></B190>
</B100>
<B200>
<B210><DNUM><PDAT>09405653</PDAT></DNUM></B210>
<B211US><PDAT>09</PDAT></B211US>
<B220><DATE><PDAT>19990924</PDAT></DATE></B220>
</B200>
<B500>
<B510>
<B511><PDAT>G01N 33551</PDAT></B511>
<B512><PDAT>G01N 33553</PDAT></B512>
<B516><PDAT>7</PDAT></B516>
</B510>
<B520>
<B521><PDAT>436524</PDAT></B521>
<B522><PDAT>257 40</PDAT></B522>
<B522><PDAT>257 64</PDAT></B522>
<B522><PDAT>257200</PDAT></B522>
<B522><PDAT>257164</PDAT></B522>
<B522><PDAT>257613</PDAT></B522>
<B522><PDAT>257642</PDAT></B522>
<B522><PDAT>420528</PDAT></B522>
<B522><PDAT>420555</PDAT></B522>
<B522><PDAT>420576</PDAT></B522>
<B522><PDAT>420577</PDAT></B522>
<B522><PDAT>430 56</PDAT></B522>
<B522><PDAT>430 60</PDAT></B522>
<B522><PDAT>436525</PDAT></B522>
<B522><PDAT>428402</PDAT></B522>
<B522><PDAT>428403</PDAT></B522>
<B522><PDAT>435  6</PDAT></B522>
</B520>
<B540><STEXT><PDAT>Water-soluble luminescent quantum dots and biomolecular conjugates thereof and related compositions and method of use</PDAT></STEXT></B540>
<B560>
<B561>
<PCIT>
<DOC><DNUM><PDAT>3996345</PDAT></DNUM>
<DATE><PDAT>19761200</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Ullman et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4637988</PDAT></DNUM>
<DATE><PDAT>19870100</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Hinshaw et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4777128</PDAT></DNUM>
<DATE><PDAT>19881000</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Lippa</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5248772</PDAT></DNUM>
<DATE><PDAT>19930900</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Siiman et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5319209</PDAT></DNUM>
<DATE><PDAT>19940600</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Miyakawa et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5389377</PDAT></DNUM>
<DATE><PDAT>19950200</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Chagnon et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5441746</PDAT></DNUM>
<DATE><PDAT>19950800</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Chagnon</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5505928</PDAT></DNUM>
<DATE><PDAT>19960400</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Alivisatos et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>423299</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5674698</PDAT></DNUM>
<DATE><PDAT>19971000</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Zarling et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5751018</PDAT></DNUM>
<DATE><PDAT>19980500</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Alivisatos et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>257 64</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5990479</PDAT></DNUM>
<DATE><PDAT>19991100</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Weiss et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>250307</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>6251303</PDAT></DNUM>
<DATE><PDAT>20010600</PDAT></DATE>
<KIND><PDAT>B1</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Bawendi et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>2 342 651</PDAT></DNUM>
<DATE><PDAT>20000400</PDAT></DATE>
<CTRY><PDAT>GB</PDAT></CTRY>
</DOC>
</PCIT>
<CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>WO 91/09678</PDAT></DNUM>
<DATE><PDAT>19910700</PDAT></DATE>
<CTRY><PDAT>WO</PDAT></CTRY>
</DOC>
</PCIT>
<CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>WO 93/15117</PDAT></DNUM>
<DATE><PDAT>19930800</PDAT></DATE>
<CTRY><PDAT>WO</PDAT></CTRY>
</DOC>
</PCIT>
<CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>WO 93/26019</PDAT></DNUM>
<DATE><PDAT>19931200</PDAT></DATE>
<CTRY><PDAT>WO</PDAT></CTRY>
</DOC>
</PCIT>
<CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>WO 98/04740</PDAT></DNUM>
<DATE><PDAT>19980200</PDAT></DATE>
<CTRY><PDAT>WO</PDAT></CTRY>
</DOC>
</PCIT>
<CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>WO 00/17656</PDAT></DNUM>
<DATE><PDAT>20000300</PDAT></DATE>
<CTRY><PDAT>WO</PDAT></CTRY>
</DOC>
</PCIT>
<CITED-BY-OTHER/>
</B561>
<B562><NCIT><STEXT><PDAT>Lawless et al. (1995). Bifunctional capping of CdS nanoparticles and bridging to TiO2. J. Phys. Chem. 99:10329-10335.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Hines et al. (1996). Synthesis and characterization of strongly luminescing ZnS-capped CdSe nanocrystals. J. Phys. Chem. 100:468-471.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Matsumoto et al. (1996). Preparation of nonodisperse CdS nanocrystals by size selective photocorrosion. J. Phys. Chem. 100:13781-13785.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Danek et al. (1996). Synthesis of luminescent thin-film CdSe/ZnSe quantum dot composites using CdSe quantum dots passivated with an overlayer of ZnSe. Chem. Mat. 8:173-180.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Dabbousi et al. (1997). (CdSe)ZnS core-shell quantum dots: synthesis and characterization of a size series of highly luminescent nanocrystallites. J. pHys Chem. B. 101:9463-9475.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Murray et al. (1993). Synthesis and characterization of nearly monodisperse CdE (E&equals;S, Se, Te) semiconductor nanocrystallites. J. Am. Chem. Soc. 115(19):8706-8715.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Norris et al. (1996). Measurement and assignment of the size-dependent optical spectrum in CdSe quantum dots. Phys. Rev. B. 53(24):16338-16346.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Norris et al. (1996). Size dependence of exciton fine structure in CdSe quantum dots. Phys. Rev. B. 53(24):16347-16354.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Covin et al. (1994). Light-emitting diodes made from cadmium selenide nanocrystals and a semiconducting polymer. Nature. 370:354-357.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Dabbousi et al. (1995). Electroluminescence from CdSe quantum-dot/polymer composites. Appl. Phys. Lett. 66(11):1316-1318.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Alivisatos (1996). Perspective on the physical chemistry of semiconductor nanocrystals. J. Phys. Chem. 100(31):13226-13239.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Nirmal et al. (1996). Fluorescence intermittency in single cadmium selenide nnocrystals. Nature. 383:802-804.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Alivisatos et al., &ldquo;Organization of Nanocrystal Molecules Using DNA,&rdquo; </PDAT><HIL><ITALIC><PDAT>Nature, </PDAT></ITALIC></HIL><PDAT>382, 609-611 (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Bruchez et al., &ldquo;Semiconductor Nanocrystals as Fluoredcent Probes for Biology,&rdquo; </PDAT><HIL><ITALIC><PDAT>Cytometry, Supp. 9, </PDAT></ITALIC></HIL><PDAT>26(1998). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Coffer et al., &ldquo;Characterization of Quantum-Confined CdD Nanocrystallites Stablized by Deoxyribonucleic Acid (DNA),&rdquo; </PDAT><HIL><ITALIC><PDAT>Nanotechnol., </PDAT></ITALIC></HIL><PDAT>3, 69-76 (1992). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Jacoby, &ldquo;Quantum Dots Meet Biomolecules,&rdquo; </PDAT><HIL><ITALIC><PDAT>C&amp;E News, </PDAT></ITALIC></HIL><PDAT>9/28, 8 (,819,898,8). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Kagan et al., &ldquo;Electronic Energy Transfer in CdSe Quantum Dot Solids,&rdquo; </PDAT><HIL><ITALIC><PDAT>Phys. Rev. Lett., </PDAT></ITALIC></HIL><PDAT>76, 1577-1580 (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Kuno et al., &ldquo;The Band Edge Luminescence of Surface Modified CdSe Nanocrystalline: Probing the Luminescing State,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Chem. Phys., </PDAT></ITALIC></HIL><PDAT>106, 9869-9882 (1997). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Liz-Marzan et al., &ldquo;Synthesis of Nanosized Gold-Silica Core-Shell Particles,&rdquo; </PDAT><HIL><ITALIC><PDAT>Langmuir, </PDAT></ITALIC></HIL><PDAT>12, 4329-4335 (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Mahtab et al., &ldquo;Preferential-Absorption of a &lsquo;Kinked&rsquo; DNA to a Neutral Curved Surface: Comparison to and Implications for Nonspecific DNA-Protein Interactions,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc., </PDAT></ITALIC></HIL><PDAT>118, 7028-7032 (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Mikulec et al., </PDAT><HIL><ITALIC><PDAT>Mat. Res. Soc. Symp., </PDAT></ITALIC></HIL><PDAT>452, 359-364 (1997). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Murphy et al., &ldquo;Quantum Dots as Inorganic DNA-Binding Proteins,&rdquo; </PDAT><HIL><ITALIC><PDAT>Mat. Res. Soc. Symp., </PDAT></ITALIC></HIL><PDAT>452, 597-600 (1997). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Nicolaou et al., &ldquo;Radiofrequency Encoded Cominatorial Chemistry,&rdquo; </PDAT><HIL><ITALIC><PDAT>Ignew. Chem. Int. Ed. Engl., </PDAT></ITALIC></HIL><PDAT>34, 2289-2291 (1991). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Peng et al., &ldquo;Epitaxial Growth of Highly Luminescent CdSe/Cds Core/Shell Nanocrystals with Photostability and Electronic Accessibilty,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc., </PDAT></ITALIC></HIL><PDAT>119, 7019-1029 (1997). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Shrock et al., &ldquo;Multicolor Spectral Karyotyping of Human Chromosomes,&rdquo; </PDAT><HIL><ITALIC><PDAT>Science, </PDAT></ITALIC></HIL><PDAT>273, 494-497 (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Whitesell et al., &ldquo;Directionally Aligneed Helical Peptides on Surfaces,&rdquo; </PDAT><HIL><ITALIC><PDAT>Science, </PDAT></ITALIC></HIL><PDAT>261, 73-76 (1993). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Zhang et al., &ldquo;Novel Flow Cytometry Compensation Standards: Internally Stained Fluorescent Microspheres with Matched Emission Spectra and Long-Term Stability,&rdquo; </PDAT><HIL><ITALIC><PDAT>Cytometry, </PDAT></ITALIC></HIL><PDAT>33, 244-248 (1998). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Alivisatos, &ldquo;Semiconductor Clusters, Nanocrystals, and Quantum Dots,&rdquo; </PDAT><HIL><ITALIC><PDAT>Science, </PDAT></ITALIC></HIL><PDAT>271, 933-37 (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Alivisatos, &ldquo;Perspectives on the Physical Chemistry of Semiconductor Nanocrystals,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Phys. Chem., </PDAT></ITALIC></HIL><PDAT>100, 13226-39 (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Blanton et al., &ldquo;Photoluminescence Wandering in Single CdSe Nanocrystals,&rdquo; </PDAT><HIL><ITALIC><PDAT>Appl. Phys. Lett., </PDAT></ITALIC></HIL><PDAT>69, 3905 (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Bowden Katari et al., &ldquo;X-ray Photoelectron Spectroscopy of CdSe Nanocrystals with Applications to Studies of the Nanocrystal Surfaces,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Phys. Chem., </PDAT></ITALIC></HIL><PDAT>98, 4109-4117 (1994). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Brus, &ldquo;Quantum Crystallites and Nonlinear Optics,&rdquo; </PDAT><HIL><ITALIC><PDAT>Appl. Phys., </PDAT></ITALIC></HIL><PDAT>A 53, 465-74 (1991). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Dabbousi et al., &ldquo;(CdSe)ZnS Core-Shell Quantum Dots: Synthesis and Characterization of a Size Serries of Highly Luminescent Nanocrystallites,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Phys. Chem., </PDAT></ITALIC></HIL><PDAT>B 101, 9463-75 (1997). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Edwards et al., &ldquo;Thew Nucleation of Receptor-Mediated Endocytosis,&rdquo; </PDAT><HIL><ITALIC><PDAT>PNAS, </PDAT></ITALIC></HIL><PDAT>93(5), 1786-1791 (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Empedocles et al., &ldquo;Photoluminescence Spectroscopy of Single CdSe Nanocrystalliter Quantum Dots,&rdquo; </PDAT><HIL><ITALIC><PDAT>Phys. Rev. Lett., </PDAT></ITALIC></HIL><PDAT>77, 3873 (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Henglein, &ldquo;Small-Particle Research: Physicochemical Properties of Extremely Small Colloidal Metal and Semiconductor Particles,&rdquo; </PDAT><HIL><ITALIC><PDAT>Chem. Rev., </PDAT></ITALIC></HIL><PDAT>89, 1861-73 (1989). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Hines et al., &ldquo;Synthesis and Characterization of Strongly Luminescing ZnS-Capped CdSe Nanocrystals,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Phys. Chem., </PDAT></ITALIC></HIL><PDAT>100, 468-71 (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Lee et al., &ldquo;Surface Derivatization of Nanocrystalline CdSe Semiconductors,&rdquo; </PDAT><HIL><ITALIC><PDAT>Mat. Res. Soc. Symp. Proc., </PDAT></ITALIC></HIL><PDAT>452, 232-328 (1997). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Mikulec et al., &ldquo;Fluorescent Semiconductor Nanocrystallites Derivatized with Biomolecules,&rdquo; </PDAT><HIL><ITALIC><PDAT>Abst. Papers of Am. Chem. Soc., </PDAT></ITALIC></HIL><PDAT>216(3), P 018 MACR (1998). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Murray et al., &ldquo;Synthesis and Characterization of Nearly Monodisperse CdE (E&equals;S, Se, Te) Semiconductor Nanocrystallites,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc., </PDAT></ITALIC></HIL><PDAT>115, 8706-8715 (1993). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Nirmal et al., &ldquo;Fluorescence Intermittency in Single Cadmium Selenide Nanocrystals,&rdquo; </PDAT><HIL><ITALIC><PDAT>Nature, </PDAT></ITALIC></HIL><PDAT>383, 802 (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Smythe et al., &ldquo;The Mechanism of Receptor-Mediated Endocytosis,&rdquo; </PDAT><HIL><ITALIC><PDAT>Eur. J. Biochem., </PDAT></ITALIC></HIL><PDAT>202, 689(1991). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Weller, &ldquo;Colloidal Semiductor Q-Particle: Chemistry in the Transition Region Between Solid State and Molecules,&rdquo; </PDAT><HIL><ITALIC><PDAT>Angew. Chem. Int. Ed. Engl., </PDAT></ITALIC></HIL><PDAT>32, 41-53 (1993). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Wilson et al., &ldquo;Quantum Confinement in Sized-Selected, Surface-Oxidized Silicon Nanocrystals,&rdquo; </PDAT><HIL><ITALIC><PDAT>Science, </PDAT></ITALIC></HIL><PDAT>262, 1242-46 (1993).</PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
</B560>
<B570>
<B577><PDAT>16</PDAT></B577>
<B578US><PDAT>1</PDAT></B578US>
</B570>
<B580>
<B582><PDAT>430 56</PDAT></B582>
<B582><PDAT>430 60</PDAT></B582>
<B582><PDAT>420528</PDAT></B582>
<B582><PDAT>420555</PDAT></B582>
<B582><PDAT>420576</PDAT></B582>
<B582><PDAT>420577</PDAT></B582>
<B582><PDAT>257 64</PDAT></B582>
<B582><PDAT>257 40</PDAT></B582>
<B582><PDAT>257200</PDAT></B582>
<B582><PDAT>257613</PDAT></B582>
<B582><PDAT>257164</PDAT></B582>
<B582><PDAT>257642</PDAT></B582>
<B582><PDAT>436524</PDAT></B582>
<B582><PDAT>436525</PDAT></B582>
<B582><PDAT>428402</PDAT></B582>
<B582><PDAT>428403</PDAT></B582>
<B582><PDAT>435  6</PDAT></B582>
</B580>
<B590><B595><PDAT>4</PDAT></B595><B596><PDAT>4</PDAT></B596></B590>
</B500>
<B600>
<B680US><DOC><DNUM><PDAT>60/131987</PDAT></DNUM><DATE><PDAT>19990430</PDAT></DATE><KIND><PDAT>00</PDAT></KIND></DOC></B680US>
<B680US><DOC><DNUM><PDAT>60/101748</PDAT></DNUM><DATE><PDAT>19980924</PDAT></DATE><KIND><PDAT>00</PDAT></KIND></DOC></B680US>
</B600>
<B700>
<B720>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Shuming</PDAT></FNM><SNM><STEXT><PDAT>Nie</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Bloomington</PDAT></CITY>
<STATE><PDAT>IN</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Warren C. W.</PDAT></FNM><SNM><STEXT><PDAT>Chan</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Bloomington</PDAT></CITY>
<STATE><PDAT>IN</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Steven R.</PDAT></FNM><SNM><STEXT><PDAT>Emory</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Los Alamos</PDAT></CITY>
<STATE><PDAT>NM</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
</B720>
<B730>
<B731>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Advanced Research and Technology Institute, Inc.</PDAT></STEXT></ONM></NAM>
<ADR><CITY><PDAT>Indianapolis</PDAT></CITY><STATE><PDAT>IN</PDAT></STATE></ADR>
</PARTY-US>
</B731>
<B732US>
<PDAT>02</PDAT>
</B732US>
</B730>
<B740>
<B741>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Leydig, Voit &amp; Mayer, Ltd.</PDAT></STEXT></ONM></NAM>
</PARTY-US>
</B741>
</B740>
<B745>
<B746>
<PARTY-US>
<NAM><FNM><PDAT>Christopher L.</PDAT></FNM><SNM><STEXT><PDAT>Chin</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B746>
<B748US><PDAT>1641</PDAT></B748US>
</B745>
</B700>
</SDOBI>
<SDOAB>
<BTEXT>
<PARA ID="P-00001" LVL="0"><PTEXT><PDAT>The present invention provides a water-soluble luminescent quantum dot, a biomolecular conjugate thereof and a composition comprising such a quantum dot or conjugate. Additionally, the present invention provides a method of obtaining a luminescent quantum dot, a method of making a biomolecular conjugate thereof, and methods of using a biomolecular conjugate for ultrasensitive nonisotopic detection in vitro and in vivo.</PDAT></PTEXT></PARA>
</BTEXT>
</SDOAB>
<SDODE>
<RELAPP>
<BTEXT>
<PARA ID="P-00002" LVL="0"><PTEXT><PDAT>This application claims priority to U.S. provisional patent application Ser. No. 60/101,748, filed Sep. 24, 1998, and U.S. provisional patent application Ser. No. 60/131,987, filed Apr. 30, 1999.</PDAT></PTEXT></PARA>
</BTEXT>
</RELAPP>
<GOVINT>
<BTEXT>
<H LVL="1"><STEXT><PDAT>GOVERNMENT SUPPORT</PDAT></STEXT></H>
<PARA ID="P-00003" LVL="0"><PTEXT><PDAT>This invention was made, in part, with funding from the National Science Foundation under Grant No. CHE-9610254 and from the Department of Energy under Grant No. FG02-98ER14873. Therefore, the United States of America may have certain rights in the invention.</PDAT></PTEXT></PARA>
</BTEXT>
</GOVINT>
<BRFSUM>
<BTEXT>
<H LVL="1"><STEXT><PDAT>TECHNICAL FIELD OF INVENTION</PDAT></STEXT></H>
<PARA ID="P-00004" LVL="0"><PTEXT><PDAT>The present invention relates to a water-soluble luminescent quantum dot, a biomolecular conjugate thereof and a composition comprising such a quantum dot or conjugate. Additionally, the present invention relates to a method of obtaining a luminescent quantum dot, a method of making a biomolecular conjugate thereof, and methods of using a biomolecular conjugate for ultrasensitive nonisotopic detection in vitro and in vivo.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>BACKGROUND OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00005" LVL="0"><PTEXT><PDAT>The development of sensitive nonisotopic detection systems for use in biological assays has significantly impacted many research and diagnostic areas, such as DNA sequencing, clinical diagnostic assays, and fundamental cellular and molecular biology protocols. Current nonisotopic detection methods are mainly based on organic reporter molecules that undergo enzyme-linked color changes or are fluorescent, luminescent, or electroactive (Kricka, Ed., </PDAT><HIL><ITALIC><PDAT>Nonisotopic Probing, Blotting, and Sequencing, </PDAT></ITALIC></HIL><PDAT>Academic Press, New York, 1995; Issac, Ed., </PDAT><HIL><ITALIC><PDAT>Protocols for Nucleic Acid Analysis by Nonradioactive Probes, </PDAT></ITALIC></HIL><PDAT>Humana, Totowa, N.J., 1994; and Diamandis and Christopoulos, Eds., </PDAT><HIL><ITALIC><PDAT>Immunoassay, </PDAT></ITALIC></HIL><PDAT>Academic Press, New York, 1996). While these nonisotopic systems solve the problems associated with radioisotopic detection, such as short half-lives of radioisotopes, health hazards and expensive removal of radioactive waste, they are not as sensitive or stable as nonisotopic detection systems that utilize luminescent semiconductor quantum dots. For example, highly luminescent semiconductor quantum dots, such as ZnS-capped CdSe quantum dots, are twenty times brighter, one hundred times more stable against photobleaching, and three times narrower in spectral line width than organic dyes, such as fluorescent rhodamine.</PDAT></PTEXT></PARA>
<PARA ID="P-00006" LVL="0"><PTEXT><PDAT>Over the past decade, much progress has been made in the synthesis and characterization of a wide variety of semiconductor quantum dots. Recent advances have led to large-scale preparation of relatively monodisperse quantum dots (Murray et al., </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc.,</PDAT></ITALIC></HIL><PDAT>115, 8706-15 (1993); Bowen Katari et al., </PDAT><HIL><ITALIC><PDAT>J. Phys. Chem., </PDAT></ITALIC></HIL><PDAT>98, 4109-17 (1994); and Hines et al., </PDAT><HIL><ITALIC><PDAT>J. Phys. Chem., </PDAT></ITALIC></HIL><PDAT>100, 468-71 (1996)). Other advances have led to the characterization of quantum dot lattice structures (Henglein, </PDAT><HIL><ITALIC><PDAT>Chem. Rev., </PDAT></ITALIC></HIL><PDAT>89, 1861-73 (1989); and Weller et al., </PDAT><HIL><ITALIC><PDAT>Chem. Int. Ed. Engl. </PDAT></ITALIC></HIL><PDAT>32, 41-53(1993)) and also to the fabrication of quantum-dot arrays (Murray et al., </PDAT><HIL><ITALIC><PDAT>Science, </PDAT></ITALIC></HIL><PDAT>270, 1335-38 (1995); Andres et al., </PDAT><HIL><ITALIC><PDAT>Science, </PDAT></ITALIC></HIL><PDAT>273, 1690-93 (1996); Heath et al., </PDAT><HIL><ITALIC><PDAT>J. Phys. Chem., </PDAT></ITALIC></HIL><PDAT>100, 3144-49 (1996); Collier et al., </PDAT><HIL><ITALIC><PDAT>Science, </PDAT></ITALIC></HIL><PDAT>277, 1978-81 (1997); Mirkin et al., </PDAT><HIL><ITALIC><PDAT>Nature, </PDAT></ITALIC></HIL><PDAT>382, 607-09 (1996); and Alivisatos et al., </PDAT><HIL><ITALIC><PDAT>Nature, </PDAT></ITALIC></HIL><PDAT>382, 609-11 (1996)) and light-emitting diodes (Colvin et al., </PDAT><HIL><ITALIC><PDAT>Nature, </PDAT></ITALIC></HIL><PDAT>370, 354-57 (1994); and Dabbousi et al., </PDAT><HIL><ITALIC><PDAT>Appl. Phys. Let., </PDAT></ITALIC></HIL><PDAT>66, 1316-18 (1995)). In particular, IIB-VIB semiconductors have been the focus of much attention, leading to the development of a CdSe quantum dot that has an unprecedented degree of monodispersivity and crystalline order (Murray (1993), supra).</PDAT></PTEXT></PARA>
<PARA ID="P-00007" LVL="0"><PTEXT><PDAT>Further advances in luminescent quantum dot technology have resulted in a dramatic enhancement of the fluorescence efficiency and stability of the quantum dots. The remarkable luminescent properties of quantum dots arise from quantumsize confinement, which occurs when metal and semiconductor core particles are smaller than their exciton Bohr radii, about 1 to 5 nm (Alivisatos, </PDAT><HIL><ITALIC><PDAT>Science, </PDAT></ITALIC></HIL><PDAT>271, 933-37 (1996); Alivisatos, </PDAT><HIL><ITALIC><PDAT>J. Phys. Chem., </PDAT></ITALIC></HIL><PDAT>100, 13226-39 (1996); </PDAT><HIL><ITALIC><PDAT>Brus, Appl. Phys., A </PDAT></ITALIC></HIL><PDAT>53, 465-74 (1991); Wilson et al., </PDAT><HIL><ITALIC><PDAT>Science, </PDAT></ITALIC></HIL><PDAT>262, 1242-46 (1993); Henglein (1989), supra; and Weller (1993), supra). Recent work has shown that improved luminescence can be achieved by capping a size-tunable lower band gap core particle with a higher band gap shell. For example, CdSe quantum dots passivated with a ZnS layer are strongly luminescent (35 to 50% quantum yield) at room temperature, and their emission wavelength can be tuned from blue to red by changing the particle size. Moreover, the ZnS capping protects the core surface and leads to greater stability of the quantum dot (Hines (1996), supra; and Dabbousi et al., </PDAT><HIL><ITALIC><PDAT>J. Phys. Chem. </PDAT></ITALIC></HIL><PDAT>B 101, 9463-75 (1997)).</PDAT></PTEXT></PARA>
<PARA ID="P-00008" LVL="0"><PTEXT><PDAT>Despite the remarkable advances in luminescent quantum dot technology, the capped luminescent quantum dots are not suitable for biological applications because they are not water-soluble. In addition, it has not been possible to attach a quantum dot to a biomolecule in such a manner as to preserve the biological activity of the biomolecule. However, because luminescent quantum dots offer significant advantages over currently available nonisotopic detection systems, there remains an unfulfilled desire for a luminescent quantum dot that can be used for detection purposes in biological assays. In view of this, it is an object of the present invention to provide a luminescent quantum dot that is suitable for biological applications. It is another object of the present invention to provide a biomolecular conjugate of a luminescent quantum dot that is suitable for biological applications. In particular, the present invention seeks to provide a biomolecular conjugate of a luminescent quantum dot in which the biomolecule retains its biological activity and the resultant conjugate is suitable for biological applications. Accordingly, it is yet another object of the present invention to provide a method of making such a luminescent quantum dot and a method of making a biomolecular conjugate thereof. Still yet another object of the present invention is to provide a composition comprising such a quantum dot or a biomolecular conjugate thereof. A further object of the present invention is to provide methods of using the biomolecular conjugate for ultrasensitive nonisotopic detection in vitro and in vivo. These and other objects and advantages, as well as additional. inventive features, of the present invention will become apparent to one of ordinary skill in the art upon reading the detailed description provided herein.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>BRIEF SUMMARY OF THE PRESENT INVENTION</PDAT></STEXT></H>
<PARA ID="P-00009" LVL="0"><PTEXT><PDAT>The present invention provides a water-soluble luminescent quantum dot, which comprises a core, a cap and a hydrophilic attachment group. Also provided is a composition comprising the water-soluble luminescent quantum dot and an aqueous carrier. The present invention further provides a conjugate, which comprises the water-soluble luminescent quantum dot and a biomolecule, wherein the biomolecule is attached directly or indirectly to the hydrophilic attachment group. Also provided is a composition comprising the conjugate and an aqueous carrier.</PDAT></PTEXT></PARA>
<PARA ID="P-00010" LVL="0"><PTEXT><PDAT>Further provided by the present invention are a method of obtaining a watersoluble luminescent quantum dot and methods of making biomolecular conjugates thereof. Other methods provided by the present invention include methods of detecting biomolecules in vitro and in vivo.</PDAT></PTEXT></PARA>
</BTEXT>
</BRFSUM>
<DRWDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BRIEF DESCRIPTION OF THE FIGURES</PDAT></STEXT></H>
<PARA ID="P-00011" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> is a schematic diagram of a bioconjugate comprising a single-stranded oligonucleotide having a stem and loop structure and the bioconjugate bound to a target nucleic acid.</PDAT></PTEXT></PARA>
<PARA ID="P-00012" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT> is a schematic diagram of a method of detecting multiple nucleic acids in a sample in accordance with the present invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00013" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 3</PDAT></FGREF><PDAT> is a schematic diagram of a method of detecting a viral nucleic acid in a sample in accordance with the present invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00014" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 4</PDAT></FGREF><PDAT> is a schematic diagram of bioconjugates comprising a luminescent semiconductor quantum dot and an oligonucleotide and the bioconjugates bound by a DNA linker.</PDAT></PTEXT></PARA>
</BTEXT>
</DRWDESC>
<DETDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>DETAILED DESCRIPTION OF THE PRESENT INVENTION</PDAT></STEXT></H>
<PARA ID="P-00015" LVL="0"><PTEXT><PDAT>The present invention provides means and methods of ultrasensitive nonisotopic detection of biomolecules in vitro and in vivo. The present invention is premised on the surprising, unexpected and advantageous discovery that capped luminescent quantum dots can be rendered water-soluble by attaching a hydrophilic attachment group to the cap of the quantum dot and that these quantum dots retain their luminescent properties. The present invention is also premised on the discovery that various biomolecules can be directly and indirectly attached to the hydrophilic attachment group on the cap of the quantum dot and that these biomolecules can retain their biological activity.</PDAT></PTEXT></PARA>
<PARA ID="P-00016" LVL="0"><PTEXT><PDAT>In view of the above, the present invention provides, in one embodiment, a water-soluble luminescent semiconductor quantum dot, which comprises a core, a cap and a hydrophilic attachment group. The &ldquo;core&rdquo; is a nanoparticle-sized semiconductor. While any core of the IIB-VIB, IIIB-VB or IVB&mdash;IVB semiconductors can be used in the context of the present invention, the core must be such that, upon combination with a cap, a luminescent quantum dot results. A IIB-VIB semiconductor is a compound that contains at least one element from Group IIB and at least one element from Group VIB of the periodic table, and so on. Preferably, the core is a IIB-VIB, IIIB-VB or IVB&mdash;IVB semiconductor that ranges in size from about 1 nm to about 10 nm. The core is more preferably a IIB-VIB semiconductor and ranges in size from about 2 nm to about 5 nm. Most preferably, the core is CdS or CdSe. In this regard, CdSe is especially preferred as the core, in particular at a size of about 4.2 nm.</PDAT></PTEXT></PARA>
<PARA ID="P-00017" LVL="0"><PTEXT><PDAT>The &ldquo;cap&rdquo; is a semiconductor that differs from the semiconductor of the core and binds to the core, thereby forming a surface layer on the core. The cap must be such that, upon combination with a given semiconductor core, results in a luminescent quantum dot. The cap should passivate the core by having a higher band gap than the core. In this regard, the cap is preferably a IIB-VIB semiconductor of high band gap. More preferably, the cap is ZnS or CdS. Most preferably, the cap is ZnS. In particular, the cap is preferably ZnS when the core is CdSe or CdS and the cap is preferably CdS when the core is CdSe.</PDAT></PTEXT></PARA>
<PARA ID="P-00018" LVL="0"><PTEXT><PDAT>The &ldquo;attachment group&rdquo; as that term is used herein refers to any organic group that can be attached, such as by any stable physical or chemical association, to the surface of the cap of the luminescent semiconductor quantum dot and can render the quantum dot water-soluble without rendering the quantum dot no longer luminescent. Accordingly, the attachment group comprises a hydrophilic moiety. Preferably, the attachment group enables the hydrophilic quantum dot to remain in solution for at least about one hour. More preferably the attachment group enables the hydrophilic quantum dot to remain in solution for at least about one day. Even more preferably, the attachment group allows the hydrophilic quantum dot to remain in solution for at least about one week, most preferably for at least about one month. Desirably, the attachment group is attached to the cap by covalent bonding and is attached to the cap in such a manner that the hydrophilic moiety is exposed. Preferably, the hydrophilic attachment group is attached to the quantum dot via a sulfur atom. More preferably, the hydrophilic attachment group is an organic group comprising a sulfur atom and at least one hydrophilic attachment group. Suitable hydrophilic attachment groups include, for example, a carboxylic acid or salt thereof, a sulfonic acid or salt thereof, a sulfamic acid or salt thereof, an amino substituent, a quaternary ammonium salt, and a hydroxy. The organic group of the hydrophilic attachment group of the present invention is preferably a C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>6 </PDAT></SB></HIL><PDAT>alkyl group or an aryl group, more preferably a C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>6 </PDAT></SB></HIL><PDAT>alkyl group, even more preferably a C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>alkyl group. Therefore, in a preferred embodiment, the attachment group of the present invention is a thiol carboxylic acid or thiol alcohol. More preferably, the attachment group is a thiol carboxylic acid. Most preferably, the attachment group is mercaptoacetic acid.</PDAT></PTEXT></PARA>
<PARA ID="P-00019" LVL="0"><PTEXT><PDAT>Accordingly, a preferred embodiment of a water-soluble luminescent semiconductor quantum dot is one that comprises a CdSe core of about 4.2 nm in size, a ZnS cap and an attachment group. Another preferred embodiment of a water-soluble luminescent semiconductor quantum dot is one that comprises a CdSe core, a ZnS cap and the attachment group mercaptoacetic acid. An especially preferred water-soluble luminescent semiconductor quantum dot comprises a CdSe core of about 4.2 nm, a ZnS cap of about 1 nm and a mercaptoacetic acid attachment group.</PDAT></PTEXT></PARA>
<PARA ID="P-00020" LVL="0"><PTEXT><PDAT>In another embodiment, the present invention also provides a composition comprising a water-soluble luminescent semiconductor quantum dot as described above and an aqueous carrier. Any suitable aqueous carrier can be used in the composition. Desirably, the carrier renders the composition stable at a desired temperature, such as room temperature, and is of an approximately neutral pH. Examples of suitable aqueous carriers are known to those of ordinary skill in the art and include saline solution and phosphate-buffered saline solution (PBS).</PDAT></PTEXT></PARA>
<PARA ID="P-00021" LVL="0"><PTEXT><PDAT>In yet another embodiment, the present invention provides a conjugate comprising a water-soluble luminescent semiconductor quantum dot as described above and a biomolecule, wherein the biomolecule is attached to the quantum dot via the hydrophilic attachment group. The biomolecule should not render the quantum dot water-insoluble. Preferably, the biomolecule is a protein, a fragment of a protein, or a nucleic acid. Use of the phrase &ldquo;protein or a fragment thereof&rdquo; is intended to encompass a protein, a glycoprotein, a polypeptide, a peptide, and the like, whether isolated from nature, of viral, bacterial, plant or animal (e.g., mammalian, such as human) origin, or synthetic. A preferred protein or fragment thereof for use as a biomolecule in the present inventive conjugate is an antigen, an epitope of an antigen, an antibody, or an antigenically reactive fragment of an antibody. Use of the phrase &ldquo;nucleic acid&rdquo; is intended to encompass DNA and RNA, whether isolated from nature, of viral, bacterial, plant or animal (e.g., mammalian, such as human) origin, synthetic, single-stranded, double-stranded, comprising naturally or nonnaturally occurring nucleotides, or chemically modified. A preferred nucleic acid is a singlestranded oligonucleotide comprising a stem and loop structure and the hydrophilic attachment group is attached to one end of the single-stranded oligonucleotide and a quenching moiety is attached to the other end of the single-stranded oligonucleotide and the quenching moiety quenches the luminescent semiconductor quantum dot.</PDAT></PTEXT></PARA>
<PARA ID="P-00022" LVL="0"><PTEXT><PDAT>The biomolecule can be attached, such as by any stable physical or chemical association, to the hydrophilic attachment group of the water-soluble luminescent quantum dot directly or indirectly by any suitable means. Desirably, the biomolecule is attached to the attachment group directly or indirectly through one or more covalent bonds. If the biomolecule is attached to the hydrophilic attachment group indirectly, the attachment preferably is by means of a &ldquo;linker.&rdquo; Use of the term &ldquo;linker&rdquo; is intended to encompass any suitable means that can be used to link the biomolecule to the attachment group of the water-soluble luminescent quantum dot. The linker should not render the water-soluble luminescent quantum dot water-insoluble and should not adversely affect the luminescence of the quantum dot. Also, the linker should not adversely affect the function of the attached biomolecule. If the conjugate is to be used in vivo, desirably the linker is biologically compatible.</PDAT></PTEXT></PARA>
<PARA ID="P-00023" LVL="0"><PTEXT><PDAT>For example, if the attachment group is mercaptoacetic acid and a nucleic acid biomolecule is being attached to the attachment group, the linker preferably is a primary amine, a thiol, streptavidin, neutravidin, biotin, or a like molecule. If the attachment group is mercaptoacetic acid and a protein biomolecule or a fragment thereof is being attached to the attachment group, the linker preferably is strepavidin, neutravidin, biotin, or a like molecule. In accordance with the invention, the linker should not contact the protein biomolecule or a fragment thereof at an amino acid which is essential to the function or activity of the attached protein. Crosslinkers, such as intermediate crosslinkers, can be used to attach a biomolecule to the attachment group of the water-soluble luminescent quantum dot. Ethyl-3-(dimethylaminopropyl) carbodiimide (EDAC) is an example of an intermediate crosslinker. Other examples of intermediate crosslinkers for use in the present invention are known in the art. See, for example, </PDAT><HIL><ITALIC><PDAT>Bioconjugate Techniques </PDAT></ITALIC></HIL><PDAT>(Academic Press, New York, (1996)).</PDAT></PTEXT></PARA>
<PARA ID="P-00024" LVL="0"><PTEXT><PDAT>Catalytic crosslinkers also can be used to attach a biomolecule to the attachment group of the water-soluble luminescent quantum dot. Catalytic crosslinkers effect direct attachment of the biomolecule to the attachment group. Examples of catalytic crosslinkers are also known in the art. See, for example, </PDAT><HIL><ITALIC><PDAT>Bioconjugate Techniques </PDAT></ITALIC></HIL><PDAT>(1996), supra.</PDAT></PTEXT></PARA>
<PARA ID="P-00025" LVL="0"><PTEXT><PDAT>Attachment of a biomolecule to the attachment group of the water-soluble luminescent quantum dot also can be effected by a bi-functional compound as is known in the art. See, for example, </PDAT><HIL><ITALIC><PDAT>Bioconjugate Techniques </PDAT></ITALIC></HIL><PDAT>(1996), supra.</PDAT></PTEXT></PARA>
<PARA ID="P-00026" LVL="0"><PTEXT><PDAT>In those instances where a short linker could cause steric hindrance problems or otherwise affect the functioning of the biomolecule, the length of the linker can be increased, e.g., by the addition of from about a 10 to about a 20 atom spacer, using procedures well-known in the art (see, for example, </PDAT><HIL><ITALIC><PDAT>Bioconjugate Techniques </PDAT></ITALIC></HIL><PDAT>(1996), supra). One possible linker is activated polyethylene glycol, which is hydrophilic and is widely used in preparing labeled oligonucleotides.</PDAT></PTEXT></PARA>
<PARA ID="P-00027" LVL="0"><PTEXT><PDAT>Accordingly, a preferred conjugate in accordance with the present invention is a conjugate comprising a CdSe core of about 4.2 nm, a ZnS cap, a hydrophilic attachment group and a biomolecule. Another preferred conjugate in accordance with the present invention is a conjugate comprising a CdSe core, a ZnS cap, a mercaptoacetic acid attachment group and a biomolecule. An especially preferred conjugate comprises a CdSe core of about 4.2 nm, a ZnS coating of about 1 nm, a mercaptoacetic acid attachment group and a biomolecule.</PDAT></PTEXT></PARA>
<PARA ID="P-00028" LVL="0"><PTEXT><PDAT>An alternatively preferred conjugate in accordance with the present invention is a conjugate essentially as described above, wherein the biomolecule is a single-stranded oligonucleotide comprising a stem and a loop. The hydrophilic attachment group is attached to one end of the single-stranded oligonucleotide, and a quenching moiety is attached to the other end of the single-stranded oligonucleotide. The quenching moiety quenches the luminescent semiconductor quantum dot.</PDAT></PTEXT></PARA>
<PARA ID="P-00029" LVL="0"><PTEXT><PDAT>Any suitable quenching moiety that quenches the luminescence of the quantum dot can be used in the alternatively preferred conjugate described above. Preferably, the alternatively preferred conjugate comprises a primary amine group at the 3&prime; end and a biotin group at the 5&prime; end. The quenching moiety is preferably a nonfluorescent organic chromophore, which is covalently linked to the 3&prime; amino group of the oligonucleotide. More preferably, the quenching moiety is 4-&lsqb;4&prime;-dimethylaminophenylazo&rsqb;benzoic acid (DABCYL). Preferably, the luminescent quantum dot of the bioconjugate is first derivatized with streptavidin according to well-known cross-linking methods and then conjugated to the 5&prime; biotin group, preferably at a 1:1 molar ratio.</PDAT></PTEXT></PARA>
<PARA ID="P-00030" LVL="0"><PTEXT><PDAT>Thus, in another embodiment, the present invention also provides a composition comprising a conjugate as described above and an aqueous carrier. Any suitable aqueous carrier can be used in the composition. Desirably, the carrier renders the composition stable at a desired temperature, such as room temperature, and is of an approximately neutral pH. Examples of suitable aqueous carriers are known to those of ordinary skill in the art and include saline solution and PBS.</PDAT></PTEXT></PARA>
<PARA ID="P-00031" LVL="0"><PTEXT><PDAT>In view of the above, the present invention further provides a method of obtaining a water-soluble luminescent semiconductor quantum dot as described. The method comprises (a) reacting a luminescent semiconductor quantum dot as described above in a nonpolar organic solvent with a first aqueous solution comprising an attachment group; (b) adding a second aqueous solution of about neutral pH and mixing; and (c) extracting an aqueous layer, thereby obtaining a water-soluble luminescent semiconductor quantum dot. Preferably, the nonpolar organic solvent is chloroform and the attachment group is mercaptoacetic acid.</PDAT></PTEXT></PARA>
<PARA ID="P-00032" LVL="0"><PTEXT><PDAT>The present invention also provides a method of making a conjugate comprising a water-soluble luminescent semiconductor quantum dot and a biomolecule as described above. Where the biomolecule is to be directly attached to the attachment group of the quantum dot, the method comprises (a) contacting a water-soluble luminescent semiconductor quantum dot as described above with a biomolecule, which can directly attach to the attachment group on the cap of the water-soluble luminescent semiconductor quantum dot; and (b) isolating the conjugate. Preferably, the biomolecule is a protein or a fragment thereof or a nucleic acid. In one embodiment of the method of directly attaching the biomolecule to the attachment group, the attachment group is mercaptoacetic acid and the biomolecule is a protein. In another embodiment of the direct attachment method, the quantum dot and the biomolecule are contacted in the presence of a catalytic crosslinker.</PDAT></PTEXT></PARA>
<PARA ID="P-00033" LVL="0"><PTEXT><PDAT>Where the biomolecule is to be indirectly attached to the attachment group of the water-soluble luminescent semiconductor quantum dot, the present invention provides a method comprising (a) contacting a water-soluble semiconductor luminescent quantum dot as described above with a linker, which can attach to the attachment group and the biomolecule; (b) isolating the water-soluble luminescent semiconductor quantum dot to which is attached a linker; (c) contacting the water-soluble luminescent semiconductor quantum dot to which is attached a linker with a biomolecule; and (d) isolating the conjugate.</PDAT></PTEXT></PARA>
<PARA ID="P-00034" LVL="0"><PTEXT><PDAT>Alternatively, the method comprises (a) contacting a biomolecule with a linker, which can attach to the attachment group and the biomolecule; (b) isolating the biomolecule to which is attached a linker; (c) contacting the biomolecule to which is attached a linker with a water-soluble luminescent quantum dot; and (d) isolating the conjugate. In one embodiment of the method of indirectly attaching the biomolecule to the attachment group, the linker is a primary amine or streptavidin, the attachment group is mercaptoacetic acid and the biomolecule is a nucleic acid.</PDAT></PTEXT></PARA>
<PARA ID="P-00035" LVL="0"><PTEXT><PDAT>In another embodiment of the method of indirectly attaching the biomolecule to the attachment group, the method comprises (a) contacting a water-soluble luminescent quantum dot with an intermediate crosslinker or a bifunctional molecule, either one of which can attach to the attachment group and the biomolecule; (b) isolating the water-soluble luminescent quantum dot to which is attached the intermediate crosslinker or the bifunctional molecule; (c) contacting the water-soluble luminescent quantum dot to which is attached the intermediate crosslinker or the bifunctional molecule with a biomolecule; and (d) isolating the conjugate.</PDAT></PTEXT></PARA>
<PARA ID="P-00036" LVL="0"><PTEXT><PDAT>Alternatively, the method comprises (a) contacting a biomolecule with an intermediate crosslinker or a bifunctional molecule, either one of which can attach to the attachment group and the biomolecule; (b) isolating the biomolecule to which is attached the intermediate crosslinker or the bifunctional molecule; (c) contacting the biomolecule to which is attached the intermediate crosslinker or the bifunctional molecule with a water-soluble luminescent quantum dot; and (d) isolating the conjugate. An example of such an embodiment is a method employing mercaptoacetic acid as the attachment group, a protein or a fragment thereof as the biomolecule, and EDAC as the intermediate crosslinker.</PDAT></PTEXT></PARA>
<PARA ID="P-00037" LVL="0"><PTEXT><PDAT>Also provided by the present invention is a method of detecting a protein in a sample. The method comprises (a) contacting the sample with a conjugate as described above, wherein the biomolecule of the conjugate specifically binds to the protein; and (b) detecting luminescence, wherein the detection of luminescence indicates that the conjugate bound to the protein in the sample.</PDAT></PTEXT></PARA>
<PARA ID="P-00038" LVL="0"><PTEXT><PDAT>Preferably, in the method of protein detection, the biomolecule of the conjugate is a protein or a fragment thereof, such as an antibody or an antigenically reactive fragment thereof, and the protein in the sample is an antigen or an epitope thereof that is bound by the antibody or an antigenically reactive fragment thereof. The antigen or epitope thereof preferably is part of a virus or a bacterium. Alternatively and preferably, the biomolecule of the conjugate is an antigen or an epitope thereof and the protein in the sample is an antibody or an antigenically reactive fragment thereof that binds to the antigen or epitope thereof. The antibody or the antigenically reactive fragment thereof preferably is specific for a virus, a bacterium, or a part of a virus or a bacterium. In yet another alternative and preferred embodiment, the biomolecule of the conjugate is a nucleic acid and the protein in the sample is a nucleic acid binding protein, e.g., a DNA binding protein.</PDAT></PTEXT></PARA>
<PARA ID="P-00039" LVL="0"><PTEXT><PDAT>Another method provided by the present invention is a method of detecting a nucleic acid in a sample. The method comprises (a) contacting the sample with a conjugate as described above, wherein the biomolecule of the conjugate specifically binds to the nucleic acid; and (b) detecting luminescence, wherein the detection of luminescence indicates that the conjugate bound to the nucleic acid in the sample. Preferably, the biomolecule of the conjugate is a nucleic acid. Alternatively and preferably, the biomolecule of the conjugate is a protein or a fragment thereof that binds to a nucleic acid, such as a DNA binding protein.</PDAT></PTEXT></PARA>
<PARA ID="P-00040" LVL="0"><PTEXT><PDAT>As shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT>, the present invention also provides another method of detecting a nucleic acid in a sample. This method involves the use of a bioconjugate comprising a single-stranded oligonucleotide having a stem-and-loop structure, a quantum dot moiety, and a quenching moiety. The loop of the oligonucleotide comprises a probe sequence that is complementary to a target sequence in the nucleic acid to be detected in a sample. Desirably, the loop is of sufficient size such that it opens readily upon contact with a target sequence, yet not so large that it is easily sheared. Preferably, the loop is from about 10 nucleotides to about 30 nucleotides and more preferably from about 15 nucleotides to about 25 nucleotides. The probe sequence can comprise all or less than all of the loop. Preferably, the probe sequence is at least about 15 nucleotides in length. The stem is formed by the annealing of complementary sequences that are at or near the two ends of the single-stranded oligonucleotide. A luminescent quantum dot moiety is covalently linked to one end of the single-stranded oligonucleotide and a quenching moiety is covalently linked to the other end of the single-stranded oligonucleotide. The stem keeps the luminescent quantum dot and quenching moieties in close proximity to each other so that the luminescence of the quantum dot is quenched when the single-stranded oligonucleotide is not bound to a target sequence. In this regard, the complementary sequences of which the stem is comprised must be sufficiently close to the ends of the oligonucleotide as to effect quenching of the luminescent quantum dot. When the probe sequence encounters a target sequence in a nucleic acid to be detected in a sample, it binds, i.e., hybridizes, to the target sequence, thereby forming a probe-target hybrid that is longer and more stable than the stem hybrid. The length and rigidity of the probe-target hybrid prevents the simultaneous formation of the stem hybrid. As a result, the structure undergoes a spontaneous conformational change that forces the stem to open, thereby separating the quantum dot moiety and the quenching moiety and restoring luminescence.</PDAT></PTEXT></PARA>
<PARA ID="P-00041" LVL="0"><PTEXT><PDAT>Accordingly, the method comprises (a) contacting the sample with a conjugate, in which the biomolecule is a single-stranded oligonucleotide comprising a stem-and-loop structure and in which the hydrophilic attachment group is attached to one end of the single-stranded oligonucleotide and a quenching moiety is attached to the other end of the single-stranded oligonucleotide, such that the quenching moiety quenches the luminescent semiconductor quantum dot, all as described above. The loop comprises a probe sequence that binds to a target sequence in the nucleic acid in the sample. Upon binding, the conjugate undergoes a conformational change that forces the stem to open, thereby separating the quantum dot and the quenching moiety. The method further comprises (b) detecting luminescence. The detection of luminescence indicates that the conjugate bound to the nucleic acid in the sample.</PDAT></PTEXT></PARA>
<PARA ID="P-00042" LVL="0"><PTEXT><PDAT>As shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT>, the present invention provides yet another method of detecting a single-stranded nucleic acid, such as mRNA, cDNA, or denatured double-stranded DNA in a sample, by attachment to a solid support, such as a membrane, glass bead, transparent polymer and the like. The method comprises (a) contacting a sample comprising a first single-stranded nucleic acid with a solid support to which is attached a second single-stranded nucleic acid that can bind to the first single-stranded nucleic acid, (b) contacting the solid support with a conjugate as described above, in which the biomolecule is a third single-stranded nucleic acid that specifically binds to the first single-stranded nucleic acid in a region other than that which is bound by the second single-stranded nucleic acid; and (c) detecting luminescence, wherein the detection of luminescence indicates that the third single-stranded nucleic acid of the conjugate bound to the first single-stranded nucleic acid in the sample.</PDAT></PTEXT></PARA>
<PARA ID="P-00043" LVL="0"><PTEXT><PDAT>Preferably, the second single-stranded nucleic acid is an oligonucleotide capture probe, such as a synthetic thymine (poly-T) or adenosine (poly-A) oligonucleotide. Preferably, the second single-stranded nucleic acid is attached to the solid support by standard crosslinking procedures in accordance with methods known in the art (see, e.g., Joos et al., </PDAT><HIL><ITALIC><PDAT>Anal. Biochem., </PDAT></ITALIC></HIL><PDAT>247, 96-101 (1997); Running et al., </PDAT><HIL><ITALIC><PDAT>BioTechniques, </PDAT></ITALIC></HIL><PDAT>8, 276-277 (1990)). The second single-stranded nucleic acid should be of sufficient length and density on the solid support so as to bind stably and efficiently with the first single-stranded nucleic acid. Preferably, the capture probe is at least about 35 bases in length.</PDAT></PTEXT></PARA>
<PARA ID="P-00044" LVL="0"><PTEXT><PDAT>More broadly, the present invention provides a method of detecting a nucleic acid in a sample. The method comprises attaching a nucleic acid capture probe to a solid support. The nucleic acid capture probe comprises a sequence that binds to the nucleic acid in the sample. The attached nucleic acid capture probe is then contacted with the sample, thereby immobilizing the nucleic acid on the solid support. The method further comprises contacting the immobilized nucleic acid with a conjugate comprising a water-soluble luminescent semiconductor quantum dot and a biomolecule. The biomolecule of the conjugate specifically binds to the nucleic acid. Then, the method comprises detecting luminescence. The detection of luminescence indicates that the conjugate bound to the nucleic acid in the sample.</PDAT></PTEXT></PARA>
<PARA ID="P-00045" LVL="0"><PTEXT><PDAT>The present invention also provides a method whereby two or more different molecules and/or two or more regions on a given molecule can be simultaneously detected in a sample. The method involves using a set of conjugates as described above, wherein each of the conjugates in the set has a differently sized quantum dot or a quantum dot of different composition attached to a biomolecule that specifically binds to a different molecule or a different region on a given molecule in the sample. Preferably, the quantum dots of the conjugates range in size from 1 nm to 10 nm, which sizes allow the emission of luminescence in the range of blue to red. The quantum dot size that corresponds to a particular color emission is well-known in the art. Within this size range, any size variation of quantum dot can be used as long as the differently sized quantum dots can be excited at a single wavelength and differences in the luminescence between the differently sized quantum dots can be detected. Desirably, the differently sized quantum dots have a capping layer that has a narrow and symmetric emission peak. Preferably, the differently sized quantum dots have an inorganic capping layer that matches the structure of the core. More preferably, the differently sized quantum dots have a ZnS or a CdSe capping layer. Similarly, quantum dots of different composition or configuration will vary with respect to particular color emission. Any variation of composition between quantum dots can be used as long as the quantum dots differing in composition can be excited at a single wavelength and differences in the luminescence between the quantum dots of different composition can be detected. Detection of the different target molecules in the sample arises from the emission of multicolored luminescence generated by the quantum dots differing in composition or the differently sized quantum dots of which the set of conjugates is comprised. This method also enables different functional domains of a single protein, for example, to be distinguished.</PDAT></PTEXT></PARA>
<PARA ID="P-00046" LVL="0"><PTEXT><PDAT>Accordingly, the present invention provides a method of simultaneously detecting two or more different molecules and/or two or more regions of a given molecule in a sample. The method comprises contacting the sample with two or more conjugates of a water-soluble luminescent semiconductor quantum dot and a biomolecule, wherein each of the two or more conjugates comprises a quantum dot of a different size or composition and a biomolecule that specifically binds to a different molecule or a different region of a given molecule in the sample. The method further comprises detecting luminescence, wherein the detection of luminescence of a given color is indicative of a conjugate binding to a molecule in the sample.</PDAT></PTEXT></PARA>
<PARA ID="P-00047" LVL="0"><PTEXT><PDAT>In accordance with the present invention, two or more proteins or fragments thereof can be simultaneously detected in a sample. Alternatively, two or more nucleic acids can be simultaneously detected. In this regard, a sample can comprise a mixture of nucleic acids and proteins (or fragments thereof).</PDAT></PTEXT></PARA>
<PARA ID="P-00048" LVL="0"><PTEXT><PDAT>Preferably, in the method of detecting two or more proteins or fragments thereof, the biomolecule of each of the conjugates is a protein or a fragment thereof, such as an antibody or an antigenically reactive fragment thereof, and the proteins or fragments thereof in the sample are antigens or epitopes thereof that are bound by the antibody or the antigenically reactive fragment thereof. Alternatively and also preferably, the biomolecules of each of the conjugates is an antigen or epitope thereof and the proteins or fragments thereof in the sample are antibodies or antigenically reactive fragments thereof that bind to the antigen or epitope thereof. Also preferably, the biomolecule of each of the conjugates is a nucleic acid and the proteins or fragments thereof in the sample are nucleic acid binding proteins, e.g., DNA binding proteins.</PDAT></PTEXT></PARA>
<PARA ID="P-00049" LVL="0"><PTEXT><PDAT>Also, in accordance with the present invention, two or more nucleic acids can be simultaneously detected in a sample. Any of the above-described methods for detecting a nucleic acid in a sample can be used with two or more conjugates comprising differently sized quantum dots attached to biomolecules that can bind to nucleic acids. Accordingly, one method of simultaneously detecting two or more nucleic acids in a sample comprises (a) contacting the sample with two or more conjugates, in which each conjugate comprises a differently sized quantum dot attached to a biomolecule, preferably a nucleic acid, in particular a single-stranded nucleic acid, or a protein or fragment thereof, such as a DNA binding protein, that specifically binds to a target nucleic acid in the sample; and (b) detecting luminescence, wherein the detection of luminescence of a given color indicates that a conjugate bound to its target nucleic acid in the sample.</PDAT></PTEXT></PARA>
<PARA ID="P-00050" LVL="0"><PTEXT><PDAT>Another method of simultaneously detecting two or more nucleic acids in a sample involves using two or more conjugates, each of which comprises a different above-described single-stranded oligonucleotide having a stem-and-loop structure, in accordance with the methods for using such a conjugate as set forth above. Yet another method of simultaneously detecting two or more nucleic acids in a sample involves using the above-described method, wherein the nucleic acids to be detected are attached to a solid support of the kind described above, in accordance with the described methods for attaching a nucleic acid in a sample and the described methods for detecting said nucleic acid as set forth above. One embodiment of this method is depicted in FIG. </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00051" LVL="0"><PTEXT><PDAT>In another embodiment of the inventive method of simultaneously detecting two or more molecules in a sample, the sample comprises at least one nucleic acid and at least one protein or fragment thereof The simultaneous detection of a nucleic acid and a protein or fragment thereof in a sample can be accomplished using the methods described above in accordance with the described methods for detecting a protein or fragment thereof in a sample and the described methods for detecting a nucleic acid in a sample as set forth above.</PDAT></PTEXT></PARA>
<PARA ID="P-00052" LVL="0"><PTEXT><PDAT>The above described conjugates and methods can be adapted for use in numerous other methods and biological systems to effect the detection of a biomolecule. Such methods include, for example, in situ hybridization and the like. The present invention also has broad application for the real-time observation of cellular mechanisms in living cells, e.g. ligand-receptor interaction and molecular trafficking, due to the increased photostability of the quantum dot.</PDAT></PTEXT></PARA>
<PARA ID="P-00053" LVL="0"><PTEXT><PDAT>The present invention has application in various diagnostic assays, including, but not limited to, the detection of viral infection, cancer, cardiac disease, liver disease, genetic diseases, and immunological diseases. The present invention can be used in a diagnostic assay to detect certain viruses, such as HIV and Hepatitis, by, for example, (a) removing a sample to be tested from a patient; (b) contacting the sample with a water-soluble luminescent quantum dot biomolecular conjugate, wherein the biomolecule is an antibody or antigenically reactive fragment thereof that binds to the virus; and (c) detecting the luminescence, wherein the detection of luminescence indicates that the virus is present in the sample. The patient sample can be a bodily fluid, such as saliva, tears, blood, serum or urine. For example, an antibody to HIV gp120 can be used to detect the presence of HIV in a sample; alternatively, HIV gp120 can be used to detect the presence of antibodies to HIV in a sample.</PDAT></PTEXT></PARA>
<PARA ID="P-00054" LVL="0"><PTEXT><PDAT>The present invention also can be used in a diagnostic assay to determine ultra-low-level viral loads of certain viruses, such as HIV and Hepatitis, by detecting the viral nucleic acid. Determining the viral load of a patient is useful in instances where the number of viral particles is below the detection limits of current techniques. For example, this technique can be particularly useful for tracking ultra-low HIV levels in AIDS patients during advanced drug treatment, such as triple drug therapy, in which the viral load of the patient has been greatly reduced. The detection of viral nucleic acid can be accomplished by, for example, (a) removing a sample to be tested from a patient; (b) treating the sample to release the viral DNA or RNA; (c) contacting the sample with a water-soluble luminescent quantum dot biomolecular conjugate, wherein the biomolecule binds to the nucleic acid of the virus; and (d) detecting the luminescence, wherein the detection of luminescence indicates that the virus is present in the sample.</PDAT></PTEXT></PARA>
<PARA ID="P-00055" LVL="0"><PTEXT><PDAT>One embodiment of the inventive method is shown in FIG. </PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT>. Using this method, the detection of viral nucleic acid is accomplished by (a) removing a sample to be tested from a patient; (b) treating the sample to release the viral DNA or RNA; (c) attaching capture probes to a solid support, wherein the capture probes comprise a sequence that binds to the viral nucleic acid in the sample; (d) contacting the attached capture probes with the viral nucleic acid, thereby immobilizing the viral nucleic acid on the solid support; (e) contacting the immobilized viral nucleic acid with a luminescent quantum dot conjugate, wherein the biomolecule of the conjugate specifically binds to the viral nucleic acid; and (f) detecting luminescence, wherein the detection of luminescence indicates that the conjugate bound to the viral nucleic acid in the sample.</PDAT></PTEXT></PARA>
<PARA ID="P-00056" LVL="0"><PTEXT><PDAT>Preferably, the solid support is a glass surface, a transparent polymer surface, a membrane, or the like, to which the capture probe can be attached. The capture probe can be any molecule that is capable of both attaching to the solid support surface and binding to the target viral nucleic acid. Preferably, the capture probe is a singlestranded oligonucleotide comprising a first nucleic acid sequence that binds to a complementary sequence attached to the solid support and a second nucleic acid sequence that binds to a third nucleic acid sequence in the viral genome. The oligonucleotide comprising the first and second nucleic acid sequences can have a length of about 20 to 50 bases. Preferably, the oligonucleotide has a length of at least about 30 bases. Desirably, the third nucleic acid sequence in the viral genome is a conserved sequence.</PDAT></PTEXT></PARA>
<PARA ID="P-00057" LVL="0"><PTEXT><PDAT>The luminescent quantum dot conjugate comprises a luminescent quantum dot attached to a biomolecule that specifically binds to the third sequence of the target viral nucleic acid in a region other than that which is bound by the second sequence of capture probe sequence. The biomolecule can be any molecule that can bind to the target viral nucleic acid. Preferably, the biomolecule is an oligonucleotide that contains a fourth sequence that is complementary to the third sequence in the target viral genome. Alternatively, the biomolecule can be a DNA binding protein that binds specifically to the target viral nucleic acid.</PDAT></PTEXT></PARA>
<PARA ID="P-00058" LVL="0"><PTEXT><PDAT>In addition to the detection of a single virus, the present invention can be used to detect simultaneously the viral load of various types of viruses or the viral load of various sub-types of a single virus by detecting the different species of viral nucleic acid. One method of simultaneously detecting multiple viral nucleic acids in a sample comprises (a) contacting the sample with a set of conjugates, wherein each conjugate of the set comprises a differently sized quantum dot attached to a probe biomolecule that specifically binds to a target viral nucleic acid in the sample; and (b) detecting the multicolored luminescence, wherein the detection of multicolored luminescence indicates that each of the differently conjugates bound to its target viral nucleic acid in the sample. Yet another method of simultaneously detecting two or more nucleic acids in a sample involves using the above-described method, which is also depicted in FIG. </PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00059" LVL="0"><PTEXT><PDAT>The present invention can be used in a similar manner to detect certain disease states, such as, for example, cancer, cardiac disease or liver disease, by (a) removing a sample to be tested from a patient; (b) contacting the sample with a water-soluble luminescent quantum dot biomolecular conjugate, wherein the biomolecule is an antibody or antigenically reactive fragment thereof that binds to a protein associated with a given disease state, wherein the disease is, for example, cancer, cardiac disease or liver disease; and (c) detecting the luminescence, wherein the detection of luminescence indicates the existence of a given disease state. In these cases, the sample can be a cell or tissue biopsy or a bodily fluid, such as blood, serum or urine. The protein can be a marker or enzyme associated with a given disease, the detection of which indicates the existence of a given disease state. The detection of a disease state can be either quantitative, as in the detection of an over- or under-production of a protein, or qualitative, as in the detection of a non-wild-type (mutated or truncated) form of the protein. In regard to quantitative measurements, preferably the luminescence of the quantum dot conjugate-target protein complex is compared to a suitable set of standards. A suitable set of standards comprises, for example, the luminescent quantum dot conjugate of the present invention in contact with various, predetermined concentrations of the target being detected. One of ordinary skill in the art will appreciate that an estimate of, for example, amount of protein in a sample, can be determined by comparison of the luminescence of the sample and the luminescence of the appropriate standards.</PDAT></PTEXT></PARA>
<PARA ID="P-00060" LVL="0"><PTEXT><PDAT>The present invention also can be used to detect a disease state, such as a genetic disease or cancer, by (a) removing a sample to be tested from a patient; (b) contacting the sample with water-soluble luminescent quantum dot biomolecular conjugate, wherein the biomolecule is a nucleic acid that specifically hybridizes with a nucleic acid of interest; and (c) detecting the luminescence, wherein the detection of luminescence indicates the existence of a given disease state. In these cases, the sample can be a derived from a cell, tissue or bodily fluid. The gene of interest can be a marker for a disease-state, such as BRCA</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>, which may indicate the presence of breast cancer.</PDAT></PTEXT></PARA>
<PARA ID="P-00061" LVL="0"><PTEXT><PDAT>The above-described methods also can be adapted for in vivo testing in an animal. The conjugate should be administered to the animal in a biologically acceptable carrier. The route of administration should be one that achieves contact between the conjugate and the biomolecule, e.g., protein or nucleic acid, to be assayed. The in vivo applications are limited only by the means of detecting luminescence. In other words, the site of contact between the conjugate and the biomolecule to be assayed must be accessible by a luminescence detection means. In this regard, fiber optics can be used. Fiber optics enable light emission and detection as needed in the context of the present inventive methods.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLES</PDAT></STEXT></H>
<PARA ID="P-00062" LVL="0"><PTEXT><PDAT>The present invention is described further in the following examples. These examples serve to illustrate further the present invention and are not intended to limit the scope of the invention.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 1</PDAT></STEXT></H>
<PARA ID="P-00063" LVL="0"><PTEXT><PDAT>This example demonstrates how to obtain a water-soluble luminescent quantum dot by attaching an attachment group, one end of which can bind to the cap of a luminescent quantum dot and the other end of which comprises a hydrophilic moiety.</PDAT></PTEXT></PARA>
<PARA ID="P-00064" LVL="0"><PTEXT><PDAT>Quantum dots comprising a CdSe core of 4.2 nm and a ZnS cap were prepared in accordance with the procedure developed by Hines and Guyot-Sionnest (</PDAT><HIL><ITALIC><PDAT>J. Phys. Chem., </PDAT></ITALIC></HIL><PDAT>100, 468-71 (1996)). The quantum dots were dissolved in chloroform and reacted with 1.0 M glacial mercapto-acetic acid for 2 hrs at room temperature with slow stirring. Subsequently,. an equal volume of aqueous PBS, pH 7.4, was added to the reaction mixture with vigorous shaking for 30 mins. Upon spontaneous separation of the chloroform and aqueous layers, the aqueous layer containing the mercapto-coated quantum dots was extracted. The aqueous layer was then centrifuged to pellet the mercapto-coated quantum dots and extracted at least four times to remove excess mercapto-acetic acid. The final pellet was resuspended in 10 ml of PBS, pH 7.4, and stored at room temperature until use. The mercapto-coated quantum dots remained soluble for at least one month.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Comparative Example 1a</PDAT></STEXT></H>
<PARA ID="P-00065" LVL="0"><PTEXT><PDAT>This example demonstrates the preparation of a quantum dot which is not water-soluble.</PDAT></PTEXT></PARA>
<PARA ID="P-00066" LVL="0"><PTEXT><PDAT>Quantum dots having mercaptobenzoic acid groups on the surface thereof were constructed. Mercaptobenzoic acid was dissolved in a solution of 50% DMSO/50% methanol. The pH of the solution was adjusted to 11 by addition of tetramethyl ammonium hydroxide. The final concentration of mercaptobenzoic acid was 5 mM.</PDAT></PTEXT></PARA>
<PARA ID="P-00067" LVL="0"><PTEXT><PDAT>A 1 ml aliquot of the mercaptobenzoic acid solution was added to approximately 1 mg of the ZnS-capped quantum dots prepared as described in Example 1 and heated at 70&deg; C. Although the mercaptobenzoic acid-bound quantum dots had temporarily solubilized, the mercaptobenzoic quantum dots began to aggregate rapidly after approximately one hour. Aggregation of quantum dots out of solution is an indication of instability. The mercaptobenzoic quantum dots were then purified using acetone and subsequently placed in PBS. Again, the quantum dots were unstable and precipitated out of solution after a few hours.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 2</PDAT></STEXT></H>
<PARA ID="P-00068" LVL="0"><PTEXT><PDAT>This example demonstrates how to attach a proteinaceous biomolecule, such as a ligand, to an attachment group on the cap of a luminescent quantum dot by means of a crosslinking agent.</PDAT></PTEXT></PARA>
<PARA ID="P-00069" LVL="0"><PTEXT><PDAT>A 1 ml solution of the purified mercapto-quantum dots of Example 1 was reacted with 2 mg of transferring (Sigma Chemical Co., St. Louis, Mo.) and 1 mg of the crosslinking reagent EDAC (Sigma Chemical Co.) overnight at room temperature while vortexing. The solution was then centrifuged at 50,000 RPM for 1 hr to pellet the quantum dot-transferring bioconjugate and the supernatant was removed. This centrifugation step was repeated twice more. The purified transferring bioconjugates were dissolved in PBS (pH 7.4) and stored at room temperature.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 3</PDAT></STEXT></H>
<PARA ID="P-00070" LVL="0"><PTEXT><PDAT>This example demonstrates how to attach a proteinaceous biomolecule, such as an antibody, to the attachment group on the cap of a luminescent quantum dot by means of a crosslinking agent.</PDAT></PTEXT></PARA>
<PARA ID="P-00071" LVL="0"><PTEXT><PDAT>A 1 ml solution of the purified mercapto-quantum dots of Example 1 was reacted with 2 mg of Immunoglobulin G (IgG) (Sigma Chemical Co.) and 1 mg of EDAC overnight at room temperature while vortexing. The solution was then centrifuged at 50,000 RPM for 1 hr to pellet the quantum dot-immunoglobulin bioconjugate and the supernatant was removed. This centrifugation step was repeated twice more. The purified immunoglobulin bioconjugates were dissolved in PBS (pH 7.4) and stored at room temperature.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 4</PDAT></STEXT></H>
<PARA ID="P-00072" LVL="0"><PTEXT><PDAT>This example demonstrates how to attach a nucleic acid to the attachment group on the cap of a luminescent quantum dot by means of a linker, such as a free amine group.</PDAT></PTEXT></PARA>
<PARA ID="P-00073" LVL="0"><PTEXT><PDAT>A 1 ml solution of the purified mercapto-quantum dots of Example 1 is reacted with 3&prime;- or 5&prime;-amine-modified oligonucleotides (Midland Certified Reagents, Midland, Tex.) and 1 mg of EDAC overnight at room temperature while vortexing. The solution is then centrifuged at 50,000 RPM for 1 hr to pellet the quantum dot-oligonucleotide bioconjugates and the supernatant is removed. This centrifugation step is repeated twice more. The purified oligonucleotide bioconjugates are dissolved in PBS (pH 7.4) and stored at room temperature. Using this approach, a direct linkage is formed between the carboxylic acid group on the quantum dot and an amine group on the nucleic acid.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 5</PDAT></STEXT></H>
<PARA ID="P-00074" LVL="0"><PTEXT><PDAT>This example demonstrates how to attach a nucleic acid biomolecule to an attachment group on the cap of a luminescent quantum dot by means of a linker, such as streptavidin or neutravidin.</PDAT></PTEXT></PARA>
<PARA ID="P-00075" LVL="0"><PTEXT><PDAT>Streptavidin (Sigma Chemical Co.) is covalently linked to the mercapto-quantum dots according to the procedures given in Examples 2 and 3. After coating the quantum dots with streptavidin, biotinylated oligonucleotides (Midland Certified Reagents) are incubated with the streptavidin-coated quantum dots overnight at room temperature with vortexing. The quantum dot-streptavidin-biotinylated-oligonucleotides are purified by centrifugation at 50,000 RPM for 1 hr. The supernatant is discarded and the pellet is redissolved in PBS (pH 7.4). The centrifugation step is repeated twice more. The purified quantum dot-streptavidin-biotinylated-oligonucleotide is dissolved and stored in PBS. The same method can be used substituting neutravidin for streptavidin.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 6</PDAT></STEXT></H>
<PARA ID="P-00076" LVL="0"><PTEXT><PDAT>This example demonstrates the method of using an antibody bioconjugate to detect an antibody in vitro, wherein the method is an immuno-agglutination assay.</PDAT></PTEXT></PARA>
<PARA ID="P-00077" LVL="0"><PTEXT><PDAT>A purified immunoglobulin bioconjugate comprising a water-soluble luminescent quantum dot attached to an immunoglobulin molecule, such as IgG, was prepared by the procedure given in Example 3. The luminescent quantum dot-immunoglobulin bioconjugate was reacted with 0.5 &mgr;g/ml of anti-Fab antibody, which binds to IgG molecules. The reaction mixture was allowed to incubate for one hour at room temperature. The anti-Fab antibody bound to the IgG molecules of the luminescent quantum dot-immunoglobulin bioconjugate, causing the luminescent bioconjugates to agglutinate. Agglutination was determined by detecting the luminescence with an epi-fluorescence microscope equipped with a high-resolution CCD camera (1.4 million pixels, Photometrix, Tuscon, Ariz.) and a 100 W mercury excitation lamp.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 7</PDAT></STEXT></H>
<PARA ID="P-00078" LVL="0"><PTEXT><PDAT>This example demonstrates a method of using a protein bioconjugate to detect an antibody in vitro, wherein the method is an immuno-agglutination assay.</PDAT></PTEXT></PARA>
<PARA ID="P-00079" LVL="0"><PTEXT><PDAT>A purified protein bioconjugate comprising a water-soluble luminescent quantum dot and a proteinaceous biomolecule, such as an antigen, is prepared according to the procedure in Examples 2 and 3. A purified cell lysate is prepared from a blood sample by lysing the cells, centrifuging the sample to pellet the cellular debris, and then extracting the supernatant, which contains the purified cell lysate. The purified cell lysate is incubated with the luminescent quantum dot-antigen bioconjugate. If the antibody of interest is present in the cell lysate sample, it will recognize and bind to the antigen attached to the luminescent quantum dot-antigen conjugate, causing the luminescent quantum dots to agglutinate. Therefore, agglutination of the luminescent quantum dot conjugates indicates the presence of the antibody in the cell lysate sample. Agglutination is determined by luminescence according to the procedure given in Example 6. If desired, duplicate methods can be performed in order to compare the sample to a control. A suitable control includes the addition of the luminescent quantum dot-bioconjugate to a physiologically equivalent composition not comprising the target antibody.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 8</PDAT></STEXT></H>
<PARA ID="P-00080" LVL="0"><PTEXT><PDAT>This example demonstrates a method of using an antibody bioconjugate, to detect a protein in vitro, wherein the method is an immuno-agglutination assay.</PDAT></PTEXT></PARA>
<PARA ID="P-00081" LVL="0"><PTEXT><PDAT>A purified antibody conjugate comprising a water-soluble luminescent quantum dot and an antibody is prepared according to the procedure in Example 3. A purified cell lysate is prepared from a blood or tissue sample according to the procedure given in Example 7. The purified cell lysate is incubated with the luminescent quantum dot-antibody conjugate. If the protein of interest is present in the cell lysate sample, the antibody molecule attached to the luminescent quantum dot-antibody conjugate will recognize and bind to the protein in the sample, causing the luminescent quantum dots to agglutinate. Agglutination, therefore, indicates the presence of the protein in the sample. The degree of agglutination will indicate the concentration of protein present in the cell lysate sample. The degree of agglutination is determined by luminescence according to the procedure given in Example 6. Of course, to estimate the concentration of protein in a sample, the luminescence of the quantum dot-conjugate-protein complex is compared to a series of standards comprising the luminescent quantum dot-bioconjugate of the present invention in contact with predetermined concentrations of target protein.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 9</PDAT></STEXT></H>
<PARA ID="P-00082" LVL="0"><PTEXT><PDAT>This example demonstrates a method of using a protein bioconjugate to detect an antibody in vitro, wherein the method is a direct immunoassay.</PDAT></PTEXT></PARA>
<PARA ID="P-00083" LVL="0"><PTEXT><PDAT>A purified cell lysate is prepared from a blood sample according to the procedure given in Example 7. A purified protein bioconjugate comprising the water-soluble luminescent quantum dot and a proteinaceous biomolecule, such as an antigen, is prepared according to the procedure in Example 2. The chosen attached antigen is one which is specifically recognized by the antibody of interest. A sample of the purified cell lysate is pipetted onto a polystyrene surface and allowed to incubate for two hours at room temperature. The sample is removed and the polystyrene surface is washed with distilled water. To prevent non-specific binding, a 1% solution of Bovine Serum Albumin (BSA) (Sigma Chemical Co.) in PBS is pipetted onto the polystyrene surface and allowed to incubate for one hour at room temperature. After removing the BSA and washing the polystyrene surface with distilled water, the water-soluble luminescent quantum dot-antigen bioconjugate is pipetted onto the polystyrene surface and allowed to incubate. If the antibody of interest is present in the cell-lysate sample, it will recognize and bind to the antigen attached to the luminescent quantum dot-antigen bioconjugate. Luminescence of the quantum dot-antigen bioconjugate is detected by exciting the sample with an Ar</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>/Kr</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> laser at 514 nm.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 10</PDAT></STEXT></H>
<PARA ID="P-00084" LVL="0"><PTEXT><PDAT>This example demonstrates a method of using an antibody bioconjugate to detect a protein in vitro, wherein the method is a sandwich immunoassay.</PDAT></PTEXT></PARA>
<PARA ID="P-00085" LVL="0"><PTEXT><PDAT>A purified cell lysate is prepared from a blood or tissue sample according to the procedure given in Example 7. An antibody bioconjugate comprising the water-soluble luminescent quantum dot and an antibody is prepared according to the procedure given in Example 3. The chosen attached antibody is one which specifically recognizes the protein of interest. First, a &ldquo;capturing&rdquo; antibody which recognizes the protein of interest is pipetted onto a polystyrene surface and allowed to incubate for two hours at room temperature. The antibody is removed and the polystyrene surface is washed with distilled water. To prevent non-specific antibody binding, a 1% solution of BSA in PBS is pipetted onto the polystyrene surface and allowed to incubate for one hour at room temperature. After removing the BSA and washing the polystyrene surface with distilled water, the purified cell lysate is pipetted onto the polystyrene surface and allowed to incubate for two hours at room temperature. If the protein of interest is present in the cell-lysate sample, the &ldquo;capturing&rdquo; antibody will bind the protein. The polystyrene surface is washed with distilled water to remove unbound protein. Finally, the luminescent quantum dotantibody bioconjugate is added and allowed to incubate for two hours at room temperature. If the protein of interest is present, the antibody attached to the luminescent quantum dot-antibody bioconjugate will bind to it. Luminescence of the quantum dot-antibody bioconjugate is detected by exciting the sample with an Ar</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>/Kr</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT> laser at 514 nm.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 11</PDAT></STEXT></H>
<PARA ID="P-00086" LVL="0"><PTEXT><PDAT>This example demonstrates a method of using a nucleic acid bioconjugate to detect a nucleic acid in vitro.</PDAT></PTEXT></PARA>
<PARA ID="P-00087" LVL="0"><PTEXT><PDAT>A purified mRNA sample is prepared from cells or tissue according to methods well-known in the art. The particular mRNA of interest will dictate which method and which cells or tissue will be used to isolate the MRNA. A nucleic acid bioconjugate comprising a water-soluble luminescent quantum dot and a nucleic acid is prepared according to the procedure given in Examples 4, 5, or 14. The attached nucleic acid is comprised of an oligonucleotide sequence which specifically hybridizes to the nucleic acid sequence of interest. An amine-modified polythymidine (Midland Certified Reagents) is covalently attached to a Biodyne C membrane (Pall Gelman Sciences, Ann Arbor, Mich. ) by adding 100 &mgr;l of 0.1 &mgr;M amine-modified poly-thymidine, one strip of the Biodyne C membrane (0.5 cm&times;0.5 cm), and 1 mg of EDAC into a centrifuge tube and allowing the mixture to incubate overnight at room temperature. The next day, the Biodyne C membranes are rinsed with distilled water 3-4 times. The purified mRNA sample is added to the Biodyne C membrane to which the amine-modified poly-thymidine is attached and allowed to incubate for two hours at room temperature. The polyA tail of the mRNA molecules will hybridize with the attached poly-thymidine, allowing the mRNA to be attached to the Biodyne C membrane. The Biodyne C membrane is washed several times with distilled water to remove non-hybridized mRNA. Next, the oligonucleotide bioconjugate, comprising a water-soluble luminescent quantum dot and an oligonucleotide which specifically hybridizes to the mRNA of interest, is reacted with the Biodyne C membrane to which the amine-modified poly-thymidine and mRNA is attached and allowed to incubate overnight at room temperature. If the mRNA of interest is present, the luminescent quantum dot-oligonucleotide bioconjugate will hybridize to it. The Biodyne C membrane is washed several times with distilled water to remove excess non-hybridized luminescent quantum dot-oligonucleotide bioconjugates. Luminescence of the quantum dot-oligonucleotide bioconjugate is detected by exciting the sample with an Ar</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>/Kr</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> laser at 514 nm.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 12</PDAT></STEXT></H>
<PARA ID="P-00088" LVL="0"><PTEXT><PDAT>This example demonstrates a method of using a protein bioconjugate to detect receptor-mediated endocytosis in vivo.</PDAT></PTEXT></PARA>
<PARA ID="P-00089" LVL="0"><PTEXT><PDAT>A biomolecular conjugate comprising the water-soluble luminescent quantum dot and transferrin was prepared according to the procedure given in Example 2. HeLa cells were grown in minimum essential medium (MEM) containing 10% fetal calf serum, 1% penicillin/streptomycin, and fungizone. The cultured cells were incubated with the luminescent quantum dot-transferrin bioconjugates at 37&deg; C. overnight. After repeated washing to remove excess bioconjugate, the cells were removed from the petri dish by trypsinization and placed on a glass coverslip for imaging with an epi-fluorescence microscope equipped with a high-resolution CCD camera (1.4 million pixels, Photometrix) and a 100 W mercury excitation lamp as described in Example 6. Luminescence inside of the HeLa cells indicated that the transferrin of the conjugate was still biologically active and was recognized by transferrin receptors on the HeLa cell surfaces. HeLa cells incubated with the water-soluble luminescent quantum dots of Example 1 were not luminescent. Measurement of the amount of internal luminescence over time enables the determination of the rate of endocytosis.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 13</PDAT></STEXT></H>
<PARA ID="P-00090" LVL="0"><PTEXT><PDAT>This example demonstrates how to attach a proteinaceous biomolecule, such as a ligand, to an attachment group on the cap of a luminescent quantum dot by means of a linker, such as streptavidin or neutravidin.</PDAT></PTEXT></PARA>
<PARA ID="P-00091" LVL="0"><PTEXT><PDAT>Streptavidin (Sigma Chemical Co.) is covalently linked to the mercaptoquantum dots according to the procedures given in Example 2. A protein, such as transferrin, is attached to biotin using the EDAC cross-linking method. The attachment to biotin must occur at an amino acid which can be derivatized with little change in protein activity. A solution of purified streptavidin-coated quantum dots is reacted with the biotinylated transferrin overnight at room temperature while vortexing. The biotinylated transferrin and streptavidin-coated quantum dots can be reacted in a specific molar ratio, such as 1:1, 1:2, etc., so as produce the desired number of protein molecules per quantum dot. The solution is then centrifuged at 50,000 RPM for 1 hr to pellet the quantum dot-transferrin bioconjugate and the supernatant is removed. This centrifugation step is repeated twice more. The purified transferrin bioconjugates are dissolved in PBS (pH 7.4) and stored at room temperature.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 14</PDAT></STEXT></H>
<PARA ID="P-00092" LVL="0"><PTEXT><PDAT>This example demonstrates how to attach a nucleic acid to the attachment group on the cap of a luminescent quantum dot by means of a linker, such as a thiol group.</PDAT></PTEXT></PARA>
<PARA ID="P-00093" LVL="0"><PTEXT><PDAT>Quantum dots comprising a CdSe core of 4.2 nm and a ZnS cap are prepared in accordance with the procedure developed by Hines and Guyot-Sionnest (1996), supra. Thiol-modified oligonucleotides are purchased or prepared using standard synthesis procedures. A 1 ml solution of CdSe(ZnS) quantum dots is reacted with thiol-modified oligonucleotides. The ZnS coat of the quantum dot contains unreacted Zn molecules to which the thiol group of the modified oligonucleotide can bind. The solution is then centrifuged at 50,000 RPM for 1 hr to pellet the quantum dot-oligonucleotide bioconjugates and the supernatant is removed. This centrifugation step is repeated twice more. The purified oligonucleotide bioconjugates are dissolved in PBS (pH 7.4) and stored at room temperature.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 15</PDAT></STEXT></H>
<PARA ID="P-00094" LVL="0"><PTEXT><PDAT>This example demonstrates a method of making a specially designed nucleic acid bioconjugate which further contains a quencher to detect a nucleic acid in vitro.</PDAT></PTEXT></PARA>
<PARA ID="P-00095" LVL="0"><PTEXT><PDAT>The specially designed nucleic acid bioconjugate comprises a single-stranded oligonucleotide having a stem-and-loop structure, a quantum dot moiety, and a quenching moiety. The oligonucleotide is modified to have a primary amine group at the 3&prime; end, which amine-modified oligonucleotide is available from Midland Certified Reagents. Using standard cross-linking procedures, the oligonucleotide is further modified to have a biotin group at the 5&prime; end. A nonfluorescent organic chromophore, 4-&lsqb;4&prime;-dimethylaminophenylazo&rsqb; benzoic acid (DABCYL), is covalently linked to the 3&prime; amino group by using an amino-reactive derivative DABCYL (available from Molecular Probes, Eugene, Oreg.). Quantum dots are first derivatized with strepavidin according to the methods described in Example 2 and then conjugated to the 5&prime; biotin group at a 1:1 molar ratio. The oligonucleotide bioconjugate is purified using gel-filtration columns and HPLC.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 16</PDAT></STEXT></H>
<PARA ID="P-00096" LVL="0"><PTEXT><PDAT>This example demonstrates how to obtain a water-soluble luminescent quantum dot by attaching a mercaptosuccinic attachment group to the cap of a luminescent quantum dot. This example further demonstrates how to attach a nucleic acid to the mercaptosuccinic attachment group by means of a linker, such as a free thiol group.</PDAT></PTEXT></PARA>
<PARA ID="P-00097" LVL="0"><PTEXT><PDAT>Quantum dots comprising a CdSe core of 4.2 nm and a ZnS cap were prepared as described previously. The quantum dots were dissolved in mercaptosuccinic acid (0.5 g/ml, pH 9.0) and allowed to mix for 15-30 mins at room temperature. A series of acetone precipitations at a concentration of 30% acetone/70% quantum dot were preformed to purify sufficiently the hydrophilic luminescent quantum dot. The resulting mercaptosuccinic acid-quantum dots were suspended in 15 mM EDAC solution at pH 6.0.</PDAT></PTEXT></PARA>
<PARA ID="P-00098" LVL="0"><PTEXT><PDAT>A 1 ml solution of the purified mercaptosuccinic-coated luminescent quantum dots was reacted with either 3&prime;- or 5&prime;-thiol-terminated, 15-mer oligonucleotides (Midland Certified Reagents) at a relative concentration of approximately 100 oligonucleotides per quantum dot. The reaction was allowed to proceed for 30-60 mins while mixing. The luminescent quantum dot-DNA conjugates were purified several times by acetone precipitation (30% acetone/70% conjugate). The luminescent quantum dot-DNA conjugates were subsequently stored in a hybridization buffer (0.4 M NaCl, pH 7.0).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 17</PDAT></STEXT></H>
<PARA ID="P-00099" LVL="0"><PTEXT><PDAT>This example demonstrates a method of using a nucleic acid bioconjugate to detect a nucleic acid in vitro.</PDAT></PTEXT></PARA>
<PARA ID="P-00100" LVL="0"><PTEXT><PDAT>Equal aliquots of the 3&prime;- and 5&prime;-thiol-terminated oligonucleotide-luminescent quantum dot conjugates produced as described in Example 16 were suspended in a hybridization buffer (0.4 NaCl, pH 7.0). A complementary 30-mer linker was added to the hybridization buffer at a relative concentration of about one linker for every two luminescent quantum dot conjugates. The 30-mer linker was specifically designed to hybridize with the thiol-terminated 15-mer oligonucleotides of the luminescent quantum dot conjugates. Therefore, if the oligonucleotides of the luminescent quantum dot conjugates retained their biological activity, two quantum dots would hybridize to the linker oligonucleotide and subsequently aggregate as demonstrated in FIG. </PDAT><HIL><BOLD><PDAT>4</PDAT></BOLD></HIL><PDAT>. Hybridization was monitored for 1-12 hours and aggregation of the bioconjugates was observed. Aggregation was imaged using an inverted wide-field Hg lamp excitation and sensitive CCD detection.</PDAT></PTEXT></PARA>
<PARA ID="P-00101" LVL="0"><PTEXT><PDAT>All of the references cited herein, including patents, patent applications and publications, are hereby incorporated in their entireties by reference.</PDAT></PTEXT></PARA>
<PARA ID="P-00102" LVL="0"><PTEXT><PDAT>While this invention has been described with an emphasis upon preferred embodiments, it will be apparent to those of ordinary skill in the art that variations in the preferred embodiments can be prepared and used and that the invention can be practiced otherwise than as specifically described herein. The present invention is intended to include such variations and alternative practices. Accordingly, this invention includes all modifications encompassed within the spirit and scope of the invention as defined by the following claims.</PDAT></PTEXT></PARA>
</BTEXT>
</DETDESC>
</SDODE>
<SDOCL>
<H LVL="1"><STEXT><PDAT>What is claimed is: </PDAT></STEXT></H>
<CL>
<CLM ID="CLM-00001">
<PARA ID="P-00103" LVL="0"><PTEXT><PDAT>1. A water-soluble luminescent semiconductor quantum dot, which comprises a core, a cap and a hydrophilic attachment group, wherein said hydrophilic attachment group is an organic group comprising a sulfur atom and at least one hydrophilic substituent selected from the group consisting of a sulfonic acid or salt thereof, a sulfamic acid or salt thereof, a quaternary ammonium salt, and a hydroxy, wherein the water-soluble luminescent semiconductor quantum dot remains in solution for at least one day.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00002">
<PARA ID="P-00104" LVL="0"><PTEXT><PDAT>2. The water-soluble luminescent semiconductor quantum dot of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the hydrophilic attachment group is attached to said quantum dot via the sulfur atom.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00003">
<PARA ID="P-00105" LVL="0"><PTEXT><PDAT>3. The water-soluble luminescent semiconductor quantum dot of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said organic group is a C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>6 </PDAT></SB></HIL><PDAT>alkyl group or an aryl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00004">
<PARA ID="P-00106" LVL="0"><PTEXT><PDAT>4. The water-soluble luminescent semiconductor quantum dot of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said organic group is a C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>6 </PDAT></SB></HIL><PDAT>alkyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00005">
<PARA ID="P-00107" LVL="0"><PTEXT><PDAT>5. The water-soluble luminescent semiconductor quantum dot of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said hydrophilic attachment group is a thiol alcohol.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00006">
<PARA ID="P-00108" LVL="0"><PTEXT><PDAT>6. The water-soluble luminescent semiconductor quantum dot of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the core of the quantum dot is selected from the group consisting of IIB-VIB semiconductors, IIIB-VB semiconductors, and IVB-IVB semiconductors and the size of the core is from about 1 nm to about 10 nm.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00007">
<PARA ID="P-00109" LVL="0"><PTEXT><PDAT>7. The water-soluble luminescent semiconductor quantum dot of </PDAT><CLREF ID="CLM-00006"><PDAT>claim 6</PDAT></CLREF><PDAT>, wherein the core of the quantum dot is selected from the group consisting of IIB-VIB semiconductors and the size of the core is from about 2 nm to about 5 nm.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00008">
<PARA ID="P-00110" LVL="0"><PTEXT><PDAT>8. The water-soluble luminescent semiconductor quantum dot of </PDAT><CLREF ID="CLM-00007"><PDAT>claim 7</PDAT></CLREF><PDAT>, wherein the core of the quantum dot is CdS or CdSe.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00009">
<PARA ID="P-00111" LVL="0"><PTEXT><PDAT>9. The water-soluble luminescent semiconductor quantum dot of </PDAT><CLREF ID="CLM-00008"><PDAT>claim 8</PDAT></CLREF><PDAT>, wherein the core of the quantum dot is CdSe.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00010">
<PARA ID="P-00112" LVL="0"><PTEXT><PDAT>10. The water-soluble luminescent semiconductor quantum dot of </PDAT><CLREF ID="CLM-00008"><PDAT>claim 8</PDAT></CLREF><PDAT>, wherein the cap is ZnS.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00011">
<PARA ID="P-00113" LVL="0"><PTEXT><PDAT>11. The water-soluble luminescent semiconductor quantum dot of </PDAT><CLREF ID="CLM-00009"><PDAT>claim 9</PDAT></CLREF><PDAT>, wherein the size of the core is about 4.2 nm.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00012">
<PARA ID="P-00114" LVL="0"><PTEXT><PDAT>12. The water-soluble luminescent semiconductor quantum dot of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the cap is selected from the group consisting of IIB-VIB semiconductors of high band gap.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00013">
<PARA ID="P-00115" LVL="0"><PTEXT><PDAT>13. The water-soluble luminescent semiconductor quantum dot of </PDAT><CLREF ID="CLM-00012"><PDAT>claim 12</PDAT></CLREF><PDAT>, wherein the cap is ZnS.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00014">
<PARA ID="P-00116" LVL="0"><PTEXT><PDAT>14. The water-soluble luminescent semiconductor quantum dot of </PDAT><CLREF ID="CLM-00012"><PDAT>claim 12</PDAT></CLREF><PDAT>, wherein the cap is CdS.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00015">
<PARA ID="P-00117" LVL="0"><PTEXT><PDAT>15. The water-soluble luminescent quantum dot of </PDAT><CLREF ID="CLM-00009"><PDAT>claim 9</PDAT></CLREF><PDAT>, wherein the cap is CdS.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00016">
<PARA ID="P-00118" LVL="0"><PTEXT><PDAT>16. A composition comprising the water-soluble luminescent semiconductor quantum dot of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT> and an aqueous carrier.</PDAT></PTEXT></PARA>
</CLM>
</CL>
</SDOCL>
<SDODR ID="DRAWINGS">
<EMI ID="EMI-D00001" ALT="embedded image" FILE="US06468808-20021022-D00001.TIF"/>
<EMI ID="EMI-D00002" ALT="embedded image" FILE="US06468808-20021022-D00002.TIF"/>
<EMI ID="EMI-D00003" ALT="embedded image" FILE="US06468808-20021022-D00003.TIF"/>
<EMI ID="EMI-D00004" ALT="embedded image" FILE="US06468808-20021022-D00004.TIF"/>
</SDODR>
</PATDOC>

<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PATDOC SYSTEM "ST32-US-Grant-025xml.dtd" [
<!ENTITY US06469788-20021022-M00001.NB SYSTEM "US06469788-20021022-M00001.NB" NDATA NB>
<!ENTITY US06469788-20021022-M00001.TIF SYSTEM "US06469788-20021022-M00001.TIF" NDATA TIF>
<!ENTITY US06469788-20021022-M00002.NB SYSTEM "US06469788-20021022-M00002.NB" NDATA NB>
<!ENTITY US06469788-20021022-M00002.TIF SYSTEM "US06469788-20021022-M00002.TIF" NDATA TIF>
<!ENTITY US06469788-20021022-D00000.TIF SYSTEM "US06469788-20021022-D00000.TIF" NDATA TIF>
<!ENTITY US06469788-20021022-D00001.TIF SYSTEM "US06469788-20021022-D00001.TIF" NDATA TIF>
<!ENTITY US06469788-20021022-D00002.TIF SYSTEM "US06469788-20021022-D00002.TIF" NDATA TIF>
<!ENTITY US06469788-20021022-D00003.TIF SYSTEM "US06469788-20021022-D00003.TIF" NDATA TIF>
]>
<PATDOC DTD="2.5" STATUS="Build 20020918">
<SDOBI>
<B100>
<B110><DNUM><PDAT>06469788</PDAT></DNUM></B110>
<B130><PDAT>B2</PDAT></B130>
<B140><DATE><PDAT>20021022</PDAT></DATE></B140>
<B190><PDAT>US</PDAT></B190>
</B100>
<B200>
<B210><DNUM><PDAT>09820094</PDAT></DNUM></B210>
<B211US><PDAT>09</PDAT></B211US>
<B220><DATE><PDAT>20010327</PDAT></DATE></B220>
</B200>
<B500>
<B510>
<B511><PDAT>G01J  400</PDAT></B511>
<B512><PDAT>G01B 1106</PDAT></B512>
<B516><PDAT>7</PDAT></B516>
</B510>
<B520>
<B521><PDAT>356369</PDAT></B521>
<B522><PDAT>356630</PDAT></B522>
<B522><PDAT>356 73</PDAT></B522>
</B520>
<B540><STEXT><PDAT>Coherent gradient sensing ellipsometer</PDAT></STEXT></B540>
<B560>
<B561>
<PCIT>
<DOC><DNUM><PDAT>3985447</PDAT></DNUM>
<DATE><PDAT>19761000</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Aspnes</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4053232</PDAT></DNUM>
<DATE><PDAT>19771000</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Dill et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5232547</PDAT></DNUM>
<DATE><PDAT>19930800</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Drowley et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>356357</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5517312</PDAT></DNUM>
<DATE><PDAT>19960500</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Finarov</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>6031611</PDAT></DNUM>
<DATE><PDAT>20000200</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Rosakis et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
</B560>
<B570>
<B577><PDAT>29</PDAT></B577>
<B578US><PDAT>1</PDAT></B578US>
</B570>
<B580>
<B582><PDAT>356369</PDAT></B582>
<B583US><PDAT>356364-368</PDAT></B583US>
<B582><PDAT>356601</PDAT></B582>
<B582><PDAT>356602</PDAT></B582>
<B582><PDAT>356612</PDAT></B582>
<B582><PDAT>356630</PDAT></B582>
<B582><PDAT>356631</PDAT></B582>
<B582><PDAT>356632</PDAT></B582>
<B582><PDAT>356451</PDAT></B582>
<B582><PDAT>356453</PDAT></B582>
<B582><PDAT>356 73</PDAT></B582>
<B582><PDAT>250225</PDAT></B582>
<B582><PDAT>25055922</PDAT></B582>
<B582><PDAT>25055923</PDAT></B582>
<B582><PDAT>25055927</PDAT></B582>
</B580>
<B590><B595><PDAT>3</PDAT></B595><B596><PDAT>3</PDAT></B596><B597US/>
</B590>
</B500>
<B600>
<B680US><DOC><DNUM><PDAT>60/192648</PDAT></DNUM><DATE><PDAT>20000327</PDAT></DATE><KIND><PDAT>00</PDAT></KIND></DOC></B680US>
<B690US>
<DOC>
<DNUM><PDAT>20020012122</PDAT></DNUM>
<DATE><PDAT>20020131</PDAT></DATE>
<CTRY><PDAT>US</PDAT></CTRY>
<KIND><PDAT>A1</PDAT></KIND>
</DOC>
</B690US></B600>
<B700>
<B720>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>David A.</PDAT></FNM><SNM><STEXT><PDAT>Boyd</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>South Pasadena</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Ares J.</PDAT></FNM><SNM><STEXT><PDAT>Rosakis</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Altadena</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>David M.</PDAT></FNM><SNM><STEXT><PDAT>Owen</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Redondo Beach</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
</B720>
<B730>
<B731>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>California Institute of Technology</PDAT></STEXT></ONM></NAM>
<ADR><CITY><PDAT>Pasadena</PDAT></CITY><STATE><PDAT>CA</PDAT></STATE></ADR>
</PARTY-US>
</B731>
<B732US>
<PDAT>02</PDAT>
</B732US>
</B730>
<B740>
<B741>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Fish &amp; Richardson P.C.</PDAT></STEXT></ONM></NAM>
</PARTY-US>
</B741>
</B740>
<B745>
<B746>
<PARTY-US>
<NAM><FNM><PDAT>Hoa Q.</PDAT></FNM><SNM><STEXT><PDAT>Pham</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B746>
<B748US><PDAT>2877</PDAT></B748US>
</B745>
</B700>
</SDOBI>
<SDOAB>
<BTEXT>
<PARA ID="P-00001" LVL="0"><PTEXT><PDAT>Systems and techniques for integrating an optical coherent gradient sensing (CGS) module and another optical sensing module to simultaneously measure the curvature and another property of a specularly reflective surface.</PDAT></PTEXT></PARA>
</BTEXT>
</SDOAB>
<SDODE>
<RELAPP>
<BTEXT>
<PARA ID="P-00002" LVL="0"><PTEXT><PDAT>This application claims the benefit of U.S. Provisional Application No. Ser. No. 60/192,648, filed on Mar. 27, 2000.</PDAT></PTEXT></PARA>
</BTEXT>
</RELAPP>
<GOVINT>
<BTEXT>
<PARA ID="P-00003" LVL="0"><PTEXT><PDAT>The U.S. Government may have certain rights in this invention pursuant to Grant No. DMS-9615858 awarded by NSF/DARPA.</PDAT></PTEXT></PARA>
</BTEXT>
</GOVINT>
<BRFSUM>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BACKGROUND</PDAT></STEXT></H>
<PARA ID="P-00004" LVL="0"><PTEXT><PDAT>This application relates to optical detection of properties of a material or structure with a reflective surface.</PDAT></PTEXT></PARA>
<PARA ID="P-00005" LVL="0"><PTEXT><PDAT>An optical beam may be used as a probe to detect properties of various materials and structures that can interact with the optical beam. In particular, optical reflection of the optical probe beam from a reflective surface of a structure may be measured and processed to determine certain properties of that surface. For example, material parameters such as the optical absorption coefficient or the refractive index of the material that forms the surface may be measured from the optical reflection. Also, geometrical parameters of the surface, such as the thickness of a thin film that is at least partially transparent, or the curvature of the reflective surface, may be measured from the optical reflection.</PDAT></PTEXT></PARA>
<PARA ID="P-00006" LVL="0"><PTEXT><PDAT>Optical detection may achieve certain advantages. For example, when the power of the probe beam can be kept at a sufficiently low power level, the optical detection can be non destructive or evasive so that the properties of the measured object may be preserved. The probe beam may also be expanded to illuminate an area of a target object so that each location in the entire illuminated area may be measured at the same time. Optical detection may also be used to achieve full-field measurements at high speeds or with high accuracy.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>SUMMARY</PDAT></STEXT></H>
<PARA ID="P-00007" LVL="0"><PTEXT><PDAT>This application includes techniques and systems that integrate an optical coherent gradient sensing (CGS) module and another optical sensing module such as an optical ellipsometer to use a single probe beam to simultaneously measure properties of a specularly reflective surface. A collimated coherent optical probe beam is used to illuminate a target area on the reflective surface to obtain information on each location within the illuminated target area for measurements of both the ellipsometer and the CGS module. The reflected beam is split into a first part for the ellipsometry measurements and a second part for the CGS measurements. The ellipsometer operates to determine the optical properties of the sample. For example, refractive indices, the absorption coefficient of a thin film formed on a substrate, or the thickness of the thin film, among others, may be determined. The CGS module operates to determine the surface curvature of each location of the illuminated area. Notably, the material properties and the surface curvature of each location within the illuminated area are measured at the same location and time by extracting information from the same reflected beam from the surface under measurement. Measurements at different locations within the illuminated area are made at the same time.</PDAT></PTEXT></PARA>
</BTEXT>
</BRFSUM>
<DRWDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BRIEF DESCRIPTION OF THE DRAWINGS</PDAT></STEXT></H>
<PARA ID="P-00008" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> illustrates the optical layout of an optical coherent gradient sensing (CGS) ellipsometer according to one embodiment.</PDAT></PTEXT></PARA>
<PARA ID="P-00009" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT> illustrates the operation of the coherent gradient sensing module for extracting curvature information from the reflected beam by using two identical gratings aligned parallel to each other.</PDAT></PTEXT></PARA>
<PARA ID="P-00010" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 3</PDAT></FGREF><PDAT> shows another embodiment of the CGS detector having two optical arms for two different shearing directions.</PDAT></PTEXT></PARA>
</BTEXT>
</DRWDESC>
<DETDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>DETAILED DESCRIPTION</PDAT></STEXT></H>
<PARA ID="P-00011" LVL="0"><PTEXT><PDAT>Ellipsometry measures a change in the state of polarization of a reflected or transmitted beam from the state of polarization of an incident beam caused by reflection or transmission of a sample material. When the reflected beam is measured, the surface of the sample material is generally a specularly reflective surface. This change in the state of polarization may be represented by two parameters, the amplitude and the phase of the complex reflectance ratio of the illuminated spot. When the reflective surface is a bare substrate, ellipsometry may be used to determine the refractive index and absorption coefficient of the substrate. If the reflective surface includes a thin dielectric film formed over a substrate, then two unknown parameters of the film and the substrate may be determined. For example, the two parameters may be any two of the refractive indices and absorption coefficients of the film and the substrate and the thickness of the substrate.</PDAT></PTEXT></PARA>
<PARA ID="P-00012" LVL="0"><PTEXT><PDAT>The ellipsometry technique may be used with an expanded and collimated optical beam for illuminating a target area so that an ellipsometric image may be obtained from the reflected beam to represent the change in polarization caused by different spots in the illuminated target area. See, e.g., Jin et al., Imaging Ellipsometry Revisited: Developments for Visualization of Thin Transparent Layers on Silicon Substrate, Review of Scientific Instruments, Vol. 67(8), 2930-2936 (August, 1996). This full-field imaging technique may be used to eliminate the need for scanning the probe beam over a target area to measure one location at a time and to increase the processing speed.</PDAT></PTEXT></PARA>
<PARA ID="P-00013" LVL="0"><PTEXT><PDAT>Ellipsometry by itself, however, cannot measure the surface curvature of the illuminated spot. The surface curvature is an important parameter in part because it can be used to analyze surface stress caused by a change in temperature or integration of parts with different mechanical, physical and thermal properties. Stresses may lead to degradation or even failure in device performance and adversely affect the long-term reliability of some integrated devices such as integrated circuits, electro-optical devices, and MEMS devices which typically include multiple layers of dielectrics and metals on a semiconductor substrate.</PDAT></PTEXT></PARA>
<PARA ID="P-00014" LVL="0"><PTEXT><PDAT>In addition, the curved surfaces can also pose problems for determining the ellipsometric parameters. For example, for certain materials such as Si, the ellipsometric parameters are strong functions of the angle of incidence, especially near the Brewster angle. For full field ellipsometry in applications, it is generally difficult to accurately determine the ellipsometric parameters without knowing the curvature of the surface. For example, if an initially highly collimated incident beam and the sample surface is flat, the incident angle is known. When the sample surface is locally curved, different rays of the collimated input beam may have different incident angles that vary from location to location throughout the incident beam. The curvature of the sample surface is needed in order to determine the incident angles at different locations on the surface and hence to obtain proper ellipsometric parameters.</PDAT></PTEXT></PARA>
<PARA ID="P-00015" LVL="0"><PTEXT><PDAT>The curvature measurement may be implemented simultaneously by using an optical coherent gradient sensing (CGS) technique where the wavefront of a reflected beam is processed to obtain the curvature information of the illuminated spot. U.S. Pat. No.6,031,611 to Rosakis et al. When the reflective surface is curved, the wavefront of the reflected probe beam is distorted and thereby the reflected probe beam acquires an optical path difference or phase change associated with the curvature of the surface under measurement. A first grating diffracts the reflected probe beam to spatially separate diffraction components of different spatial frequencies. A second grating further diffracts each diffraction component produced by the first grating. An optical element (e.g., a lens) is positioned relative to the second grating and combines two selected diffraction components produced by the second grating by diffracting two different diffraction components produced by the first grating. The two selected diffraction components are substantially parallel to each other and are directed to overlap and interfere with each other to produce an interference pattern. The diffraction by the two gratings effectuates a relative spatial displacement between the two selected diffraction components. This allows for extraction of a spatial gradient of the phase distortion caused by the curvature of the reflective surface from the interference pattern. This spatial gradient, in turn, can be further processed to obtain the curvature information.</PDAT></PTEXT></PARA>
<PARA ID="P-00016" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> shows one embodiment </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT> of an optical coherent gradient sensing (CGS) ellipsometer based on a combination of the ellisometry and the CGS technique. A sample stage </PDAT><HIL><BOLD><PDAT>101</PDAT></BOLD></HIL><PDAT> is used to hold a specimen surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> which is specularly reflective and not optically diffusive. The reflective specimen surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> can be a uniformly smooth or polished surface or have reflective segments to form patterns and structures therein.</PDAT></PTEXT></PARA>
<PARA ID="P-00017" LVL="0"><PTEXT><PDAT>A light source </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT> such as a laser produces a coherent optical probe beam </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT>A. A polarizer 104 and an optical phase compensator </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> are placed in the optical path of the beam </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT>A to control the polarization of the input beam </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT>A. An optical collimator </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> is positioned between the compensator </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> and the sample stage </PDAT><HIL><BOLD><PDAT>101</PDAT></BOLD></HIL><PDAT> to collimate and expand the beam </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT>A to produce an expanded, collimated probe beam </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>A. The incident angle of the beam </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>A is controlled at a desired angle to facilitate the measurements. The specimen surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> reflects the probe beam </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>A to produce a reflected probe beam </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00018" LVL="0"><PTEXT><PDAT>A beam splitter </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> is placed in the optical path of the reflected probe beam </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> to split a portion of the reflected beam </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> as a first beam </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT>A to an ellisometry detector </PDAT><HIL><BOLD><PDAT>133</PDAT></BOLD></HIL><PDAT> for ellisometry measurements. The remaining portion of the reflected probe beam </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT>, still represented by the numeral </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT>, is directed into a CGS detector </PDAT><HIL><BOLD><PDAT>134</PDAT></BOLD></HIL><PDAT> for the CGS measurements. This system allows for the simultaneous monitoring of the curvature of the surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> and a change in the polarization state of the reflected beam caused by the surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00019" LVL="0"><PTEXT><PDAT>The ellipsometry detector </PDAT><HIL><BOLD><PDAT>133</PDAT></BOLD></HIL><PDAT> may include a polarization analyzer </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT> and a photosensitive detector array </PDAT><HIL><BOLD><PDAT>122</PDAT></BOLD></HIL><PDAT> such as a CCD array. For a given set of angles for the polarizer </PDAT><HIL><BOLD><PDAT>104</PDAT></BOLD></HIL><PDAT> and the analyzer </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT>, the spatial power variation in the transmitted beam </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT>A through the analyzer </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT> represents a spatial variation in a non-curvature property of the specimen surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>, such as a thickness of a thin film, a refractive index, an optical absorption coefficient of the film, or a combination thereof. The detector array </PDAT><HIL><BOLD><PDAT>122</PDAT></BOLD></HIL><PDAT> includes an array of sensing pixels. Each sensing pixel uniquely corresponds to a spatial location in the illuminated area of the surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> and receives reflected light from that location. Therefore, the pixel signals of the detector array </PDAT><HIL><BOLD><PDAT>122</PDAT></BOLD></HIL><PDAT> represent an ellipsometry image of the illuminated area in the surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>. A lens imaging system </PDAT><HIL><BOLD><PDAT>121</PDAT></BOLD></HIL><PDAT> may be positioned in the optical path between the array </PDAT><HIL><BOLD><PDAT>122</PDAT></BOLD></HIL><PDAT> and the polarizer </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT> to reduce the image size.</PDAT></PTEXT></PARA>
<PARA ID="P-00020" LVL="0"><PTEXT><PDAT>The CGS detector </PDAT><HIL><BOLD><PDAT>134</PDAT></BOLD></HIL><PDAT>, although receiving essentially the same beam as the ellipsometry detector </PDAT><HIL><BOLD><PDAT>133</PDAT></BOLD></HIL><PDAT>, is configured to extract completely different information content in the reflected probe beam </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT>. A pair of gratings, </PDAT><HIL><BOLD><PDAT>140</PDAT></BOLD></HIL><PDAT> (G</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>) and </PDAT><HIL><BOLD><PDAT>150</PDAT></BOLD></HIL><PDAT> (G</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) are separated from each other by a specified distance, &Dgr;, and are placed in the optical path of the beam </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT>. The reflected probe beam </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> is diffracted by the gratings </PDAT><HIL><BOLD><PDAT>140</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>150</PDAT></BOLD></HIL><PDAT> to produce multiple diffracted orders. An optical element </PDAT><HIL><BOLD><PDAT>160</PDAT></BOLD></HIL><PDAT> is positioned relative to the grating </PDAT><HIL><BOLD><PDAT>150</PDAT></BOLD></HIL><PDAT> to combine at least two selected diffraction orders produced by the grating </PDAT><HIL><BOLD><PDAT>150</PDAT></BOLD></HIL><PDAT> by diffracting two different diffraction orders produced by the grating </PDAT><HIL><BOLD><PDAT>140</PDAT></BOLD></HIL><PDAT>. The two selected diffraction components interfere with each other to produce an interference pattern. A lens may be used as the optical element </PDAT><HIL><BOLD><PDAT>160</PDAT></BOLD></HIL><PDAT> to select certain diffraction orders produced by the grating </PDAT><HIL><BOLD><PDAT>150</PDAT></BOLD></HIL><PDAT> to form distinct diffraction spots on a filter plane </PDAT><HIL><BOLD><PDAT>170</PDAT></BOLD></HIL><PDAT> which is spaced from the lens by about its focal length.</PDAT></PTEXT></PARA>
<PARA ID="P-00021" LVL="0"><PTEXT><PDAT>A spatial filter </PDAT><HIL><BOLD><PDAT>172</PDAT></BOLD></HIL><PDAT>, such as an aperture as shown, is placed in the filter plane </PDAT><HIL><BOLD><PDAT>170</PDAT></BOLD></HIL><PDAT> to select a diffraction order of interest and block other signals. The selected diffraction order is then imaged through an imaging lens onto a photosensing device which may include a semiconductor photosensing array of multiple photosensing pixels (e.g., a CCD array) or a photosensing medium (e.g., a photographic film). A camera </PDAT><HIL><BOLD><PDAT>180</PDAT></BOLD></HIL><PDAT> is shown to represent a combination of the imaging lens and the photosensing medium. The imaging lens may be used to reduce the image size. The output signal from the camera </PDAT><HIL><BOLD><PDAT>180</PDAT></BOLD></HIL><PDAT> is processed by a signal processor </PDAT><HIL><BOLD><PDAT>190</PDAT></BOLD></HIL><PDAT> to extract the curvature information. The signal processor may include a microprocessor which is programmed to perform the data processing. The operation of the light source </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> may also be controlled by the signal processor.</PDAT></PTEXT></PARA>
<PARA ID="P-00022" LVL="0"><PTEXT><PDAT>The wavefront of the reflected probe beam </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> is modified by the specimen surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> and has information on the surface curvature. The diffraction by the two gratings </PDAT><HIL><BOLD><PDAT>140</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>150</PDAT></BOLD></HIL><PDAT> effects a relative spatial displacement between the two selected diffraction orders produced by the grating </PDAT><HIL><BOLD><PDAT>150</PDAT></BOLD></HIL><PDAT>. This allows for extraction of a spatial gradient of the phase distortion caused by the curvature of the reflective surface from the interference pattern. This spatial gradient, in turn, can be further processed to obtain the curvature information.</PDAT></PTEXT></PARA>
<PARA ID="P-00023" LVL="0"><PTEXT><PDAT>The two gratings </PDAT><HIL><BOLD><PDAT>140</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>150</PDAT></BOLD></HIL><PDAT> in general may be any gratings, with different grating periods and oriented with respect to each other at any angle. Preferably, the two gratings may be oriented with respect to each other in the same direction and may have the same grating periods to simplify the data processing.</PDAT></PTEXT></PARA>
<PARA ID="P-00024" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT> illustrates the operating mechanism of the CGS detector </PDAT><HIL><BOLD><PDAT>134</PDAT></BOLD></HIL><PDAT> shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> in two dimensions by using two identical gratings </PDAT><HIL><BOLD><PDAT>140</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>150</PDAT></BOLD></HIL><PDAT> aligned parallel to each other. Consider a Cartesian coordinate system (x</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>, x</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, x</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>) in which the x</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>axis is parallel to the grating rulings of both the gratings </PDAT><HIL><BOLD><PDAT>140</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>150</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00025" LVL="0"><PTEXT><PDAT>The grating </PDAT><HIL><BOLD><PDAT>140</PDAT></BOLD></HIL><PDAT> (G</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>) diffracts the reflected probe beam </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> into several diffraction waves denoted as E</PDAT><HIL><SB><PDAT>0</PDAT></SB></HIL><PDAT>, E</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>, E</PDAT><HIL><SB><PDAT>&minus;1</PDAT></SB></HIL><PDAT>, E</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, E</PDAT><HIL><SB><PDAT>&minus;2</PDAT></SB></HIL><PDAT>, etc. For illustrative purpose, only the first three diffraction orders, i.e., zero-order wave </PDAT><HIL><BOLD><PDAT>144</PDAT></BOLD></HIL><PDAT> (E</PDAT><HIL><SB><PDAT>0</PDAT></SB></HIL><PDAT>), &plus;1-order </PDAT><HIL><BOLD><PDAT>142</PDAT></BOLD></HIL><PDAT> (E</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>), and &minus;1-order wave </PDAT><HIL><BOLD><PDAT>146</PDAT></BOLD></HIL><PDAT> (E</PDAT><HIL><SB><PDAT>31 1</PDAT></SB></HIL><PDAT>) are shown. Each of these wave fronts is further diffracted by the second grating </PDAT><HIL><BOLD><PDAT>150</PDAT></BOLD></HIL><PDAT> (G</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) to generate multiple wavefronts. For example, the &plus;1-order </PDAT><HIL><BOLD><PDAT>142</PDAT></BOLD></HIL><PDAT> (E</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>) is diffracted to produce wavefronts </PDAT><HIL><BOLD><PDAT>142</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>a </PDAT></ITALIC></HIL><PDAT>(E</PDAT><HIL><SB><PDAT>1,1</PDAT></SB></HIL><PDAT>), </PDAT><HIL><BOLD><PDAT>142</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>b </PDAT></ITALIC></HIL><PDAT>(E</PDAT><HIL><SB><PDAT>1,0</PDAT></SB></HIL><PDAT>), </PDAT><HIL><BOLD><PDAT>142</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>c </PDAT></ITALIC></HIL><PDAT>(E</PDAT><HIL><SB><PDAT>1,&minus;1</PDAT></SB></HIL><PDAT>), etc.; zero-order </PDAT><HIL><BOLD><PDAT>144</PDAT></BOLD></HIL><PDAT> (E</PDAT><HIL><SB><PDAT>0</PDAT></SB></HIL><PDAT>) is diffracted to produce wavefronts </PDAT><HIL><BOLD><PDAT>144</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>a </PDAT></ITALIC></HIL><PDAT>(E</PDAT><HIL><SB><PDAT>0,1</PDAT></SB></HIL><PDAT>), </PDAT><HIL><BOLD><PDAT>144</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>b </PDAT></ITALIC></HIL><PDAT>(E</PDAT><HIL><SB><PDAT>0,0</PDAT></SB></HIL><PDAT>), </PDAT><HIL><BOLD><PDAT>144</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>c </PDAT></ITALIC></HIL><PDAT>(E</PDAT><HIL><SB><PDAT>0,&minus;1</PDAT></SB></HIL><PDAT>), etc.; and &minus;1-order </PDAT><HIL><BOLD><PDAT>146</PDAT></BOLD></HIL><PDAT> (E</PDAT><HIL><SB><PDAT>&minus;1</PDAT></SB></HIL><PDAT>) is diffracted to produce wavefronts </PDAT><HIL><BOLD><PDAT>146</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>a </PDAT></ITALIC></HIL><PDAT>(E</PDAT><HIL><SB><PDAT>&minus;1,1</PDAT></SB></HIL><PDAT>), </PDAT><HIL><BOLD><PDAT>146</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>b </PDAT></ITALIC></HIL><PDAT>(E</PDAT><HIL><SB><PDAT>&minus;1,0</PDAT></SB></HIL><PDAT>), </PDAT><HIL><BOLD><PDAT>146</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>c </PDAT></ITALIC></HIL><PDAT>(E</PDAT><HIL><SB><PDAT>&minus;1,&minus;1</PDAT></SB></HIL><PDAT>), etc.</PDAT></PTEXT></PARA>
<PARA ID="P-00026" LVL="0"><PTEXT><PDAT>Certain diffracted beams generated by the grating </PDAT><HIL><BOLD><PDAT>150</PDAT></BOLD></HIL><PDAT> from different diffraction orders generated by the grating </PDAT><HIL><BOLD><PDAT>140</PDAT></BOLD></HIL><PDAT> are parallel since the two gratings </PDAT><HIL><BOLD><PDAT>140</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>150</PDAT></BOLD></HIL><PDAT> are identical. This could also occur when the ratio of the grating periods of the two gratings </PDAT><HIL><BOLD><PDAT>140</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>150</PDAT></BOLD></HIL><PDAT> is an integer. Under such conditions, a lens can be conveniently used as the optical element </PDAT><HIL><BOLD><PDAT>160</PDAT></BOLD></HIL><PDAT> to overlap various sets of parallel diffracted beams emerged from the grating </PDAT><HIL><BOLD><PDAT>150</PDAT></BOLD></HIL><PDAT> with one another at or near the filtering plane </PDAT><HIL><BOLD><PDAT>170</PDAT></BOLD></HIL><PDAT> to form multiple diffraction spots. These diffraction spots have interference fringes due to the interference of the overlapped beams. The interference fringes have information indicative of the gradient of the phase distortion in the wavefront of the reflected probe beam </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00027" LVL="0"><PTEXT><PDAT>For example, the zero-order diffraction beam </PDAT><HIL><BOLD><PDAT>142</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>b </PDAT></ITALIC></HIL><PDAT>(E</PDAT><HIL><SB><PDAT>1,0</PDAT></SB></HIL><PDAT>) originated from the beam </PDAT><HIL><BOLD><PDAT>142</PDAT></BOLD></HIL><PDAT> is parallel to the &plus;1-order diffraction beam </PDAT><HIL><BOLD><PDAT>144</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>a </PDAT></ITALIC></HIL><PDAT>(E</PDAT><HIL><SB><PDAT>0,1</PDAT></SB></HIL><PDAT>) originated from the beam </PDAT><HIL><BOLD><PDAT>144</PDAT></BOLD></HIL><PDAT>. These two beams </PDAT><HIL><BOLD><PDAT>142</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>b </PDAT></ITALIC></HIL><PDAT>and </PDAT><HIL><BOLD><PDAT>144</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>a </PDAT></ITALIC></HIL><PDAT>are focused to a point </PDAT><HIL><BOLD><PDAT>174</PDAT></BOLD></HIL><PDAT> (D</PDAT><HIL><SB><PDAT>&plus;1</PDAT></SB></HIL><PDAT>) on the filter place </PDAT><HIL><BOLD><PDAT>170</PDAT></BOLD></HIL><PDAT> by the lens </PDAT><HIL><BOLD><PDAT>160</PDAT></BOLD></HIL><PDAT>. Similarly, the diffracted beams </PDAT><HIL><BOLD><PDAT>142</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>c </PDAT></ITALIC></HIL><PDAT>and </PDAT><HIL><BOLD><PDAT>144</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>b </PDAT></ITALIC></HIL><PDAT>overlap and interfere with each other to form a spot D</PDAT><HIL><SB><PDAT>0</PDAT></SB></HIL><PDAT>, and beams </PDAT><HIL><BOLD><PDAT>144</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>c </PDAT></ITALIC></HIL><PDAT>and </PDAT><HIL><BOLD><PDAT>146</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>b </PDAT></ITALIC></HIL><PDAT>overlap and interfere with each other to form a spot D</PDAT><HIL><SB><PDAT>&minus;1</PDAT></SB></HIL><PDAT>, respectively.</PDAT></PTEXT></PARA>
<PARA ID="P-00028" LVL="0"><PTEXT><PDAT>The interference pattern of any of these spots has the information of the gradient of the phase distortion in the wavefront of the reflected probe beam </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> and can be used to determine the curvature of the specimen surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>. The example in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT> shows the spot </PDAT><HIL><BOLD><PDAT>174</PDAT></BOLD></HIL><PDAT> (D</PDAT><HIL><SB><PDAT>&plus;1</PDAT></SB></HIL><PDAT>) is selected by the aperture </PDAT><HIL><BOLD><PDAT>172</PDAT></BOLD></HIL><PDAT> in the filter plane.</PDAT></PTEXT></PARA>
<PARA ID="P-00029" LVL="0"><PTEXT><PDAT>Assume that the wavefront of the reflected probe beam </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> is approximately planar and has a local phase variation S(x</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>, x</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>). The net effect of the diffraction by the gratings </PDAT><HIL><BOLD><PDAT>140</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>150</PDAT></BOLD></HIL><PDAT> is to produce a lateral shift, or &ldquo;shearing&rdquo;, of the incident wave front along the direction of the gratings, i.e., in the x</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-direction. For example, the wavefront of the diffracted beam </PDAT><HIL><BOLD><PDAT>142</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>b </PDAT></ITALIC></HIL><PDAT>(E</PDAT><HIL><SB><PDAT>1,0</PDAT></SB></HIL><PDAT>) is shifted by an amount, &ohgr;, along the x</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-direction as compared to the wave front of the diffracted beam </PDAT><HIL><BOLD><PDAT>144</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>a </PDAT></ITALIC></HIL><PDAT>(E</PDAT><HIL><SB><PDAT>0,1</PDAT></SB></HIL><PDAT>) so that the wavefronts of the beams </PDAT><HIL><BOLD><PDAT>142</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>b </PDAT></ITALIC></HIL><PDAT>and </PDAT><HIL><BOLD><PDAT>144</PDAT></BOLD></HIL><HIL><ITALIC><PDAT>a </PDAT></ITALIC></HIL><PDAT>are given by S(x</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>, X</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&plus;&ohgr;) and S(x</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>, x</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), respectively. The wave front shift is parallel to the principal axis of the gratings, i.e. along x</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>if the grating lines are oriented along x</PDAT><HIL><SB><PDAT>1 </PDAT></SB></HIL><PDAT>as shown in FIG. </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00030" LVL="0"><PTEXT><PDAT>The magnitude of the spatial shift &ohgr; is a function of the grating separation, &Dgr;, and the diffraction angle, &thgr;, which is identical in both gratings </PDAT><HIL><BOLD><PDAT>140</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>150</PDAT></BOLD></HIL><PDAT>:</PDAT></PTEXT></PARA>
<PARA ID="P-00031" LVL="0"><PTEXT><F><PTEXT><PDAT>&ohgr;&equals;&Dgr;tan &thgr;. </PDAT></PTEXT></F></PTEXT></PARA>
<PARA ID="P-00032" LVL="7"><PTEXT><PDAT>where the diffraction angle, &thgr;, is determined by the wavelength &lgr; of the reflected probe beam </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> and the grating period, p, according to the following relation: </PDAT>
<CWU>
<MATH-US ID="MATH-US-00001">
<MATHEMATICA ID="MATHEMATICA-00001" ALT="mathematica file" FILE="US06469788-20021022-M00001.NB"/>
<MATHML>
<math>
<mrow>
  <mi>&theta;</mi>
  <mo>=</mo>
  <mrow>
    <mi>arcsin</mi>
    <mo>&it;</mo>
    <mstyle>
      <mtext>&emsp;</mtext>
    </mstyle>
    <mo>&it;</mo>
    <mrow>
      <mfrac>
        <mi>&lambda;</mi>
        <mi>p</mi>
      </mfrac>
      <mo>.</mo>
    </mrow>
  </mrow>
</mrow>
</math>
</MATHML>
<EMI ID="EMI-M00001" ALT="embedded image" FILE="US06469788-20021022-M00001.TIF"/>
</MATH-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00033" LVL="7"><PTEXT><PDAT>For shallow surfaces with gradual curvature variation, i.e., the secondary derivative of the surface profile over surface position is much less than 1, the curvature tensor can be approximately written as, </PDAT>
<CWU>
<MATH-US ID="MATH-US-00002">
<MATHEMATICA ID="MATHEMATICA-00002" ALT="mathematica file" FILE="US06469788-20021022-M00002.NB"/>
<MATHML>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <msub>
            <mi>&kappa;</mi>
            <mi>&alpha;&beta;</mi>
          </msub>
          <mo>&af;</mo>
          <mrow>
            <mo>(</mo>
            <mrow>
              <msub>
                <mi>x</mi>
                <mn>1</mn>
              </msub>
              <mo>,</mo>
              <msub>
                <mi>x</mi>
                <mn>2</mn>
              </msub>
            </mrow>
            <mo>)</mo>
          </mrow>
        </mrow>
        <mo>&TildeTilde;</mo>
        <mstyle>
          <mtext>&emsp;</mtext>
        </mstyle>
        <mo>&it;</mo>
        <mfrac>
          <mrow>
            <msup>
              <mo>&PartialD;</mo>
              <mn>2</mn>
            </msup>
            <mo>&it;</mo>
            <mrow>
              <mi>f</mi>
              <mo>&af;</mo>
              <mrow>
                <mo>(</mo>
                <mrow>
                  <msub>
                    <mi>x</mi>
                    <mn>1</mn>
                  </msub>
                  <mo>,</mo>
                  <msub>
                    <mi>x</mi>
                    <mn>2</mn>
                  </msub>
                </mrow>
                <mo>)</mo>
              </mrow>
            </mrow>
          </mrow>
          <mrow>
            <mrow>
              <mo>&PartialD;</mo>
              <msub>
                <mi>x</mi>
                <mi>&alpha;</mi>
              </msub>
            </mrow>
            <mo>&it;</mo>
            <mrow>
              <mo>&PartialD;</mo>
              <msub>
                <mi>x</mi>
                <mi>&beta;</mi>
              </msub>
            </mrow>
          </mrow>
        </mfrac>
      </mrow>
    </mtd>
  </mtr>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mo>&TildeTilde;</mo>
          <mstyle>
            <mtext>&emsp;</mtext>
          </mstyle>
          <mo>&it;</mo>
          <mrow>
            <mfrac>
              <mi>p</mi>
              <mrow>
                <mn>2</mn>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>&Delta;</mi>
              </mrow>
            </mfrac>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mrow>
              <mo>(</mo>
              <mfrac>
                <mrow>
                  <mo>&PartialD;</mo>
                  <mrow>
                    <msup>
                      <mi>n</mi>
                      <mrow>
                        <mo>(</mo>
                        <mi>&alpha;</mi>
                        <mo>)</mo>
                      </mrow>
                    </msup>
                    <mo>&af;</mo>
                    <mrow>
                      <mo>(</mo>
                      <mrow>
                        <msub>
                          <mi>x</mi>
                          <mn>1</mn>
                        </msub>
                        <mo>,</mo>
                        <msub>
                          <mi>x</mi>
                          <mn>2</mn>
                        </msub>
                      </mrow>
                      <mo>)</mo>
                    </mrow>
                  </mrow>
                </mrow>
                <mrow>
                  <mo>&PartialD;</mo>
                  <msub>
                    <mi>x</mi>
                    <mi>&beta;</mi>
                  </msub>
                </mrow>
              </mfrac>
              <mo>)</mo>
            </mrow>
          </mrow>
        </mrow>
        <mo>,</mo>
        <mrow>
          <msup>
            <mi>n</mi>
            <mrow>
              <mo>(</mo>
              <mi>&alpha;</mi>
              <mo>)</mo>
            </mrow>
          </msup>
          <mo>=</mo>
          <mn>0</mn>
        </mrow>
        <mo>,</mo>
        <mrow>
          <mo>&PlusMinus;</mo>
          <mn>1</mn>
        </mrow>
        <mo>,</mo>
        <mrow>
          <mo>&PlusMinus;</mo>
          <mn>2</mn>
        </mrow>
        <mo>,</mo>
        <mi>&hellip;</mi>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
</MATHML>
<EMI ID="EMI-M00002" ALT="embedded image" FILE="US06469788-20021022-M00002.TIF"/>
</MATH-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00034" LVL="7"><PTEXT><PDAT>where, &agr;, &bgr; are 1 or 2. Hence the curvature tensor is directly related to the gradients of a CGS interferogram. For a given CGS system with certain parameters p and &Dgr;, the curvature at any location on a specimen surface can be determined by measuring the number of fringes per unit length in desired directions. Thus, a CGS interferogram provides a full field technique for determining the instantaneous value of the specimen curvature tensor at any point, (x</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>, x</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00035" LVL="0"><PTEXT><PDAT>Referring back to </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT>, the CGS ellipsometer </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT> further uses a processing circuit </PDAT><HIL><BOLD><PDAT>190</PDAT></BOLD></HIL><PDAT> to receive and process signals </PDAT><HIL><BOLD><PDAT>122</PDAT></BOLD></HIL><PDAT>A and </PDAT><HIL><BOLD><PDAT>180</PDAT></BOLD></HIL><PDAT>A from the detector arrays </PDAT><HIL><BOLD><PDAT>122</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>180</PDAT></BOLD></HIL><PDAT>, respectively. A microprocessor may be included in the circuit </PDAT><HIL><BOLD><PDAT>190</PDAT></BOLD></HIL><PDAT> for data processing.</PDAT></PTEXT></PARA>
<PARA ID="P-00036" LVL="0"><PTEXT><PDAT>In processing the CGS signal </PDAT><HIL><BOLD><PDAT>180</PDAT></BOLD></HIL><PDAT>A, the circuit </PDAT><HIL><BOLD><PDAT>190</PDAT></BOLD></HIL><PDAT> may be programmed to perform the following signal processing operations. First, the CGS image of a specimen is digitized. Then, a coordinate system is assigned to the CGS image such that each location on the surface of the specimen is registered in the coordinate system and the coordinates of the CGS image have a known relation with the actual specimen dimensions. Next, the distribution of the CGS infringes as a function of the coordinates in the assigned coordinate system is determined. For a shallow surface, a local Cartesian coordinate system (x</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>, x</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) can be used and fringe distribution functions n</PDAT><HIL><SP><PDAT>(</PDAT></SP></HIL><PDAT>1) (x</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>, x</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) and n</PDAT><HIL><SP><PDAT>(2) </PDAT></SP></HIL><PDAT>(x</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>, x</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) respectively corresponding to two mutually orthogonal directions e</PDAT><HIL><SB><PDAT>1 </PDAT></SB></HIL><PDAT>and e</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>can be determined. Subsequently, partial derivatives of the fringe distribution functions n</PDAT><HIL><SP><PDAT>(1) </PDAT></SP></HIL><PDAT>(x</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>, x</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) and n</PDAT><HIL><SP><PDAT>(2) </PDAT></SP></HIL><PDAT>(x</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>, x</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) with respect to x</PDAT><HIL><SB><PDAT>1 </PDAT></SB></HIL><PDAT>and x</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>are computed to obtain &part;n</PDAT><HIL><SP><PDAT>(1)</PDAT></SP></HIL><PDAT>/&part;x</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>, &part;n</PDAT><HIL><SP><PDAT>(1)</PDAT></SP></HIL><PDAT>/&part;x</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, &part;n</PDAT><HIL><SP><PDAT>(2)</PDAT></SP></HIL><PDAT>/&part;x</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>, and &part;n</PDAT><HIL><SP><PDAT>(2)</PDAT></SP></HIL><PDAT>/&part;x</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>. Finally, the curvature tensor elements &kgr;</PDAT><HIL><SB><PDAT>11</PDAT></SB></HIL><PDAT>, &kgr;</PDAT><HIL><SB><PDAT>12</PDAT></SB></HIL><PDAT>, &kgr;</PDAT><HIL><SB><PDAT>22 </PDAT></SB></HIL><PDAT>and &kgr;</PDAT><HIL><SB><PDAT>21 </PDAT></SB></HIL><PDAT>are calculated for each and every location in the specimen surface to produce the curvature map of the specimen surface ed for further analysis (e.g., stress analysis).</PDAT></PTEXT></PARA>
<PARA ID="P-00037" LVL="0"><PTEXT><PDAT>The CGS detector </PDAT><HIL><BOLD><PDAT>134</PDAT></BOLD></HIL><PDAT> shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> has two gratings </PDAT><HIL><BOLD><PDAT>140</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>150</PDAT></BOLD></HIL><PDAT> to perform the spatial shearing of different diffraction orders. The rulings of the two gratings are parallel so that the spatial shearing is perpendicular to the rulings. The spatial shearing may be performed in at least two different directions such as two orthogonal directions to obtain the curvature map of a surface. One way to achieve spatial shearing in two directions is to place the specimen </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> on a rotating stage in the system </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT>. A CGS interferogram for one shearing direction is first obtained. The specimen </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> is then rotated to another direction, e.g., an orthogonal direction, to obtain a second CGS interferogram for the second direction.</PDAT></PTEXT></PARA>
<PARA ID="P-00038" LVL="0"><PTEXT><PDAT>Another way uses two separate optical arms to simultaneously perform the spatial shearing in two directions. </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 3</PDAT></FGREF><PDAT> is a diagram showing one embodiment having two optical arms. A beam splitter </PDAT><HIL><BOLD><PDAT>310</PDAT></BOLD></HIL><PDAT> splits the reflected probe beam from the specimen </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> into two beams that are sent into two different optical arms. The two gratings in each optical arm may be parallel to each other but are perpendicular to the grating direction of another arm. This configuration can be configured to obtain CGS interferograms in two different shearing directions in essentially the same time so that time-varying effects on the curvature of the specimen surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> can be properly measured.</PDAT></PTEXT></PARA>
<PARA ID="P-00039" LVL="0"><PTEXT><PDAT>Upon completion of the curvature measurement, the processing circuit </PDAT><HIL><BOLD><PDAT>190</PDAT></BOLD></HIL><PDAT> can then process the ellipsometric data based on the curvature map of the surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> to correct errors associated with the surface curvature and thus compute the ellipsometric parameters for each and every location within the illuminated area on the surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>. This is because the ellipsometric parameters are sensitive to the angle of incidence so that the curvature must be known to accurately determine the optical properties. First, based on the known curvature for each location on the surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>, the directions of reflected beams from different locations on the surface can be determined. Secondly, since the location and orientation of the beam splitter </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT>, the polarizer, the optional lens </PDAT><HIL><BOLD><PDAT>121</PDAT></BOLD></HIL><PDAT>, and the array </PDAT><HIL><BOLD><PDAT>122</PDAT></BOLD></HIL><PDAT> are known, the locations of the reflected beams received on the array </PDAT><HIL><BOLD><PDAT>122</PDAT></BOLD></HIL><PDAT> can be uniquely associated to the locations on the surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>. Based on the above information, the circuit </PDAT><HIL><BOLD><PDAT>190</PDAT></BOLD></HIL><PDAT> can compute the ellipsometric parameters associated with different locations on the surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> based on the relative orientations, azimuth angles, of the elements </PDAT><HIL><BOLD><PDAT>104</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>, and </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT> for producing a minimum intensity in the beam </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT>A at these locations.</PDAT></PTEXT></PARA>
<PARA ID="P-00040" LVL="0"><PTEXT><PDAT>In operation, the CGS ellipsometer </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT> is calibrated. Initially, the beam is referenced to an optically flat mirror as the surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>. The polarization components are adjusted so that the image from the reference mirror is completely nulled at the detector array </PDAT><HIL><BOLD><PDAT>122</PDAT></BOLD></HIL><PDAT>. The CGS components in the detector </PDAT><HIL><BOLD><PDAT>134</PDAT></BOLD></HIL><PDAT> are adjusted to produce completely constructive interference or an image with no fringes. Subsequent film deposition, will for many common deposition material, change the polarization state of the reflected light, these changes will be evidenced by changes in the image intensity.</PDAT></PTEXT></PARA>
<PARA ID="P-00041" LVL="0"><PTEXT><PDAT>Notably, the CGS ellipsometer </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT> uses the same incident illumination beam </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>A to obtain information on both the curvature and the ellipsometric parameters at the same time. Hence, this single operation replaces what would otherwise two separate measurements, one on the surface curvature and another on the ellipsometric parameters. If two separate operations were used, errors could coocur from the mismatch between the exact locations of measurement and also possibly from temporal variations. This system can significantly reduce or eliminate the errors in spatially correlating the curvature map to the ellipsometric map since there is no change in the position of the sample surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> relative to the incident beam </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>A. When the sample surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> constantly changes, this system can also significantly reduce or eliminate the errors in temporarily correlating the curvature map to the ellpsometric map since, the information for the curvature and the information for the ellispometric measurements are obtained and updated from the reflected beam </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> at the same time. As the surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> changes, the measurements obtained in both the CGS detector </PDAT><HIL><BOLD><PDAT>134</PDAT></BOLD></HIL><PDAT> and the ellipsometric detector </PDAT><HIL><BOLD><PDAT>133</PDAT></BOLD></HIL><PDAT> also change and are updated. Hence, the present technique may be used for in-situ measurements in real time, such as in semiconductor fabrication, where the CGS measurements may be used to determine the surface curvature, the change in surface curvature, and the ellipsometric measurements may be used to measure the spatial distribution of the relative film thickness and film parameters such as refractive index and the optical absorption.</PDAT></PTEXT></PARA>
<PARA ID="P-00042" LVL="0"><PTEXT><PDAT>The CGS ellipsometer may be used to determine associated stress distribution on the surface due to deposition of films since both film thickness and curvature may be needed to determine the film stress. Other properties, such a change in stress caused by the changing film thickness, changes in material properties and their association with the stress, may also be monitored.</PDAT></PTEXT></PARA>
<PARA ID="P-00043" LVL="0"><PTEXT><PDAT>Further, when the CGS ellipsometer </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT> is calibrated, it may be used examine the degree of collimation of the incident beam </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>A by using a uniform and flat reflective reference surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>. A beam which is not well collimated will not have a uniform angle of incidence and will give errors in the ellipsometric parameter values or false curvature measurements of the surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>. Such errors can be used to determine the degree of the beam collimation.</PDAT></PTEXT></PARA>
<PARA ID="P-00044" LVL="0"><PTEXT><PDAT>The CGS ellipsometer </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT> in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> uses a null-ellipsometric arrangement. In a null ellipsometer arrangement, the relative azimuth angles of the polarizer </PDAT><HIL><BOLD><PDAT>104</PDAT></BOLD></HIL><PDAT>, compensator </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>, and the analyzer </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT> are adjust such that the light reaching the detector is at a minimum or zero in an ideal case. Also, the relative retardation of the compensator </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> may be adjusted as well to locate the position at which the intensity of light received by the detector array </PDAT><HIL><BOLD><PDAT>122</PDAT></BOLD></HIL><PDAT> is minimum. The compensator </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> may also be located in the optical path of the beam </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT>A between the analyzer </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT> and the beam splitter </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> or be replaced by a rotator modulated optical rotator.</PDAT></PTEXT></PARA>
<PARA ID="P-00045" LVL="0"><PTEXT><PDAT>The ellipsometric configuration in the system </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT> may also be configured in a photometric ellipsometric mode based on measuring variation in the detected light with changing one of ellipsometric parameters. The parameter may be statically or dynamically changing. A typical example is the rotating analyzer ellipsometer. In one embodiment, the analyzer </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT> in the above null ellipsometer is engaged to a rotating device to rotate at a given angular frequency. In another embodiment, the compensator </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT> may be replaced by a retardation element whose retardation can be varied with time, such as a photoelastic modulator.</PDAT></PTEXT></PARA>
<PARA ID="P-00046" LVL="0"><PTEXT><PDAT>It is further contemplated that, the ellipsometric detector module </PDAT><HIL><BOLD><PDAT>133</PDAT></BOLD></HIL><PDAT>, under certain circumstances, may be used to measure the sign of the surface curvature at each location within the illuminated area on the surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>. For example, if the thickness of a thin film formed on the surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> is known, the additional optical path traveled at different parts of a curved film can be used to infer the sign of the curvature, e.g., concave or convex. For another example in an in-situ operation where the film is evolving or being deposited on a substrate, the variation of measured optical path with time can also be used to infer the sign of curvature.</PDAT></PTEXT></PARA>
<PARA ID="P-00047" LVL="0"><PTEXT><PDAT>The above system </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT> in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> may be simplified so that the detector </PDAT><HIL><BOLD><PDAT>122</PDAT></BOLD></HIL><PDAT> measures the reflected beam </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT>A without the full ellipsometric measurements. For example, the polarization elements </PDAT><HIL><BOLD><PDAT>104</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>, and </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT> may be removed. The incident beam </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>A may be unpolarized. The detector array </PDAT><HIL><BOLD><PDAT>122</PDAT></BOLD></HIL><PDAT> is used to measure changes in absolute reflectance, typically done during film growth to monitor rate of deposition. In full field measurements, this system could provide useful relative deposition information or coverage can be performed at multiple angles.</PDAT></PTEXT></PARA>
<PARA ID="P-00048" LVL="0"><PTEXT><PDAT>In another simplified version of the system </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT>, the input beam </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT>A is polarized, typically P polarized along a direction parallel to the incidence plane at the surface </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>. The reflected light is directly received by the detector array </PDAT><HIL><BOLD><PDAT>122</PDAT></BOLD></HIL><PDAT> without the analyzer </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT> so that changes in the absolute intensity of the reflected polarized light are recorded. This scheme may be particularly useful when incident at the Brewster or pseudo Brewster angle for a given material. A polarized light source such as a laser may be used the light source </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT>. The polarizer </PDAT><HIL><BOLD><PDAT>104</PDAT></BOLD></HIL><PDAT> may be used to control the input polarization.</PDAT></PTEXT></PARA>
<PARA ID="P-00049" LVL="0"><PTEXT><PDAT>Although the present disclosure only includes a few embodiments, it is understood that various modifications and enhancements may be made without departing from the following claims.</PDAT></PTEXT></PARA>
</BTEXT>
</DETDESC>
</SDODE>
<SDOCL>
<H LVL="1"><STEXT><PDAT>What is claimed is: </PDAT></STEXT></H>
<CL>
<CLM ID="CLM-00001">
<PARA ID="P-00050" LVL="0"><PTEXT><PDAT>1. A system, comprising:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>a sample stage configured to hold a sample which has a specularly reflective surface; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>an input module configured and positioned to produce and direct a substantially collimated coherent input probe beam incident to the reflective surface at an incident angle, optical reflection at the reflective surface producing a reflected probe beam; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a beam splitter positioned in an optical path of said reflected probe beam to transmit a portion of said reflected probe beam as a first reflected probe beam and to reflect another portion of said probe beam as a second reflected probe beam; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a first detector module positioned to receive said first reflected probe beam and operable to measure curvature of the reflective surface; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a second detector module positioned to receive said second reflected probe beam and operable to measure properties of the sample. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00002">
<PARA ID="P-00051" LVL="0"><PTEXT><PDAT>2. The system as in </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said first detector module includes two optical gratings disposed process said first reflected probe beam and a first optical detector to receive an output from said two optical gratings.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00003">
<PARA ID="P-00052" LVL="0"><PTEXT><PDAT>3. The system as in </PDAT><CLREF ID="CLM-00002"><PDAT>claim 2</PDAT></CLREF><PDAT>, wherein said input module is configured so that said input probe beam is polarized, and wherein said second detector module includes a polarization analyzer to receive said second reflected probe beam and an optical sensing array with a plurality of optical sensing pixels to receive transmission of said polarization analyzer.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00004">
<PARA ID="P-00053" LVL="0"><PTEXT><PDAT>4. The system as in </PDAT><CLREF ID="CLM-00003"><PDAT>claim 3</PDAT></CLREF><PDAT>, further comprising a processing circuit coupled to receive output signals from said first and said second detector modules and operable to process information from said second detector module based on said measured curvature from said first detector module to extract information of the sample at each location that is associated with curvature at said each location.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00005">
<PARA ID="P-00054" LVL="0"><PTEXT><PDAT>5. The system as in </PDAT><CLREF ID="CLM-00003"><PDAT>claim 3</PDAT></CLREF><PDAT>, further comprising a rotating device engaged to said polarization analyzer to rotate said analyzer.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00006">
<PARA ID="P-00055" LVL="0"><PTEXT><PDAT>6. The system as in </PDAT><CLREF ID="CLM-00003"><PDAT>claim 3</PDAT></CLREF><PDAT>, wherein said input module includes an optical retardation element operable to produce a time-varying phase retardation on said input probe beam.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00007">
<PARA ID="P-00056" LVL="0"><PTEXT><PDAT>7. The system as in </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said input module and said second detector module are configured to form an ellipsometer to measure a change in a state of polarization of said input probe beam.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00008">
<PARA ID="P-00057" LVL="0"><PTEXT><PDAT>8. The system as in </PDAT><CLREF ID="CLM-00007"><PDAT>claim 7</PDAT></CLREF><PDAT>, wherein said ellipsometer is a null ellipsometer.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00009">
<PARA ID="P-00058" LVL="0"><PTEXT><PDAT>9. The system as in </PDAT><CLREF ID="CLM-00007"><PDAT>claim 7</PDAT></CLREF><PDAT>, wherein said ellipsometer is photometric ellipsometer.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00010">
<PARA ID="P-00059" LVL="0"><PTEXT><PDAT>10. The system as in </PDAT><CLREF ID="CLM-00007"><PDAT>claim 7</PDAT></CLREF><PDAT>, wherein said first detector module includes:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>first and second gratings spaced relative to each other in an optical path of said first reflected probe beam and configured to produce a predetermined phase manipulation on a wavefront of said first reflected probe beam; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a lens positioned to receive said first reflected probe beam from said first and second gratings and configured to select and combine two diffraction components from said second grating to produce an interference pattern, wherein said selected two diffraction components are produced by said second grating from diffracting two different diffraction components from said first grating and are substantially parallel to each other; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>an optical sensing device disposed relative to said lens to receive said interference pattern and produce an electrical signal indicative of said interference pattern. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00011">
<PARA ID="P-00060" LVL="0"><PTEXT><PDAT>11. The system as in </PDAT><CLREF ID="CLM-00010"><PDAT>claim 10</PDAT></CLREF><PDAT>, further comprising a signal processor connected to receive said electrical signal and configured to extract a spatial gradient information on the wavefront of said reflected probe beam caused by a curvature of the reflective surface, wherein said signal processor determines said curvature of the reflective surface according to said spatial gradient information and processes information from said second detector module based on said curvature to determine a property of the sample.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00012">
<PARA ID="P-00061" LVL="0"><PTEXT><PDAT>12. A system, comprising:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>a light source configured to produce and direct a substantially collimated coherent input probe beam; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a sample stage configured to hold a sample which has a specularly reflective surface and positioned in an optical path of said input probe beam, the reflective surface reflecting said input probe beam to produce a reflected probe beam; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a polarizer positioned to receive said input probe beam and control a polarization of said input probe beam incident to the reflective surface at an incident angle; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a beam splitter positioned in an optical path of said reflected probe beam to transmit a portion of said reflected probe beam as a first reflected probe beam and to reflect another portion of said probe beam as a second reflected probe beam; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a first detector module positioned to receive said first reflected probe beam and comprising two spaced optical gratings through each of which said first reflected probe beam is diffracted, and a first optical sensing array to receive a selected optical signal from diffracted signals from said two optical gratings, said first detector module operable to measure curvature of the reflective surface; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a second detector module positioned to receive said second reflected probe beam and comprising a polarization analyzer and an optical sensing array, said second detector operable to measure a change in polarization in said reflected probe beam caused by the sample; an optical phase compensator disposed in an optical path between said polarizer and said polarization analyzer in said second detector module to control polarization of said second reflected probe beam incident to said polarization analyzer; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a processing circuit coupled to said first and said second detector modules to determine a property of the sample based on said curvature and said change in polarization. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00013">
<PARA ID="P-00062" LVL="0"><PTEXT><PDAT>13. The system as in </PDAT><CLREF ID="CLM-00012"><PDAT>claim 12</PDAT></CLREF><PDAT>, wherein said optical phase compensator is configured to produce a time-varying retardation on said second reflected probe beam.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00014">
<PARA ID="P-00063" LVL="0"><PTEXT><PDAT>14. The system as in </PDAT><CLREF ID="CLM-00012"><PDAT>claim 12</PDAT></CLREF><PDAT>, wherein said polarization analyzer is configured to rotate.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00015">
<PARA ID="P-00064" LVL="0"><PTEXT><PDAT>15. The system as in </PDAT><CLREF ID="CLM-00012"><PDAT>claim 12</PDAT></CLREF><PDAT>, wherein said first and second gratings are spaced relative to each other in an optical path of said first reflected probe beam and configured to produce a predetermined phase manipulation on a wavefront of said first reflected probe beam, wherein said first detector module further includes:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>a lens positioned to receive said first reflected probe beam from said first and second gratings and configured to select and combine two diffraction components from said second grating to produce an interference pattern, wherein said selected two diffraction components are produced by said second grating from diffracting two different diffraction components from said first grating and are substantially parallel to each other, and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein said a first optical sensing array is disposed relative to said lens to receive said interference pattern and produce an electrical signal indicative of said interference pattern. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00016">
<PARA ID="P-00065" LVL="0"><PTEXT><PDAT>16. A method, comprising:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>illuminating a sample having a specularly reflective sample surface with a collimated coherent probe beam to produce a reflected probe beam that has information about said sample; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>splitting said reflected probe beam into a first portion and a second portion that have said same information; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>processing said first portion to obtain a curvature of said sample surface from said same information; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>processing said second portion to obtain another property of said sample from said same information. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00017">
<PARA ID="P-00066" LVL="0"><PTEXT><PDAT>17. The method as in </PDAT><CLREF ID="CLM-00016"><PDAT>claim 16</PDAT></CLREF><PDAT>, wherein a change in polarization of said reflected probe beam is measured in processing said second portion.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00018">
<PARA ID="P-00067" LVL="0"><PTEXT><PDAT>18. The method as in </PDAT><CLREF ID="CLM-00017"><PDAT>claim 17</PDAT></CLREF><PDAT>, wherein said another property of said sample includes a thickness of a film formed said sample surface.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00019">
<PARA ID="P-00068" LVL="0"><PTEXT><PDAT>19. The method as in </PDAT><CLREF ID="CLM-00017"><PDAT>claim 17</PDAT></CLREF><PDAT>, wherein said another property of said sample includes a refractive index.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00020">
<PARA ID="P-00069" LVL="0"><PTEXT><PDAT>20. The method as in </PDAT><CLREF ID="CLM-00017"><PDAT>claim 17</PDAT></CLREF><PDAT>, wherein said another property of said sample includes an optical absorption coefficient.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00021">
<PARA ID="P-00070" LVL="0"><PTEXT><PDAT>21. The method as in </PDAT><CLREF ID="CLM-00017"><PDAT>claim 17</PDAT></CLREF><PDAT>, wherein said another property of said sample includes a stress.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00022">
<PARA ID="P-00071" LVL="0"><PTEXT><PDAT>22. The method as in </PDAT><CLREF ID="CLM-00016"><PDAT>claim 16</PDAT></CLREF><PDAT>, wherein the processing of said second portion includes:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>diffracting said second portion by first and second gratings spaced relative to each other in an optical path of said first reflected probe beam to produce a predetermined phase manipulation on a wavefront of said first portion, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>combining two diffraction components from said second grating to produce an interference pattern, wherein said selected two diffraction components are produced by said second grating from diffracting two different diffraction components from said first grating and are substantially parallel to each other, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>processing said interference pattern to extract a spatial gradient information on the wavefront of said reflected probe beam caused by a curvature of the reflective surface, and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>determining said curvature of the reflective surface according to said spatial gradient information. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00023">
<PARA ID="P-00072" LVL="0"><PTEXT><PDAT>23. The method as in </PDAT><CLREF ID="CLM-00016"><PDAT>claim 16</PDAT></CLREF><PDAT>, wherein said sample surface is a flat mirror, and further comprising using an error in a measurement of said property to determine a degree of collimation of said probe beam.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00024">
<PARA ID="P-00073" LVL="0"><PTEXT><PDAT>24. A method, comprising:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>illuminating a sample having a specularly reflective sample surface with a collimated coherent probe beam to produce a reflected probe beam that has information about said sample; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>controlling polarization of said probe beam at a desired input polarization prior to incidence upon said sample surface; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>performing an ellipsometric measurement on a first portion of said reflected probe beam; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>measuring a second portion of said reflected probe beam to obtain a curvature of said sample surface from said information; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>processing said ellisometric measurement by using said curvature to determine a property of said sample. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00025">
<PARA ID="P-00074" LVL="0"><PTEXT><PDAT>25. The method as in </PDAT><CLREF ID="CLM-00024"><PDAT>claim 24</PDAT></CLREF><PDAT>, wherein said property includes a thickness of a film formed on said sample.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00026">
<PARA ID="P-00075" LVL="0"><PTEXT><PDAT>26. The method as in </PDAT><CLREF ID="CLM-00024"><PDAT>claim 24</PDAT></CLREF><PDAT>, wherein said property includes a stress on said sample.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00027">
<PARA ID="P-00076" LVL="0"><PTEXT><PDAT>27. The method as in </PDAT><CLREF ID="CLM-00024"><PDAT>claim 24</PDAT></CLREF><PDAT>, further comprising using said ellipsometric measurement to determine a degree of collimation of said probe beam.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00028">
<PARA ID="P-00077" LVL="0"><PTEXT><PDAT>28. The method as in </PDAT><CLREF ID="CLM-00024"><PDAT>claim 24</PDAT></CLREF><PDAT>, wherein said curvature is measured by diffracting said second portion of said reflected probe beam through two optical gratings and measuring an interference signal produced by combining two selected diffracted signals.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00029">
<PARA ID="P-00078" LVL="0"><PTEXT><PDAT>29. The method as in </PDAT><CLREF ID="CLM-00024"><PDAT>claim 24</PDAT></CLREF><PDAT>, further comprising measuring an optical property of said first portion of said reflected probe beam to infer whether a location on said sample surface is concave or convex.</PDAT></PTEXT></PARA>
</CLM>
</CL>
</SDOCL>
<SDODR ID="DRAWINGS">
<EMI ID="EMI-D00000" ALT="embedded image" FILE="US06469788-20021022-D00000.TIF"/>
<EMI ID="EMI-D00001" ALT="embedded image" FILE="US06469788-20021022-D00001.TIF"/>
<EMI ID="EMI-D00002" ALT="embedded image" FILE="US06469788-20021022-D00002.TIF"/>
<EMI ID="EMI-D00003" ALT="embedded image" FILE="US06469788-20021022-D00003.TIF"/>
</SDODR>
</PATDOC>

